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Kurzzusammenfassung (deutsch)
Anfängliche Synthesestudien zeigten, dass Dess-Martin-Oxidation eine geeignete Methode
für die Synthese der empfindlichen neuen Allyl-3,4,6-tri-O-benzyl-β-d-arabino-hexopyranosid-2-
ulose darstellt. In gleicher Weise konnten die entsprechenden bekannten 3,4,6-benzylgeschützten
β-Benzyl- und β-Methyl-2-keto-glucoside (2-Uloside) aus den entsprechenden 2-OH-ungeschütz-
ten Glucosiden erhalten werden. Ausgehend von dem entsprechenden Allyl-2-ulosid wurde
zunächst die Synthese von 1,2-anellierten Kohlenhydraten mit trans-Decalin-artiger Struktur
(polyhydroxylierte 2,10-Dioxadecaline) verfolgt. Das 2-keto-Substrat wurde durch Vinylierung
des Ketons, gefolgt von Ringschlussmetathese, syn-/anti-Dihydroxylierung und globaler
Entschützung in die 1,2-Pyran-anellierten Zielmoleküle überführt, die eine neue Klasse von
bicyclischen Kohlenhydraten mit β-manno-Konfiguration darstellen. Die Strukturaufklärung
der außerordentlich polaren anellierten Zucker erfolgte mittels NMR-Spektroskopie in D2O.
Ein weiterer Strukturbeweis konnte für die entsprechende syn-konfigurierte Zielverbindung
durch Röntgenstrukturanalyse gewonnen werden, welche Einblicke in ein dichtes Netzwerk
an Wasserstoffbrückenbindungen lieferte. Für strukturell verwandte 1,2-anellierte Zucker
konnte gezeigt werden, dass diese Kohlenhydratmimetika darstellen, und als Inhibitoren
von natürlichen Glycosidaseenzymen wirken können. Ausgehend vom entsprechenden β-
Benzyl-2-keto-glucosid lieferte die Umsetzung mit lithiierten Alkinspezies (Propargylalde-
hydacetale oder Propargylalkoholderivate) 2-C -alkinylverzweigte Mannoside. Durch par-
tielle Hydrierung der Alkinfunktion, gefolgt von syn-/anti-Dihydroxylierung, konnten 1,2,3-
trihydroxyprop-1-yl-verzweigte Mannoside mit variabler Konfiguration der Seitenkette erhalten
werden. Diese trihydroxypropyl-verzweigten Intermediate wurden durch selektive Oxidation
der primären Alkoholfunktion in 2-Spirofuranose-Pyranosen umgesetzt, welche eine bisher
unbekannte Klasse von Kohlenhydrat-Hybridmolekülen darstellen. Die selektive Oxidation
erfolgte unter Verwendung eines neuen Oxidationsprotokolls mit der bekannten Kombination
TEMPO/Trichlorisocyanursäure in einem optimierten Puffer-/Lösungsmittelsystem. Globale
Debenzylierung der Spirofuranose-Intermediate lieferte 4-C -formylverzweigte Octosen mit
variabler Konfiguration der C -2/3 Stereozentren in Form von komplexen Isomerengemis-
chen aus entsprechenden cyclischen Halbacetalformen. Detaillierte NMR-Studien in D2O
identifizierten die vorliegenden Hauptisomere als anellierte 1,5-Pyranose-9,7-pyranosen bzw.
spiro-1,4-Furanose-9,7-pyranosen, und damit als Bis(Halbacetal)-Isomere. Die entsprechenden
9,7-Pyranose-1,9-pyranoseformen (Acetal-Halbacetal-Isomere), strukturell verwandt mit dem
Naturstoff Bradyrhizose, konnten nicht als Hauptisomere der komplexen höheren Zucker
gefunden werden. In einem abschließenden Projekt wurden die drei benzylgeschützten 2-keto-
Glucoside (β-Allyl/Benzyl/Methyl-2-uloside) durch Eliminierung von Benzylalkohol unter
basischen Bedingungen in die 3,6-Di-O-benzyl-4-desoxy-β-d-glycero-hex-3-enopyranosid-2-
ulosen (3,2-Enolone) überführt. Diese 3,4-ungesättigten 2-keto-Glucoside gehen mit basischen
Reagenzien (Kalium-tert-butanolat) in DMF eine Umlagerung in racemische 2-Benzyloxy-
4-benzyloxymethyl-4-hydroxy-5-alkoxycyclopent-2-enone ein. Mechanistische Erklärungen
für diese neue Reaktion wurden ausgearbeitet, und diskutiert im Kontext von bekannten
Umlagerungen, welche zu den regioisomeren 5-hydroxy-substituierten Cyclopent-2-enonen
führen.
xv
Abstract
Initial synthetic studies identified Dess-Martin oxidation to be the method of choice for the
formation of the unknown, sensitive allyl 3,4,6-tri-O-benzyl-β-d-arabino-hexopyranoside-2-
ulose. In a similar manner, the respective known 3,4,6-O-benzylated β-benzyl and β-methyl
2-keto-glycosides (2-ulosides) could be obtained from the corresponding 2-OH-unprotected
glucosides. In a project directed towards the synthesis of 1,2-annulated carbohydrates with a
trans-decalin structure (polyhydroxylated 2,10-dioxadecalins), the respective allyl 2-uloside
underwent vinylation of the 2-ketone, followed by ring-closing metathesis. Stereoselective syn-
or anti-dihydroxylation and debenzylation afforded the wanted 1,2-pyran-annulated target
structures as a new class of bicyclic carbohydrate derivatives with the previously undescribed
β-manno-configuration. Structural characterizations of the highly polar annulated sugars
included NMR analysis in D2O. Furthermore, X-ray crystallography confirmed the structure
of the respective syn-isomer, and provided insight into a dense network of hydrogen-bonding
interactions. Structurally related published 1,2-annulated sugars have been reported to be
carbohydrate mimetics acting as inhibitors for natural glycosidase enzymes. Following a
related synthetic route, the corresponding benzyl 2-uloside was treated with alkynyllithium
species, either derived from propiolaldehyde acetals or from propargyl alcohol derivatives,
to afford the 2-C -alkynylated mannosides. A sequence comprising partial hydrogenation
of the alkyne, followed by syn- or anti-dihydroxylation, afforded 1,2,3-trihydroxyprop-1-yl-
branched mannosides with diverse stereochemical configurations of the hydroxylated side
chain. These trihydroxypropyl-branched intermediates were converted into 2-spirofuranose-
pyranoses, reducing carbohydrate hybrid molecules with previously undescribed structure,
via selective primary alcohol oxidation. For this transformation, a new oxidation protocol
utilizing the known combination TEMPO/trichloroisocyanuric acid in combination with an
optimized solvent/buffer system was developed. Global debenzylation of the spirofuranose
intermediates yielded 4-C -formyl octoses with diverse configurations of the C -2/3 stereogenic
centers as complex mixtures of cyclic hemiacetal isomers. Detailed structural NMR studies
in D2O identified the major isomers to be the annulated 1,5-pyranose-9-7-pyranose forms,
or the 1,4-furanose-9,7-pyranose spiro-forms, and thus, isomeric forms with two hemiacetal
functionalities. The corresponding 9,7-pyranose-1,9-pyranose isomeric forms (acetal-hemiacetal
forms), structurally related to the natural product bradyrhizose, were not identified to be major
constituents of these complex higher sugars. In a concluding project, all three benzylated 2-
keto-glucosides (β-allyl/benzyl/methyl 2-ulosides) were transformed into the corresponding 3,6-
di-O-benzyl-4-deoxy-β-d-glycero-hex-3-enopyranoside-2-uloses (3,2-enolones) by base-induced
elimination of benzyl alcohol. Reactivity studies revealed that these 3,4-unsaturated 2-keto-
glucosides undergo a rearrangement into racemic 2-benzyloxy-4-benzyloxymethyl-4-hydroxy-5-
alkoxycyclopent-2-enones in the presence of basic reagents (potassium tert-butoxide) in DMF.
Mechanistic considerations for this previously undescribed rearrangement were established,
and discussed in the context of related published transformations, which were reported to
give the regioisomeric 5-hydroxy-substituted cyclopent-2-enones.
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1. Introduction
d-Glucose A (Scheme 1.1), the most abundant monosaccharide on earth, is produced
in the photosynthesis of green plants, and is incorporated into structural polysaccharides
like cellulose B or chitin. In that regard, carbohydrates constitute the major fraction of
the biomass on earth.[1] Apart from these structural stability purposes, bioavailable
saccharides like d-glucose A, or polysaccharides like starch or glycogen, are crucial in
terms of energy supply. As either direct or indirect substrates for the glycolysis metabolic
pathway they play the key role in the carbohydrate catabolism, and the formation
of energy-rich ATP for the intracellular energy transfer in biological systems.[2] Two
numbers can be given to properly demonstrate the importance of carbohydrates in this
macroscopic context: cellulose B is produced in the photosynthesis in annual amounts
of ca. 1.5 · 1012 tons, and is therefore the most prevalent source of renewable organic
feedstock.[3] In a similar period of one year, the total industrial starch production from
crops like corn, rice or wheat is roughly 4.9 · 107 tons.[4]
On a rather microscopic picture, carbohydrates have gained attention in what is
now referred to as the field of glycobiology. Carbohydrates themselves are not directly
encoded for by the genome. However, carbohydrate-processing enzymes like glycosyl-
transferases and glycosidases are encoded, and a combination of these enzymes results in
individual glycosylation patterns of biomolecules in living organisms.[5] As a prominent
example, all cell surfaces are coated by a dense layer (the glycocalyx) of structurally
diverse glycans bound by proteins (glycoproteins) or lipids (glycolipids).[6] In this
individually different, heterogeneous functionalization of the cell surface, carbohydrates
operate as anchor points for biological processes of high importance, for example cell-
cell recognition and cell signaling, or host-pathogen interactions and the host immune
response in the case of infections.[5, 6] In such recognition events, proteins (lectins)
with carbohydrate recognition domains are reversibly mediating interactions with high
specificity for certain glycosylation patterns. The ensemble of biological processes relying
on such carbohydrate recognition events is still subject to scientific investigation and
far beyond the scope of this introduction.[7] The glycosylated moieties addressed by
lectins are diverse and dependent on the individual protein. Apart from conventional
sugar residues like d-galactose C or N -acetyl-d-glucosamine D, more sophisticated,
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Scheme 1.1 Top: abundant saccharides d-glucose A and cellulose B. Bottom: carbohy-
drates frequently found in lectin binding motifs: d-galactose C, N -acetyl-d-
glucosamine D, l-fucose E and α-sialic acid F.
macroscopically rare monosaccharides like l-fucose E or derivatives of α-sialic acid F
are found in the saccharidic ligands of biomolecules targeted by lectins.[6]
In terms of structurally peculiar carbohydrates, however, a certain environment is
unchallenged: incorporated into the outer membrane of Gram-negative bacteria, a
carbohydrate-rich component termed the lipopolysaccharides (LPS, Fig. 1.1), a dense
protective layer, is the residence of unique sugars found nowhere else in nature.[8, 9]
Bacterial LPS usually feature three distinct regions (Scheme 1.2). The lipid A region
consists of a glucosamine disaccharide (GlcN)2, functionalized with anionic phosphate
groups, which is anchored to the outer membrane of the bacterium by acylation with
fatty acid residues. The core region is attached to this glucosamine dimer via glycosidic
linkages. Here, higher sugars (heptoses and octoses) like 3-deoxy-α-d-manno-oct-2-
ulosonic acid (or keto-deoxyoctulosonate, Kdo) G and l-glycero-d-manno-heptose
(LDmanHep) H form an oligosaccharide.[10] Further glycosides are incorporated into
this core oligosaccharide, but their number and nature is highly dependent on the
individual bacterium and strain.[9] The core oligosaccharide is further functionalized
with an outer repetitive glycan (either branched or linear), which is referred to as the
O-polysaccharide (or O-antigen). This saccharide is structurally the most variable region
of the LPS, and a number of relevant biological interactions between the bacterium and
a potential host (e.g. evasion or triggering of immune responses) are dependent on this
saccharide region.[8] O-saccharides usually possess highly immunogenic properties and
are capable of provoking strong antibody responses. Although the chain length and
monosaccharide constituents of the repeating unit of O-polysaccharides vary widely,
3Figure 1.1 Membrane region of Gram-negative bacteria including the outer membrane
(OM) and the cytoplasmic membrane (CM). Top left: Lipopolysaccharide (LPS)
with lipid A, core region and O-antigen. OMPs = outer membrane proteins.
Figure gratefully reprinted with permission from Oxford University Press.[9]
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this region was found to contain rare sugars such as keto-sugars or branched sugars.[8]
In addition, structurally unique higher sugars have been extracted from bacterial O-
saccharide regions (Scheme 1.3). In this regard, the interesting structures of the
4-C -branched erwiniose I[11], the carbocyclic formylalkyl-branched caryose J[12], and
the galactoside-annulated inositol (carbasugar) bradyrhizose K[13] serve as appropriate
examples.
Naturally, due to the peculiar structures and high biological relevance frequently
associated with it, such higher sugars have been attractive targets for synthetic carbohy-
drate chemistry. For instance, in the first total synthesis of bradyrhizose K as published
in 2015 by Yu, Molinaro and Coworkers, 26 synthetic steps were required to transform
a simple glucal precursor into the challenging carbohydrate target K.[14] In this regard,
the chemical synthesis of complex higher sugars can be seen as a subdomain of the field
of natural product synthesis. Apart from this, simple carbohydrates are popular starting
materials for the synthesis of non-carbohydrate natural products, too. Focussing on such
carbohydrate-based total synthesis strategies, a landmark review article was published
by Nicolaou and Mitchell in 2001.[15] As a result of such extensive synthetic endeavors,
synthetically useful transformations of easily accessible carbohydrate precursors for
the generation of advanced molecular complexity are developed by the carbohydrate
chemistry community with great efforts, and can still be seen as a key research objective
in this area.
In this context, the present thesis reports on synthetic endeavors towards three
individual carbohydrate target structures T-3,4,5, each of them featuring structural
analogies to naturally occurring unusual saccharides, or contributing to the molecular
diversity accessible from simpler carbohydrate-derived building blocks (Scheme 1.4).
The developed synthetic approaches are covered in individual chapters of this thesis
(Chapters 3–5), and can be regarded as independent synthesis projects. In each
5chapter, a strong emphasis is put on the basic reactivities of the traversed carbohydrate
intermediates in order to extend the collection of reliable transformations of sugar
building blocks. Furthermore, detailed structural characterizations of the advanced
carbohydrate products are described with a focus on the highly complex carbohydrate
stereochemistry.
As a connection between these individual projects, retrosynthetic considerations
identified 2-keto-sugars T-2 as common carbohydrate precursors for the following
approaches towards the advanced carbohydrate derivatives. The synthesis of such
keto-sugar precursors T-2, partially known and partially novel, is covered in Chapter
2.
Chapter 3 reports on the synthesis of non-reducing (non-hemiacetal) 1,2-annulated
sugars T-3 with a hydroxylated trans-decalin type annulated framework. Due to the C -2
carbonyl functionality, the common precursors T-2 serve as suitable substrates for the
introduction of a C -2 side chain via classic carbonyl addition reactions. These products
can subsequently be transformed into the desired 1,2-annulated carbohydrate derivatives
T-3. Structurally related synthetic molecules have attracted interest as carbohydrate
mimetics, for example in relation with natural glycosidase enzymes. Therefore, structural
investigations into such annulated carbohydrates and new synthetic strategies towards
such structures are of interest.
In a related synthetic sequence described in Chapter 4, the corresponding reducing
(free hemiacetal) derivatives T-4 of such 1,2-annulated sugars were targeted. This class
of compounds (4-C -formyl branched octoses in the open-chain forms) features structural
analogies to the naturally occurring annulated hemiacetal bradyrhizose K (Scheme
1.3). With a focus on stereo- and chemoselective oxidation reactions of the introduced
side chain, detailed synthetic studies towards this type of molecules are described, and
can be seen as an addition to the chemistry of higher-carbon sugars. Furthermore, the
complex hemiacetal equilibria of the target compounds T-4 are analyzed, and compared
to the isomeric forms found for the natural bradyrhizose K.
Finally, in Chapter 5, new reactivity of the 2-keto-sugar precursors T-2 in a cascade
reaction, affording racemic 4-hydroxycyclopent-2-enones T-5, is presented. Mechanistic
experiments are reported and a plausible mechanism is given, and compared to related
transformations described in the literature.
Each of the individual chapters is preceded by an introduction to the target compounds
of interest, and relevant published work is summarized where appropriate.
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Scheme 1.4 Schematic representation of the synthetic projects covered in this thesis. R/R’
= protecting groups. For clarity, the reducing higher sugars T-4 of Chapter
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2. Synthesis of 2-Uloside Precursors
As key intermediates for the synthesis of higher sugars, and for the generation of
carbohydrate-derived molecular diversity as delineated in the following chapters, suitably
protected 2-keto-sugars of the general structure T-2 (Scheme 1.4 on page 6) were
required. After an introduction to the chemistry of this class of carbohydrate compounds,
synthetic studies towards known an unknown 2-keto-sugars are described in this chapter.
2.1. Introduction to the Chemistry of 2-Ulosides
The oxidation of a secondary hydroxyl group in an aldose results in a keto-sugar which
can be referred to as a ketoaldose or as an aldosulose[16], an important member within
the diverse class of carbohydrate oxidation products.[17] The corresponding glycosides
of such dicarbonyl sugars are termed aldosulosides, frequently referred to as ulosides
in a simplified manner. Formal oxidation of the C -2 in d-glucose A gives the 2-ulose
d-glucosone L (GlcOS, Scheme 2.1, a), which can be regarded as the prototype
example of an aldos-2-ulose carbohydrate. Together with other dicarbonyl saccharides,
L is formed in the Maillard reaction, the reaction of reducing carbohydrates with amino
compounds like proteins, during the processing of food as well as under physiological
conditions.[18, 19] In such processes, L is tentatively formed via oxidation of the Amadori
product (an 1-amino-1-deoxyketose). However, the exact formation of L is still not
fully understood, and a protein-free mechanism involving direct autocatalytic oxidation
of the 1,2-enediol derived from d-glucose is also discussed.[20] Due to the biological
importance of such sugar 1,2-dicarbonyls, the chemical synthesis of pure L, or derivatives
of it, has attracted early interests.[21, 22] Apart from this, other naturally occurring
substances are known to incorporate a 2-uloside (2-keto-sugar) moiety. For example,
highly bioactive steroidal glycosides belonging to the cardenolide glycosides (a subgroup
of the cardiac glycosides) were found to contain an annulated 2-uloside fragment. The
affinosides, isolated from seeds of the plant Anodendron affine, belong to this family,
and the structure M of affinoside A (Scheme 2.1, b) shows a 4,6-dideoxy-2-uloside
moiety annulated to the steroidal backbone via a fused 1,4-dioxane.[23] The general
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Scheme 2.1 (a) Structure of d-glucosone L. (b) Structure M of the cardenolide glycoside
affinoside A.[23] (c) Enzymatic transformations of d-glucose A to d-glucosone
L. BQ = benzoquinone. HQ = hydroquinone.[24–29]
question how keto-sugars might be formed biosynthetically has been addressed. For
example, certain enzymes, mostly from fungi resident on wood decay, have been found
to catalyze the oxidation of aldoses to aldos-2-uloses (Scheme 2.1, c). In most cases,
these types of enzymes are rather unspecific, and several saccharides can be substrates
for one individual enzyme. Pyranose 2-oxidase (POx, EC 1.1.3.10) is an intracellular,
tetrameric flavoenzyme capable of oxidizing d-glucose A to d-glucosone L using oxygen
as an electron acceptor. Notably, this enzyme class is able to transform other saccharide
substrates with similar configurations and pyranose conformations (d-xylose, l-sorbose
or d-glucono-1,5-lactone) to the oxidized products. Hydrogen peroxide is formed as the
byproduct, and can potentially be used as a substrate for peroxidases involved in the
degradation of lignocellulose (ligninolysis).[24–26] In contrast, pyranose 2-dehydrogenase
(PDH, EC 1.1.99.29) is an extracellular, monomeric flavoenzyme. Since this enzyme
class is not able to use molecular oxygen, other electron acceptors like the system
benzoquinone/hydroquinone (BQ/HQ) must be employed. A wide range of substrates
including reducing and non-reducing monosaccharides and oligosaccharides of different
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Scheme 2.2 (a) Cyclic forms of d-glucosone L in D2O at 27 ◦C.[30] (b) Major degradation
pathway of d-glucosone L in aqueous phosphate buffer.[20]
anomeric configurations can be transformed. Although d-glucose A is intermediately
converted to d-glucosone L by the PDH enzyme, the corresponding 3-keto derivative is
also formed, and upon prolonged reaction time oxidation to the 2,3-diketo product is
observed.[27–29]
Aldos-2-uloses, although structurally simple molecules, exhibit an interesting chem-
istry that can pose challenges towards synthesis, isolation and purification. As compared
to conventional sugars, the second carbonyl group can participate in additional hemi-
acetal ring closures. Furthermore, 1,2-dicarbonyl systems of carbohydrates are prone
to the formation of hydrates, and these factors result in often complex mixtures of
unprotected 2-uloses in solution. Köpper and Freimund analyzed the cyclic forms of
d-glucosone L in aqueous solution by NMR spectroscopy (Scheme 2.2, a).[30] Accord-
ingly, the equilibrium was found to contain the hydrated forms of the α-1,5-pyranose
(36%) and the β-1,5-pyranose (31%), along with the hydrates of the β-2,6-pyranose
(21%) and the β-2,5-furanose (12%). Since L, as part of the glucose degradation pro-
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cess, is degraded under physiological conditions or ex vivo in near-neutral solution,
Zhang and Serianni utilized NMR spectroscopy, in combination with isotope label-
ing of L, to track the initial steps of its degradation in phosphate-buffered solution
(Scheme 2.2, b).[20] The major degradation pathway, determining the fate of 90%
of L, was found to proceed via formation of the 2,3-enediol, tautomerization to the
1,3-dicarbonyl, and hydroxide-induced cleavage of the 1,3-dicarbonyl, giving d-ribulose
and formate as the byproduct. These studies further revealed that 10% of L undergo a
phosphate-catalyzed skeletal rearrangement, albeit, the formed product is d-ribulose,
too. Noteworthy, in other studies, base-induced rearrangements of the corresponding
methyl glycosides of L into the 3-keto derivatives have been observed, and Liu and
Tsuda disclosed the rearrangements of 2-ulosides to the 3-ulosides to progress via a
hydride shift mechanism.[31]
In this regard, the chemistry of d-glucosone L as introduced here serves as a rep-
resentative example for the general chemistry of 2-ulosides, which is characterized
by reactions like carbonyl hydration, tautomerization/enediol formation, and elimina-
tion/dehydration. Several of these reactions can also be observed for protected 2-uloside
carbohydrates, a topic which will briefly be discussed in Section 2.1.1.
2.1.1. Synthesis of Protected 2-Ulosides
The synthesis of protected 2-ulosides, for example as building blocks in carbohydrate
chemistry, can be achieved by subjecting suitable carbohydrate precursors to oxidation,
furnishing the 2-keto functionality. Obviously, a possible strategy would involve oxidation
of the free secondary C -2-OH group to the corresponding ketone, and this frequently
applied method has been summarized in an early review.[32] In this context, initial work
was done by Theander and Coworkers, who treated partially unprotected glycosides with
chromium trioxide to obtain mixtures of isomeric ulosides.[33, 34] Later, many common
alcohol oxidation methods proved to be reliable (Scheme 2.3). For example, Hughes
utilized the combination DMSO/acetic anhydride for the oxidation of 1,6-anhydro-
galactopyranose N to the 2-uloside O, which was found to be prone to hydration,
forming the hydrate P while standing open overnight.[35] Other DMSO-based methods
have been applied, too. For instance, Nakamura and Shiozaki used the classic Swern
oxidation protocol for the synthesis of the allyl α-2-uloside R, which was needed
as a synthetic intermediate in the total synthesis of the antifungal natural product
sphingofungin E.[36] Recently, Priebe and Coworkers treated benzylidene acetal S with
Dess-Martin periodinane (DMP) to obtain 2-uloside T, which was next subjected to
the gluco-selective reduction with NaBD4 to give access to 2-deuterated glucosides.[37]
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Apart from O-2-unprotected glycosides, 2-oxyglycal derivatives have been found to
be suitable substrates for the oxidative formation of 2-ulosides (Scheme 2.4), and the
majority of the work in this area, as well as the chemistry of related compounds, was
done by Lichtenthaler and Coworkers. Accordingly, 2-benzoyloxyglucal U was found
to undergo syn-addition of bromine to the vicinal dibromides V and W, which could
be hydrolyzed with transposition of the benzoyloxy group in the presence of silver
carbonate to the 2-ulosides X and Y.[38] Furthermore, when similar 2-acyloxyglycals
like Z are treated with hydroxylamine hydrochloride (Scheme 2.5), upon cleavage
of the intermediary oxime with acetaldehyde in acidic solution, 1,5-anhydrouloses like
AA (the 1-deoxy derivatives) can be obtained.[39, 40] The proanomeric center in AA
was found to be susceptible to radical reactions, and photobromination gave anomeric
α-ulosyl bromides like AB.[41] As an alternative to the radical photobromination,
electrophilic bromination with NBS[42], in combination with a low molecular alcohol
as a sacrificial nucleophile, can furnish the same ulosyl bromide products, and this
method was also applicable for the transformation of the corresponding benzyl protected
derivative AC to ulosyl bromide AD.[43] Subsequently, the glycosylation chemistry of
both benzoylated AB and benzylated AD was explored by the Lichtenthaler group in
detail. Standard Koenigs-Knorr[45] conditions (alcohol, silver carbonate in CH2Cl2) were
identified to be applicable to these ulosyl bromide donors (Scheme 2.5, bottom). The
electron-withdrawing 2-oxo-substituent is believed to facilitate SN2-type displacement
12 2. Synthesis of 2-Uloside Precursors
Br2, CCl4,
U
0 to 20 °C, 20 min
Lichtenthaler 1977:
O
BzO
OBz
BzO
BzO OBzO
BzO
OBz
BzO
Br
Br
V
+
OBzO
BzO
OBz
Br Br
OBz
W(> 90%,    2:1)
Ag2CO3, 
Me2CO/H2O, 20 °C
OBzO
BzO
OBz
O
OBz
OBzO
BzO
OBz
OOBz
X (65%) Y (36%)
~
~
Scheme 2.4 Bromination of oxyglucal U, and hydrolysis of the addition products to the
2-ulosides X and Y.[38]
Z
Lichtenthaler 1980 and 1983:
O
BzO
OBz
AcO
BzO OBzO
BzO
OBz
O
1. H2NOH  HCl
2. H3CCHO,      
    HCl, MeCN
AA
Br2, hν, 
BaCO3, CCl4,
reflux, 1.5 h
OBzO
BzO
OBz
OBr
AB (78%)
AC
Lichtenthaler 1994:
O
BnO
OBn
AcO
BnO OBnO
BnO
OBn
O
NBS, EtOH,
MS 3 Å, CH2Cl2,
AD (92%, crude)
0 °C, 2 min
Br
ORO
RO
OR
OBr
AB: R = Bz
Lichtenthaler 1983-1994:
AD: R = Bn
i-PrOH, Ag2CO3, 
MS 3 Å, CH2Cl2,
20 °C,
for AB: 2 h
for AD: 30 s
ORO
RO
OR
O
OiPr
AE: R = Bz (90%)
AF: R = Bn (91%)
NaBH4, MeOH, 
CH2Cl2, 20 °C
for AE: 20 min 
for AF: 120 min
ORO
RO
OR
OH
OiPr
AG: R = Bz
AH: R = Bn
H
manno/gluco = 3:1
manno/gluco = 50:1
Scheme 2.5 Reactions involving the formation of ulosyl bromides AB[41] and AD[42,
43], β-selective glycosylations giving AE/AF, and manno-selective hydride
reduction to AG/AH.[44]
2.1. Introduction to the Chemistry of 2-Ulosides 13
of the bromide under heterogeneous conditions, resulting in a high β-selectivity of
the glycosylation reaction when condensing AB/AD with alcohols in the presence of
insoluble silver carbonate. Such glycosylations have evolved to be established methods
for the preparation of 2-ulosides of type AE/AF. Furthermore, the hydride reductions
of β-2-ulosides, e.g. with NaBH4, proceed with high equatorial selectivity and give
the corresponding mannoside products AG/AH. Since the preparation of 1,2-cis-
glycosides like β-mannosides is usually challenging[46, 47], this combination of β-selective
ulosyl bromide glycosylation, followed by manno-selective hydride reduction, has found
application in the synthesis of β-mannosides.[44]
Apart from enabling the described stereoselective halogenation and glycosylation
reactions at the anomeric position, the 2-keto functionality of 2-ulosides results in
an activation of position 3. As a consequence, deprotonation of the H -3, followed by
elimination reactions, are side reactions frequently encountered in transformations
of 2-ulosides. This type of chemistry, including subsequent degradation reactions of
the primary elimination products, can be regarded as a transition from carbohydrate
chemistry to the chemistry of unsaturated heterocycles. Since the results covered in
Chapter 5 of this thesis are related to this field, some basic reactions of 2-ulosides
towards unsaturated downstream products will be introduced in Section 2.1.2.
2.1.2. From 2-Ulosides to Unsaturated Heterocycles
In early experiments involving the oxidative formation of 2-ulosides from the corre-
sponding 2-O-unprotected glycosides, Lichtenthaler and Heidel observed that glucoside
AI (Scheme 2.6), upon oxidation with DMSO/acetic anhydride to the intermediate
2-uloside AJ, undergoes direct elimination of acetic acid to form an unsaturated product
of lower molecular weight, which was identified to be the 3-enol-2-ketone (or, simplified:
3,2-enolone[48]) AK.[49] Putatively, this transformation would involve deprotonation of
the H -3 to form an enol speciesAJ-a, which could undergo 1,4-elimination of acetic acid.
Subsequently, such elimination reactions were found to be common for transformations
involving 2-ulosides, either as substrates or as products, under a variety of conditions.
For example, Rayner and Coworkers synthesized the acetylated 2-uloside AM via
oxidation of AL with RuO4. Thermal treatment (175 ◦C) upon gas chromatography of
AM gave a second component in the collected product, which could be characterized as
the 3,2-enolone AN.[50] In a comparable manner with in situ generated RuO4, Lundt
and Pedersen prepared benzoylated 2-uloside AP. Upon subjecting AP to weakly basic
conditions at elevated temperatures (NaHCO3 in wet benzene at 80 ◦C), 3,2-enolone
AQ could be isolated as the major product.[51] The nature of the 4-O-protecting group
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Scheme 2.6 Synthetic sequences involving the elimination of 2-uloside intermediates to the
corresponding 3,2-enolones AK[49], AN[50] and AQ[51].
can be expected to have an influence on the enolone formation from 2-ulosides, and
indeed, the majority of examples described in the literature feature ester-protected
2-ulosides with the corresponding carboxylate as a suitable leaving group. Examples
involving other protecting groups like 4,6-O-benzylidene acetals[52] or benzyl ethers[53]
do exist, however, in these cases stronger basic reagents in polar solvents (e.g. Wittig
reagents in DMSO, or K2CO3 in MeOH) are required for the elimination step.
An interesting cascade of advanced degradation reactions of 3,2-enolone intermediates
was initially observed by Lichtenthaler and Heidel[49], and later expanded onto variably
protected 3,2-enolones.[51, 54] Accordingly, when 3,2-enolone intermediates like AK
are subjected to harsh acidic conditions, for example neat trifluoroacetic acid (Scheme
2.7, top), a second equivalent of carboxylic acid is lost, and achiral acylated derivatives
of kojic acid like acetylkojic acid AR (a γ-pyrone system) are formed.[49] In a similar
transformation, but under basic conditions, dibenzoylkojic acid AS can be obtained
upon heating of benzoylated 3,2-enolone AQ in pyridine at 60 ◦C.[51] Because of the
interesting biological activities of kojic acid itself, which can be used as a whitening
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agent due to its tyrosinase inhibiting properties[55], such transformations of 3,2-enolones
to kojic acid derivatives have been explored in detail. Lichtenthaler and Coworkers
proposed a mechanism involving the initial formation of a vinylogous enol/enolate
via H -5 deprotonation (Scheme 2.7, bottom).[54] Subsequent acyl group migration
and expulsion of the anomeric substituent could give the kojic acid derivative AS.
Notably, the nature of the anomeric substituent can have an influence: whereas 1-O-
acylated (R = acyl) enolones with a suitable leaving group at position 1 undergo a fast
reaction to the respective kojic acid derivatives, the corresponding methyl derivatives
(R = Me) are rather insensitive towards acids, tentatively because expulsion of the
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anomeric substituent is disfavored.[54] Remarkably, the exact progression of this type
of degradation reactions seems to be dependent on the individual conditions, and some
1-O-alkyl 3,2-enolones like AT, in combination with pyridine as the base, undergo
5,6-elimination to the exo-methylene intermediate rather than vinylogous enolization
(Scheme 2.8).[54, 56] In this case, after hydrolysis, other γ-pyrone products like
methoxy-allomaltol AU can be obtained, together with multiple other, unidentified
products. Interestingly, when piperidine is used as the base, the pathway towards
dibenzoylkojic acid AS is favored again, demonstrating that this kind of degradation
and rearrangement chemistry of unsaturated sugars is diverse.
In this context, it should be noted that in very early work in 1936, K. Maurer examined
reactions of acylated 2-ulosides (acetylated and benzoylated derivatives of glucosone L).
Upon treatment of these 2-keto-sugars with NaOAc/Ac2O or pyridine/Ac2O, Maurer
made the early observation that kojic acid derivatives are formed.[21, 57] However, the
mechanistic picture of these reaction cascades (e.g. the formation of 3,2-enolones as the
initial elimination products) was not yet fully understood, and required the deliberate
synthesis of 3,2-enolones from available sugar intermediates as achieved by Lichtenthaler
and others.
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Scheme 2.9 Schematic representation of the synthetic routes described in this chapter
towards target 2-ulosides T-2.
The synthesis of β-2-uloside precursors of type T-2 with diverse anomeric substituents
R’, the synthetic key precursors towards the target compounds T-3,4,5, is covered in
this chapter (Scheme 2.9). First, early efforts for the synthesis of allyl β-2-ulosides
1a and 2a from Lichtenthaler’s ulosyl bromides AB and AD (route i) are discussed.
Subsequently, the formation of allyl uloside 2a, benzyl uloside 2b and methyl uloside 2c
via oxidation of the C -2-OH (route ii) is described. The majority of compounds traversed
in route ii are known. However, since most reactions were carried out with variations
from the published procedures, these syntheses are included in the Experimental Part
(Chapter 6) to ensure reproducibility of the experiments.
2.3. Results and Discussion
In initial synthetic studies, Lichtenthaler’s ulosyl bromide donorsAB andAD, accessible
from d-glucose in 4–5 steps, were anticipated to be suitable starting materials for
the synthesis of the unknown allyl β-2-ulosides 1a and 2a (Scheme 2.10). For that
purpose, benzoylated ulosyl bromideAB was condensed with allyl alcohol under Koenigs-
Knorr[45] conditions (Ag2CO3 and molecular sieves in CH2Cl2) according to the reported
protocol.[42] After 3 h, TLC confirmed the formation of a single product, however,
upon workup and chromatographic purification (SiO2), only traces of the wanted allyl
uloside 1a, together with 3,2-enolone 3a as the major product (31%), could be isolated.
Accordingly, acylated 2-ulosides have frequently been observed to undergo elimination to
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Scheme 2.10 Initial Koenigs-Knorr glycosylations of ulosyl bromides AB and AD in
the formation of allyl 2-ulosides 1a and 2a, and the derived decomposition
products 3a,b and 4.
the 3,2-enolone products (comp. Section 2.1.2) under a variety of conditions, including
silica-induced elimination upon chromatography.[58] Consequently, benzyl-protected
allyl 2-uloside 2a was anticipated to be more resistant towards elimination/3,2-enolone
formation, and therefore benzylated ulosyl donor AD was reacted with allyl alcohol
under standard conditions.[43] After a short reaction time of 5min TLC indicated the
formation of a complex mixture. After workup and chromatography (SiO2) of the crude
oil, 2a was obtained in a severely impure manner in decent yields (<63%), albeit,
repeated chromatography resulted in significant loss of material, and only < 10% of 2a
could be isolated in pure form. Notably, upon chromatography of 2a, the corresponding
3,2-enolone 3b was not found. Surprisingly, from the great number of endeavors to
isolate pure 2a in a satisfactory yield, benzylated d-arabino-1,4-lactone 4 was isolated in
low yield (10%) upon chromatographic purification, and spectral properties were in full
accordance with published data.[59, 60] Albeit, all attempts to reproduce the formation
of 4 from 2a, tentatively proceeding via expulsion of the anomeric carbon, remained
unsuccessful, and therefore effects of contamination of reagents, solvents or glassware,
respectively, must be taken into account. Nevertheless, low yields in the isolation of 2a
without isolation of the 3,2-enolone 3b, together with the enigmatic and unreproducible
formation of 4, indicated that Lichtenthaler’s ulosyl bromides AB/AD in combination
with Koenigs-Knorr conditions were unsuitable for sensitive allyl ulosides of type 1a or
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Scheme 2.11 Synthesis of allyl glucoside 7 and methyl glucoside 8 via methyl orthoesters 5
and 6 employing protocols published by Draghetti et al.[61] and Nepogodiev
et al.[62].
2a. Therefore, access to 2a by oxidation of the C -2-OH of a corresponding protected
allyl glucoside substrate was explored as an alternative (route ii).
A well-known strategy for the synthesis of O-2-unprotected β-glucosides, the required
substrates for the oxidative formation of 2-ulosides of type 2, utilizes carbohydrate
1,2-orthoesters as intermediates. This class of compounds was explored in detail for
their applicability in carbohydrate chemistry by Kochetkov and Coworkers.[63] Such
carbohydrate 1,2-orthoesters are amenable to Lewis acid-promoted 1,2-trans-selective
glycosylation, followed by selective deacetylation of the C -2-OAc to furnish the O-2-
unprotected glucosides.[64] In line with this, Draghetti et al. described the synthesis
of 3,4,6-tri-O-benzylated allyl β-d-glucoside 7 via the formation of the intermediate
methyl orthoester.[61] Based on these published results, a similar synthetic route with
minor variations was utilized in the present work (Scheme 2.11). The synthesis
started with the carbohydrate precursor tetra-O-acetylglucopyranosyl bromide AV,
which was subjected to Lemieux’s tetra-n-butylammonium bromide-promoted in situ
anomerization[65] in the presence of methanol and 2,4,6-collidine as a base to afford
acetylated methyl orthoester 5 as an exo/endo-mixture. A protocol using nitromethane
as the solvent, instead of neat collidine as proposed by Draghetti, was published by
Nepogodiev et al. for the corresponding benzyl orthoester 9, and was found to facilitate
the workup procedure since smaller amounts of high-boiling collidine had to be re-
moved.[62] Subsequently, heating of 5 in benzyl chloride in the presence of NaOH gave
benzylated 6 in a one-pot deacetylation/benzylation reaction, which was also utilized
by Nepogodiev et al.[62] Although orthoester 6 was putatively received as an isomeric
exo/endo mixture similar to 5, determination of the isomeric ratio by NMR integration
was not feasible. Reaction of 6 in anhydrous allyl alcohol as the solvent in the presence
20 2. Synthesis of 2-Uloside Precursors
OAcO
AcO
OAc
AcOBr
AV
ORO
RO
OR
O
O
OBn
O
OH
BnO
BnO
OBn
OBn
9: R = Ac (83%)
10: R = Bn (83%)
n-Bu4NBr, BnOH, 
2,4,6-collidine,
MeNO2, r.t., 24 h
exo/endo = 25:1BnCl, NaOH, 
135 °C, 5 h
11 (85%, 2 steps)
1. BnOH, HgBr2,
MeNO2, 93 °C, 6 h
2. NaOMe, 
    MeOH/CH2Cl2 (1:1),
    r.t., 7 d
exo/endo = 25:1
Scheme 2.12 Synthesis of benzyl glucoside 11 via benzyl orthoesters 9 and 10 employing
a protocol published by Nepogodiev et al.[62]
of catalytic amounts of TMSOTf initiated the Lewis acid-mediated orthoester cleavage
and gave a mixture of the O-2-acetylated allyl glucoside, together with deacetylated 7 as
reported by Draghetti et al.[61] The crude mixture was finally deacetylated under Zem-
plén’s[66] conditions to provide allyl β-glucoside 7 as a substrate for oxidative formation
of the corresponding 2-uloside 2a. In a completely analogous manner from orthoester 6,
methyl glucoside 8 could be obtained (Scheme 2.11), which was previously synthesized
by Mayato et al.[67] The corresponding benzyl glucoside 11 was prepared by the route
described by Nepogodiev et al.[62] After analogous formation of acetylated benzyl
orthoester 9 (Scheme 2.12) and deacetylation/benzylation, benzylated orthoester 10
was available. HgBr2-mediated orthoester cleavage in nitromethane, a method from early
orthoester chemistry[63], was found to be superior as compared to other methods, and
gave the 2-O-acetylated glucoside conveniently on a 30 g scale. Zemplén deacetylation of
the crude material, in a mixture of methanol and dichloromethane due to low solubility
in methanol, gave benzyl glucoside 11.[62]
With the O-2-unprotected substrates in hand, glucosides 7, 8 and 11 were subjected
to oxidation reactions for the synthesis of 2-ulosides of type 2. Dess-Martin oxidation[68]
as a mild method was used before for the synthesis of sensitive 2-ulosides.[37] Thus, both
benzyl glucoside 11 and methyl glucoside 8 were reacted with Dess-Martin periodinane
(Scheme 2.13), and gave the corresponding 2-ulosides 2b and 2c in excellent yields
after chromatography (96% each). Although both 2b[37] and 2c[69] were prepared
before via other synthetic routes, the here described syntheses were evaluated to be
beneficial due to the clean and highly convenient Dess-Martin oxidation. Surprisingly,
2a was found to be more susceptible towards the unwanted acid-mediated formation of
3,2-enolone 3b under the conditions of the Dess-Martin oxidation. Hence, NaHCO3 was
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Scheme 2.13 Dess-Martin oxidations towards 2-ulosides 2a,b,c, and decomposition of 2a
upon chromatography, giving 3,2-enolone 3b.
added to the Dess-Martin oxidation as a buffer in the transformation of 7. Conventional
silica gel chromatography, as applied to crude 2b/2c, resulted in severe loss of material
in the case of 2a, and the elimination product 3b could be isolated in significant
amounts (15%). Chromatography on neutral Al2O3 provided 3b as the major product
(70%). Noteworthy, the wanted allyl uloside 2a was previously synthesized by Bundle
and Coworkers, albeit, the compound was not characterized, and transformed into
the corresponding mannoside via hydride reduction without further purification.[70]
While acylated 2-ulosides are frequently reported to undergo elimination and 3,2-
enolone formation upon workup or purification, similar observations for benzylated
2-ulosides seem to be rather scarce. In contrast, problems concerning the purification
of other benzylated 2-ulosides were attributed to the formation of ketone hydrates
by Danishefsky.[46] Particularly, structurally related allyl 2-ulosides like C -glycosidic
BU[71] (Scheme 3.6 on page 35) or benzylidene acetal R[36] (Scheme 2.3 on page 11)
could be isolated in pure form. Therefore, the here described property of 2a to undergo
elimination upon purification can be regarded as uncommon, but somewhat in agreement
with the aforementioned problems in the synthesis of 2a via glycosylation chemistry
from AD. All other attempts for the purification of 2a, either by recrystallization or by
solvent extractions of the crude material, remained unsuccessful, and therefore crude
2a as obtained from the buffered Dess-Martin oxidation was subjected to the following
transformations without further purification.
Both the known benzyl glucoside 11 as well as the known derived 2-uloside 2b were
isolated in the form of highly crystalline material. Since crystal structures of sensitive
keto-sugars are rare, X-ray crystallography was applied to single crystals obtained from
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Figure 2.1 X-ray structure of glucoside 11. Hydrogen atoms of the benzyl ethers are
omitted for clarity. Ellipsoids are drawn at the 50% probability level. Red =
oxygen, gray = carbon, white = hydrogen. Significant distances and torsion
angles: C30-O6 1.424Å, O6-C30-C20-O3 −60.2°, O6-C30-C6-O1 65.4°.
Figure 2.2 X-ray structure of 2-uloside 2b. Hydrogen atoms of the benzyl ethers and a
disorder involving the O51 benzyl group are omitted for clarity. Ellipsoids are
drawn at the 50% probability level. Red = oxygen, gray = carbon, white =
hydrogen. Significant distances and torsion angles: C2-O21 1.204Å, O21-C2-
C1-O11 −8.5°, O21-C2-C3-O31 11.8°.
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11 and 2b to provide insight into potential changes of the ring conformation upon
introduction of the ketone functional group. Benzyl glucoside 11 crystallized in the
orthorhombic space group P212121 with Z  4 (Fig. 2.1). As expected, 11 occupied
the 4C 1 conformation. The O-C-C-O torsion angles involving the C -2-OH were close
to the expected value of 60° for bis(equatorial) orientations (O6-C30-C20-O3 −60.2°,
O6-C30-C6-O1 65.4°).
Benzyl 2-uloside 2b (Fig. 2.2) crystallized in the monoclinic space group P21 with
Z  2, and the bond length of the C -2-ketone moiety (C2-O21 1.204Å) was found to
be as anticipated and comparable to other keto-sugars.[72] An analysis of the torsion
angles around the ketone (O21-C2-C1-O11 −8.5°, O21-C2-C3-O31 11.8°) revealed a
considerably planarized geometry as compared to 11. Nevertheless, 2b exhibited a
distorted 4C 1 conformation, and similar observations were made for 3-keto-pyranosides,
which were also found to exhibit a distorted 4C 1 conformation in the solid state.[72]
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Dess-Martin oxidation, a method previously utilized for the synthesis of other keto-
sugars, was found to transform the 3,4,6-tri-O-benzylated glucosides 11 and 8 into
the wanted known 2-ulosides 2b and 2c in a clean and convenient manner (Scheme
2.14). In contrast, the previously unknown allyl 2-uloside 2a, derived from known
glucoside 7, was found to be surprisingly prone to the elimination of benzyl alcohol,
and formation of the 3,2-enolone 3b occurred upon unbuffered Dess-Martin oxidation
or upon chromatographic purification. The elusive allyl 2-uloside 2a could be obtained
in pure form for characterization purposes, however, only in mediocre yield. For this
reason, the application of crude material of 2a was evaluated to be the method of
choice for following transformations involving the sensitive keto-sugar. In previously
reported similar elimination reactions of benzyl-protected keto-sugars, basic reagents
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in combination with highly polar solvents were required to invoke the elimination of
benzyl alcohol. In this regard, the observed unusual property of 2a is an addition to
the chemistry of 2-ulosides and derived carbohydrate 3,2-enolones, and might be of use
for other syntheses employing 2-ulosides as carbohydrate building blocks. X-ray single
crystal analyses of the known benzyl glucoside 11 and the derived known 2-uloside 2b
provided insight into structural features of 2-keto-sugars, and proved that 2b exhibited
a distorted 4C 1 conformation in the solid state.
Having established a convenient method to obtain 2-ulosides 2b,c in pure form, and
the sensitive allyl derivative 2a in crude form, the application of these keto-sugars
as carbohydrate building blocks in the syntheses of target compounds T-3,4,5 was
feasible.

3. Non-Reducing Higher Sugars:
Polyhydroxylated Dioxadecalins
Based on the investigations regarding the synthesis of 2-keto-sugars as described in
Chapter 2, application of these valuable precursors as building blocks for the synthesis
of complex carbohydrates was feasible. In this regard, allyl 2-uloside 2a (Scheme 2.14
on page 24) was envisioned to be a suitable precursor for the synthesis of 1,2-annulated
sugars of type T-3 (Scheme 1.4 on page 6), since the 2-ketone as well as the anomeric
allyl residue should potentially be amenable to straightforward functionalizations. The
results obtained in this context are covered after a general introduction to annulated
carbohydrates with a decalin-type structure.
3.1. Introduction to Carbohydrate-Derived Decalin
Structures
An interesting class of compounds, arising from the formal annulation of a parent carbo-
hydrate precursor with a second six-membered ring, can be referred to as carbohydrate-
derived decalins due to their potential structural similarity with the decalin (decahydron-
aphthalene or bicyclo[4.4.0]decane) framework. Interesting stereochemical properties
arise from the introduction of such an annulation, and the diversity of products can
be accounted for by the following general considerations: 1,2-annulation of a generic
pyranose with a second six-membered ring (Scheme 3.1, a) results in the formation of
a bicyclic product, which may further be functionalized by substituents at the positions
of the ring fusion (R, R’), by the incorporation of heteroatoms X at any position in
the second ring, and by further functionalizations Y of the annulated ring. As shown
for a simple annulated product without functionalizations of the second ring (Y = H),
the chair-chair ring fusion can occur in four different modes (Scheme 3.1, b) and
is defined by the anomeric configuration (α or β) and by its relative configuration to
the connection at position 2 (cis or trans). Both 1,2-cis-fused isomers α-cis and β-cis
each give rise to a set of two different isomers (1-axial-2-equatorial or 1-equatorial-2-
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Scheme 3.1 (a) 1,2-Annulation of a generic pyranose with a six-membered ring. (b)
Stereochemical considerations for the obtained 1,2-annulated products. X =
CH2 or heteroatom. R, R’, Y = H, OH or organic residue.
axial), one exhibiting a 4C 1 conformation and the other a 1C 4 conformation, which are
interconvertible via ring flip (analogous to the ring flip in cis-decalin between two enan-
tiomeric isomers). The corresponding 1,2-trans-fused isomers α-trans and β-trans both
only exist in the 1,2-diequatorial isomer. For α-trans, the bicyclic compound exhibits a
1C 4 conformation, and for β-trans a 4C 1 conformation. In analogy to the situation in
trans-decalin, ring flip from these trans-isomers is not possible, since it would result
in an unfavorable trans-diaxial fusion not feasible for annulated six-membered rings.
These considerations demonstrate the interesting stereochemical properties imposed on
a simple monosaccharide upon annulation with a second saturated six-membered ring.
As a result, such annulated sugars (or sugar derivatives like carbasugars or iminosugars)
exhibiting diverse patterns of annulations and functionalizations have been popular
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targets for synthetic carbohydrate chemistry, and several reviews have been published,
particularly for the synthesis of 1,2-annulated carbohydrates.[73–75]
The following sections give a brief summary of such annulated carbohydrates with
different positions of annulation and functionalizations of the non-carbohydrate ring,
and with a focus on annulations of a six-membered ring and, consequently, oxadecalin-
type structures. In this regard, examples are given for molecules from either natural or
synthetic origin. However, several types of natural products with annulated frameworks
bear resemblance to the carbohydrate-derived decalin structures discussed here, but
are not subject to this introduction. Among these, the polycyclic ladder polyethers of
the marine polyketides, and the fused oxasqualenoid natural products of the marine
terpenoids, feature highly annulated decalin-type frameworks, but their low degree of
hydroxylation and non-carbohydrate based biosynthesis (polyketide or terpene biosyn-
thesis) preclude a discussion here.[76] Furthermore, natural products with aromatic
annulated rings, like the flavonoids, shall not be discussed.
3.1.1. Natural Carbohydrate-Derived Decalins
Annulated sugars forming a decalinic structural unit have been identified in a number
of structurally peculiar natural products, many of them with interesting biological
activities. For example, the aminocyclitol antibiotic spectinomycin AW (Scheme 3.2,
a), isolated from the bacterium Streptomyces spectabilis, is a used drug for the treatment
of gonorrhea in patients allergic to penicillin. It features a 2,3-diulose moiety (4,4a
in the spectinomycin numbering), which is annulated to the aminocyclitol ring via
a 1,2-cis-annulated 1,4-dioxane ring in an overall cis-cisoid-trans fashion.[77] Similar
cis-cisoid-trans dioxane linkages of keto-sugars were identified in unusual steroidal
natural products, including the affinosides like M (Scheme 2.1 on page 8).[23] Other
structurally related steroids like gomphosideAZ (Scheme 3.2, b) have been found, and
have been synthesized by the Lichtenthaler group by employing the ulosyl donor approach
(comp. Section 2.1.1) starting with unsaturated ulosyl chloride AX and the 2,3-diol
AY.[78] A structurally unique class of natural products incorporating a carbohydrate-
derived decalin framework are the herbicidins, complex nucleoside undecose antibiotics
like herbicidin C (BA in Scheme 3.3, a) with a hydroxylated trans-dioxadecalin moiety.
BA itself, isolated from bacteria of the genus Streptomyces, possesses some interesting
biological properties. It is, for example, a growth inhibitor of another bacterium
(Xanthomonas oryzae) that causes leaf blight infection in rice. Notably, the complex
annulated sugar structure in BA, together with the N -glycosidic nucleoside moiety, have
been attractive challenges for total syntheses, and a selection of former synthetic routes
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Scheme 3.2 (a) Structure of the aminocyclitol antibiotic spectinomycin AW and repre-
sentation of the cis-cisoid-trans relationship with omitted substituents.[77]
(b) Structure AZ of the steroid gomphoside and Lichtenthaler’s synthetic
approach from ulosyl chloride AX and gomphogenin AY.[78]
together with a modern synthetic approach is given in a recent publication by Trauner
and Coworkers.[79] Additionally, some norlignan glucosides isolated from the plant
Curculigo sinensis contain unusual annulated glycoside residues, among these sinenside
A (BB in Scheme 3.3, b). Together with other co-isolated glucosides, BB displayed
a strong radical scavenging activity comparable to that of ascorbic acid. The unusual
structure of BB shows a 1,2-trans-annulated β-glucoside fused to a 1,4-dioxane, forming
a trioxadecalin. A second annulation to a tetrahydropyran ring completes the tricyclic
skeleton. Recently, Vadhadiya and Ramana described a total synthesis for BB based
on glucose-1,2-orthoester glycosylation chemistry.[80] Another peculiar representative
of a naturally occurring annulated sugar is bradyrhizose (K in Scheme 1.3 on page
4), which can be described as an inositol (or: carbasugar) annulated to a reducing
galactose moiety. The oxadecalin K was isolated as a monosaccharide constituent of
the lipopolysaccharides of certain nitrogen-fixing Gram-negative soil bacteria, and is
believed to play a role in the initiation of symbiosis with their corresponding host plant
(for a detailed discussion, see Chapter 4.3).[13]
The examples given here, although not a comprehensive collection, illustrate the
unusual ways in which simple monosaccharides are incorporated into complex natural
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Scheme 3.3 (a) Structure BA of herbicidin C.[79] (b) Structure BB of sinenside A.[80]
products through diverse ring annulations. In addition to such carbohydrate-derived
decalinic structures of natural origin, similar designed frameworks have been synthe-
sized, for example with the goal of creating molecular diversity from readily available
carbohydrates. In this regard, some examples will be given in the upcoming section.
3.1.2. Synthetic Carbohydrate-Derived Decalins
Annulated sugars comprise a diverse stereochemistry (comp. Scheme 3.1) in combina-
tion with a potentially very high density of (often hydroxylated) stereogenic centers.
Annulation of a pyranose furthermore produces a conformationally restricted carbohy-
drate derivative, and this reduced conformational flexibility is particularly distinct in
1,2-trans-annulated systems where ring flip isomerism of the bicyclic system is not pos-
sible. Since further functionalizations of such conformationally locked bicyclic systems
could be expected to be feasible with a high level of stereocontrol, carbohydrate-derived
decalin systems have been employed as chiral building blocks for the elaboration of
complex molecules.
For instance, Fraser-Reid and Coworkers developed the concept of pyranosidic ho-
mologation during their efforts to establish stereoselective syntheses for the complex
ansa chains of the ansamycin antibiotics.[81, 82] Stereoselective formation of a polycyclic
annulated carbohydrate scaffold, incorporating the stereoinformation of the future ansa
chain, was envisioned to be favorable due to the conformational bias of such annu-
lated systems, and the resulting feasibility of highly stereoselective reactions and the
facilitated characterization of the bicyclic products. With this objective, Fraser-Reid
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Scheme 3.4 Top: Fraser-Reid’s approach to carbohydrate-derived dioxadecalin BH.[81,
82] Bottom: diversity-oriented approach towards dioxadecalin BK.[83]
and Coworkers subjected epoxide BC (Scheme 3.4, top) to epoxide opening with an
in situ formed alkinylalane, followed by Lindlar hydrogenation. Treatment with TFA
induced intramolecular glycosylation/silyl migration upon opening of the 1,6-anhydro
bridge, giving bicyclic alkene BE. Epoxidation with VO(acac)2/t-BuOOH gave epoxide
BF as the major product due to the directing effect of the C -3-OH, whereas epoxi-
dation with m-CPBA gave epoxide BG as the major isomer. trans-Diaxial epoxide
opening of BG with LiMe2Cu gave the expected 1,2-cis-fused dioxadecalin BH as an
advanced synthetic intermediate for the subsequent installation of further stereogenic
centers. Apart from such target-oriented strategies, with the goal of generating bicyclic
molecular complexity from simpler carbohydrates, Martín, Padrón and Coworkers used
homoallylic alcohol BI (Scheme 3.4, bottom) for the Fe(III)-catalyzed Prins reaction
with different aldehydes to generate trans-dioxadecalinic products like BJ with complete
stereocontrol of the formed stereogenic centers.[83] The chloride, resulting from trapping
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Scheme 3.5 (a) Structures of swainsonine BL and 1-deoxynojirimycin BM and the derived
marketed drugs miglitol BN and miglustat BO.[84] (b) Vankar’s synthesis of
galactose-annulated iminosugar BS.[85]
of the intermediate carbenium ion with TMSCl, could then be dehalogenated with
Bu3SnH/AIBN.
A frequently addressed area of research arises from the following lines of thought:
the carbohydrate-processing enzymes, glycosidases (or glycoside hydrolases, GHs) and
glycosyltransferases (GTs), are involved in a plethora of highly relevant biological
processes, and malfunctions of these enzymes are associated with severe diseases
like diabetes, HIV/AIDS, cancer and lysosomal storage disorders.[86–88] Hence, in-
hibitors of these enzymes are potential biological tools with possible applications as
drugs. Several iminosugars like the naturally occurring swainsonine BL (Scheme
3.5, a) and 1-deoxynojirimycin BM (DNJ) possess glycosidase inhibiting properties.
1-Deoxynojirimycin BM itself is an α-glucosidase inhibitor, and its derivatives miglitol
BN (against type II diabetes) and miglustat BO (against type I Gaucher’s disease and
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Niemann-Pick type C disease) are marketed drugs derived from the natural product.[84]
Understandably, due to their closely carbohydrate-related structures, such iminosugars
are believed to be mimetics for the carbohydrate substrates of enzymes, or for the
transition state traversed in the enzymatic reaction. However, early iminosugar drugs
like BN or BO suffer from low specificity for the target enzyme and, consequently,
considerable clinical side-effects.[84] Among the diverse strategies for the structural im-
provement of glycosidase or glycosyltransferase inhibitors concerning their applicability
as therapeutics, novel annulated iminosugar compounds have attracted interest.[89]
Alteration of the chemical structure by annulation is, in this regard, expected to pro-
vide conformationally rigid bicyclic molecules with improved enzymatic specificity and
higher resistance towards enzymatic degradation of the inhibitor, respectively. Along
these lines, considerable effort has been invested in the synthesis of novel annulated
carbohydrate mimetics like iminosugars, but also annulated carbasugars or conven-
tional sugars, as inhibitors for clinically relevant glycosidases and glycosyltransferases.
For instance, Vankar and Coworkers (Scheme 3.5, b) introduced a synthesis for
d-galactose-annulated iminosugar hybrid molecules.[85] 2-Nitrogalactal BP underwent
anomeric vinylation with vinylmagnesium bromide, and subsequent reduction of the
nitro group and Boc-protection of the amine gave 1-deoxy-1-C -vinyl-β-d-galactosamine
BQ together with other stereoisomeric products. Allylation of the amine, followed by
ring-closing metathesis with the Grubbs 1st generation catalyst[90], gave bicyclic alkene
BR. Osmium-based syn-dihydroxylation occurred from the α-side, and after deprotec-
tion steps annulated BS could be isolated. The trans-decalin type structure with 4C 1
conformation of the galactose moiety was confirmed by X-ray structural analysis of the
N -Boc-protected pentaacetate of BS. Glycosidase inhibition studies revealed that BS
is a moderate inhibitor of α-glucosidase (rice yeast) and β-galactosidase (bovine liver),
and other stereoisomers of BS were found to be inhibitors of other glycosidases. Simi-
larly, numerous other approaches towards annulated iminosugar scaffolds as potential
glycosidase inhibitors have been published.[89, 91–94]
Apart from iminosugars, Vankar and Coworkers designed several other bicyclic car-
bohydrate analogs, such as C -glycosidically inositol-annulated carbohydrates BX and
BZ (Scheme 3.6).[95] Starting from benzylated 1,2-anhydro-d-glucose BT, β-selective
anomeric allylation, followed by oxidation of the C -2-OH, gave C -glycosidic 2-ulose
BU. Allylation of the ketone with equatorial selectivity and ring-closing metathesis
provided alkene precursor BV for the syn-dihydroxylation, which gave a separable 4:1
mixture of major BW via addition from the α-side, and minor BY. Hydrogenolytic
debenzylation gave mannose-annulated carbasugars BX and BZ, respectively. The
minor isomer BZ was identified to be a moderate inhibitor of β-galactosidase (bovine).
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Scheme 3.6 Vankar’s synthesis of carbohydrate-derived oxadecalins BX and BZ via
allylation/ring-closing metathesis and dihydroxylation.[95]
In a related project, the Vankar group synthesized pyran-annulated O-glycosides via a
comparable route (Scheme 3.7).[93] 2-Acetoxyglucal CA was reacted with allyl alcohol
in the presence of BF3·Et2O in a Ferrier reaction[96] followed by enone formation. After
gluco-selective vinylation of the ketone and silyl-protection of the deprotected primary
C -6-OH, ring-closing metathesis with the Grubbs 2nd generation catalyst[97] gave
1,2-trans-annulated bicyclic diene CD. Dihydroxylation of both alkene functionalities
occurred from the β-face and gave, after subsequent deprotection steps, dioxadecalin CF
with galacto-configuration of the parent pyranose moiety. Notably, due to the β-trans
nature of the annulation, CF must be assumed to adopt a 1C 4 conformation of the galac-
tose ring, although the authors did not comment on this detail. In glycosidase inhibition
studies with CF and a collection of structurally related compounds, CF was found
to be a remarkably selective inhibitor of β-galactosidase (bovine liver). This approach
provided structurally interesting O-glycosidically fused carbohydrate-decalin-structures.
However, a disadvantage of this strategy can be seen in the following circumstances:
both the C -3 and C -4 stereogenic centers of the substrate CA are lost in the Ferrier
reaction/elimination step. As a consequence, four hydroxylated stereogenic centers
have to be established in the dihydroxylation step (CD to CE). This can be regarded
as a restriction of the stereochemical variety of products potentially accessible with
this synthetic approach. Concludingly, a synthetic strategy with complete conservation
of the carbohydrate stereochemical information at the non-fusion positions would be
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Scheme 3.7 Synthesis of annulated 1C 4-system CF via vinylation/ring-closing metathesis
and dihydroxylation as published by Vankar and Coworkers.[93]
desirable. In this regard, the development of a synthetic approach towards structurally
related annulated sugars is discussed in the upcoming section.
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Scheme 3.8 Top: schematic representation of the synthetic routes described in this chap-
ter for 1,2-annulated target compounds T-3. Bottom: structurally related
published oxadecalin BX[95] and dioxadecalin CF[93].
In light of the aforementioned efforts in the synthesis of either natural or of designed
carbohydrate-derived products with an annulated decalin-type structure, allyl 2-ulosides
1a or 2a were assumed to be ideal precursors for the synthesis of new 1,2-annulated
carbohydrates. Specifically, the given synthetic strategy followed from a retrosynthetic
analysis, and based on the assumption that both the carbonyl functional group and
the allyl residue in 1a/2a were amenable to straightforward further functionalizations
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(Scheme 3.8, top). Thus, vinylation of the ketone moiety could give a diene in-
termediate as a suitable substrate for ring-closing metathesis, which would provide
a bicyclic alkene as an annulated intermediate. Subsequently, syn- or anti-selective
dihydroxylation of the bicyclic alkene, followed by global deprotection, were anticipated
to furnish dioxadecalins of type T-3 with variable configurations of the side chain diol
moiety.
Analogous synthetic routes with a ring-closing metathesis/dihydroxylation approach
were frequently utilized by the Vankar group for the synthesis of 1,2-annulated sugars
like BX[95] or CF[93] (Scheme 3.8, bottom), both with the objective of synthesizing
new carbohydrate mimetics as glycosidase inhibitors. The target compounds T-3 can,
from a heterocyclic point of view, be described as 2,10-dioxadecalins (or: pyranopyrans),
or as 1,2-pyran-annulated β-mannosides focussing on the carbohydrate moiety. Due
to the β-trans nature of the annulation, both syn- and anti-isomers of T-3 (syn-15
and anti-21) can be anticipated to exist in a trans-decalin-type structure with 4C 1
conformation of the parent β-mannose. In this context, compounds T-3 can be regarded
as hybrid molecules between Vankar’s inositol-annulated (C -glycosidic) β-mannosideBX
in 4C 1 conformation, and pyran-annulated (O-glycosidic) α-galactoside CF, which can
be expected to adopt a 1C 4 conformation. Notably, although a large number of bicyclic
carbohydrate analogs have been prepared to date (comp. Section 3.1.2), an approach
towards O-glycosidic β-mannosides of the type T-3 has not been developed. As an
additional feature, the described synthetic route involving 2-keto-sugars would proceed
with complete conservation of the configurations of the carbohydrate C -3,4,5 stereogenic
centers, thereby offering potential for a diversification of this synthesis with respect to
the starting keto-sugar. Given the fact that mannosides are widely present in biologically
highly relevant molecular patterns, and considering the synthetic challenge generally
associated with 1,2-cis-glycosides, the development of a synthesis of target compounds
T-3 would be desirable.[46, 47, 98] Apart from this, a detailed structural characterization
of the deprotected target compounds would be of interest, especially from the perspective
that similar highly hydroxylated, and thus, highly polar carbohydrate mimetics are
frequently characterized as their protected (e.g. peracetylated) derivatives for reasons
of convenience.
3.3. Results and Discussion
Taking into account the challenges encountered in the isolation of allyl β-2-ulosides
1a and 2a from the corresponding ulosyl bromides AB and AD (Scheme 2.10 on
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page 18), a preliminary synthetic route towards target structures T-3 was developed
based on the following considerations: whereas benzylated AD gave a complex mixture
upon reaction with allyl alcohol under Koenigs-Knorr conditions, benzoylated AB
reacted with allyl alcohol in a clean manner to give a single product 1a. Albeit, isolation
and purification of 1a was not feasible due to the formation of 3,2-enolone 3a upon
chromatographic purification. As a result, in initial experiments towards T-3, the
application of crude 1a as received from the Koenigs-Knorr glycosylation of AB was
explored. A discussion of these early investigations is given in Section 3.3.1.
3.3.1. Preliminary Synthetic Studies
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Scheme 3.9 Preliminary synthetic studies towards syn-15 from ulosyl bromide AB.
In initial experiments, Lichtenthaler’s benzoylated ulosyl bromideAB[42] was condensed
with allyl alcohol in the presence of Ag2CO3 and molecular sieves in CH2Cl2 according to
the standard procedure (Scheme 3.9). After removal of the insoluble components and
evaporation of the volatile parts, crude 1a was treated with vinylmagnesium bromide
at −80 ◦C in THF. Due to the more electrophilic nature of the ketone functionality, a
selective addition to the ketone in the presence of the benzoyl groups was anticipated.
In this way, the desired 2-C -vinylated product 12 could be isolated in mediocre yield
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(29%). The low yield and sluggish nature of the formation of 12 must be attributed to
the unwanted formation of 3,2-enolone 3a (Scheme 2.10 on page 18), observed as a
side product with high chromatographic mobility in TLC control under the conditions
of the Grignard reaction. Since 3a could not be isolated from the reaction in significant
amounts, it most likely reacts with further available vinylmagnesium bromide to derived
decomposition products. In addition, upon prolonged reaction time, an increased
number of decomposition products with low chromatographic mobility suggested at
least partial reaction of the benzoyl groups under these conditions. Nevertheless, diolefin
12 could be characterized by its NMR-spectroscopic properties to be a single isomer with
β-manno-configuration. The β-configuration of the anomeric center was evident from the
direct coupling constant 1JC1,H1=160.8Hz (Fig. 3.1, a) measured in an undecoupled
13C NMR experiment, which was significant for a β-glycoside (ca. 160Hz) and smaller
than would be expected for an α-anomer (ca. 170Hz).[99, 100] Likewise, the anomeric
β-configuration of 12 could additionally be confirmed by the H,H-NOESY spectrum
(Fig. 3.1, b), which showed NOE contacts between the carbohydrate H -1, H -3 and
H -5 as expected for the spatial proximity associated with a 1,3,5-triaxial relationship.
In a similar manner, if not stated otherwise, the configurations of the following other
2-C -branched saccharides could be determined from comparable spectral properties.
Notably, the vinylation proceeded with complete stereoselectivity for the equatorial
attack, giving product 12 with manno-configuration. This finding is in accordance with
detailed studies on nucleophilic addition reactions at structurally related 2-ulosides by
Ley and Coworkers.[101] In general, α-2-ulosides react via axial attack, giving products
of α-gluco-configuration, whereas β-2-ulosides usually react via equatorial attack, giving
the corresponding β-manno-products as observed. In the following reaction, diene 12
was subjected to ring-closing metathesis[90] with the Hoveyda-Grubbs catalyst of the
second generation[102, 103], which proceeded smoothly and provided bicyclic alkene
13 in 88% yield. Dihydroxylation of alkene 13 under Standard Upjohn conditions[104]
was found to progress reluctantly, and a slightly elevated temperature (45 ◦C) and
prolonged reaction time (12 d) was required. In this manner, bicyclic diol 14 was
furnished via addition from the α-face and opposite to that of the axial C -2-OH.
Spectroscopically, the stereochemistry of the dihydroxylation reaction was evident
from the 1H NMR spectrum, which displayed vicinal coupling constants of the side
chain methylene C -9a,b as expected for one axial-equatorial (3J 8,9a=5.8Hz) and one
axial-axial (3J 8,9b=10.9Hz) relationship. Similarly, comprehensive examinations by
Kishi and Coworkers on the osmoylation of allylic alcohols have confirmed the general
preference for the addition from the anti-face with respect to the preexisting hydroxyl
group.[105, 106] This finding is sometimes referred to as “Kishi’s empirical rule“. Finally,
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Figure 3.1 (a) Anomeric region of the undecoupled 13C NMR spectrum of diolefin 12
at 150.9MHz in acetone-D6 with assignment of the 1JC1,H1 coupling constant.
(b) Section of the H,H-NOESY spectrum of 12 at 400.2MHz in acetone-D6.
Significant signals are labeled, and dashed arrows indicate NOE contacts
between the axial H -1, H -3 and H -5. The shown spectrum is symmetrized.
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debenzoylation of tribenzoate 14 under Zemplén’s[66] conditions gave target compound
syn-15. The highly polar hexol was found to be insoluble in organic solvents like DMSO
or methanol, but in water. Therefore, in these early experiments, the purification of
crude syn-15 was realized by washing of the solid with mixtures of organic solvents to
obtain pure syn-15 with a manageable loss of product in 76% yield.
Based on these promising initial results, the low-yield vinylation of crude 2-uloside 1a
for the formation of 12 was evaluated to be a substantial disadvantage. For that reason,
a screening for suitable reagents and conditions for the vinylation of 1a was performed
(Table 3.1). Starting from the initial procedure (entry 1), which gave 12 in 29% yield
over 2 steps from AB by using commercial vinylmagnesium bromide in THF, a compara-
ble experiment was conducted with vinylmagnesium bromide freshly prepared from vinyl
bromide and magnesium (entry 2).[107] Notably, in some cases, serious improvements
are reported for the prepared reagent over commercial material.[108] Nevertheless, the
reaction proceeded sluggishly, and gave 12 in a 26% two-step yield and thus comparable
to the commercial reagent. Solvating ether additives like bis(2-methoxyethyl) ether
(diglyme) are known to increase the nucleophilicity of Grignard reagents, and Song
and Coworkers found that additional catalytic quaternary ammonium salts lead to an
increase of the addition reaction over enolization/reduction side reactions.[109] Albeit,
in the transformation of 1a, in the presence of diglyme (entry 3) or diglyme/catalytic
n-Bu4NCl (entry 4), no improved results could be observed. Subsequently, metal addi-
tives for Grignard reactions were explored. Nakamura and Coworkers could show that
challenging substrates like enolizable ketones or α,β-unsaturated ketones give better
results in Grignard reactions upon addition of equimolar amounts of anhydrous CeCl3,
and the method has been shown to be compatible with vinylmagnesium bromide.[110]
In the reaction of 1a (entry 5), however, no improvements could be detected, and 12
was formed in comparably low yield (25%). In a similar method for the Lewis acid
activation of Grignard reagents, Knochel and Coworkers reported the THF-soluble
complex LaCl3·2LiCl as a suitable activator in stoichiometric or catalytic amounts.[111]
Nevertheless, application of this protocol to the transformation of 1a (entry 6) in
combination with vinylmagnesium chloride as the Grignard species did not lead to
better results, and 12 was formed in an unsatisfactory yield (25%).
Concludingly, although the formation of diene 12 from benzoylated ulosyl bromide
AB was thoroughly examined, no adequate method could be found. Under all tested
conditions, the formation of 12 proceeded sluggishly and in mediocre yields below
30%. For this reason, in advanced synthetic studies, another approach was examined.
Benzylated allyl 2-uloside 2a, although not accessible via Koenigs-Knorr glycosylation
of ulosyl bromide AD, was formed in the Dess-Martin oxidation of 2-O-unprotected allyl
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Table 3.1 Reaction screening for the formation of diene 12 from crude 1a.
OBzO
BzO
OBz
OBr
AB
OH
Ag2CO3, MS 3 Å,
CH2Cl2, r.t., 3 h
OBzO
BzO
OBz
O
OAll
1a
OBzO
BzO
OBz
O
OH
12
MgX
additive
+
conditions,
solv.: THF
# X additivea T, t yield 12b Ref.
1c Br — −80 ◦C, 30min 29% —
2 Brd — −80 ◦C, 90min 26% [107, 108]
3 Br diglyme −80 ◦C, 2 h 22% [109]
4 Br diglyme, n-Bu4NCl −80 ◦C, 2 h 27% [109]
5 Br CeCl3 −80 ◦C, 24 h 25% [110]
6 Cl LaCl3·2LiCle −80 ◦C, 24 h 25% [111]
a Equivalents according to the given reference.
b Chromatographically isolated yield over 2 steps from AB.
c Experimental procedure given in Chapter 6.
d Grignard reagent freshly prepared from vinylbromide/Mg.
e According to the stoichiometric protocol: 1.1 equiv. LaCl3, 2.2 equiv. LiCl.
glucoside 7 in a clean and reliable manner (Scheme 2.13 on page 21). Chromatographic
purification of 2a resulted in elimination of benzyl alcohol and formation of 3,2-enolone
3b, together with diminished amounts of impure 2a. Consequently, crude 2a, as
obtained from the Dess-Martin oxidation, was anticipated to be a suitable substrate for
the following vinylation.
3.3.2. Optimized Synthetic Route
Accordingly, an optimized synthetic route was conceived to involve Dess-Martin oxidation
of allyl glucoside 7, giving allyl 2-uloside 2a as reported in Chapter 2, followed by
vinylation of the crude material to furnish the 2-C -vinyl-branched product. Two aspects
of this approach were expected to be favorable as compared to the synthesis involving
benzoylated 2-uloside 1a. Dess-Martin oxidation of 7 was found to provide ketone
2a in high yield and in a very clean reaction, as opposed to the somewhat unclean
Koenigs-Knorr glycosylation of AB, which can, in addition to that, potentially form
minor amounts of the undesired α-anomeric product. Moreover, comparing the quality
of the leaving group at the O-4-position, the benzoylated derivative 1a was assumed to
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Scheme 3.10 Optimized (method a) and unoptimized (method b) synthesis of diene 16
via Dess-Martin oxidation/Grignard addition.
have a higher tendency for elimination and formation of the unwanted 3,2-enolone as
compared to benzylated 2a, featuring the poor benzyl oxide leaving group.
Hence, as described in Chapter 2, allyl glucoside 7 was treated with Dess-Martin
periodinane in the presence of NaHCO3 as a buffer to give allyl 2-uloside 2a (Scheme
3.10). Treatment of crude 2a with vinylmagnesium bromide, which was slowly added
to the reaction mixture over 2 h, provided 2-C -vinyl-branched 16 in an excellent 83%
two-step yield and without observable formation of the unwanted elimination product
3b (Scheme 3.10, method a). The presence of the buffer NaHCO3 in the Dess-Martin
oxidation, a non-basic workup (NaHCO3/Na2S2O3), and subsequent slow addition
(over 2 h) of the Grignard reagent were all found to be beneficial for the overall yield
of 16. Opposed to this, in an earlier unoptimized procedure (method b), a sequence
of unbuffered Dess-Martin oxidation, followed by basic workup (K2CO3) and rapid
addition of the Grignard reagent (over 10min), provided 16 in lower yield (58%),
together with 15% of 3,2-enolone 3b. By employing the optimized synthetic sequence,
16 was conveniently available on gram scale, and thus a promising intermediate.
Ring-closing metathesis of 16 with the Hoveyda-Grubbs catalyst of the second gener-
ation[102, 103] gave, similar to the unoptimized reactions involving benzoyl-protected
derivatives, bicyclic benzylated alkene 17 (Scheme 3.11 on page 46). Annulated 17
was isolated in an excellent yield (94%), and from n-hexane/ethyl acetate, single crystals
suitable for X-ray structural analysis could be obtained. 17 crystallized in the mono-
clinic space group P21 with Z  2, and the molecular structure (Fig. 3.2, a) confirmed
the anticipated 4C 1 conformation of the mannoside moiety. The annulated dihydropyran
ring could be determined to exist in a distorted envelope (E) type conformation with the
side chain (C6,C7,C8 in the crystal structure numbering), the carbohydrate O-1 (O6)
and the carbohydrate C -2 (C2) in a quasi-planar arrangement, and the carbohydrate
C -1 (C1) below the plane (Fig. 3.2, b). Only a very slight out-of-plane distortion of
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Figure 3.2 (a) X-ray structure of bicyclic alkene 17. Hydrogen atoms of the benzyl ethers
are omitted for clarity. Ellipsoids are drawn at the 50% probability level. Red
= oxygen, gray = carbon, white = hydrogen. (b) Molecular structure of 17
(benzyl ethers not shown) for clarification of the chair and envelope-like ring
conformations. (c) Calculated plane through atoms C2,C6,C7,C8 and distances
to the plane: O6 0.208Å, C1 0.597Å.
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Scheme 3.11 Optimized syntheses of annulated target compounds syn-15 and anti-21
via bicyclic alkene 17.
O6 indicative of a weak tendency to a half-chair (H ) conformation could be observed. In
accordance, to a plane calculated through C2,C6,C7,C8, a considerably smaller distance
of O6 (0.208Å) than the out-of-plane C1 (0.597Å) illustrated these relationships (Fig.
3.2, c). Usually, monocyclic dihydropyrans occupy a half-chair conformation[112], and
envelope conformations of six-membered rings are only observed in highly rigid systems
like carbohydrate-derived α,β-unsaturated carbonyls (enuloses).[113] Thus, in the case of
17, the realization of an envelope-like conformation must be attributed to a rigidifying
effect caused by the annulated mannose moiety. Accordingly, in structurally comparable
fused molecules, similar partial planarizations of a dihydropyran moiety towards an
envelope-like conformation are observable.[114]
Subsequently, syn- and anti-selective dihydroxylations of bicyclic alkene 17 were
explored (Scheme 3.11). syn-Dihydroxylation of 17 under standard Upjohn condi-
tions[104] (cat. OsO4, NMO in acetone/t-BuOH/water) proceeded reluctantly similar
to the reaction of benzoylated 13. Therefore, alternative protocols were tested. Among
the multitude of osmium-based dihydroxylation protocols with diverse co-oxidants and
additives, DeCamp and Mills published a protocol using Me3NO as the stoichiometric
oxidant and pyridine as an additive for the large-scale dihydroxylation of a hindered
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trisubstituted alkene.[115] Under these conditions, alkene 17 could be transformed
into triol 18 in 95% yield in a reasonable reaction time of 5 d. The attack from the
α-face of the alkene opposite to the axial C -2-OH[105, 106] can be rationalized by using
an annulated half-chair model (Scheme 3.12, a) that is frequently utilized in this
regard.[116, 117] The model clearly demonstrates the unfavorable interactions with
the axial hydroxyl group in a potential approach of OsO4 from the β-side. Finally,
hydrogenolytic debenzylation of 18 gave, after an optimized purification involving
RP-C18 chromatography, the highly polar hexol syn-15 in quantitative yield, and
thus in 74% yield over 5 steps from the known allyl glucoside 7 (10 steps in total
from d-glucose). Spectroscopic data obtained for syn-15 fully corresponded to those
obtained for material as received from the debenzoylation of 14.
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In order to get access to the corresponding side chain anti-diol isomer, a sequence of
epoxidation and nucleophilic epoxide opening was explored. The initially tested reactions
for the epoxidation of 17 involved common epoxidizing agents like m-CPBA (unbuffered
or buffered with NaHCO3), peroxyacetic acid[118], trifluoroperoxyacetic acid[119, 120]
and DMDO[121]. Albeit, surprisingly, all tested methods failed to give satisfactory
results in the transformation of 17. Transition metal-catalyzed epoxidations are known
to be particularly useful for the site-selective epoxidation of allylic alcohols[122, 123],
and therefore this type of epoxidation reactions was tested next. Barriault and Deon
reported on the vanadium-catalyzed directed epoxidation[122, 124] of a trans-fused
bicyclic alkene with a tertiary allylic alcohol, and thus, structurally closely related
to 17.[125] Application of comparable conditions including catalytic VO(acac)2 and
stoichiometric t-BuOOH in toluene at 60 ◦C (Scheme 3.11 on page 46) gave epoxide 19
via epoxidation from the β-face and in a syn-fashion with respect to the tertiary hydroxyl
as expected. It should be noted, that the yield of the epoxidation reaction was found to be
heavily dependent on the individual batch of the substrate 17. A possible explanation
might involve residual ruthenium impurities in 17 from the preceding ring-closing
metathesis step that could have an adverse effect on the metal-catalyzed epoxidation. In
a protocol published by Liu and Coworkers, polar vinyl ethers were applied to ruthenium
carbene residues, forming stable Fischer carbene complexes and thereby facilitating
chromatographic separation of the catalyst residues.[126] Consequently, according to
the published protocol, di(ethylene glycol) vinyl ether was added to crude 17 prior to
chromatographic purification. Using substrate 17 pretreated in this way gave epoxide
19 in reproducibly good yield (72%). Subsequently, treatment of 19 with KOH in
DMSO/water gave, after a prolonged reaction time (7 d) anti-diol 20. The epoxide
opening occurred as expected with preference for the diaxial product, and thus, in
conformity with Fürst-Plattner[127] considerations of stereoelectronic circumstances
in the annulated half-chair model (Scheme 3.12, b). Finally, deprotection of 20 via
hydrogenolytic debenzylation provided the second target compound anti-21 in a total
yield of 31% over 6 steps from the known allyl glucoside 7 (11 steps in total from
d-glucose). The highly polar target compound anti-21 displayed high solubility in
water and, as opposed to syn-15, in methanol, too.
3.3.3. Characterization of the Target Compounds
Both syn-15 and anti-21 were amenable to NMR-spectroscopic characterization in
D2O. A comparison of the 1H NMR spectra (Fig. 3.3) of both compounds revealed
similar low-field and high-field boundary signals. The anomeric H -1 signals were detected
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Figure 3.3 1H NMR spectra of target compounds syn-15 and anti-21 in the range 3.4–
4.8 ppm in D2O at 400.2MHz. The shown spectra are unprocessed.
as singlets in proximity to the solvent residual signal at ca. 4.7 ppm (syn-15: 4.74 ppm,
anti-21: 4.72 ppm), and the carbohydrate H -5 gave rise to resolved ddd’s at ca. 3.5 ppm
(3.46, 3.47 ppm). The remaining signals were, in a typical manner for deprotected
saccharides[128], found in a narrow region between 3.6 ppm and 4.2 ppm. In the case of
syn-15, the coupling constants for the side chain H -8 allowed for the determination
of the configurations of the diol stereogenic centers. H -8 gave rise to a resolved ddd
with coupling constants as expected for one trans-diaxial (J 8,9b=11.3Hz) and two
axial-equatorial (J 8,9a=5.6, J 7,8=3.2Hz) relationships, thus giving clear evidence for
the depicted stereochemistry. For anti-21, the side chain signals of H -7 and H -9a/b
were observed as a heavily obscured multiplet. Likewise, H -8 exhibited a weakly
resolved signal. Albeit, the visible absence of a large trans-diaxial splitting (> 7Hz[128])
suggested the equatorial orientation of H -8. The H,H-NOESY spectrum of anti-21 was
inconclusive, and did not allow for the determination of significant contacts. However,
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for precursor 20, the H,H-NOESY spectrum (Fig. 3.4) displayed an NOE contact
between the axial C -2-OH, which was visible in acetone-D6, and the side chain H -7,
thereby giving evidence for the trans-diaxial diol orientation of 20, and indirectly, of
the derived anti-21.
Due to its only weak solubility in methanol, target compound syn-15 could be
recrystallized from a mixture of methanol and water. Fortunately, in this way, colorless
plates were obtained of a quality suitable for X-ray structural analysis. The highly
hydroxylated syn-15 was found to crystallize in the monoclinic space group P21 with
Z  4, and with two molecules in the asymmetric unit. The molecular structure (Fig.
3.5) of syn-15 clearly confirmed the preference for a trans-decalin-like structure with
both the parent β-mannoside moiety as well as the annulated 1-deoxypyranose ring in
a 4C 1 conformation. An analysis of the bond lengths (for selected bond lengths and
angles, see Table A.4 on page 278) revealed endocyclic carbon-carbon bond lengths
in the range 1.524–1.535Å and a shorter exocyclic bond length (C5-C6 1.507Å). The
exocyclic carbon-oxygen bond lengths were found to be in the range 1.421–1.438Å. In
contrast, the endocyclic carbon-oxygen bonds could be separated into two groups: the
distances around the anomeric C1 were shorter than the exocyclic distances (C1-O1
1.405, C1-O1’ 1.411Å), whereas the remaining two C-O bonds were longer than the
exocyclic C-O bonds (C5-O1 1.455, C1’-O1’ 1.446Å). The majority of the endocyclic
bond angles were found to be in an anticipated range slightly above the ideal tetrahedron
angle (109.7–111.1°). However, the bond angles around the fusion positions at C1 and
C2 deviated from this: the endocyclic O-C-O angle around the anomeric C1 was
considerably narrower (O1-C1-O1’ 104.2°), and the angle involving the C2 position was
slightly wider (C3-C2-C3’ 113.7°), both indicating a subtle distortion of the decalinic
system.
As highly hydroxylated molecules, carbohydrate structures possess a great number
of functional groups (hydroxyl groups) that can act both as a hydrogen bond donor,
and as an acceptor. In this regard, solid-state structures of carbohydrates differ
from multiple other biomolecules like proteins, in which the donor/acceptor roles
are clearly separated (e.g. N-H donors and C=O acceptors). This fact, together
with the high biological relevance of carbohydrates in general, have prompted a great
number of detailed solid-state examinations of carbohydrate structures with regard to
hydrogen-bonding interactions, either by neutron diffraction or, more frequently, by
X-ray crystallography.[129] Typically, the majority of hydrogen-bonding interactions
found in carbohydrates can be regarded as moderately strong interactions, characterized
by O···O distances (donor oxygen to acceptor oxygen) in the range 2.5–3.2Å and
O-H···O angles above 130°. An aspect which is frequently observed in carbohydrate
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Figure 3.5 Molecular structure of syn-15. A second molecule in the asymmetric unit is
omitted. Ellipsoids are drawn at the 50% probability level. Red = oxygen,
gray = carbon, white = hydrogen. For a selection of bond lengths, angles and
torsion angles, see Table A.4 on page 278.
solid-state structures, and which has attracted detailed examinations, is a high fraction
of bifurcated (or multifurcated) hydrogen bonds. The term bifurcated is traditionally
used to describe a hydrogen-bonding interaction, in which one donor (O-H) interacts
with two acceptors (O, O’) simultaneously (type: O···H(-O)···O’).[130] Another type of
multicentered hydrogen-bonding is characterized by one acceptor binding two donors
simultaneously (type: H···O···H’), and this type of interaction is sometimes termed
three-centered. Albeit, some confusion regarding this terminology exists in the literature,
and one term or the other is sometimes used to describe both types of interactions. In
extensive neutron diffraction studies on pyranoses and pyranosides, a high fraction of
25% of all hydrogen-bonding interactions was evaluated to be bifurcated (type: O···H(-
O)···O’).[131] As a possible explanation, it was reasoned that the ring oxygen present
in carbohydrates could only participate as a hydrogen bond acceptor (as opposed to the
hydroxyl groups), resulting in an overproportional number of acceptors, and therefore in
a competitive energetic contribution of bifurcated hydrogen-bonding interactions.[131,
132]
An analysis of the hydrogen-bonding interactions within the crystal lattice of syn-15
was performed with the following frequently applied criteria: inter-atomic distances
between the acceptor oxygen atoms and the donor hydrogen atoms were required to
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Figure 3.6 (a) Bifurcated hydrogen-bonding interaction in syn-15. Significant distances
and angles: major component: O23···O21 3.006Å, H23D···O21 2.238Å, O23-
H23D···O21 152.1°; minor component: O23···O26 3.119Å, H23D···O26 2.455Å,
O23-H23D···O26 136.5°. Remaining angle: O21···H23D···O26 70.8°. (b)Molec-
ular packing and hydrogen-bonding interactions of syn-15 along the crystallo-
graphic a-axis. The two crystallographically independent molecules are labeled
(I) and (II). Ellipsoids are drawn at the 50% probability level. Red = oxygen,
gray = carbon, white = hydrogen.
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be below 3.0Å (distance criterion: dO···H < 3.0 Å), and the hydrogen bonding angle
above 90° (angle criterion: θO−H···O > 90◦).[130, 133] Since the treatment of hydrogen
atoms in the X-ray structural analysis included constraints to ideal geometries (O-H
0.84Å, C-O-H 109.5°), all further discussions of hydrogen bond distances can, as an
alternative, be on the basis of O···O distances, which is also a parameter commonly used
to describe hydrogen bond distances in X-ray structures. Under the criteria mentioned
above, the crystal lattice of syn-15 revealed a prototype bifurcated hydrogen-bonding
interaction involving the O23-H23D hydroxyl group (Fig. 3.6, a). As is usually
the case for bifurcated hydrogen bonds[130, 133], in the observed interaction a major
component with a shorter contact and an angle closer to a linear bonding can be
observed (O23···O21 3.006Å, H23D···O21 2.238Å, O23-H23D···O21 152.1°), together
with a minor component with longer distance and narrower angle (O23···O26 3.119Å,
H23D···O26 2.455Å, O23-H23D···O26 136.5°). Another criterion for a bifurcated
hydrogen bond is the requirement, that the hydrogen atom should be in close proximity
to a plane spanned by the surrounding three oxygen atoms.[133] For a quantification,
the sum of angles around the hydrogen atom, which is 360° in the ideal case and below
360° in the case of pyramidal distortion, can be calculated. In the given example, a
sum of angles of 359.4° around H23D expresses an almost ideally planar arrangement.
An expansion of the hydrogen-bonding analysis for syn-15 revealed a dense network of
hydrogen bonds in the crystal lattice (Fig. 3.6, b). Among the multiple hydrogen-
bonding interactions (for a summary of identified hydrogen bonds, see Table A.5 on
page 279), O···O distances were found to vary in the range between 2.73Å (O1’-O3
and O6-O23) and 3.40Å (O23-O2’). Both the hydroxyl groups and the acetal ring
oxygen atoms were found to participate as hydrogen bond acceptors. The general
tendency, that shorter hydrogen-bonding interactions usually feature an angle closer to
linearity[130], was also observed for the structure of syn-15. This can be expressed
by the following calculated average angle values: for dO···O′ < 3.0 Å: θ¯O−H···O′  161.6◦,
and for dO···O′ > 3.0 Å: θ¯O−H···O′  127.6◦. Of the identified hydrogen bonds, at least 6
out of 13 interactions have to be evaluated as truly bifurcated (type: O···H(-O)···O’) in
nature, and several other interactions (classified as two-centered) could be identified to
be part of a H···O···H’ type bonding. However, it should be noted that a solely X-ray
crystallography-based analysis of hydrogen-bonding interactions should be evaluated as
prone to errors, for example with regards to the determination of detailed geometric
parameters of specific interactions. In particular, the identification of a contact to be of
a structure-determining nature, and not just a consequence of geometric circumstances,
can be commonly regarded as questionable.
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Detailed synthetic examinations provided an optimized protocol for the formation of the
elusive allyl 2-uloside 2a by Dess-Martin oxidation, followed by C -2 vinylation of crude
2a under optimized conditions (Scheme 3.13). The obtained 2-C -vinyl branched
allyl mannoside was transformed into bicyclic alkene 17 as a key intermediate via ring-
closing metathesis. Stereoselective syn- or anti-selective dihydroxylations of the side
chain enabled, after debenzylation, the formation of the annulated target compounds
syn-15 and anti-21 in 10–11 steps from d-glucose, respectively. As a major advantage,
and as opposed to several other approaches, this synthetic route to O-glycosidically
1,2-annulated carbohydrates proceeded with conservation of the configurations of the
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C -3,4,5 stereogenic centers of the parent carbohydrate. Both highly hydroxylated target
compounds could be structurally characterized by multiple methods, including detailed
NMR studies in aqueous solution (D2O). In these spectroscopic experiments, the syn-
and anti-configurations of the side chain diols could be derived. Most notably, X-ray
structural analysis of syn-15 confirmed the anticipated trans-decalin type molecular
framework, and allowed for the characterization of a dense network of hydrogen-bonding
interactions in the crystal lattice. Structurally comparable 1,2-annulated sugar motifs
are found in natural products, or in synthetic molecules with interesting biological
properties, for example as glycomimetic inhibitors for glycosidase enzymes. However,
similar O-glycosidically 1,2-annulated sugars with the synthetically challenging β-manno
configuration have not been prepared previously. Therefore, the described synthetic
strategy utilizing allyl 2-ulosides for the synthesis of such annulated carbohydrate analogs
is a valuable preparative contribution. In this context, the given discussion of synthetic
challenges encountered in reactions involving allyl 2-uloside 2a could potentially facilitate
the application of other sensitive keto-sugars as versatile carbohydrate building blocks.
In following studies beyond the scope of this thesis, an evaluation of the obtained
target compounds syn-15 and anti-21 with respect to potential glycosidase-inhibiting
properties would be of interest. Furthermore, the developed synthetic strategy could
be utilized to obtain structurally related stereoisomers of T-3 with axially-oriented
substituents at the parent carbohydrate, e.g. by employing 2-keto-glycosides of the
altro-, ido- or talo-configuration.
4. Reducing Higher Sugars: Octoses
with Analogy to Bradyrhizose
A second project pursued in the course of this thesis based on the application of
benzyl 2-uloside 2b[37] (Scheme 2.14 on page 24) as a synthetic intermediate. The
2-keto-sugar was anticipated to be a suitable substrate for functionalizations of the
C -2, and thus, for the generation of structurally diverse 2-C -branched carbohydrates
in a manner comparable to the vinylation of the allyl derivative 2a as captured in
Chapter 3. After several synthetic transformations starting from 2b, formyl-branched
higher sugars (octoses) T-4 were expected to be accessible. These target compounds
can potentially occupy bicyclic hemiacetal isomeric forms with structural analogies to
the unique natural monosaccharide bradyrhizose K (Scheme 1.3 on page 4). In this
context, detailed synthetic studies towards the target higher sugars T-4 are described,
followed by an examination of isomeric hemiacetal forms. Thus, the identified isomeric
forms of reducing sugars T-4 can be compared to the isomeric distribution found for
the natural monosaccharide K.
First, an introduction to nitroxyl radical-mediated methods for the oxidation of
alcohols is provided, since this type of transformation is relevant to the results discussed
here. Following this, a general introduction to the chemistry of higher sugars is
given, with a focus on published synthetic approaches for structurally interesting
target molecules. Subsequently, relevant published work regarding the natural product
bradyrhizose K is summarized.
4.1. Introduction to Nitroxyl Radical-Based Alcohol
Oxidations
Persistent nitroxyl radicals, the most prevalent being 2,2,6,6-tetramethylpiperidin-N -
oxyl (TEMPO), are a class of organic compounds amenable to a sophisticated redox
chemistry (Scheme 4.1). TEMPO, itself a commercially available, red crystalline
solid, can undergo formal single electron oxidation to the derived oxoammonium ion
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Scheme 4.1 Schematic representation of the redox chemistry involving TEMPO, the hy-
droxylamine TEMPO-H and the derived oxoammonium ion TEMPO+.
TEMPO+. Furthermore, in very acidic media (pH< 2), reversible disproportionation to
the hydroxylamine TEMPO-H and the same oxoammonium ion can be observed.[134]
Whereas TEMPO (and structurally related nitroxyl radicals[135, 136]) can be regarded
as weaker oxidants, the corresponding oxoammonium ions were found to be suitable
mediators for the oxidation of alcohols.[137] For such transformations of alcohols,
TEMPO is usually utilized in catalytic quantities, together with a secondary oxidant
capable of supplying the reactive oxoammonium ion TEMPO+ from TEMPO, or from
the reduced hydroxylamine form TEMPO-H. In this regard, the reaction mechanism
for the formation of TEMPO+ from the reduced TEMPO species, by reaction with the
respective stoichiometric oxidant, is usually of a rather enigmatic nature. Although this
step is rarely discussed in the relevant literature, it can be expected to be dependent on
the nature of the utilized stoichiometric oxidant, and on the conditions of the oxidation
reaction.
In contrast, the critical mechanistic step involving the reaction of the oxoammonium
ion TEMPO+ with the corresponding substrate alcohol has been subject to detailed
studies. Accordingly, a complex mechanistic picture has been developed, involving two
distinct mechanisms depending on the pH of the reaction medium.[134, 138] In basic
media (Scheme 4.2, a) the reaction is thought to proceed via nucleophilic attack of
an alkoxide onto the oxoammonium nitrogen. The resulting tetrahedral intermediate
forms preferentially for sterically less crowded alcohols due to the bulky tetramethylated
environment of the oxoammonium ion, and therefore primary alcohols react selectively
over secondary alcohols. Noteworthy, due to the generally high stability constants
of the intermediate, even small alkoxide concentrations (e.g. at pH 5) allow for this
mechanism. Fragmentation of the intermediate (the overall rate-determining step) gives
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Scheme 4.2 Catalytic cycles suggested for TEMPO-catalyzed oxidation reactions of al-
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the carbonyl product and the hydroxylamine TEMPO-H, which can be converted to
TEMPO or to the oxoammonium ion TEMPO+ by the secondary oxidant. In acidic
media (Scheme 4.2, b), an alternative bimolecular mechanism is thought to proceed
via hydride transfer of the alcohol to the oxoammonium ion oxygen. Since this hydride
transfer is faster for higher substituted alcohols, secondary alcohols tend to react faster.
However, the rate of this reaction is significantly lower as compared to the reaction
under basic conditions. As a result, in many oxidation protocols, a buffer is added to
neutralize any acidic species, for example derived from the stoichiometric oxidant (see
below). In this way, a clean and fast reaction following mechanism (a) can be expected,
exhibiting high selectivity for primary over secondary alcohols.
A large number of conditions involving diverse stoichiometric oxidants for TEMPO-
catalyzed oxidations have been published to date.[139, 140] A widely employed alcohol
oxidation protocol was introduced by Anelli et al. (Scheme 4.3, a).[141] Sodium
hypochlorite is used as a secondary oxidant, and the reaction is run in a biphasic
solvent mixture (CH2Cl2/H2O). Sodium hydrogen carbonate is added as a buffer, and a
bromide salt (KBr) was found to have an accelerating effect on the reaction. Optionally,
quaternary ammonium salts (Aliquat 336) can be added as phase-transfer catalysts to
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further increase the reaction rate. With this protocol, primary and secondary alcohols
can be oxidized to the corresponding carbonyl products, and by controlling the reaction
time and the amount of NaOCl, overoxidation of aldehydes (in hydrated form) to the
carboxylic acids can be prevented. Although these reaction conditions can be regarded
as generally mild, for specifically functionalized substrates, side reactions have to be
considered. In this regard, vicinal diols can be cleaved under these conditions, and
therefore only minimum amounts of the strong oxidant NaOCl should be used.[142]
Likewise, lactols are easily converted to lactones with excessive oxidant.[143] Neverthe-
less, this method is frequently applied for otherwise challenging transformations. Due to
the high selectivity of primary over secondary alcohols, this protocol can be regarded as
a method of choice for such a selective transformation.[144] To overcome problems with
side reactions, induced by NaOCl or by the derived acid HOCl, several modifications of
this protocol have been developed, the most prevalent being the variant described by
Piancatelli and Margarita (Scheme 4.3, b).[145] In this reaction, PhI(OAc)2 is used
as a stoichiometric oxidant in combination with catalytic TEMPO. The reaction can be
run in CH2Cl2 as the sole solvent, and thus, under anhydrous conditions. Notably, in
this reaction, similarly high selectivities for primary alcohol oxidations in the presence
of secondary alcohols were observed.
R R'
OH
H
TEMPO (1 mol%),
NaOCl (> 1 equiv.),
KBr (10 mol%), NaHCO3,
(a)
R R'
O TEMPO (10 mol%),PhI(OAc)2 (> 1 equiv.),
(b)
R R'
OH
H
R R'
O
CH2Cl2, 20 °CCH2Cl2, H2O, 0 °C
(Aliquat 336)
Scheme 4.3 (a) Anelli’s protocol for TEMPO-catalyzed alcohol oxidation, using NaOCl
in a biphasic medium.[141] (b) Piancatelli’s and Margarita’s protocol for
TEMPO-catalyzed alcohol oxidation, using PhI(OAc)2 in CH2Cl2.[145] R, R’
= H, organic residue.
Although these protocols have found widespread application as synthetic tools, fur-
ther investigations into the oxidation chemistry mediated by nitroxyl radicals are still
being pursued. For example, sterically less demanding adamantane-derived nitroxyl
radicals have been shown to be superior for the oxidation of sterically crowded secondary
alcohols, for which TEMPO-based methods are unsuitable.[146] Furthermore, chiral
nitroxyl radicals (or chiral oxoammonium species) have been developed, enabling the
enantioselective oxidation of the alcohol substrates, for example in kinetic resolution by
oxidation processes.[147]
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4.2. Introduction to Higher Sugars
The vast majority of the naturally occurring carbohydrates belong to the pentoses or
the hexoses, featuring a chain length of 5 or 6 consecutive carbon atoms, respectively.
Accordingly, sugars with a chain length above 6 carbon atoms are commonly referred to
as higher sugars. This interesting and diverse class of carbohydrates is associated with
complex molecular structures and is frequently involved in many biological processes.
An appropriate short introduction is given in a synthetic work by Baptistella and
Coworkers.[148] Thus, higher-carbon sugars with 7 or 8 carbon atoms (heptoses and
octoses) are frequently located in bacterial lipopolysaccharides, for example 3-deoxy-α-
d-manno-oct-2-ulosonic acid (Kdo, G in Scheme 1.2 on page 3) or l-glycero-d-manno-
heptose (LDmanHep, H in Scheme 1.2). 9-Carbon sugars (nonoses) are prominently
represented by the natural neuraminic acids/sialic acids family (like sialic acid F in
Scheme 1.1), which are important components of saccharidic ligands targeted by
lectins in biological recognition processes. Such heptoses, octoses and nonoses found in
nature have been subject to intensive studies, and multiple reviews have been published
on these well-known types of higher sugars.[10, 149–151] In contrast, higher sugars with
10 or more carbon atoms can be regarded as rare, some of them being found as the
glycosidic components of natural products (see below).
Higher sugars in general have been attractive targets for synthetic carbohydrate
chemistry. Typical synthetic strategies often involve conventional hexoses as starting
materials and suitable homologation reactions for the chain elongation. Stereogenic
centers in the target molecules, often hydroxylated, are frequently installed after
chain elongation, for example via selective hydroxylation reactions of unsaturated
intermediates.[152] A short summary of interesting synthetic strategies described in the
literature is given below.
Early syntheses of higher sugars, as reported by R. Schaffer, were based on the aldol-
selfcondensation of protected monosaccharides under basic conditions.[153, 154] In these
experiments, carbon-branched higher sugars of purely synthetic origin could be isolated.
Later, synthetic work on higher sugars frequently focussed on the targeted synthesis of
unusual saccharides of natural origin. An interesting class of antibiotic natural products
isolated from several strains of Streptomyces are the quinocyclines, which possess a
tetracyclic anthraquinoid framework as the aglycon.[157] The glycosidic components
of the quinocyclines have been identified to be unusual 4-C -branched 2,6-dideoxy l-
sugars. For example, the glycosidic component of quinocycline A and isoquinocycline
A was found to be the monosaccharide dihydrotrioxacarcinose B (depicted as its α-l-
methyl glycoside CK in Scheme 4.4). In an early total synthesis of CK, Paulsen
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Scheme 4.4 Top: Paulsen’s synthesis of methyl α-dihydrotrioxacarcinoside B (structure
CK) via vinylation/epoxidation.[155] Bottom: Myers’ synthesis of methyl
α-trioxacarcinoside B CP via Stille coupling/dihydroxylation.[156]
and Coworkers subjected epoxy alcohol CG, derived from l-rhamnal, to a ruthenium-
based C -4 oxidation to provide 4-uloside CH.[155] Addition of vinyllithium gave
vinyl-branched CI, together with other isomeric products. Epoxidation of the side chain
gave, unfortunately, the wanted epoxide isomer CJ as the minor product. Reduction of
the diepoxide with LiAlH4 resulted in the formation of target compound CK. Although
CK should be regarded as a 4-C -hydroxyethyl-branched hexose, the unusual sugar
is sometimes referred to as an octose.[155] For reasons of structural elucidation, CK
was treated with dilute trifluoroacetic acid to induce the formation of bicyclic CL, a
suitable example for the peculiar structures that such higher sugars can possess. The
related natural products quinocycline B and isoquinocycline B feature a structurally
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comparable glycosidic component referred to as trioxacarcinose B (depicted as its
α-l-methyl glycoside CP in Scheme 4.4), formally arising from CK by oxidation
of the side chain secondary alcohol to the ketone. In a modern total synthesis of
CP, Myers and Coworkers employed a Stille reaction between vinyl triflate CM and
an ethoxyvinylstannane to furnish, after acidic hydrolysis, enone CN.[156] Since the
corresponding epoxide derived from CN (not shown) was unreactive, a sequence of
syn-dihydroxylation, reaction with thionyl chloride and subsequent oxidation of the
sulfur was used for the formation of the cyclic sulfate CO. This sulfate intermediate
was more electrophilic than the epoxide, thereby enabling nucleophilic displacement
with cesium acetate, followed by hydrolytic removal of the sulfate and deacetylation to
give the target glycoside CP.
A class of compounds generally associated with structurally diverse higher sugars
are the undecose nucleosides (see also BA in Scheme 3.3 on page 31). A peculiar
representative of this class, the anthelmintic natural product hikizimycin features an
undecose core (termed hikosamine) consisting of a 4-deoxy-4-amino-glucopyranose linked
via the C -5 to a fully oxygenated mannitol moiety (depicted as its α-methyl glycoside
in peracetylated form CV in Scheme 4.5). In a synthetic approach to the hikosamine
undecose, Danishefsky and Coworkers reacted d-galactose-derived aldehyde CQ with
reactive diene CR in a MgBr2-mediated Hetero-Diels-Alder reaction.[158] The obtained
dihydropyran-4-one CS was subjected to Luche reduction of the enone, epoxidation with
syn-selectivity with respect to the allylic hydroxyl group, and debenzoylation to provide
CT with manno-configuration. Reduction of the hemiacetal and perbenzylation gave
CU, which incorporated all required stereogenic centers of the side chain. Subsequent
steps transformed the galactose residue (R) into a 4-deoxy-4-amino-glucopyranose, and
the target methyl peracetyl-α-hikosaminide CV was available. In a different approach
to the hikosamine undecose (Scheme 4.5, bottom), Schreiber and Coworkers started
from l-(+)-di-iso-propyl tartrate CW.[159] After benzylation, a two-directional elabo-
ration of the chain started with Horner-Wadsworth-Emmons olefination under reducing
conditions to give diene CX. Site-selective dihydroxylation and silylation provided CY,
which incorporated 6 of the stereogenic centers required for the hikosamine structure.
In subsequent steps involving sequential DIBAL-H reductions, Swern oxidations, olefina-
tions and dihydroxylations, further two-directional elongation of the chain towards the
hikosamine undecose could be achieved. Apart from the mentioned, other syntheses of
the unusual hikosamine higher sugar were developed, including a modern two-fragment
approach by Fürstner and Coworkers.[160]
As a prototypical example of a structurally unique higher sugar, Pérez and Coworkers
isolated the natural product peltalosa CZ from roots of the Mexican plant Psacalium
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Scheme 4.5 Top: Danishefsky’s approach to peracetylated methyl α-hikosaminide CV via
Hetero-Diels-Alder reaction and epoxidation/hydride reductions.[158] Bottom:
Schreiber’s synthetic route for the intermediate CY towards the open-chain
hikosamine.[159]
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Scheme 4.6 Top: proposed structures of the natural product peltalosa CZ and its open-
chain diulose form DA (configurations unknown).[161] Bottom: Menzel and
Ziegler’s synthetic approach towards symmetrical 5,6-diulose DF with connec-
tivity identical to CZ.[162]
peltatum in 2005.[161] The compound exhibited an interesting hypoglycemic activity,
and was thus potentially interesting for the therapeutic treatment of type 2 diabetes
mellitus. Although the structural characterization described by the authors did not allow
for the assignment of the stereochemical configurations, mass spectra in combination
with an unexpected simplicity of the NMR spectra suggested the structure of a C 2-
symmetric decalin-like molecule CZ (Scheme 4.6, top). Drawn in its corresponding
open-chain isomeric form DA, the structure can be identified to be a symmetric deco-
5,6-diulose. In a synthetic approach towards similar symmetric 5,6-diulose systems,
Menzel and Ziegler utilized a sequence of Wittig-olefination and alkene metathesis
homodimerization for the synthesis of arabinose-derived symmetrical dec-5-enitol DD
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(Scheme 4.6, bottom).[162] The α-diketone could be constructed by a sequence of
dihydroxylation followed by oxidation of the diol, but the latter turned out to be
nontrivial. A modified Swern-type protocol employing DMSO/trifluoroacetic anhydride
(TFAA) in combination with Hünig’s base proceeded reliably, and the 5,6-diulose DE
was obtained. After deprotection the diulose occupied a cis-decalin-type structure DF
which was confirmed by X-ray crystallography. Although a comparison of the spectral
properties of DF with those reported for the isolated CZ suggested that it was a
stereoisomer of the natural product, this approach can be regarded as a general route
to such structurally interesting higher-carbon diuloses.
In all of the examples given above, the syntheses involved oxidative functionalizations
of alkene substrates via syn-dihydroxylation or epoxidation. These types of transfor-
mations can thus be regarded as essential reactions for the synthesis of higher sugars,
but the prediction of the stereoselectivity of the product formation can be intricate for
complex substrates. In this regard, S. Jarosz performed investigations on the stereochem-
ical outcome of the osmoylation[163] and epoxidation[164] of the higher bis-glycosidic
allylic alcohols DG and DH (Scheme 4.7). Accordingly, syn-dihydroxylation of DG
(Scheme 4.7, a) resulted in the formation of major isomer DI (d.r.= 86:14). This
finding was in accordance with Kishi’s empirical rule[105, 106], which suggests attack of
osmium tetroxide from the face of the alkene opposite to that of the allylic hydroxyl in an
eclipsed conformation, with the allylic hydrogen in plane with the alkene. Surprisingly,
under the same conditions, the diastereoisomeric allyl alcohol DH was transformed
into major isomer DJ (d.r.= 67:33), obviously via attack from the side of the allylic
hydroxyl, and thus, in an “anti-Kishi“ sense. In this case, by the author, this finding
was attributed to a dominating repulsive effect of the furanose (Sug2) ring oxygen over
the repulsive effect of the allylic hydroxyl. An investigation of epoxidations of allylic
alcohol DG revealed comparably false predictions of established models (Scheme 4.7,
b). Epoxidation of DG with m-CPBA gave DK (d.r. = 81:19), commonly designated
as the threo-product. An analysis employing the Sharpless model[165] for acyclic allylic
alcohols, which proposes a dihedral angle HO-C-C=C of 120° and peroxy acid attack
from the side of the allylic hydroxyl, was in accordance, and also predicted the formation
of the threo-product DK. In contrast, epoxidation of the same substrate DG with
VO(acac)2/t-BuOOH gave the same major threo-product DK, although a comparable
analysis with the Sharpless model for vanadium-catalyzed epoxidations ([V]O-C-C=C:
50°) suggested the formation of the corresponding erythro-product, which was only
observed as the minor component (d.r. = 63:37). Obviously, due to the crowded nature
of the substrate allylic alcohols, additional steric factors result in deviations from the
standard models that usually give good predictions for simpler substrates.
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Scheme 4.7 (a) Structures of higher sugar allylic alcohols DG and DH, major isomers
DI and DJ formed in syn-dihydroxylations, and proposed modes of attack
of osmium tetroxide. (b) Epoxidations of allylic alcohol DG and Sharpless’
models for the predicted modes of attack.[163, 164]
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Whereas the examples given above can be seen as a general introduction to strategies
for the synthesis of higher sugars, the following section introduces a naturally occur-
ring higher sugar with special relevance to this thesis. The unusual monosaccharide
bradyrhizose K (Scheme 1.3) is structurally related to the target higher sugars T-4.
Accordingly, a summary of published work on K is given below.
4.3. Introduction to Bradyrhizose: An Unusual Higher
Monosaccharide
The reduction of atmospheric dinitrogen to biologically available ammonia as a nitrogen
source is of tremendous ecological relevance. Industrially, this conversion is achieved in
the Haber process. By far the most prevalent natural source of fixed nitrogen stems
from symbioses of certain flowering plants (mostly legumes) with gram-negative soil
bacteria capable of nitrogen-fixation, thus enabling the host plant to live in a potentially
nitrogen-poor environment. On the side of the host plant, ca. 70% of all legume
species, together with multiple other actinorhizal plants can potentially undergo such a
symbiosis. On the side of the soil bacteria, hundreds of species of Proteobacteria (Alpha-
and Betaproteobacteria) share the ability of nitrogen fixation in symbioses with legume
host plants, and this type of bacteria is referred to as rhizobia. In contrast, symbioses
of the non-legume actinorhizal plants can only be established by Actinobacteria of one
genus (Frankia).[166, 167]
On a molecular level, bacterial nitrogen fixation is facilitated by the nitrogenase
enzyme, a two-protein complex with Fe-S- and Mo-Fe-S-cluster core elements, which
is capable of the reduction of molecular dinitrogen.[168] This reducing nitrogenase
complex is irreversibly damaged by the action of atmospheric oxygen, however, the
rhizobia themselves do rely on oxygen for respiratory purposes. On the level of the
plant-rhizobium-symbiosis, this contradiction is addressed by the formation of nodules,
symbiosis-specific organs, which are usually clearly visible at the roots of the host
plant (comp. Fig. 4.1) or, less frequently, at the stem. These nodules are densely
populated by the rhizobia, which then differentiate into nitrogen-fixing bacteroids.[170]
The interior of the nodules is characterized by a low concentration of free oxygen, and a
certain plant hemoglobin (leghemoglobin) is synthesized within the nodules to provide
the guest bacteroids with oxygen, showing the high degree of sophistication achieved
in such symbiotic relationships.[166, 167] From this perspective, an initiation of the
symbiosis is required to result in the formation of nodules (a process termed nodulation)
before nitrogen fixation within the nodules is feasible. This initiation process has been
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Figure 4.1 Nodulated soybean root. Picture taken in Dodge County, Wisconsin, U.S.
Picture gratefully reprinted with permission from CropWatch.[169]
subject to detailed investigations, and at least three different modes of initiation are
currently discussed. In this regard, the most prevalent and best understood mechanism,
realized in efficient symbioses between most rhizobia and various legume plants, is
referred to as the Nod strategy.[167] This type of mechanism relies on the mutual
exchange of diffusible signaling substances between the potential host plant and the
rhizobium. Initially, flavonoid signaling molecules are produced by the legume plant.
As a result, in the rhizobia, nodulation genes (nod genes) are expressed, facilitating the
biosynthesis of strain-specific lipochitooligosaccharides, which are universally designated
as Nod factors. In the vast majority of rhizobia, three enzymes are involved in the
biosynthesis of these lipochitooligosaccharides, and all three enzymes are encoded for by
what is referred to as the canonical nodABC genes. In turn, in the host plant, receptor
recognition of the Nod factors results in a biochemical cascade culminating in root (or
stem) nodulation, and finally, in infection by the rhizobia.[166, 167, 171]
In 2007, Giraud et al. discovered that two photosynthetic strains of the genus
Bradyrhizobium (Bradyrhizobium BTAi1 and ORS278) were capable of establishing
nitrogen-fixing symbioses with the aquatic legume plants Aeschynomene sensitiva and
indica, accompanied by nodulation of the plant’s roots and of the stems.[171] Unexpect-
edly, although functional symbioses could be observed, the determination of the complete
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Scheme 4.8 (a) Structure K of the bradyrhizose monosaccharide and open-chain Fischer
projection with carbocyclic moiety. (b) Repeating unit of the Bradyrhizobium
BTAi1 O-antigen polysaccharide with α
(
1→7) connectivity. (c) Isomeric
distribution of reducing bradyrhizose K in D2O.[14]
genomic sequences of both Bradyrhizobium strains indicated the absence of the canonical
nodABC genes. Since all other previously characterized rhizobia contained the nodABC
genes, these findings indicated a completely novel mode of initiation of symbiosis. The
question arose, how these types of Nod factor-independent symbioses are established.
In this context, an involvement of the bacterial Lipopolysaccharides (LPS, Fig. 1.1 on
page 3) in the early recognition events of the symbiosis were investigated by Molinaro
and Coworkers in 2011.[13] Due to the, in general, immunologically highly active nature
of the LPS, and their known involvement in a plethora of bacterium-host-interaction
processes (comp. Chapter 1), this question was addressed for Bradyrhizobium BTAi1.
From dried cells of Bradyrhizobium BTAi1, Molinaro and Coworkers were able to isolate
the LPS.[13] The O-antigen (Fig. 1.1) region of the extracted rhizobial LPS could be
characterized, and its repeating unit was found to be composed of a single, structurally
unique monosaccharide, which was designated bradyrhizose K.
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Figure 4.2 Results of molecular mechanics and dynamics calculations. Top: Connolly
surface of the bradyrhizose eicohexasaccharide, showing a two-fold helicoidal
conformation. Bottom: two representations of the calculated hydrophobic tunnel
(bicyclic framework pointing inwards, hydroxyl and methyl groups pointing
outwards) in the helicoidal conformation of a bradyrhizose octasaccharide.
Figure gratefully reprinted with permission from John Wiley and Sons.[13]
The structure of K (Scheme 4.8, a) can be described as a methylated inositol,
which is annulated to a galactose moiety in a trans-decalin-type fusion. Within the
repeating unit of the O-antigen polysaccharide of Bradyrhizobium BTAi1 (Scheme
4.8, b), the monosaccharide is connected via α
(
1→7) linkages. Comparably, the LPS
of Bradyrhizobium ORS278, the second strain for which absence of nodABC genes
was observed, is also composed of α
(
1→7)-linked bradyrhizose units, but in this case
the α
(
1→9)-linked isomers were found, too.[172] The structure of monomeric K is
usually depicted in the shown 1,5-pyranose form, however, later structural studies by
Yu, Molinaro and Coworkers revealed a complex mixture of isomers for the reducing
monosaccharide (Scheme 4.8, c).[14] Thus, in aqueous solution (D2O), K exists in the
α- and β-form of the major 1,5-pyranose (83.5% total isomeric contribution), together
with the minor 1,4-spirofuranose form (α and β, 8.8%) and the minor 1,9-pyranose (β-
isomer only, 7.7%). To study possible conformations adopted by the O-antigen structure
(the bradyrhizose polysaccharide), the authors performed molecular mechanics and
dynamics calculations. Thus, calculations on a bradyrhizose eicohexasaccharide (Fig.
4.2, top) suggested the preference for a right-handed two-fold helical conformation.
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The bicyclic framework was found to point towards the inside of the helix, thus forming
a “hydrophobic tunnel“, with all hydroxy and methyl substituents pointing outwards
(Fig. 4.2, bottom).[13]
The structurally unique bradyrhizose monosaccharide, together with the interesting
conformational behavior suggested by computational results, raised the question whether
the nature of the O-antigen of Bradyrhizobium BTAi1 was essential for the initiation
of symbiosis with the host plant Aeschynomene indica. In subsequent immunological
studies, A. indica and other model plants were subjected to either the intact LPS of
Bradyrhizobium BTAi1, or to its O-antigen polysaccharide. A potential innate immune
response was tracked by the elicitation of an oxidative burst caused by the generation of
reactive oxygen species. Notably, neither the intact LPS, nor the O-antigen, triggered
an immune response in the tested plants, including their host plant A. indica, and were
thus not recognized as microbe-associated molecular patterns. This seemed to be the
first evidence for a bacterial LPS unit which does not result in a defensive immune
answer in plants. These results suggested that the structure of bradyrhizose K, and of
the derived O-antigen, might be involved in the initiation of symbiosis. Specifically, the
authors stated the hypothesis that the rhizobium Bradyrhizobium BTAi1 evolutionarily
acquired the unusual O-antigen structure to evade being recognized by ist host plant A.
indica as a hostile microbe.[13]
In 2015, the first total synthesis of bradyrhizose K was disclosed by Yu, Molinaro
and Coworkers.[14] The synthesis of the monosaccharide could be achieved in 26 steps
in an overall 9% yield. Starting with 2-C -alkenyl-branched glucal DL (Scheme 4.9),
which was available from direct Pd-catalyzed C -2-functionalization of tri-O-acetyl
glucal, the axial C -2-OH was obtained from an epoxidation/epoxide opening sequence,
giving C -2-branched mannoside DM after protecting group transformations. DIBAL-H
reduction of the ester, silylation and acetylation gave DN, which was converted into
the primary iodide DO. Dess-Martin oxidation and elimination of the iodide gave the
unstable conjugated enone intermediate, which was directly treated with MeLi to install
the axial methyl group in DP. Further protecting group manipulations gave DQ. In a
Hg(OAc)2-mediated Ferrier carbocyclization (Ferrier II reaction) as a key step (Scheme
4.10), DQ was converted into the keto-inositol DR, which underwent reduction under
Evans-Saksena conditions with Me4NHB(OAc)3 to give, after selective benzoylation of
the equatorial hydroxyl group, DS. Dess-Martin oxidation, followed by axially-selective
hydride reduction, gave the inverted product, which was then protected as the silyl
ether DT. Dihydroxylation of the alkene under Sharpless conditions, with AD-mix α
and MeSO2NH2, required additional co-oxidant (K2S2O8), ligand ((DHQ)2PHAL) and
potassium osmate, and resulted in side products due to acetyl migration. Therefore, the
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Scheme 4.9 Total synthesis of bradyrhizose K by Yu, Molinaro and Coworkers.[14] Syn-
thesis of intermediate DQ.
crude mixture was subjected to selective deacetylation in the presence of the benzoyl
group, with Mg(OMe)2, to give the side chain triol DU. Selective oxidation of the
primary alcohol in DU to the corresponding aldehyde was found to be challenging.
For example, oxidation with TEMPO/PhI(OAc)2 (comp. Chapter 4.1) resulted in
partial oxidative diol cleavage. Under milder conditions, employing the combination
TEMPO/trichloroisocyanuric acid (TCICA), clean conversion to the aldehyde was
observed, but the following desilylation with TBAF was accompanied by epimerization
of the α-stereogenic center. For this reason, DU was directly silylated to give DV,
which was next treated with TEMPO/TCICA in the described method. Since partial
overoxidation of the intermediately formed lactol to the corresponding lactone could not
be prevented, the reaction was deliberately run until complete conversion to the lactone
was observable, and subsequent DIBAL-H reduction furnished the wanted lactol DW.
In the final step, hydrogenolytic debenzylation provided the target bradyrhizose K. In
2017, Yu, Molinaro and Coworkers developed an extension of this synthetic strategy
to enable the synthesis of the corresponding bradyrhizose tetra- and pentasaccharides
via glycosylation chemistry.[173] When these synthetic oligosaccharides were employed
in plant immunological studies, in agreement with previous results using the natural
bradyrhizose-containing material, no immune response was registered.
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Scheme 4.10 Continued: Total synthesis of bradyrhizose K by Yu, Molinaro and Cowork-
ers.[14] Completion of the synthesis.
In a recent publication in 2019, Lowary and Coworkers reported on a second synthetic
approach to the bradyrhizose monosaccharide.[172] Based on a racemic synthesis and
a late-stage resolution, both the natural d- and the l-enantiomer of K could be
synthesized in 25 steps. The synthesis started from the known racemic orthoester
(±)-DX (Scheme 4.11), which was derived from myo-inositol (a meso compound).
Swern oxidation gave a ketone, which displayed a high tendency for the formation of a
hydrate upon purification. Therefore, the crude ketone was treated with MeMgBr to
give the corresponding tertiary alcohol and, after benzylation, (±)-DY was obtained.
Reductive opening of the orthoester with DIBAL-H, followed by the introduction of a
tri-iso-propylsilyl (TIPS) protecting group provided intermediate (±)-DZ. A second
DIBAL-H reduction of the benzylidene acetal resulted in the formation of two isomeric
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Scheme 4.11 Total synthesis of bradyrhizose K by Lowary and Coworkers.[172] Synthesis
of racemic intermediate (±)-ED. Only the d-enantiomers are shown.
alcohols as a mixture, which gave the single product (±)-EA upon benzylation. After
Pd-catalyzed deallylation, the deprotected intermediate was reacted with CS2/MeI
in the presence of LiHMDS as a base, forming the xanthate (±)-EB. Next, Barton-
McCombie deoxygenation gave (±)-EC, and upon acidic PMB-cleavage, followed by
Swern oxidation, the key intermediate (±)-ED was obtained. The racemic synthesis
continued (Scheme 4.12) with the addition of lithiated ethyl propiolate to the ketone
functionality in (±)-ED with equatorial selectivity, giving alkynyl-branched inositol
(±)-EE. Reduction to the (E)-alkene was successful with the Red-Al reagent, and
desilylation gave (±)-EF. Direct dihydroxylation of (±)-EF under Sharpless AD
conditions progressed reluctantly, and the corresponding spirolactone resulting from
cleavage of the ethyl ester was isolated as a side product. Therefore, further protecting
group transformations were required. Benzylation of the crowded tertiary alcohol
in (±)-EF was not feasible, but a sequence of benzylidene acetal formation in the
presence of camphorsulfonic acid (CSA), followed by regioselective reductive opening
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Scheme 4.12 Continued: total synthesis of bradyrhizose K by Lowary and Coworkers.[172]
Synthesis of racemic intermediate (±)-EJ. Only the d-enantiomers are
shown.
with Et3SiH/PhBCl2 provided benzylated (±)-EH. Further protection of the secondary
hydroxyl group was found to be necessary to obtain a suitable substrate for the
subsequent dihydroxylation reaction, and therefore (±)-EH was converted into the
silylated intermediate (±)-EI. The syn-dihydroxylation under conventional Sharpless
AD conditions (K2OsO4 and the ligand (DHQ)2PHAL) displayed only slow conversion,
but an optimized procedure involving O-(4-chlorobenzoyl)hydroquinine (DHQ-CLB)
as the ligand was capable of the transformation to the wanted side chain diol (±)-EJ.
The resolution of this final racemic intermediate (Scheme 4.13) could be achieved
by acylation with (S)-Mosher’s acid [(S)-α-methoxy-α-(trifluoromethyl)phenylacetic
acid, (S)-MTPA], which was found to react selectively with the l-enantiomer, giving
acylated l-EK in 50% yield. Under these conditions, 36% of the corresponding d-
4.3. Introduction to Bradyrhizose: An Unusual Higher Monosaccharide 77
enantiomer d-EJ could be reisolated. In the final stages of the synthesis of the
natural d-enantiomer, unreacted d-EJ was desilylated with TBAF in the presence
of NH4F, giving a mixture of the desilylation product together with the lactone due
to ester-cleavage. Reduction of this mixture with DIBAL-H provided d-EL, which
was subjected to hydrogenolytic debenzylation to obtain the natural enantiomer d-
bradyrhizose d-K. For the synthesis of the l-enantiomer, a deacylation step was required
to remove the chiral auxiliary. However, common deacylation methods like NaOMe in
MeOH were unsuccessful. Therefore, l-EK was treated with LiBH4, which resulted
in removal of the Mosher ester accompanied by complete reduction of the side chain
to the primary alcohol. Subsequent desilylation provided the tetrol l-EM. Finally,
comparable to the first total synthesis by Yu and Molinaro, selective primary alcohol
oxidation was achieved with the combination TEMPO/TCICA to afford a mixture of
the lactol and the lactone. DIBAL-H reduction of the mixture gave the lactol l-EL,
and, after benzyl deprotection, l-bradyrhizose l-K was available. Following these
syntheses of the d- and l-enantiomers of K, Lowary and Coworkers developed suitable
derived glycosylation donor/acceptor partners to construct bradyrhizose disaccharides
with variable stereochemical combinations (dd, dl, ld, ll, each in the form of the
methyl glycoside) and with variable nature of the glycosidic linkage (α
(
1→7), β(1→7),
α
(
1→8)). When the thus obtained disaccharides were utilized in plant immunological
tests with the model plant Arabidopsis thaliana, the majority of combinations were
found to be immunologically silent, including the “natural“ combination (dd, α
(
1→7)).
However, some other combinations involving the l-enantiomer or other types of glycosidic
linkages did result in the generation of an oxidative burst associated with a defensive
immune response. These results seemed to be in agreement with the previously stated
hypothesis, that the unusual structure of the bradyrhizose-containing O-antigens were
evolutionarily acquired to be immunologically silent.
Based on these summarized interesting results regarding the chemical and biological
properties of the natural bradyrhizoseK, the synthesis of structurally comparable higher
sugars was pursued in the context of this thesis. In this regard, the developed synthetic
routes involve key transformations related to those in the summarized syntheses of
natural K, for example represented by stereoselective dihydroxylations of alkenyl-
branched intermediates, or by the selective primary alcohol oxidation. Following a
successful synthesis of the desired analogs, a comparison of identified isomeric forms
with those described for the complex isomeric mixture of bradyrhizose K was of special
interest. The results obtained along these lines are given below.
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Scheme 4.13 Continued: total synthesis of bradyrhizose K by Lowary and Coworkers.[172]
Resolution of intermediate (±)-EJ and completion of the synthesis of enan-
tiopure d-bradyrhizose d-K and l-bradyrhizose l-K.
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Scheme 4.14 Structural comparison of the major 1,5-pyranose isomer of natural monosac-
charide bradyrhizose K with structurally related target compounds T-4
of this chapter. For clarity, T-4 is depicted in the (9S)-9,7-pyranose-1,9-
pyranose isomeric form.
An interesting isomeric distribution of cyclic hemiacetal forms was characterized for the
natural monosaccharide bradyrhizose K (Scheme 4.8, (c), on page 70). Inspired by
this, the following question was addressed: can generic target compounds of the general
structure T-4 (Scheme 4.14) be obtained, in which the inositol moiety present in K
is substituted for a conventional sugar with otherwise identical configurations of the
hydroxylated stereogenic centers (a β-mannoside)? The open-chain forms of T-4 can
be regarded as 4-C -formyl-branched octoses, and thus, higher dialdoses. Therefore, as
compared to carbocyclic monoaldehyde K, the presence of a second carbonyl functional
group amenable to additional ring closures would potentially result in an increased
number of cyclic hemiacetal isomers. As a consequence, it would be of interest to examine
whether the intuitively anticipated (9S)-9,7-pyranose-1,9-pyranose isomeric forms T-4
(the “bradyrhizose-type“ isomeric forms) can be identified to be the major isomers.
Furthermore, a stereodivergent synthesis would allow for variable configurations of the
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C -2/3 stereogenic centers. In this way, an influence of axial/equatorial substitution
patterns within the annulated pyranose ring on the respective major cyclic hemiacetal
forms could be examined. As a connection to the results described in Chapter 3, the
anticipated “bradyrhizose-type“ isomeric forms of T-4 are structurally related to the
1,2-annulated target compounds T-3. In this regard, target compounds T-4 formally
arise from oxidation of the proanomeric methylene group of the side chain in T-3 to
the reducing free hemiacetal. Since detailed structural studies on the non-reducing
dioxadecalins T-3 confirmed the trans-decalin geometry of the annulated framework,
the respective reducing isomers of T-4 could also be expected to exhibit a trans-decalin
geometry with 4C 1 conformations of both pyranose moieties.
In earlier work in our group by M. Menzel, synthetic routes were explored towards
the higher sugars of type T-4.[174] However, the structure of natural bradyrhizose K
was not yet published at that time, and therefore these studies were motivated by a
purely synthetic interest in the generic target compounds T-4, and when synthetic
challenges were encountered, the project was abandoned.
In the course of this thesis, this project was reconsidered, and preliminary synthetic
studies were performed on the synthetic approach that was initially proposed by Menzel
and Ziegler.[174] According to this approach (Scheme 4.15, a), benzyl β-2-uloside 2b
could be utilized as a substrate for the C -2-alkynylation with a metalated derivative
of a suitably protected propiolaldehyde derivative, for example as its corresponding
acetal. In this synthetic strategy, the required aldehyde oxidation state at the side
chain C -9 (the later C -1 in T-4) would be installed in this early stage of the synthesis.
Partial hydrogenation of the alkynylated intermediate, for example under Lindlar
conditions, would give the acetal of a side chain (Z )-enal. Subsequently, syn- or
anti-dihydroxylation could give the corresponding diol with variable stereochemistry
and, after global deprotection and liberation of the side chain aldehyde, T-4 could be
obtained.
In a second approach explored in later synthetic studies (Scheme 4.15, b), an
analogous alkynylation of the 2-keto functionality could be conducted with unprotected
propargyl alcohol, or with a protected propargyl alcohol derivative. In this way, either
the free side chain propargyl alcohol derivative (R = H), or a derivative with a protecting
group (R = Pg) orthogonally cleavable in the presence of the benzyl ether groups,
would be accessible. Lindlar hydrogenation would give the side chain allyl alcohol
derivative. Next, syn- or anti-dihydroxylation could be performed with either the
protected (R = Pg) or the unprotected (R = H) allyl alcohol, giving the corresponding
dihydroxylated intermediate with variable configurations of the C -7/8 diol stereogenic
centers. In the key step, and comparable to the published syntheses of bradyrhizose
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Scheme 4.15 Considered synthetic routes towards target compounds T-4. (a) Propiolalde-
hyde route (b) Late-stage oxidation route. For clarity, target compounds
T-4 are depicted in the (9S)-9,7-pyranose-1,9-pyranose isomeric form. Pg =
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82 4. Reducing Higher Sugars: Octoses with Analogy to Bradyrhizose
K[14, 172], selective oxidation of the deprotected primary alcohol of the hydroxylated
side chain could give the corresponding aldehyde. After global debenzylation of the
parent pyranose moiety, target compounds T-4 could be obtained. The results from
following both the propiolaldehyde route as well as the late-stage oxidation route are
reported below.
4.5. Results and Discussion
In a preceding analysis, the installation of the aldehyde oxidation state at the side chain
C -9 via alkynylation with a propiolaldehyde acetal derivative (Scheme 4.15, a) was
evaluated to be more promising. In contrast, the alternative selective oxidation step of
the primary hydroxyl group (Scheme 4.15, b) could result in multiple competitive
side reactions, and could thus be anticipated to be challenging. Consequently, initial
synthetic efforts following the propiolaldehyde-route are described in Section 4.5.1.
4.5.1. Preliminary Synthetic Studies
According to the propiolaldehyde route proposed by Menzel and Ziegler[174], propiol-
aldehyde dibenzyl acetal[175] (Pg = Bn) would be a suitable C3 building block for the
alkynylation of the 2-keto functional group of 2-uloside 2b. Specifically, the selection
of the dibenzyl acetal would enable the cleavage of all protecting groups in one final
deprotection step via hydrogenolytic debenzylation, and a second deprotection step to
set free the side chain aldehyde could potentially be avoided. Following these lines of
thought, propiolaldehyde dibenzyl acetal in THF was lithiated with n-BuLi at −80 ◦C,
followed by the addition of 2-uloside 2b (Scheme 4.16). In this way, the novel 2-C -
alkynyl mannoside 22 could be isolated in 85% yield. As observed for addition reactions
to allyl 2-ulosides 1a or 2a (Chapter 3), and in agreement with previous studies[101],
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Scheme 4.16 Synthesis of 2-C -(Z)-alkenyl mannoside 23 via alkynylation and partial
hydrogenation.
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Figure 4.3 13C NMR spectra of 23 in CDCl3 (top) and DMSO-D6 (bottom) in the range
80–115 ppm. The shown spectra are unprocessed.
attack of the nucleophile proceeded solely via equatorial attack, giving the product
with manno-configuration, and no diastereomeric side product could be detected. The
subsequent partial hydrogenation of 22 employing Lindlar’s catalyst[176], either in
EtOAc or in MeOH with up to 30wt% of the catalyst, proceeded very reluctantly,
and only minor conversions of the starting alkyne were observable after several days.
Switching the solvent to 1,4-dioxane had only a slightly accelerating effect on the rate
of the partial hydrogenation. These observations could most probably be attributed to
the sterical crowdedness around the alkyne functionality in 22 due to the substitution
with the bulky dibenzyl acetal and the carbohydrate moiety. In addition, if still present
in considerable amounts, the chromatographic separation of unreacted substrate 22
from alkene 23 was found to be challenging, and therefore a protocol resulting in
complete conversion to 23 was desirable. Although the partial hydrogenation under
Lindlar’s conditions has been used frequently for the semihydrogenation of alkynes, often
specific optimizations with respect to the individual substrate type are required, and
solvent effects on the reaction are hard to assess.[160, 177–180] In the transformation of
22, fortunately, a screening for suitable solvents revealed that DMF had a distinctly
accelerating effect, and alkene 23 could be obtained in 93% yield after 2 days in
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Figure 4.4 X-ray structure of (Z )-alkene 23. One out of four molecules in the asymmetric
unit is shown. Hydrogen atoms of the benzyl ethers are omitted for clarity.
Ellipsoids are drawn at the 50% probability level. Red = oxygen, gray = carbon,
white = hydrogen. Significant distances and torsion angles: C421-C422 1.325Å,
C402-C421-C422-C423 3.0°.
the presence of 50wt% of the catalyst in DMF. The alkenyl-branched mannoside 23
exhibited remarkably complex 1H and 13C NMR spectra in CDCl3 (Fig. 4.3, top).
A possible explanation could involve constrained rotation around the single bonds
adjacent to the alkene moiety caused by the crowded substitution pattern, resulting in
the observation of rotameric isomerism. When the same product sample was analyzed
in DMSO-D6 (Fig. 4.3, bottom), simpler NMR spectra were obtained, and the
structural characterization of 23 was feasible. The value of the vicinal alkene coupling
constant (J 7,8=12.4Hz) was in a region rather suggestive for a Z -alkene, but also
compatible with an E-alkene. Although usually low degrees of (E/Z )-isomerization are
observed for Lindlar hydrogenations[177], an unambiguous characterization of the double
bond (Z )-geometry in 23 was desirable. Apart from 2D NMR methods, single crystals
of 23 suitable for X-ray structural analysis could be obtained from n-pentane/EtOAc.
The molecular structure (Fig. 4.4) clearly confirmed the presence of a (Z )-alkene
(C402-C421-C422-C423 3.0°) with a bond length as expected for an isolated double
bond (C421-C422 1.325Å). In the solid state, the benzyl residues of the sterically
demanding dibenzyl acetal were found to be oriented towards each side of the side chain
alkene functionality.
4.5. Results and Discussion 85
Table 4.1 Reaction screening on the syn-dihydroxylation of alkene 23.
23
OBnO
BnO
OBn
OBn
OH
BnO
BnO
OBnO
BnO
OBn
OBn
OH
BnO
BnO
reagents,
conditions OH
OH
x
# reagents solvents T, t observationa
1 OsO4 (4 to 100mol%),
NMO
Me2CO, H2O,
t-BuOH
r.t. to 70 ◦C,
10 d
no react./
complex mixt.
2 AD-mix α,
MeSO2NH2
H2O, t-BuOH r.t., 2 d,
then: 40 ◦C, 1 h
decomp.b
3 AD-mix β,
MeSO2NH2
H2O, t-BuOH r.t., 2 d
then: 40 ◦C, 1 h
decomp.
4 OsO4 (4mol%),
Me3NO, pyridine
H2O, t-BuOH 70 to 100 ◦C, 5 d complex mixt.
5 OsO4 (100mol%),
DMAP (2 equiv.)
H2O, t-BuOH r.t., 3 d,
then: 40 ◦C, 24 h
no react.
6 RuCl3·(H2O)3 (7mol%),
NaIO4
EtOAc, MeCN,
H2O
0 ◦C, 15min,
then: r.t.
complex mixt.
a Indicated by TLC analysis of the reaction mixture.
b ESI-MS of the crude decomposition product: [M+Na]+ m/z 707 (proposed: debenzylation
and dehydration).
To establish suitable methods for the subsequent side chain dihydroxylation of 23, an
initial screening involving common methods for the syn-dihydroxylation was performed
(Table 4.1). When 23 was subjected to classic Upjohn conditions[104] (entry 1) in the
presence of NMO and catalytic amounts of OsO4 at r.t., only traces of polar products
could be identified via TLC. When up to 100mol% of OsO4 were added, and the
temperature was elevated to 70 ◦C, the reaction mixture still contained major amounts
of unreacted 23 after several days, together with a complex mixture of decomposition
products. Next, the conditions of the Sharpless Asymmetric Dihydroxylation were
explored (entries 2 and 3), and alkene 23 was treated with commercial AD-mix α or
β in the presence of MeSO2NH2 according to the published protocol.[181] At r.t., the
slow formation of a product with lower chromatographic mobility could be observed
for both reactions. However, at this temperature, the reactions stopped after minor
conversions. When higher temperatures (40 ◦C), and thus, unusual conditions for the
Sharpless AD, were applied, one single product of high chromatographic mobility was
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formed in both transformations. Albeit, ESI-MS analysis of the crude product from
the reaction with AD-mix α (entry 2) suggested decomposition of the substrate via a
sequence of debenzylation and dehydration (m/z 707). Next, several methods with
OsO4 in combination with basic additives were tested. Typically, in this regard, pyridine
is used as an additive, often in combination with Me3NO as the secondary oxidant.[182,
183]. Application of this protocol to alkene 23 (entry 4) under forcing conditions (70
to 100 ◦C) resulted in complete conversion of the substrate, but a complex mixture of
products with lower chromatographic mobility was formed. ESI-MS analysis suggested
the presence of multiple decomposition products of lower molecular weight, and the
desired diol product could not be identified. The complex of OsO4 with two equivalents
of DMAP has been described to be a powerful dihydroxylation reagent in stoichiometric
reactions.[184] In the case of 23 (entry 5), these conditions could not affect the dihy-
droxylation of the substrate, even at elevated temperatures and prolonged reaction time
(up to 40 ◦C, 4 d). Finally, a ruthenium-based method using catalytic RuCl3·(H2O)3
and stoichiometric NaIO4 in biphasic EtOAc/MeCN/H2O[185] (entry 6) resulted in no
transformation at 0 ◦C, and in a complex mixture of decomposition products at r.t.
Since even drastic conditions (e.g. stoichiometric amounts of OsO4 at 70 ◦C) could
not affect the syn-dihydroxylation, 23 seemed to be an unsuitable substrate for the
following steps of the synthesis. Most likely, the remarkably inert nature of the alkene
functional group in 23 can be ascribed to the sterically crowded environment, caused by
the dibenzyl acetal moiety and the benzyl groups at the carbohydrate positions 1 and 3.
In addition, the axial hydroxyl group at the carbohydrate C -2 could possibly have an
adverse effect on the accessibility of the alkene functionality. To study such influences
of the substitution pattern around the side chain alkene, a series of routine protecting
group manipulations was performed with alkyne 22 (Scheme 4.17). Acetylation
of the tertiary axial C -2-OH required an excess of DMAP (2 equiv.)[186, 187] and
forcing conditions (65 ◦C, 4 d) to give the propargyl acetate 24, which was in turn
transformed into (Z )-alkene 25 by applying the protocol for the Lindlar hydrogenation
in DMF. Transformation of the dibenzyl acetal group in 22 into the dimethyl acetal
26 was achieved by iodine-catalyzed transacetalization[188] in methanol, and subse-
quent Lindlar hydrogenation gave dimethyl acetal 27 as a sterically less demanding
substrate for dihydroxylation attempts. Similar iodine-catalyzed conditions with 1,3-
dihydroxypropane were found to be unsuitable for the transacetalization of 22 into the
1,3-dioxane 28, and only the corresponding free aldehyde could be detected. In contrast,
classic Brønsted acid-catalyzed transacetalization conditions (1,3-dihydroxypropane,
p-TsOH in toluene) gave 28 in good yield (84%). After Lindlar hydrogenation, 29
was available. Substitution of the acyclic dibenzyl acetal moiety for the cyclic dioxane
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Scheme 4.17 Protecting group diversifications of alkyne 22 and subsequent Lindlar hydro-
genations, giving the corresponding (Z )-alkenes 25, 27, 29 and 31. brsm =
based on recovered starting material.
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Scheme 4.18 Unwanted formation of ketone 32 from dibenzyl acetal 24 under iodine-
catalyzed transacetalization conditions. A plausible mechanism is proposed.
protecting group in 29 was anticipated to result in a less conformationally flexible acetal
group, and thus, easier access to the alkene functionality by the dihydroxylation reagent.
Finally, acetylation of the tertiary C -2-OH in 28, essentially as reported before, gave
acetate 30 in 72% yield. The following partial hydrogenation proceeded, as opposed to
the other hydrogenations, sluggishly, and gave under these unoptimized conditions 31
in a mediocre 22% yield, together with 59% of unreacted alkyne 30 (53% yield based
on recovered substrate).
Several other protecting group transformations were explored, but remained unsuc-
cessful. Among these, in an early attempt, acetylated dibenzyl acetal 24 was subjected
to the conditions for iodine-catalyzed transacetalization in ethylene glycol for the antici-
pated introduction of a dioxolane protecting group (Scheme 4.18). However, under
these conditions, a complex reaction mixture was observed. After aqueous quenching
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and reductive workup of the reaction, C -7-ketone 32, with a fully saturated side chain,
could be isolated as one major product of the reaction (33% yield). The structure
of 32 could be established from 2D NMR experiments, in combination with several
characteristic properties of the 13C NMR spectrum like a pronounced low-field shift
of the quaternary carbohydrate C -2 (88.2 ppm), the absence of signals referring to the
quaternary alkyne carbon atoms of the side chain, and a low-field signal (203.4 ppm)
of a quaternary carbon indicative of the presence of a ketone. A plausible mechanis-
tic explanation for the formation of 32 could involve iodine-activation of the wanted
dioxolane in the form of 24-a (or of another carbonyl derivative like dibenzyl acetal
24-b or aldehyde 24-c), followed by SN2’-type hydration of the activated species and
formation of a hydroxyallene, possibly in the form of a hypoiodite or the respective
free alcohol (24-d). Given the fact that allenes are universally formed in reactions of
propargyl systems under a variety of conditions, the formation of an allene intermediate
is plausible.[189] Notably, since ice was added to the reaction mixture in the first step of
the workup procedure, hydration after the transacetalization step (formation of 24-a)
seems to be likely. Tautomerization of the hydroxyallene would give the corresponding
enone 24-e which, upon reductively quenching with Na2S2O3 in the second workup
step, could undergo intramolecular conjugated addition and formation of the dioxolane.
In a similar mechanism from 24-b or 24-c, external ethylene glycol could participate
in the final conjugated addition step, followed by a cyclization step. Although 32 was
isolated in only mediocre yield, the described reaction gives an impression of potential
interesting side chain functionalizations starting from the C -2-branched propiolaldehyde
derivatives.
Surprisingly, from the obtained (Z )-alkenes 25, 27, 29 and 31, only the sterically
least crowded dimethyl acetal 27 displayed complex NMR spectra in CDCl3 similar to
23. As opposed to 23, however, in DMSO-D6, rotameric isomerism was still observable
for 27, although to a lesser extent. In high-temperature NMR experiments (50 ◦C)
in DMSO-D6, severe decomposition of the dimethyl acetal was visible, and therefore
the complete NMR-based structural elucidation of 27 was not feasible. In extended
investigations on the side chain syn-dihydroxylation, the (Z )-alkenes 25, 27 and 29
with an altered protecting group pattern were reacted under conditions similar to those
applied to 23. Since only insufficient amounts of pure material of 31 were available,
no further transformations were explored with this substrate. The tested conditions
for 25, 27 and 29 involved both classic Upjohn dihydroxylation conditions (similar to
entry 1, Table 4.1 on page 85) as well as the combination Me3NO/pyridine (similar to
entry 4). However, in all reactions, none of the substrates reacted in a clean manner.
Dimethyl acetal 27 was found to undergo rapid cleavage of the acetal group under all
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Scheme 4.19 syn-Dihydroxylation of 29 in the presence of citric acid. The reaction
was performed on a 30mg scale. The given yields are isolated yields after
chromatographic purification. Structures of products 29-a, 29-b and 29-c
are proposed structures, characterized only by ESI-MS analysis and 1H NMR
analysis (for 29-a).
tested conditions, followed by decomposition reactions of the α,β-unsaturated aldehyde,
resulting in complex mixtures. Substrates 25 and 29, on the other hand, displayed
similar behavior like the original substrate 23, and required drastic conditions (similar
to entries 1 and 4) to exhibit any transformation, resulting in mixtures of decomposition
products.
In a final attempt, a reaction sequence of syn-dihydroxylation and acidic acetal
cleavage was tested. Acidic additives like citric acid have been reported to be specifi-
cally beneficial for the syn-dihydroxylation of electron-deficient, otherwise challenging
alkenes.[190] Application of these conditions to dioxane 29 was envisioned to result in
the wanted dihydroxylation, followed by direct acid-catalyzed hydrolysis of the acetal
and liberation of the aldehyde. Indeed, when 29 was reacted under standard dihydrox-
ylation conditions in the presence of citric acid (Scheme 4.19), at high temperatures
(90 to 100 ◦C) the formation of three products with lower chromatographic mobility
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could be observed by TLC. Chromatographic purification of the crude product mixture
provided, eluting in this is order, unreacted 29 (13%), followed by products 29-a
(38%), 29-b (13%) and 29-c (25%). ESI-MS analysis of 29-a suggested cleavage of
the dioxane and formation of the aldehyde. The 1H NMR spectrum of 29-a, although
the purity of the sample did not allow for complete characterization, did not contain a
deshielded signal significant for an aldehyde proton, and therefore lactol structure 29-a
could be proposed. Although the complete structure of the hemiacetal 29-a could not
be established, its proposed structure can be regarded as an interesting new class of
spirofuranose-pyranose-hybrid molecules. In some structurally related intermediates en
route to bradyrhizose K, the tendency to form comparable spirofuranose derivatives,
e.g. as the derived lactones[172], has been described. Likewise, K itself was identified
to form a minor 1,4-spirofuranose isomer with a related structure (Scheme 4.8, (c),
on page 70).[14] ESI-MS analyses of the isolated low-yield side products 29-b and 29-c
suggested the formation of two diastereoisomers of the dihydroxylated product with
intact dioxane group. From these isolated products, in preliminary studies (Scheme
4.19), small-scale reactions for the dioxane cleavage in acetone in the presence of
catalytic p-TsOH resulted in complex mixtures of products, and the clean formation of
the free aldehyde, or of lactol 29-a, could not be achieved. Most likely, under these
conditions, the dioxane group is cleaved, however, the sensitive intermediate 29-a
undergoes subsequent acid-catalyzed decomposition reactions, for example debenzyla-
tion or dehydration reactions. Although the dihydroxylation of 29 in the presence of
citric acid resulted in the promising formation of separable dihydroxylated products,
several drawbacks were encountered. The reaction was run on a small scale (30mg
of 29), but nevertheless a long reaction time at high temperatures (90 to 100 ◦C, 3 d)
and large amounts (30mol%) of OsO4 were required to affect the major conversion
of the substrate. In addition, the obtained dihydroxylated dioxanes 29-b and 29-c
(proposed structures) could not be converted into the corresponding aldehyde, or into a
spirofuranose comparable to 29-a, without decomposition under acidic conditions.
For that reason, at this point, further investigations into the propiolaldehyde route
were abandoned. The side chain dihydroxylation, which was found to be difficult with
acetal substrates like 23, was anticipated to be less challenging when performed with
the corresponding allyl alcohol substrates as described in the late-stage oxidation route.
Considering steric factors, the allyl alcohol intermediates traversed in this synthetic
route should be more accessible for the dihydroxylation reagent than the corresponding
unsaturated acetal intermediates. Furthermore, due to the absence of the inductively
electron-withdrawing acetal group, the alkene functionality in the allyl alcohol inter-
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mediates would be expected to be a stronger nucleophile, and thus, more reactive in
oxidation reactions.
4.5.2. Synthesis of the syn-Isomers
According to the suggested late-stage oxidation route (Scheme 4.15, (b), on page 81)
towards the target higher sugars T-4, alkynylation of the ketone 2b with propargyl
alcohol (R = H), or with a suitably protected derivative thereof (R = Pg), was expected
to provide the alkynyl-branched mannosides in an addition reaction analogous to the
synthesis of 22. For the protected derivatives, the protecting group Pg was required
to be orthogonally cleavable in the presence of the benzyl ether groups, since, after
deprotection, the free primary alcohol should be transformed into the corresponding
aldehyde in the pivotal primary-selective late-stage oxidation step. Furthermore, due
to the highly basic conditions of the initial metalation/alkynylation sequence in the
presence of organometallic bases like n-BuLi, only protecting groups with sufficient
stability against base-induced cleavage would be adequate. As a suitable candidate, the
tri-iso-propylsilyl (TIPS) protecting group was surmised to be sufficiently stable under
highly basic conditions, and the selective fluoride-induced cleavage of the silylether
could set free the primary alcohol at a later stage of the synthesis in a highly orthogonal
manner. As a second option, the tetrahydro-2H -pyran-2-yl (THP) protecting group,
an acetal protecting group highly stable under basic conditions, would allow for the
selective hydrolytic cleavage of the acetal group under mildly acidic conditions that
were expected to be compatible with the benzyl protecting groups.
Thus, in order to examine these protecting groups for their suitability in the required
transformations, 2-uloside 2b[37] was subjected to alkynylation reactions with a set of
alkynes, including unprotected propargyl alcohol, TIPS-protected propargyl alcohol,
and THP-protected propargyl alcohol (Scheme 4.20). The addition of free propargyl
alcohol could be achieved by employing a protocol published by Liang and Coworkers
for the reaction of propargyl alcohols with simpler non-carbohydrate carbonyl sub-
strates.[191] Ethylmagnesium bromide (2 equiv. based on propargyl alcohol) was used
to form the corresponding propargyl alcohol-derived dianion equivalent at reflux tem-
perature in THF, and the obtained solution was reacted with 2-uloside 2b at ambient
temperature to give propargyl alcohol derivative 33 in 63% yield in a rather unclean
reaction. An analysis of the chromatographically isolated products of this reaction
revealed the presence of unreacted 2-uloside 2b (27%). Furthermore, the unwanted
gluco-isomer 39 (5%) and the 3,2-enolone 40 (5%), originating from elimination of the
4-benzyloxy group, were obtained under these conditions (Scheme 4.21, a). Interme-
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Scheme 4.20 Synthesis of propargyl alcohol derivatives 33–35 and Lindlar hydrogenations,
giving the derived allyl alcohol derivatives 36–38.
diate 33 was, in addition, available from propiolaldehyde acetal 22, which could be
subjected to hydrolysis of the acetal group to obtain a crude mixture (Scheme 4.21,
b). Treatment of the crude hydrolysis product with NaBH4 gave propargyl alcohol 33
in a 54% two-step yield. The corresponding protected derivatives 34 and 35 could be
synthesized by utilizing the protocol described for the formation of 22, which involved
lithiation of the protected propargyl alcohol with n-BuLi, followed by the reaction with
2-uloside 2b at −80 ◦C (Scheme 4.20). In this way, TIPS-protected 34 was obtained
in 72% yield, and THP-protected 35 in an excellent 93% yield. Due to the introduced
stereogenic center at the THP protecting group, 35 was isolated as a 1:1 mixture of
diastereoisomers. This can be regarded as a somewhat inconvenient feature of the
THP protecting group, since the obtained protected products display highly complex
NMR spectra. The subsequent partial hydrogenation of the alkyne proceeded only very
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Scheme 4.21 (a) Side products 39 and 40, as isolated in the formation of 33 from 2b.
(b) Synthesis of propargyl alcohol derivative 33 via acetal hydrolysis of 22,
followed by reduction of the intermediary propiolaldehyde.
reluctantly in the case of free propargyl alcohol 33. The tested conditions involved
different solvents (1,4-dioxane, acetonitrile, DMF or methanol), but only trace amounts
of the wanted (Z )-alkene 36 could be isolated. In line with this, Lindlar hydrogenations
of other free propargyl alcohol derivatives have been found to be erratic.[192] The
Lindlar hydrogenations of the protected derivatives, however, proceeded smoothly in
1,4-dioxane, and gave TIPS-protected 37 (87%) or THP-protected 38 (97%) in good
yields. According to the planned synthetic route, the dihydroxylation of the alkene
functional group could be performed with the protected allyl alcohols 37 or 38, followed
by deprotection of the primary alcohol. However, bulky protecting groups could be
expected to hamper access to the alkene functionality in the dihydroxylation step.
Likewise, for a branched (E)-allyl alcohol en route to bradyrhizose K, Yu and Molinaro
observed that a bulky TBDPS-protecting group had a retarding effect on the planned
dihydroxylation.[14] Accordingly, deprotected allyl alcohol 36 was anticipated to be
a more suitable substrate for alkene functionalizations. For that reason, since the
synthetic route involving the THP-protected intermediates was evaluated as the most
favorable, 38 was subjected to hydrolytic cleavage of the THP group, thus giving 36 in
good yield (95%). In this way, key intermediate 36 could be routinely obtained on a 5 g
scale and in a 86% three-step yield from 2-uloside 2b. Given the fact that allyl alcohol
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Scheme 4.22 Formation of spirocarbonate 41 from 36, and allyl chloride 42, identified as
a low yield side-product.
Figure 4.5 X-ray structure of spirocarbonate 41. Hydrogen atoms of the benzyl ethers are
omitted for clarity. Ellipsoids are drawn at the 50% probability level. Red =
oxygen, gray = carbon, white = hydrogen. Significant distances and torsion
angles: C53···O11 2.753Å, O52-C5-C50-C51 6.9°, C50-C51-C52-O52 −55.5°.
derivatives are universally utilized intermediates for a large number of established alkene
functionalization reactions, intermediate 36 with its 1,4-dihydroxyalk-2-ene pattern
seemed to be an interesting substrate for the generation of carbohydrate structural
diversity in general.
For synthetic purposes, some derivatizations of intermediate 36 were performed. One
explored strategy involved protection of the 1,4-diol present in 36 with a suitable diol
protecting group, resulting in the formation of a fully protected spirocyclic product.
In such a protected derivative, due to the rigid fixation of the side chain within the
spirocyclic arrangement, the alkene functionality could potentially be more easily
approachable in a subsequent dihydroxylation step. In this context, protection of 36 in
the form of a cyclic carbonate seemed to be an appropriate option, and this approach
was initially explored in a Bachelor thesis by C. Jeuck.[193] When diol 36 was reacted
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with diphosgene (trichloromethyl chloroformate) in CH2Cl2 in the presence of pyridine
(Scheme 4.22), spirocarbonate 41 was formed in a clean reaction (93% yield), and
only traces of a side product could be identified by TLC. When a similar reaction was
conducted in pyridine as the sole solvent, comparable amounts of 41 were obtained, and
the same side product could be isolated in low yield (2%). From this isolated material,
its structure could be established to be allyl chloride 42, most probably originating
from direct conversion of the primary alcohol in 36 to the respective primary chloride
by the action of diphosgene. The spirocarbonate 41 was obtained in the form of a
crystalline solid, and single crystals could be obtained from n-pentane/acetone-D6.
X-ray structural analysis provided insight into the molecular structure (Fig. 4.5)
of the interesting spirocyclic branched sugar, which was found to crystallize in the
monoclinic space group P21 with Z  2. Within the 1,3-dioxepin-2-one moiety involving
the introduced carbonate, an almost planar orientation of the carbohydrate O-2 and
C -2, the olefinic carbon atoms C -7 and C -8, and the C -9 methylene carbon (O52,
C5, C50, C51, C52 in the crystal structure numbering) is observable. Accordingly,
a small torsion angle around the C -2–C -7 bond can be observed (O52-C5-C50-C51
6.9°). The carbonate functional group adopts an orientation towards the anomeric
oxygen (C53···O11 2.753Å), with the carbonate carbon atom (C53) and one carbonate
oxygen atom (O51) outside of the five-membered planar arrangement. A torsion angle
approximate to gauche conformation of the atoms involving the former side chain
allyl alcohol (C50-C51-C52-O52 −55.5°) demonstrates this sidewards orientation of the
carbonate moiety.
The development of a synthetic route towards allyl alcohol 36 allowed for subsequent
investigations into the continuation of the synthesis. In the following steps, syn-
dihydroxylation of the alkene functionality in 36 was anticipated to install a 2,3-syn-diol
side chain, whereas anti-dihydroxylation (e.g. a series of epoxidation and epoxide
opening) could lead to target compounds T-4 with a 2,3-anti-diol moiety as present in
bradyrhizose K.
Along these lines, an examination of suitable conditions for the syn-dihydroxylation
of 36 was performed (Table 4.2). Furthermore, the spirocyclic carbonate 41 was
included in these investigations to explore its synthetic applicability. When (Z )-alkene
36 was subjected to standard Upjohn conditions[104] (entry 1), no transformation could
be observed over several days at elevated temperature (60 ◦C). Likewise, protocols
involving basic additives like pyridine[115] (entry 2), methods that were suitable for the
dihydroxylation of bicyclic intermediate 17 (Scheme 3.11 on page 46), did not affect
the dihydroxylation. The application of Sharpless AD conditions[181] (commercial
AD-mix α or β, MeSO2NH2) to substrate 36 (entries 3 and 4) did, in both cases,
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Table 4.2 Reaction screening on the syn-dihydroxylation of alkenes 36 and 41.
reagents,
conditions
36
OBnO
BnO
OBn
OBn
OH
HO 41
OBn
OBnO
BnO
OBn
O O
O
or
(7S,8S)-43
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
+
(7R,8R)-44
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
# substr. reagents solvents T, t
observationa,
yieldb (43+44),
d.r.c (43/44)
1 36 OsO4 (5mol%),
NMO
THF, H2O,
t-BuOH
r.t. to 60 ◦C,
8 d
no react.
2 36 OsO4 (5mol%),
Me3NO,
pyridine (2 equiv.)
THF, H2O,
t-BuOH
r.t. to 60 ◦C,
8 d
no react.
3 36 AD-mix α,
MeSO2NH2
H2O, t-BuOH 0 ◦C to r.t.,
3 d
no react.
4 36 AD-mix β,
MeSO2NH2
H2O, t-BuOH 0 ◦C to r.t.,
3 d
no react.
5 41 OsO4 (5mol%),
NMO
Me2CO, H2O,
t-BuOH
55 ◦C,
24 h
no react.
6 41 OsO4 (5mol%),
NMO,
pyridine (2 equiv.)
Me2CO, H2O,
t-BuOH
55 ◦C,
2 d
deprot. (36)
7 36 OsO4 (2.8mol%),
NMO,
citric acid (2 equiv.)
t-BuOH, H2O 45 ◦C,
24 h
87%, 2.8:1
8d 36 OsO4 (1.5mol%),
NMO,
citric acid (2 equiv.)
t-BuOH, H2O,
MeCN
27 ◦C,
6 d
up to 96%,
up to 6.6:1
9 41 OsO4 (5mol%),
NMO,
citric acid (2 equiv.)
t-BuOH, H2O,
MeCN
55 ◦C,
2 d
deprot. (36)
a Indicated by TLC analysis of the reaction mixture.
b Isolated yield.
c Determined by 1H NMR integration.
d Experimental procedure given in Chapter 6.
98 4. Reducing Higher Sugars: Octoses with Analogy to Bradyrhizose
not result in any transformation of the alkene. It should be noted that the included
ligands of the PHAL-class are generally referred to as unsuitable for transformations
of (Z )-alkenes, for which ligands of the IND-class were found to be superior.[194]
However, this unsuitability usually only results in diminished enantioselectivities in
asymmetric dihydroxylations. Therefore, since no reaction of 36 could be detected with
the conventional PHAL-ligands, further investigations into Sharpless AD conditions
with other ligand types were abandoned. Similarly, spirocarbonate 41 did not react
under Upjohn dihydroxylation conditions (entry 5), and in the presence of pyridine
(entry 6) only carbonate cleavage (formation of 36) was noticeable. In light of the
promising observations in the dihydroxylation of 29 (Scheme 4.19 on page 90) with
citric acid as an acidic additive[190], 36 was reacted with OsO4/NMO in the presence
of citric acid (entry 7). At 45 ◦C, full conversion of the substrate could be confirmed
after 24 h, resulting in a mixture of major diol (7S,8S)-43 and minor (7R,8R)-44
(d.r. = 2.8:1) in good yield (87%).[195] The two diastereoisomers 43 and 44 were obtained
as an inseparable mixture, and all efforts for the chromatographic separation remained
unsuccessful. Noteworthy, the configurations of the introduced stereogenic centers at
C -7/C -8 of the side chain diol moieties could not be determined from the obtained
isomeric mixture, and complete structural characterizations relied on pure material of
the separated diastereoisomers from a later stage of the synthesis (see below). Further
optimized conditions could be found (entry 8), and involved running the reaction slightly
above ambient temperature (27 ◦C) and the addition of acetonitrile as a co-solvent for
solubility reasons. In this way, although in multiple experiments somewhat variable
yields and diastereomeric ratios were obtained, the products (7S,8S)-43 and (7R,8R)-
44 were typically formed in > 90% yield and with d.r. > 4:1. In a concluding experiment
(entry 9), under analogous acidic conditions, spirocarbonate 41 was identified to be an
unsuitable substrate, and only hydrolysis of the carbonate moiety and formation of 36
occurred as expected.
With an appropriate protocol for the syn-dihydroxylation at hand, a method for the
separation of the isomers (7S,8S)-43 and (7R,8R)-44 was required. In this regard,
fractional crystallization was found to result in an increased ratio of major (7S,8S)-43
in the mother liquor, and a crystal fraction with an enriched content of (7R,8R)-44
was obtained. Among several tested combinations of solvents, crystallization from
n-hexane/chloroform (ca. 1:1) gave good results and provided sufficiently pure major
isomer (7S,8S)-43 from the mother liquor in 50% yield (Scheme 4.23). From the
precipitated crystal fraction, multiple analogous crystallization steps gave further
(7S,8S)-43 (65% total yield). Unfortunately, the minor isomer (7R,8R)-44 was not
available in isomeric purity via this crystallization protocol. In addition, this purification
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Scheme 4.23 Synthesis of chromatographically inseparable (7S,8S)-43 and (7R,8R)-44,
and separation of the isomers via fractional crystallization or via chromato-
graphically separable tribenzoates (7S,8S)-45 and (7R,8R)-46.
method including multiple crystallization steps was found to be severely time-consuming.
Therefore, in further experiments, derivatization of the mixture of diols to protected
derivatives was anticipated to facilitate chromatographic purification. Acetylation
under conventional conditions (Ac2O, pyridine, DMAP, 0 ◦C to r.t.) gave a mixture of
acetylated products, however, chromatographic separation of the two major products
could not be achieved. In contrast, benzoylation of the side chain hydroxyl groups
gave a mixture of tribenzoates (7S,8S)-45 (63% over two steps) and (7R,8R)-46
(16%), which could be separated by flash column chromatography. From these benzoyl-
protected intermediates, pure major (7S,8S)-43 and minor (7R,8R)-44 were available
by debenzoylation under Zemplén’s conditions.
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The C -7/C -8 configurations of the dihydroxylated intermediates (7S,8S)-43 and
(7R,8R)-44 could, due to the conformational flexibility of the acyclic side chain, not
be determined from simple interpretations of NOE contacts in H,H-NOESY NMR ex-
periments. Possible methods for the determination of the stereochemical configuration
based on derivatization exist, and would be an option in the present case. An established
method developed by Rychnovsky and Coworkers would involve derivatization of diol
stereogenic centers as the corresponding acetonides, followed by 13C NMR analysis of the
conformationally restricted cyclic acetals.[196] However, the 2,7,8,9-tetrahydroxylated
motif in 43/44 was expected to give a mixture of 1,2- and 1,3-acetonides, as well as mono-
and diacetonides, which would result in excessive further separation efforts. As a second
established procedure, Mosher ester analysis would allow for the required determination
of the secondary stereogenic centers.[197] In this regard, similar to tribenzoates 45/46,
the triacylated (S)- and (R)-MTPA (α-methoxy-α-trifluoromethylphenylacetyl) esters
could possibly be accessible. Notably, this method is also suitable for the structural
determination of complex natural products with polyhydroxylated frameworks.[198]
Finally, X-ray structural analysis of 43/44, or of a derivative, would unambiguously
determine the C -7/C -8 configurations. In this context, however, all efforts to obtain sin-
gle crystals from (7S,8S)-43 or (7R,8R)-44 were unsuccessful. Since derivatizations
of the isomers could potentially facilitate the crystallization properties, such a strategy
was explored next. A possible option would involve acylation with chiral camphanoyl
chloride (3-oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane-1-carbonyl chloride). This
method has application in derivatizations for the resolution of racemic alcohols[199],
and has additionally been reported to frequently result in highly crystalline derivatized
products.[200] To explore if the described camphanate method could not only facili-
tate clean crystallization, but also enable chromatographic separation of the isomers
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Scheme 4.24 Synthesis of primary major isomer-derived camphanate (7S,8S)-47 via
selective primary alcohol acylation.
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Figure 4.6 X-ray structure of primary camphanate (7S,8S)-47. Hydrogen atoms of the
benzyl ethers are omitted for clarity. Ellipsoids are drawn at the 50% probability
level. Red = oxygen, gray = carbon, white = hydrogen. Significant distances
and angles: O8···H6C 1.961Å, O8···O6 2.715Å, O6-H6C···O8 153.9°.
43/44 similar to the benzoylation route, the obtained mixture of (7S,8S)-43 and
(7R,8R)-44 (d.r.≈ 6.6:1) was reacted with one equivalent of (–)-(1S,4R)-camphanoyl
chloride (Scheme 4.24) in the presence of Hünig’s base (i-Pr2NEt). Although some
side products were observable by TLC control, as expected acylation of the primary
hydroxyl groups occurred selectively. Chromatographic separation of the obtained
isomers proved to be challenging, and had to be repeated multiple times, demonstrating
that this derivatization method was unsuitable for separation purposes on a preparative
scale. However, the major camphanate isomer (7S,8S)-47 could be obtained as a
single isomer in 52% yield. Fortunately, from diethyl ether/acetonitrile, single crystals
of sufficient purity for X-ray structural analysis could be grown. In the solid state, the
crystalline camphanate (7S,8S)-47 occupied the monoclinic space group P21 with
Z  2 formula units in the unit cell. An analysis of the molecular structure (Fig. 4.6)
revealed the (7S,8S)-configuration of the syn-diol moiety in (7S,8S)-47, and thus,
indirectly, for major isomer (7S,8S)-43. Furthermore, by applying criteria identical to
those of Section 3.3.3 (dO···H<3.0 Å and θO−H···O>90◦), an intramolecular hydrogen
bond between the axial C -2-OH (O6-H6C) and the O-8 (O8) of the side chain was
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identified (O8···H6C 1.961Å, O8···O6 2.715Å, O6-H6C···O8 153.9°). Based on the
determined (7S,8S)-configuration of this major isomer, the given structure for minor
isomer (7R,8R)-44 was established by assuming the reasonable syn-stereoselectivity
of the osmium-based dihydroxylation. In addition, in conformationally fixed cyclic
intermediates synthetically derived from (7R,8R)-44, significant NOE contacts in
H,H-NOESY experiments confirmed the given structure indirectly.
An explanation for the observed stereoselectivity of the dihydroxylation of 36 would be
of interest. A simple analysis of the modes of attack could involve the generally accepted
“H in plane“ conformations for C -9 according to Kishi’s empirical rule (comp. Scheme
4.7, (a), on page 67) and attack of OsO4 from the opposite face of the alkene.[105, 106]
However, due to the quaternary nature of C -2 and the presence of a second hydroxyl
group, suitable orientations for both C -9 and the quaternary C -2 have to be proposed.
An examination of the H,H-NOESY spectrum of alkene 36 in acetone-D6 (Fig. D.1
on page 304) revealed significant contacts between the alkene H -7 and both the axial
carbohydrate H -1 and H -3, respectively. Consequently, an eclipsed relationship be-
tween the alkene double bond and the axial C -2-OH can be assumed (Scheme 4.25,
a). At C -9, two allylic hydrogen atoms (H -9a/b) could occupy an anti-periplanar
orientation with respect to the C -2-OH, resulting in orientation of the C -9-OH either
towards the carbohydrate C -3 (conformation 36-a) or towards C -1 (36-b). It seems
plausible to assume an overall seven-membered cyclic conformation, stabilized by the
presence of an intramolecular hydrogen bond between O-9 and O-2. Notably, these
proposed seven-membered cyclic conformations bear resemblance with the structure of
seven-membered spirocarbonate 41 (Fig. 4.5 on page 95). In the protic acidic medium
(citric acid in t-BuOH/H2O/MeCN) of the dihydroxylation reaction, the postulation
of an intramolecular hydrogen bond seems to be inappropriate, since the saturation
of all hydrogen bond acceptors by external donors has to be assumed. Taking into
account that no transformation of 36 could be observed without the acidic additive
(Table 4.2 on page 97), the following circumstances are proposed (Scheme 4.25, b):
in the acidic medium, the absence of a stabilizing intramolecular hydrogen bond results
in the preference for staggered conformations (36-c and 36-d) with anti-periplanar
orientation of the C -2-OH with respect to the alkene double bond. Possibly, in these
conformations, attack of OsO4 is facilitated due to decreased steric congestion around
the alkene moiety, leading to the observed transformation of 36. Two different “H
in plane“ conformations at C -9 can be formulated (36-c and 36-d), resulting in four
different modes of attack (i)–(iv) of OsO4. Of these, (ii) and (iii) occur from the alkene
face opposite to the C -9-OH, and thus, in “Kishi“-sense, whereas (i) and (iv) can be
referred to as “anti-Kishi“. From these considerations, although purely tentative, it can
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Scheme 4.25 (a) Proposed conformations of alkene 36 in acetone-D6. Observed NOE
contacts are indicated with arrows, and refer to the spectrum in Fig. D.1
on page 304. In proposed conformations 36-a and 36-b, the interjacent
alkene function is omitted for clarity. (b) Proposed reactive conformations
36-c and 36-d for the syn-dihydroxylation of 36 in acidic protic medium,
via attack modes (i)–(iv).
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Scheme 4.26 Desired selective primary alcohol oxidation of (7S,8S)-43 to aldehyde 43-
a, or to the derived cyclic hemiacetals α,β-48. An analysis of anticipated
competitive side reactions a)–d) is given.
be suggested that the major dihydroxylation product (7S,8S)-43 is possibly formed
via attack mode (iii) involving the substrate conformation 36-d.
Following the general synthetic route (Scheme 4.15, (b), on page 81), both syn-
intermediates (7S,8S)-43 and (7R,8R)-44 serve as suitable substrates for the selective
primary alcohol oxidation, which can be regarded as the key step of the overall synthesis.
As demonstrated in an analysis of the desired reaction (Scheme 4.26), the major
substrate (7S,8S)-43 could be transformed into the acyclic aldehyde 43-a via selective
oxidation of the primary C -9-OH group of the 2,7,8,9-tetrahydroxy moiety. Subse-
quently, based on previous observations (comp. Scheme 4.19 on page 90), hemiacetal
ring closure between the aldehyde functional group and the axial C -2-OH could be
anticipated, resulting in an equilibrium between anomeric isomers α-48 and β-48.
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Several potential side reactions can be considered for the shown transformation. a)
Overoxidation of the product aldehyde 43-a (possibly via the hydrated intermediate)
or of α,β-48 would give either the unwanted free carboxylic acid, or the lactone. b) In
the course of the oxidation, epimerization of the α-stereogenic center (at C -8) via the
enol form has to be considered, e.g. from the formed aldehyde. c) Oxidative cleavage
of vicinal diols, a ubiquitous side reaction in multiple oxidative transformations, could
occur either from the substrate (7S,8S)-43, or from the wanted oxidized products. d)
Finally, the unwanted oxidation of the secondary hydroxyl groups at C -7/C -8 to the
corresponding ketones might be observed as a competitive side reaction.
A survey for comparable transformations suggested mild TEMPO-based oxidation
protocols might be suitable (comp. Chapter 4.1), since several examples involving
carbohydrate-derived polyol substrates have been described in the literature. In this
context, Iadonisi and Coworkers (Scheme 4.27, a) reported on the selective primary
oxidation of the 1,2-diol EN as a key step in a total synthesis of the unusual carbocyclic
sugar caryose J (comp. Scheme 1.3 on page 4).[201] The application of Anelli’s
protocol[141], involving TEMPO/NaOCl in biphasic H2O/CH2Cl2 under phase-transfer
conditions, gave the wanted hemiacetal products α,β-EQ and α,β-ER in 31% yield.
Lactone EO (33%) was isolated as the major side product due to overoxidation. Sig-
nificant amounts of unreacted EN were reisolated from the product mixture, however,
increased amounts of the oxidant NaOCl resulted in a higher proportion of unwanted
lactone EO. As an explanation, the authors surmised that the hydrophilic nature of
the hemiacetal products α,β-EQ and α,β-ER might favor their overoxidation in the
aqueous phase. Several variations of the originally biphasic oxidation protocol have
been developed for specific synthetic challenges. In search of a convenient and mild
synthetic access to sensitive dialdo-glycosides like ET (Scheme 4.27, b), Ramström
and Coworkers utilized the combination TEMPO/trichloroisocyanuric acid (TCICA)
as a mild oxidizing system.[202] The high polarity of the substrate glycosides ES
did not allow for the application of CH2Cl2 solvent mixtures. However, DMF as the
solvent and slightly basic conditions (NaHCO3 as a weak base) affected the clean
formation of aldehydes ET via selective oxidation of the primary C -6 in the presence
of unprotected C -2/3/4 hydroxyl groups. After an imine catch-and-release purification
of the sensitive products with amino-functionalized column material, aldehydes ET
or similar dialdo-glycosides could be isolated in excellent yields. Another relevant
example was applied by Yu and Molinaro in their total synthesis of bradyrhizose K
(Scheme 4.27, c).[14] Preliminary experiments with the side chain triol DU and the
combination TEMPO/PhI(OAc)2[145] resulted in oxidative cleavage of the side chain.
In contrast, with TEMPO/TCICA in unbuffered CH2Cl2, the aldehyde intermediate
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Scheme 4.27 Selected examples: selective primary alcohol oxidations in carbohydrate
substrates. (a) Iadonisi’s oxidation of alcohol EN, utilizing TEMPO/NaOCl
in biphasic H2O/CH2Cl2.[201] (b) Ramström’s protocol for the formation of
dialdo-glycosides like ET, using TEMPO/trichloroisocyanuric acid (TCICA)
in buffered DMF.[202] (c) Oxidation reactions with TEMPO/TCICA as
published by Yu and Molinaro for synthetic intermediates EU and EV.[14]
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could be obtained in good yield, and after desilylation the wanted lactol EU was avail-
able. However, in the following desilylation, significant amounts of the C -2-epimerized
product were isolated from the reaction with TBAF, indicating that deprotection prior
to the oxidation step would be favorable. The desilylated tetrol DV was reacted in a
similar manner, but overoxidation to the lactone at low temperature (−30 ◦C) could
not be prevented. At 0 ◦C, lactone EV was isolated as the major product, and was
subjected to DIBAL-H reduction without further purification/characterization.
For the transformation of major isomer (7S,8S)-43, due to the structurally related
substrates, the method applied by Yu and Molinaro (TEMPO/TCICA in unbuffered
CH2Cl2) was investigated in preliminary attempts (Table 4.3).[14] Under these con-
ditions (entry 1), at low temperature (−40 ◦C), only slow conversion was observable.
At −5 ◦C, a complex mixture of products was formed, and the desired hemiacetal
product α,β-48 could be isolated in only 12% yield after chromatography. An ESI-MS
analysis of the mixture of side products with higher chromatographic mobility suggested
substantial overoxidation to products of keto-lactone mass ([M–H]– m/z 623). When
Ramström’s conditions were applied (entry 2), at −8 ◦C, conversion to the product
without significant overoxidation could be observed.[202] After chromatographic pu-
rification, α,β-48 was obtained in 44% yield, however, the product still contained
impurities of similar chromatographic mobility, possibly resulting from epimerization of
the α-stereogenic center. Repeated chromatography of the impure product resulted in
a severe loss of material. Possibly, the observed loss of material could originate from
intermolecular acetal formations of the free hemiacetal products upon chromatography,
and similar assumptions have been made to explain difficulties in the isolation of
1,6-dialdo-glycosides.[203] Furthermore, direct deprotection of impure α,β-48 to the
corresponding target higher sugar seemed to be no suitable option, since the separation
of highly hydroxylated impurities from the polar target compounds could be expected to
be difficult. For this reason, a protocol for the clean formation of α,β-48 was required.
Further variations from the published protocols revealed that in anhydrous ethyl acetate
(entry 3), although a rather unusual solvent, the reaction proceeded with fast conversion
at low temperatures (−35 ◦C). After an optimized, rapid chromatography procedure
involving spherical silica, α,β-48 was obtained in 62% yield (81% based on recovered
substrate). Although a reduced complexity of the product mixture suggested a cleaner
reaction in ethyl acetate, purified α,β-48 still contained minor impurities. Repeated
chromatography allowed for the isolation of the most pronounced side product in pure
form, which was identified as the unexpected spiro-tetrahydrofuran (7S,8S)-49 (Table
4.3). Detailed TLC control experiments under similar reaction conditions suggested
that the side product (7S,8S)-49 appeared upon reductive aqueous quenching (sat.
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Table 4.3 Reaction screening on the TEMPO-based selective primary alcohol oxidation of
major isomer (7S,8S)-43.
reagents,
conditions
(7S,8S)-49
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
β-48α-48
OBnO
BnO
OBn
OBn
OHO
HO
OH
OBnO
BnO
OBn
OBn
OHO
HO
OH+
OBnO
BnO
OBn
OBn
O
HO
OH(7S,8S)-43
# reagents solvents T, t
observationa,
yieldb (α,β-48)
1 TEMPO (2.6mol%),
TCICA (2.7 equiv.)
CH2Cl2 −40 to −5 ◦C, 24 h complex mixt.
12% α,β-48,
+ overoxidationc
2 TEMPO (2.5mol%),
TCICA (0.76 equiv.),
NaHCO3 (30 equiv.)
DMF −8 ◦C, 5 h 44% α,β-48d
3 TEMPO (2.5mol%),
TCICA (0.8 equiv.),
NaHCO3 (30 equiv.)
EtOAc −35 to −15 ◦C, 4 h 62% α,β-48d,
81% brsme,
< 5% (7S,8S)-49
4f TEMPO (3mol%),
TCICA (0.85 equiv.),
MOPS (12 equiv.),
then:
Me2S (2.7 equiv.)
EtOAc/PhMe
(2:1)
−50 to −35 ◦C, 15 h
−35 ◦C, 15min
61% α,β-48,
72% brsme
a Indicated by TLC analysis of the reaction mixture.
b Isolated yield.
c ESI-MS analysis: neg. mode: [M–H]– m/z 623 (proposed: keto-lactone).
d Product impurified after chromatography.
e brsm = based on recovered starting material.
f Experimental procedure given in Chapter 6. MOPS = 3-(N-morpholino)propanesulfonic acid.
TCICA = trichloroisocyanuric acid.
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Na2S2O5) of the reaction mixture, indicating that it might possibly originate from C -9
deoxygenation by the reducing agent. Other explanations could involve the formation of
the primary chloride from (7S,8S)-43 by the stoichiometric reagent TCICA, followed by
ring closure, or direct ring closure from the TEMPO+-activated oxidation intermediate.
From the reaction in ethyl acetate as described, further improvements to the conditions
were made (entry 4): the addition of a non-polar co-solvent (toluene) was found to
be beneficial for a clean reaction, and the reaction was run in high dilution (0.005 m).
Since strictly anhydrous conditions were expected to minimize a possible epimerization
of the α-stereogenic center, NaHCO3 seemed to be an unsuitable buffer. As an unusual
alternative, good results were obtained with 3-(N -morpholino)propanesulfonic acid
(MOPS), an organic buffer with applications in biochemistry at near-neutral pH, which
was added to the reaction as a heterogeneous buffer. The side product (7S,8S)-49 was
not formed in significant amounts upon quenching the reaction with aqueous Na2S2O3
instead of Na2S2O5. Nevertheless, a mild reductive non-aqueous quenching procedure
was desirable to minimize product degradation, and thus, to obtain a product of higher
purity. For that purpose, dimethyl sulfide in ethyl acetate was added as a reductive
quench prior to the standard aqueous workup. In this way, after chromatographic
purification, the desired α,β-48 could routinely be isolated in high purity in 61% yield
(72% based on recovered substrate) and on a 150mg scale. In light of the aforementioned
problems encountered in this transformation, and given the number of potential com-
petitive side reactions (comp. Scheme 4.26 on page 104), these results were evaluated
as quite satisfactory. In addition, the developed conditions for the oxidation reaction
could be expected to have potential applicability as a general oxidation protocol, given
the mild and neutral conditions and the compatibility with low temperatures.
The obtained oxidation product α,β-48 could be fully characterized, including the
anomeric configurations of the interesting reducing spirofuranose-pyranose hybrid (for
a clarification of anomeric configurations in the Fischer projection, see Scheme 6.2,
(a), on page 183). Initially, the major component of solid α,β-48 was identified to
be its α-anomer α-48 (α/β≈ 11.1:1, Scheme 4.28). In the NMR solvent acetone-
D6 at r.t., slow anomerization occurred, resulting in major β-48 (α/β≈ 1:2.7). The
progression of the anomerization process could be monitored by accompanying NMR
experiments (Fig. 4.7 and 4.8), which confirmed that equilibration to α/β≈ 1:2.7
was complete after ca. 5–6 days. Although the mixture of anomers exhibited highly
complex NMR spectra, this NMR-monitoring allowed for the complete assignment of all
relevant signals, and thus, confirmed the purity of the obtained material. Unfortunately,
attempts to monitor the mutarotation simultaneously remained unsuccessful due to
limited solubility of the compound in acetone-D6 and, as a result, observed precipitation
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Scheme 4.28 Top: oxidative formation of spiro-ribofuranose α,β-48, and deprotection
to target 4-C -formyl octose syn-50. Bottom: formation of minor isomer-
derived spiro-lyxofuranose α,β-51, and deprotection to target 4-C -formyl
octose syn-52. Anomeric ratios are given in acetone-D6. For clarity, syn-
50 and syn-52 are depicted in the (9S)-9,7-pyranose-1,9-pyranose isomeric
form.
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Figure 4.7 13C NMR-monitoring of the anomerization process of α,β-48 at r.t. Spectra
were recorded at 100.6MHz in acetone-D6 and are given in the range 80–
110 ppm. Anomeric ratios were determined by integration of the corresponding
proton spectra. The shown spectra are unprocessed.
when storing the sample over the required time of several days. Furthermore, initially
measured changes in the specific rotation were small (< 5°), and therefore severely
error-prone. The configurations of the stereogenic centers of the spiro-ribofuranose
moiety in α-48 could be unambiguously established by significant NOE contacts in
H,H-NOESY experiments (Fig. D.2 on page 305). In addition, it should be noted that
the anomeric configurations in α,β-48 and following similar spirofuranoses were fully
consistent with published work on 13C NMR chemical shift relations for structurally
simpler furanosides.[204]
To complete the synthesis of the first target compound, α,β-48 was subjected to
hydrogenolytic debenzylation (Scheme 4.28, top) to yield syn-50 in near-quantitative
yield after RP-chromatographic purification (for characterization of target compounds,
see Section 4.5.4). In a similar manner, application of the developed oxidation protocol
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Figure 4.8 1H NMR-monitoring of the anomerization process of α,β-48 at r.t. Spectra were
recorded at 400.2MHz in acetone-D6 and are given in the range 4.85–5.30 ppm.
Benzylic methylene protons of α-48 and β-48 were used for integration. The
shown spectra are unprocessed. Top, t= 0: the original sample was evaporated,
dried and redissolved in acetone-D6 to demonstrate the reversibility of the
epimerization process.
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to minor isomer (7R,8R)-44 (Scheme 4.28, bottom) gave a mixture of spiro-
lyxofuranoses α,β-51 with α/β≈ 1.4:1, slowly epimerizing to α/β≈ 1:1 in acetone-D6.
Due to almost equal amounts of both anomers in solution, the 2D NMR spectra of
lyxofuranoses α,β-51 were more complex than for ribofuranose α,β-48. However,
significant NOE contacts (Fig. D.4 on page 307) between H -9 and H -8 (β-51) and
between H -9 and OH-8 (α-51), respectively, allowed for the determination of the
anomeric configurations. The mixture of spiro-lyxofuranoses α,β-51 was, subsequently,
subjected to global debenzylation to afford syn-52 as the second target 4-C -formyl
octose. Both target compounds could be obtained in a stereodivergent synthesis
from the common alkene intermediate 36. The synthetic route for both syn-50 and
syn-52 included 14 steps from d-glucose, and proceeded in 9 steps/30% yield (major
isomer, syn-50) and 9 steps/8% yield (minor isomer, syn-52), respectively, from the
known 2-uloside 2b. Based on the developed synthesis, an analogous synthesis of the
corresponding anti-isomers was pursued next.
4.5.3. Synthesis of the anti-Isomers
Following the course of the late-stage oxidation route (Scheme 4.15, (b), on page 81),
the anti-isomers of target compounds T-4 were anticipated to originate from nucleophilic
epoxide opening of a side chain epoxide derived from alkene 36. Thus, epoxidations of
36 were examined under a variety of conditions (Scheme 4.29). Peracid epoxidation
of 36 with m-CPBA resulted in the clean conversion to a mixture of epoxides (d.r.≈ 5:1;
1H NMR integration), of which major epoxide (7S,8S)-53 could be isolated in 72%
yield, together with 13% of the minor isomer (7R,8R)-57. Chromatographic separation
of the isomers was found to be challenging due to comparable chromatographic mobility.
Minor epoxide (7R,8R)-57, which eluted first, could only be separated from the
following fractions of major (7S,8S)-53 by optimized chromatographic conditions.
Notably, the addition of Et3N to the eluent (2%) was required, and significant loss of
material upon chromatography was observed with lower amounts of the basic additive.
The purification of m-CPBA prior to use (comp. Section 6.3.1 on page 180) was found
to be crucial for the reaction, since direct application of commercial material resulted
in a sluggish and weakly reproducible reaction. Similarly, the addition of NaHCO3
as a buffer was found to be detrimental to the reaction. Substitution of m-CPBA
for magnesium monoperoxyphthalate (MMPP·(H2O)6, NaHCO3, 1,2-dichloroethane)
required elevated temperatures (> 50 ◦C, 3 d), and gave the same major isomer (7S,8S)-
53 with lower diastereoselectivity (d.r.≈ 2:1) and with only mediocre isolated yield
(45%). When 36 was reacted with t-BuOOH in the presence of catalytic VO(acac)2, the
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Scheme 4.29 Diastereoselective epoxidations of alkene 36, giving epoxides (7S,8S)-53 and
(7R,8R)-57, and derived epoxyacetates and spirotetrahydrofuran cyclization
products.
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formation of the other epoxide occurred with rather low selectivity (d.r.≈ 2.5:1), and
major epoxide (7R,8R)-57 (58% yield) and minor isomer (7S,8S)-53 (18%) could be
isolated in a good overall yield of epoxides.
An explanation for the stereochemical outcome of the epoxidation reactions of 36
could involve an analysis of the reacting conformations of the allyloxy moiety according
to the Sharpless model (comp. Scheme 4.7, (b) on page 67).[165] However, in the
case of 36, the presence of a second allyloxy moiety (the quaternary carbohydrate
C -2-OH) has to be considered. In this regard, estimations of the preferred conformations
could be expected to be intricate, since two sterically nearly identical carbohydrate
sites (C -1 and C -3) are present. For peracid epoxidations, Sharpless and Coworkers
suggested a reacting conformation with a HO-C-C=C dihedral angle of 120°, and
peracid attack from the side of the allylic hydroxyl. Application of these requirements
to the epoxidation of 36 with m-CPBA (Scheme 4.30, a) resulted in the proposed
conformation 36-e, which included two 120° dihedral angles (HO-C2-C=C and HO-
C9-C=C). The depicted mode of attack of the peracid from the side of both hydroxyl
groups illustrates the formation of (7S,8S)-53 as the major epoxide. Minor epoxide
(7R,8R)-57 could, in this case, be either formed by an “anti-Sharpless“ mode of attack
from the top side of 36-e, or via the second conformation featuring two 120° dihedral
angles and upwards orientation of both hydroxyl groups (not shown). Alternatively,
a fixed conformation with an intramolecular hydrogen-bonding interaction could be
considered. In a conformation like 36-b, the formation of major epoxide (7S,8S)-53
would require the peracid attack to occur from the carbohydrate C -1 side.
In the epoxidation of 36 with VO(acac)2/t-BuOOH (Scheme 4.30, b), an analysis
according to the Sharpless model would involve HO-C-C=C dihedral angles of 50°.
Albeit, due to the presence of the Lewis acidic, pentavalent vanadium catalyst, it seems
plausible to formulate a conformation like 36-f, with the substrate diol forming a chelate
complex with the vanadium peroxide moiety. The proposed conformation 36-f would
result in epoxidation from the carbohydrate C -3 side, and thus, the formation of major
epoxide (7R,8R)-57. Putatively, this orientation would be more favorable than a
corresponding chelate complex oriented towards the carbohydrate C -1 (related to 36-b),
and possible reasons could involve unfavorable interactions between the anionic complex
ligands, and the carbohydrate ring oxygen lone pairs. However, the side differentiation
seems to be rather weak, as expressed by significant concomitant formation of minor
epoxide (7S,8S)-53.
In analogy to the formation of spirocarbonate 41 (Scheme 4.22 on page 95), epox-
ide (7R,8R)-57 was reacted with diphosgene, and the sensitive spiro-epoxycarbonate
(7R,8R)-61 (Scheme 4.31) could be isolated in 81% yield after recrystallization.
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Scheme 4.30 (a) Proposed conformations 36-e or 36-b for the epoxidation of 36 with
m-CPBA, giving major epoxide (7S,8S)-53. (b) Proposed conformation
36-f for the formation of major epoxide (7R,8R)-57 in the epoxidation of
36 with VO(acac)2/t-BuOOH. L = available ligand, e.g. t-BuO, acac.
Vapor diffusion of diethyl ether into the NMR sample of (7R,8R)-61 in acetone-D6
resulted in the crystallization of colorless plates suitable for X-ray crystallography.
Crystalline (7R,8R)-61 occupied the monoclinic space group P21, and Z  2 formula
units within the unit cell were found. An analysis of the molecular structure (Fig.
4.9) unambiguously confirmed the (7R,8R)-configurations of the side chain stereogenic
centers of (7R,8R)-61, and thus, of the parent epoxide (7R,8R)-57. Apart from the
presence of the epoxide, geometric properties of the seven-membered spirocarbonate
moiety were found to be largely comparable to the structure of 41, including an orienta-
tion of the carbonate functional group towards the anomeric oxygen (C9···O2 2.697Å).
Likewise, a near-planar arrangement of the former carbohydrate C -2-OH moiety and
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Scheme 4.31 Synthesis of spiro-epoxycarbonate (7R,8R)-61 from epoxide (7R,8R)-57.
Figure 4.9 X-ray structure of spiro-epoxycarbonate (7R,8R)-61. Hydrogen atoms of the
benzyl ethers are omitted for clarity. Ellipsoids are drawn at the 50% probability
level. Red = oxygen, gray = carbon, white = hydrogen. Significant distances
and torsion angles: C9···O2 2.697Å, O6-C1-C6-C7 2.4°, C6-C7-C8-O7 −61.8°.
the side chain C -7/8/9 (in crystal structure numbering: O6, C1, C6, C7, C8) can be
observed (comp. O6-C1-C6-C7 2.4°), with the former side chain C -9-OH involved in the
carbonate functional group outside of this planar arrangement (C6-C7-C8-O7 −61.8°).
In following synthetic experiments, both diastereomeric epoxides (7S,8S)-53 and
(7R,8R)-57 were subjected to conditions for nucleophilic epoxide opening for the
anticipated formation of a side chain anti-diol moiety. In this regard, both acidic
conditions (cat. p-TsOH in H2O/THF, or: cat. Sc(OTf)3 in H2O/1,4-dioxane) and
basic conditions (KOH in H2O/1,4-dioxane, or: TBAF in H2O/MeCN) were tested.
However, in all cases, elevated temperatures were required to invoke a conversion, and
the reactions resulted in inseparable complex mixtures of products. Likewise, for other
reported epoxyalcohols in higher sugars, epoxide opening reactions have been described
to be erratic.[164] To explain these observations, several potential side reactions have
to be considered. Epoxide opening reactions of α-epoxy alcohols usually occur via
regioselective attack at the β-position, and attack at the α-position is usually disfa-
vored.[205] For steric reasons, in epoxides (7S,8S)-53/(7R,8R)-57, attack at the side
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chain C -8 seemed to be more plausible. However, competitive opening at C -7 would
result in the concomitant formation of the diastereomeric anti-isomer. Furthermore,
intramolecular side reactions have to be considered. Under forceful conditions, the
unwanted cyclization of the 1,4-dihydroxy moiety to a spiro-tetrahydrofuran product
seems to be plausible (comp. compound (7S,8S)-49 on page 108), either with intact
epoxide moiety, or from the wanted diol product. Apart from this, Payne rearrangement
processes (epoxide migrations) are ubiquitous side reactions of epoxy alcohols under
acidic or basic conditions.[206] Either initiated from the side chain C -9-OH, or from the
carbohydrate C -2-OH, Payne rearrangements could result in the formation of isomeric
epoxides, potentially leading to multiple derived epoxide opening or decomposition
products of diverse stereochemistry.
As a result of these unsuccessful attempts for the direct epoxide opening, the intro-
duction of protecting groups for the free hydroxyl groups of the epoxide substrates
was anticipated to reduce the number of potential side reactions. For that purpose,
acetylation of the primary C -9-OH in (7S,8S)-53 and (7R,8R)-57 (Scheme 4.29 on
page 114) was achieved under mild conditions (stoichiometric Et3N/Ac2O, cat. DMAP
in MeCN at 0 ◦C), and gave the primary acetates (7S,8S)-54 and (7R,8R)-58, re-
spectively. Acetylation of the tertiary C -2-OH functionality was found to require harsh
conditions in the case of other C -2-branched derivatives (comp. compound 24 on page
87), and was thus not performed with the sensitive epoxide substrates. For the following
epoxide opening reactions of epoxyacetates (7S,8S)-54 and (7R,8R)-58, basic condi-
tions were anticipated to result in saponification of the acetate moiety, and thus acidic
conditions were applied. Heating of (7S,8S)-54 in a mixture of AcOH/Ac2O (1:1) at
105 ◦C, a method anticipated to give the fully acetylated product of the epoxide opening,
resulted in the formation of one major product. The same product, albeit in a cleaner
reaction, was formed when trimethylsilyl acetate (TMSOAc, 2 equiv.) was added to the
reaction mixture as an additional Lewis acid. However, complete characterization of
the product confirmed the structure of acetylated spiro-tetrahydrofuran (7S,8R)-55,
obviously formed by intramolecular displacement of the C -9-acetate leaving group
by the C -2-OH. Zemplén deacetylation of the anti-configured diacetate (7S,8R)-55
provided (7S,8R)-56, which could be determined to be a stereoisomer of syn-configured
spiro-tetrahydrofuran (7S,8S)-49 (Table 4.3 on page 108) by its spectral properties.
From diastereomeric epoxyacetate (7R,8R)-58, similar conditions for epoxide open-
ing gave the isomeric cyclization product (7R,8S)-59, or, after deprotection of the
anti-diacetate, spiro-tetrahydrofuran (7R,8S)-60.
Due to the observed difficulties in the epoxide opening reactions, in a potential
alternative to the planned synthetic route, oxidation of the primary hydroxyl group in
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Scheme 4.32 Oxidative formation of 2,3-anhydro-ribofuranose α,β-62 and 2,3-anhydro-
lyxofuranose α,β-63. Anomeric ratios are given in acetone-D6.
epoxides (7S,8S)-53 and (7R,8R)-57 to the corresponding aldehydes/lactols could
be performed prior to epoxide opening. For this transformation, due to the absence
of interfering secondary alcohols in the epoxide substrates, a variety of established
oxidation methods like Dess-Martin oxidation or methods with activated DMSO seemed
to be applicable. However, to further explore the developed oxidation protocol with
TEMPO/TCICA in the presence of MOPS as a buffer, this method was used. Oxidation
of (7S,8S)-53 under the established conditions (Scheme 4.32) gave 2,3-anhydro-
ribofuranose α,β-62, which could be isolated in good yield (82%). Likewise, under the
same conditions, (7R,8R)-57 was transformed into 2,3-anhydro-lyxofuranose α,β-63
in an excellent 92% yield. Both reactions proceeded cleanly and with relatively fast
conversions at low temperature (−50 ◦C, 3 h), demonstrating the potential applicability
of the described oxidation protocol as a generally useful transformation. For both α,β-62
and α,β-63, the respective 1,2-trans-isomer could be identified to be the major anomer
(β-62 and α-63, respectively) in acetone-D6. The anomeric configurations could be
deduced from the direct anomeric 1JC9,H9 coupling constants (Fig. 4.10) of the major
isomers (β-62: 174.5, α-63: 174.3Hz). The obtained values were fully consistent with
published data on 2,3-anhydrofuranosides, which suggested coupling constants generally
above 170Hz in the case of 1,2-trans-relationships (1,2-trans: 171–174, 1,2-cis: 163–
168Hz).[207, 208] Apart from this, further confirmation for the anomeric configuration
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Figure 4.10 Sections of the C,H-HMBC spectra of α,β-62 (top) and α,β-63 (bottom) at
100.6MHz/400.2MHz in acetone-D6. Visible residual signals of the 1JC9,H9
couplings of the major isomers are labeled, and were used to determine the
values of the direct coupling constants.
of α,β-63 could be obtained by X-ray structural analysis of a crystallized sample of
the compound (monoclinic, P21, Z  2). The molecular structure (Fig. 4.11) gave
final confirmation for the anomeric α-configuration of the reducing furanose moiety. In
a subsequent experiment, the crystalline sample of α-63 was redissolved in acetone-D6,
and NMR analysis was performed in quick succession to minimize equilibration of the
sample. The obtained 1H NMR spectrum was ascribed to the α-isomer α-63, virtually
in isomeric purity, which gave complete confirmation for the anomeric α-configuration
both in solution and in the solid state.
Unfortunately, with 2,3-anhydrofuranoses α,β-62 and α,β-63 all efforts for epoxide
opening, under similar conditions as given above for (7S,8S)-53 and (7R,8R)-57,
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Figure 4.11 X-ray structure of compound α-63. Hydrogen atoms of the benzyl ethers and
a disorder involving the C -3 benzyl group are omitted for clarity. Ellipsoids
are drawn at the 50% probability level. Red = oxygen, gray = carbon, white
= hydrogen.
failed due to unspecific decomposition of the starting anhydrofuranoses. As a result,
another synthetic strategy was pursued in following experiments. Several Lewis acid-
mediated methods have been developed for the direct conversion of acetone solutions
of epoxide substrates into 1,2-acetonides as diol equivalents. The published methods
include, amongst others, metal-based Lewis acids such as SnCl2[209], Er(OTf)3[210],
MoO2Cl2[211], CuSO4[212], or gold-based methods[213]. A survey for synthetic ap-
plications of these methods revealed a promising example published by Fuchs and
Coworkers, which involved the SnCl2-mediated epoxide opening of an epoxide-branched
free hemiacetal carbohydrate derivative, for which other methods were unsuccess-
ful.[214] When epoxide (7R,8R)-57 (the major isomer resulting from epoxidation
with VO(acac)2)/t-BuOOH) was reacted under conditions similar to those of Fuchs
and Coworkers (30mol% SnCl2 in acetone at 55 ◦C), a mixture of multiple products
was formed (Scheme 4.33). Chromatographic purification of the mixture provided
diacetonide (7R,8S)-64 (28% yield), major monoacetonide (7R,8S)-65 (44%), and
minor monoacetonide (7R,8S)-66 (15%), and the three anti-diol derivatives could
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Scheme 4.33 Synthesis of anti-intermediate (7R,8S)-67 from epoxide (7R,8R)-57 via
a sequence of SnCl2-mediated epoxide opening and acetonide hydroly-
sis/formate cleavage.
be isolated and independently characterized in pure form. Attempts to enforce the
complete conversion to diacetonide (7R,8S)-64 over prolonged reaction times met with
failure, since increased amounts of degradation products were obtained, and interfered
with chromatographic separation of the acetonides. In the following step, which was
performed for each individual acetonide derivative in an independent reaction, the
anticipated hydrolytic acetal cleavages proved to be challenging. In several experiments
(80% AcOH at 50 ◦C, or: cat. p-TsOH in 1,4-dioxane/H2O at 80 ◦C, or: 1m HCl/THF
at 45 ◦C), severe decomposition of the acetonide substrates could be observed, putatively
resulting from acidic debenzylation reactions, or from intramolecular reactions like
the previously observed 1,4-diol cyclization (tetrahydrofuran formation). Best results
were obtained upon mild hydrolysis of the acetonides in a mixture of formic acid
and water, a method which has been reported before.[215, 216] The obtained crude
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Scheme 4.34 Schematic representation of significant NOE contacts observed in H,H-
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mixtures of intermediate formates were deacylated in a successive step (NH3 in MeOH),
thus providing the wanted anti-diol intermediate (7R,8S)-67 in satisfactory yields
(42–67%). Notably, the identical product (7R,8S)-67 was independently obtained
from all three acetonides, therefore confirming the identical side chain configurations.
The (7R,8S)-configuration of (7R,8S)-67 was previously anticipated, since nucle-
ophilic epoxide opening was assumed to occur selectively at the C -8 position due to
steric factors related to the bulky carbohydrate moiety. Additionally, experimental evi-
dence for the ascribed configuration could conveniently be obtained from H,H-NOESY
experiments of the acetonide intermediates, which allowed for the determination of
significant NOE contacts (Scheme 4.34) due to the conformationally locked nature
of the cyclic acetal moieties. The (7R)-configuration was evident from a distinctive
correlation between the axial carbohydrate H -3 and the side chain H -7 observed in the
2,7-locked diacetonide (7R,8S)-64. The respective (8S)-configuration followed from
NOE contacts observed for the 7,8-locked monoacetonide (7R,8S)-65. An only weak
H -7–H -8 correlation suggested the presence of an anti-realtionship. Furthermore, the
two diastereotopic methyl groups of the isopropylidene moiety exhibited weak but visible
NOE contacts to either the H -7, or the H -8, respectively, as would be expected in the
given anti-configuration. These spectral properties, together with the transformation of
all acetonides into one single deprotected product (7R,8S)-67, gave confirmation for
the ascribed (7R,8S)-configuration.
In the final stages of the synthesis, advanced intermediate (7R,8S)-67 was sub-
jected to the previously developed TEMPO-based oxidation protocol to obtain spiro-
xylofuranose α,β-68 (Scheme 4.35). Surprisingly, under the conditions established
for the syn-intermediates, overoxidation to xylonolactone (7R,8R)-69 (84% yield)
was the major pathway, and only minor amounts of α,β-68 (6%) could be isolated.
Running the reaction at lower temperature (−65 ◦C) retarded the overoxidation to some
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Scheme 4.35 Oxidation of (7R,8S)-67 to spiro-xylofuranose α,β-68 in low yield, overoxi-
dation to xylonolactone (7R,8R)-69, and deprotection to target 4-C -formyl
octose anti-70. Anomeric ratios are given in acetone-D6. For clarity, anti-
70 is depicted in the (9S)-9,7-pyranose-1,9-pyranose isomeric form.
degree, and upon interruption of the reaction at incomplete conversion, α,β-68 could
be obtained in higher, but still mediocre yield (18%, 36% brsm). Interestingly, for the
corresponding syn-isomers, lactone formation did not occur to a significant amount.
Obviously, the presence of the 7,8-anti-diol dramatically changes the susceptibility of
(7R,8S)-67 towards oxidation to the lactone. This observation seems to be somewhat
in line with results by Yu and Molinaro in their total synthesis of bradyrhizose K.[14]
In the published reaction, the authors observed overoxidation of substrate DV, also
carrying a 2,3-anti-diol moiety, to the gluconolactone derivative EV (Scheme 4.27,
(c), on page 106). For the observed formation of xylonolactone (7R,8R)-69, an expla-
nation for the altered reactivity in connection with the 7,8-anti-diol functionality seems
to be intricate. A discussion of effects could involve, for example: (i) An increased
nucleophilicity/basicity of the hemiacetal hydroxyl group in α,β-68 involved (possibly
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in deprotonated form) in nucleophilic attack on the TEMPO-derived oxoammonium
ion. (ii) Disfavored stabilizing hydrogen-bonding interactions in substrate α,β-68, or
favored stabilizing hydrogen-bonding interactions in the product (7R,8R)-69 or in the
transition state of its formation, respectively, due to geometric circumstances. (iii) The
putatively lower overall dipole moment of the anti-diol (7R,8R)-69, or of the transition
state of its formation, as compared to the syn-derivatives. (iv) Stereoelectronic effects,
e.g. hyperconjugative effects specifically viable in the anti-diol configuration. However,
in this regard, further studies are required to determine a possible generality of these
experimental observations concerning the oxidation behavior.
To provide sufficient material of the wanted spiro-xylofuranose α,β-68, lactone
(7R,8R)-69 was treated with DIBAL-H in THF at −78 ◦C. In this way, α,β-68 was
available in reasonable yield (68% from 69), and amenable to full NMR characterization
of the mixture of anomers (d.r.≈ 1:1 in acetone-D6). Although the configurations of
the side chain stereogenic centers were indirectly concluded from NMR observations for
the acetonides 64/65 (see above), an independent confirmation for the stereochemistry
of α,β-68 could be obtained from 2D NMR analyses. The (7R)-configuration followed
from distinctive NOE contacts between the carbohydrate H -1 and H -7, and from
the absence of corresponding NOE contacts between H -7–H -3 (Fig. D.6 on page
309). Based on this, the (8R)-configuration was directly evident, since the sample
was spectroscopically clearly distinguishable from the second (7R)-isomer α,β-51.
The anomeric configurations could be established by significant magnitudes of vicinal
coupling constants within the side chain, together with a comparison of 13C NMR
chemical shift values of the anomeric C -9 signals, which were found to be in sufficiently
good agreement with those found for α,β-48 with identical (8R)-configuration [α,β-68:
96.0 (α), 103.5 (β); α,β-48: 98.9 (α), 103.6 (β) ppm]. To complete the synthesis, α,β-68
was deprotected, giving target compound anti-70 in a completely analogous manner
as previously described for the corresponding syn-isomers. The synthesis of anti-70
proceeded in a total of 16 steps from d-glucose, and in 11 steps (13% yield) from the
known keto-sugar 2b.
Having established a synthesis for three target compounds (syn-50, syn-52 and
anti-70), the remaining fourth isomer was anticipated to be available from the second
epoxide isomer. Treatment of (7S,8S)-53 under the conditions that were successfully
applied to its isomer (cat. SnCl2 in acetone) required somewhat lower loadings of the
Lewis acid (10mol% instead of 30mol%) to react in a clean manner. Surprisingly, as
opposed to the transformation of (7R,8R)-57, the formation of one major species
was observable, essentially as the only significant product of the reaction in 68% yield
(Scheme 4.36). Complete characterization of the purified product revealed several
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Scheme 4.36 Formation of bicyclic, conformationally locked 1C 4 pyranose (7R,8S)-71
from epoxide (7S,8S)-53.
unexpected spectral properties that finally resulted in the ascribed structure (7R,8S)-
71, which can be described as a 1C 4 system, which is conformationally locked by a
linkage between the carbohydrate O-4 and the side chain C -7, thus forming a bicyclic
framework with the carbohydrate substituents at positions 1,3,5 in triaxial orientation.
The unusual structure of (7R,8S)-71 could be established from the following analytical
properties (for additional clarification, see Scheme 4.37): the loss of one benzyl group
was evident from the mass spectra, as well as from 1H NMR integration, which indicated
the presence of 15 aromatic protons. C,H-HMBC measurements confirmed the positions
of the remaining benzyl groups at O-1,3,6, and furthermore indicated the depicted O-4–
C -7 ring closure by a distinct H -4–C -7 coupling. The 1C 4 conformation of the parent
carbohydrate moiety followed tentatively, since the bridging O-4–C -7 connection would
not be feasible for the bis(equatorial) orientation in a 4C 1 pyranose form. Spectroscopic
evidence for a 1C 4-like conformation was a small coupling constant J 4,5=2.6Hz, which
was inconsistent with a 1,2-diaxial, and rather suggestive for a 1,2-equatorial relationship.
Likewise, the coupling constant J 3,4=5.7Hz was smaller than conventionally anticipated
for manno-configured pyranoses, but larger than expected for a clean bis(equatorial)
orientation[128], therefore indicating a distortion of the 1C 4 chair geometry probably
caused by the rigid 2,4-connecting bicyclic framework. Similarly, distinct NOE contacts
between H -3,4,5 were significant for spatial proximity and inconsistent with trans-diaxial
relationships. The configuration of the side chain C -7 followed from a strong correlation
between H -7 and the equatorial H -1. The determination of the (8S)-configuration
required a detailed analysis of long-range NOE contacts (not shown) observed for the
diastereotopic methyl groups of the acetonide moiety, in combination with a distinct
H -3–H -8 correlation (as indicated in Scheme 4.37).
Since the reaction of (7S,8S)-53 in the presence of 10mol% SnCl2 required prolonged
reaction times (46 h at 45–55 ◦C) for complete conversion, a second experiment was con-
ducted in the presence of equimolar amounts of the Lewis acid (Scheme 4.36, reaction
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b). In this case, complete conversion of the epoxide occurred at 0 ◦C after 2 h, albeit, the
isolated product was, similarly, (7R,8S)-71 (60% yield). Concludingly, an extended
optimization of the conditions for the desired reaction seemed to be futile, since forma-
tion of the unwanted product (7R,8S)-71 was observed under two distinctly different
conditions. To explain the unusual reaction, plausible mechanistic pictures were devel-
oped based on the following rationale: in epoxide (7S,8S)-53, direct epoxide opening
at C -8 seems to be less favorable as compared to diastereomeric epoxide (7R,8R)-57,
possibly due to conformational circumstances. Therefore, longer reaction times or higher
loadings of Lewis acid are required, and deprotection/rearrangement steps occur. One
possible mechanism (Scheme 4.38, left) could involve the formation of the oxetane
53-a via intramolecular SnCl2-mediated displacement of the C -4-benzyloxy group. In
the putative oxetane intermediate, the epoxide could be converted into the anticipated
7,8-acetonide 53-b via attack at C -7, resulting in the required (7R,8S)-stereochemistry.
In the final step, acetonide migration to the C -8,9 position and oxetane opening by the
liberated O-7 would give the product (7R,8S)-71. However, both the initial oxetane
formation step, and the oxetane opening step by the remote O-7 of the equatorial
side chain, seem to be questionable. Another mechanism (Scheme 4.38, right) could
involve Lewis acid-catalyzed formation of an activated C -9 hemiacetal species 53-c.
This intermediate could be trapped intramolecularly by the remote O-4, accompanied by
nucleophile-assisted debenzylation. Due to the nine-membered cyclic acetonide moiety
in 53-d, a 1C 4-like conformation of the pyranose moiety could be feasible, leading to a
prearranged structure with O-4 and the intact epoxide in spatial proximity. Thus, a
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Lewis acid-mediated cascade, featuring epoxide opening by O-4 and acetonide migration
to C -8,9 could result in the formation of (7R,8S)-71.
In following experiments, other Lewis acids were explored for the transformation
of epoxide (7S,8S)-53 under otherwise similar conditions in acetone. However, all
reactions either resulted in complex inseparable mixtures of products (Er(OTf)3[210],
MoO2Cl2[211], Sn(OTf)2), or did not lead to any visible transformation of the epoxide
(SnF2). Since a synthesis of the most desirable anti-isomer anti-70 with side chain
configurations similar to those of the natural product bradyrhizose K was successfully
developed, further investigations into the synthesis of the second anti-isomer were
abandoned at this point.
4.5.4. Characterization of the Target Compounds
The obtained 4-C -formyl octoses syn-50, syn-52 and anti-70 were initially character-
ized by HR-ESI-TOF-MS (positive and negative mode), which confirmed the complete
absence of partially benzylated residues in the products, and gave a preliminary indica-
tion for the purity of the compounds. Following this, all three target compounds were
subjected to detailed NMR-based analyses in D2O, upon which the 1H NMR spectra
once again confirmed the absence of aromatic impurities in the products. syn-50,
syn-52 and anti-70 each exhibited highly complex NMR spectra, which indicated the
presence of a large number of isomeric forms (>5 isomers) for each target compound.
However, due to the complexity of the 1H NMR spectra, as well as limited sensitivity
of the 13C NMR experiments, no precise absolute numbers can be given. Noteworthy,
for syn-50, syn-52 and anti-70, the presence of free aldehyde isomers could be ruled
out, since the 1H NMR spectra exhibited no corresponding deshielded signal significant
for an aldehyde.
To support a following 2D NMR-based structural characterization of the major
isomeric forms present in solution, a qualitative analysis of plausible isomeric forms
was performed (Scheme 4.39 and Scheme 4.40). From the open-chain dialdehyde
form (depicted as syn-50), two pyranose ring closures are feasible (9,7-pyr and 1,5-pyr,
Scheme 4.39). 9,7-Pyranose formation results in a number of possible following ring
closures, for example the intuitively assumed “bradyrhizose-type“ (9S)-9,7-pyranose-
1,9-pyranose isomeric form, resembling the major isomer of bradyrhizose K (comp.
Scheme 4.8 on page 70). Similarly, the bicyclic 9,7-pyranose-1,5-pyranose form and the
spirocyclic 9,7-pyranose-1,4-furanose form (resembling the spirofuranose intermediates
traversed in the synthesis) are related to the minor isomers identified for the natural
product K. In this manner, several other potential isomeric forms can be derived
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from the 9,7-pyranose and 1,5-pyranose ring closures. Notably, the given analysis only
involved pyranose and furanose isomers, and smaller or larger cyclic forms, as well as
possible bridged cyclic forms, were disregarded. Nevertheless, as depicted, the number
of potential individual isomers is significantly increased by considering following ring flip
isomerism (only given for pyranoses), and by considering putative anomeric mixtures
for all isomers due to the presence of (either one or two) free hemiacetal functionalities.
In addition to these pyranose ring closures, several furanose ring closures are feasible
from the acyclic isomer (9,6-fur, 1,4-fur and 9,2-fur, Scheme 4.40).
In total, the given set of plausible isomers includes 47 individual isomeric forms,
taking into account the presence of α- and β-anomeric isomers for each hemiacetal
functionality. Subtraction of the number of free aldehyde isomers, not present according
to preliminary NMR studies, results in a total of 32 potential isomers (constitutional
isomers and diastereoisomers). Furthermore, by disregarding ring flip isomerism or
α,β-isomerism, five individual constitutional isomers can be identified. Noteworthy,
for target compounds syn-52 and anti-70, a completely analogous analysis can be
given (not shown). Based on the analysis of potential isomeric forms for syn-50,
2D NMR analyses were utilized to gain insight into the major isomeric forms of the
compounds in D2O (for 1H NMR spectra of the anomeric regions, see Fig. 4.12 on
page 135. For selected 2D NMR spectra, see Appendix D). All NMR analyses were
performed on samples of the concentration 0.075mmol/mL, and thus, with the same
concentration used for the synthesis-derived bradyrhizose K.[14] Surprisingly, detailed
NMR investigations confirmed that the intuitively anticipated, “bradyrhizose-type“
9,7-pyranose-1,9-pyranose isomer was no major constituent of the isomeric mixture
of syn-50. Instead, the annulated 1,5-pyranose-9,7-pyranose isomer, both in the 1,9-
diaxial (1R,9S)-form syn-50-A (49% isomeric contribution) and in the (1S,9S)-form
syn-50-B (37%) could be identified (for a summary of results, see Table 4.4 on page
134). The ring closures for these isomers were evident from distinct long-range couplings
in C,H-HMBC experiments (H-1–C-5/H-5–C-1). The C -1 anomeric configuration of
syn-50-B could be determined from a H -1–H -5 NOE contact, which confirmed the
1,3-diaxial relationships expected for this isomer. Furthermore, the ascribed anomeric
configurations at C -1 and C -9 were fully supported by the determined 1JC,H coupling
constants, which were in good agreement with the ranges expected for axial (158–160Hz)
or equatorial (170Hz) anomeric protons.[99, 100] Comparably, for target compound
syn-52, the 1,5-pyranose-9,7-pyranose ring closures were favored, too. In this case, the
diequatorial (1S,9R)-form syn-52-A (66% isomeric contribution) was identified, largely
from similar spectral properties as given above, and all other isomeric forms were negligi-
ble (< 13% contribution). For anti-70, two major isomers could be identified, however,
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the determined 1JC1,H1 coupling constants (175.4 and 175.5Hz) were inconsistent with α-
or β-anomeric configurations in pyranoses, and rather suggestive for a furanose. For both
identified isomers, a pronounced long-range coupling between H-1–C-4 (C,H-HMBC), as
well as a significant low-field shift of the quaternary C -4 (the former carbohydrate C -2)
as compared to the other isomers (84.2 vs. 74.0–75.8 ppm) also suggested the presence
of a spirofuranose form (related to synthetic intermediate α,β-68). The major isomer
could be determined to be anti-70-A with (1S,9S)-configuration (47% isomeric contri-
bution). The minor isomer anti-70-B (10% isomeric contribution) was found to be the
corresponding 9-equatorial isomer with (1S,9R)-configuration and similarly α-configured
xylofuranose moiety. The C -1 anomeric α-configurations were deduced from specific
NOE contacts (H-1–H-2), combined with further spectral properties (13C chemical
shifts of C -1: 94.8, 94.4 ppm; 1H NMR: 3J 1,2=4.7, 5.0Hz) that were in agreement with
literature data reported for simpler xylofuranosides.[217] It should be noted that the
NMR spectral data obtained for compounds syn-50, syn-52 and anti-70 as stated
here remained practically unchanged upon storing the solutions in D2O for several days
at ambient temperature. Thus, good evidence was obtained that equilibration of the
isomeric mixtures was completed. The results described here demonstrate that the
anticipated “bradyrhizose-type“ isomers (the potential (9S)-9,7-pyranose-1,9-pyranose
isomeric forms) are not major constituents of aqueous solutions of the target compounds
T-4. Especially in the case of anti-70, the isomer with side chain configurations
identical to the natural bradyrhizose K, these findings seem to be remarkable. In the
putative (9S)-9,7-pyranose-1,9-pyranose isomer of anti-70 (Scheme 4.41 on page
136), both hydroxyl groups at the 2,3-positions are equatorially-oriented, similar to the
major 1,5-pyranose isomer of bradyrhizose K. Nevertheless, this intuitively favorable
isomeric form was not found as a major constituent of solutions of anti-70. The
alternate 1,5-pyranose-9,7-pyranose isomer (the major form found for syn-50 and
syn-52) with 2,3-diaxial configuration seems to be unfavorable, too. Instead, the
1,4-spiro-xylofuranose forms anti-70-A and anti-70-B are preferred. Remarkably,
xylose is typically a pentose with high conformational stability, and furanose forms are
usually only trace constituents in aqueous solution.[218, 219]
The fact that the 9,7-pyranose-1,9-pyranose isomers seem to be unfavorable for
the three 4-C -formyl octoses syn-50, syn-52 and anti-70 can be addressed, in a
qualitative manner, by considering the special role of hemiacetal functionalities in
hydrogen-bonding interactions of glycosides. Both theoretical and experimental studies
have confirmed that the hemiacetal group is a comparably poor hydrogen bond acceptor,
but the strongest hydrogen bond donor in carbohydrates.[131, 220, 221] Computational
results suggested, for example, that the monohydration of glucose proceeds preferentially
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Table 4.4 Major isomers of target 4-C -formyl octoses syn-50, syn-52 and anti-70 in
aqueous solution (D2O) and key NMR data of the anomeric regions.
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a In solution: 0.075mmol/mL in D2O at 25 ◦C. After NMR analysis, the samples were stored for
several days in D2O. Unchanged spectral properties confirmed complete equilibration.
b Determined by 1H NMR integration: combined anomeric integration of the isomer in relation
to total anomeric signal integration (4.6–5.5 ppm) in baseline-corrected spectra.
c NMR signals [ppm] and coupling constants [Hz] in D2O at 700.3/176.1MHz.
d Key NMR correlations observed in the corresponding experiments.
e Weakly resolved doublet.
f Determined in F2-coupled C,H-HSQC experiments.
g Only observed isomer with > 12% contribution.
h Partially obscured by solvent signal.
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Figure 4.12 Anomeric regions (4.6–5.5 ppm) of the 1H NMR spectra of the identified
isomers for 4-C -formyl octoses syn-50, syn-52 and anti-70 in D2O at
700.3MHz. For signal assignments, see Table 4.4. The shown spectra are
unprocessed. The ratios of the isomers were determined by integration of
corresponding baseline-corrected spectra (not shown).
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Scheme 4.41 Structural comparison of the major 1,5-pyranose isomer of bradyrhizose
K (left) with the anticipated and observed isomers for target compound
anti-70.
at the exocyclic hemiacetal oxygen (the C -1-OH).[222] From this perspective, the
“bradyrhizose-type“ isomers [(9S)-9,7-pyranose-1,9-pyranose forms] can be referred to
as proximal acetal-hemiacetal forms, featuring one acetal functionality (C -9), and one
hemiacetal functionality (C -1). All identified isomers, in contrast, are bis(hemiacetal)
forms, with both C -1 and C -9 carrying a hemiacetal group. Along these lines, the
observations described here could be explained by a higher number of hemiacetal
functionalities in the observed isomers as compared to the anticipated isomers (2 vs.
1), and thus, favorable hydration properties (e.g. hydration enthalpies). In the natural
monosaccharide bradyrhizose K, due to the inositol moiety, only one aldehyde is present,
and thus, one hemiacetal functionality can be established. Understandably, the major
isomeric form is isomer 1,5-K, exhibiting the sterically favorable 2,3-bis(equatorial)
configuration.
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Scheme 4.42 Synthesis of 2-C -(Z)-alkenyl mannosides 23 and 36 via alkynylation and
Lindlar hydrogenation.
Starting from the known benzyl 2-uloside 2b[37], preliminary synthetic studies towards
the target 4-C -formyl octoses T-4 were performed following a route proposed by Men-
zel and Ziegler.[174] Thus, equatorially-selective alkynylation of the ketone 2b with
propiolaldehyde dibenzyl acetal afforded the novel 2-C -alkynyl mannoside 22 (Scheme
4.42). Extensive investigations revealed that the following partial hydrogenation of
22 under Lindlar conditions proceeded smoothly in DMF, which was found to be the
preferable solvent for semihydrogenations of sterically crowded 2-C -alkynyl branched gly-
cosides. In this way, (Z )-alkene 23 was available. The structure of 23, which displayed
solvent-dependent rotameric isomerism effects in NMR experiments, was additionally
confirmed by X-ray crystallography. Routine protecting group manipulations of alkyne
22 provided, after similar partial hydrogenations of the alkyne moieties, an extended
set of 2-C -alkynyl and 2-C -(Z )-alkenyl mannosides with an acetal-protected γ-aldehyde
functionality. Subsequently, osmium-based syn-dihydroxylations of the alkene moiety
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Scheme 4.43 Synthesis of tetrols (7S,8S)-43, (7R,8R)-44 and (7R,8S)-67 with diverse
configurations of the side chain diol moiety.
in 23 or derivatives thereof were explored. However, even forceful conditions could not
affect the desired transformation of the sterically crowded (Z )-alkene substrates.
In an alternate route, comparable alkynylations of 2b were performed with protected
propargyl alcohol derivatives, giving THP-protected 35 or similar derivatives with other
protecting groups. Partial hydrogenation of the alkyne and subsequent deprotection
provided allyl alcohol 36 as a suitable key substrate. From 36, oxidative functionaliza-
tions of the double bond enabled an exploration of the chemical space of 2-C -branched
mannosides, and of derived 2-spiroannulated molecular patterns. The osmoylation of 36
was found to require the addition of citric acid, whereas conventional methods without
additives or protocols with basic additives did not affect the dihydroxylation (Scheme
4.43). The successful syn-dihydroxylation provided major isomer (7S,8S)-43 and
minor isomer (7R,8R)-44, which could be separated either by fractional crystalliza-
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tion or by employing derivatization techniques. Furthermore, epoxidations of 36 were
examined. Peracid epoxidation with m-CPBA provided epoxyalcohol (7S,8S)-53 as
the major isomer. In contrast, vanadium-catalyzed epoxidation with the combination
VO(acac)2/t-BuOOH resulted in the formation of (7R,8R)-57 as the major epoxide
isomer. The following epoxide opening towards the desired anti-diol intermediates
proved to be challenging. In this regard, a protocol involving SnCl2-mediated epox-
ide opening in acetone, followed by deprotection reactions, was found to be suitable
for the transformation of epoxide (7R,8R)-57 into anti-diol (7R,8S)-67 as a third
intermediate with a fully hydroxylated side chain. A similar procedure from epoxide
(7S,8S)-53, however, gave only an unwanted debenzylation/rearrangement product.
The depicted stereochemistry of all side chain functionalized intermediates could be
fully established by 2D NMR spectroscopy. Furthermore, X-ray structural analyses of
derivatization products confirmed these spectroscopic results indirectly.
The synthesis continued with the obtained tetrols (7S,8S)-43, (7R,8R)-44 and
(7R,8S)-67, which were subjected to selective primary alcohol oxidations. Published
procedures suggested mild and selective TEMPO-based oxidation protocols as a suitable
method, however, under reported conditions, the reactions proceeded sluggishly and gave
impure products. A new optimized procedure could be developed by utilizing the known
combination catalytic TEMPO/trichloroisocyanuric acid (TCICA). Improvements over
published protocols involved 3-(N -morpholino)propanesulfonic acid (MOPS) as an or-
ganic buffer to ensure anhydrous conditions, ethyl acetate/toluene as the solvent mixture
at low temperatures (−65 to −35 ◦C), and a reductive quench with dimethyl sulfide prior
to aqueous workup (Scheme 4.44). In this way, the syn-configured tetrol substrates
(7S,8S)-43 and (7R,8R)-44 were cleanly converted into the corresponding reducing
spirofuranose-pyranose hybrids α,β-48 and α,β-51. Via the optimized oxidation proto-
col, these reducing furanose intermediates were obtained in high purity, whereas other
methods gave impure products and required extensive multiple chromatography steps
which led to severe loss of material of the sensitive free hemiacetals. In the case of the
anti-isomer (7R,8S)-67, major overoxidation to the lactone occurred, thus demanding
a following reduction step with DIBAL-H to afford the lactol α,β-68 in reasonable yield.
The obtained products could be fully characterized by multiple analytical methods.
Notably, the α- and β-components of the novel reducing spirofuranose-pyranose hybrids
could be independently characterized by NMR spectroscopy to a large extent. Further-
more, related synthetic explorations afforded previously undescribed molecular frame-
works (Scheme 4.44, bottom) like the corresponding spiro-tetrahydrofuran cyclization
products (7S,8S)-49/(7S,8R)-56/(7R,8S)-60, spiro-epoxycarbonate (7R,8R)-61,
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Scheme 4.44 Top: oxidative synthesis of spirofuranoses α,β-48, α,β-51 and α,β-68. Bot-
tom: molecular diversity of related 2-spiroannulated frameworks.
or the epoxide-derived 2,3-anhydrofuranoses α,β-62/α,β-63 as an addition to the
structural diversity of 2-C -branched glycosides and 2-spiroannulated carbohydrates.
Debenzylation of the spirofuranoses α,β-48, α,β-51 and α,β-68 provided the cor-
responding target 4-C -formyl octoses syn-50, syn-52 and anti-70, each as a com-
plex mixture of isomers (Scheme 4.45). Detailed NMR studies in D2O revealed the
structures of the 1,5-pyranose-9,7-pyranose (syn-50 and syn-52) or the 1,4-furanose-
9,7-pyranose (anti-70) hemiacetal forms, and these species could be identified as the
major isomeric forms in solution. In contrast, the initially anticipated isomeric forms of
target compounds T-4 (Scheme 4.45, bottom), the (9S)-9,7-pyranose-1,9-pyranose
forms with structural analogy to the natural monosaccharide bradyrhizose K, were
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not identified as major constituents. These results suggest that for higher sugars of
type T-4, isomeric forms with two hemiacetal functionalities are favorable, and thereby
preferred over the acetal-hemiacetal isomeric forms of initially anticipated compounds
T-4. Obviously, substitution of the inositol moiety in bradyrhizose K for a conventional
monosaccharide (β-mannoside) results in an alteration of the isomeric distribution. For
this reason, target compounds syn-50, syn-52 and anti-70 seem to be inadequate as
structural analogs for the natural product K. Nevertheless, detailed structural investi-
gations into isomeric equilibria of higher sugars are rare, and therefore the described
results can be seen as an addition to the synthesis and characterization of complex
higher sugars.
5. Cyclopent-2-enones from 2-Uloside
Precursors
As covered in Chapter 2, benzylated 2-ulosides 2a-c with diverse anomeric substituents
could be obtained by Dess-Martin oxidation (Scheme 2.14 on page 24), and were thus
available as precursors for the synthesis of higher sugar analogs as reported in Chapters
3 and 4. In reactions involving precursors 2a and 2b, the following observations were
made: allyl 2-uloside 2a exhibited a high tendency to form the corresponding 3,2-enolone
3b via elimination of benzyl alcohol, either under the conditions of its formation, or upon
chromatographic purification (Scheme 2.13 on page 21). In contrast, the corresponding
benzyl 2-uloside 2b was more resistant, and required highly basic conditions to afford
3,2-enolone 40 as a side product in the ketone alkynylation reaction (Scheme 4.21,
(a), on page 94).
In light of the interesting downstream chemistry of structurally similar 3,2-enolones
(comp. Section 2.1.2), further transformations of the 3,2-enolone intermediates derived
from 2a-c were explored in the course of this thesis. These results are covered in this
chapter.
5.1. Introduction to Carbohydrate-Derived
3,2-Enolones and 3,2-Enones
Within the area of carbohydrate-based building blocks, sugars incorporating an α,β-
unsaturated carbonyl moiety have attracted interest due to the high synthetic versatility
of the enone functional group. As a result, several review articles have been published
focussing on such unsaturated carbohydrate derivatives.[113, 223] The incorporation of
a ketone functionality at position 2 of a pyranose and of an unsaturation at positions
3/4 results in what can be referred to as a hex-3-enopyranoside-2-ulose according to
carbohydrate nomenclature.[16, 113] Apart from this, the following nomenclature is
frequently applied for reasons of convenience: 4-deoxy-hex-3-enopyranoside-2-uloses
can be referred to as carbohydrate 3,2-enolones (Scheme 5.1), thus emphasizing the
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Scheme 5.1 General structures of carbohydrate-derived 3,2-enolones and 3,2-enones. R =
protecting groups.
presence of an α-ketoenol arrangement. Frequently, the protecting group at O-3 is an
ester, and these protected derivatives can be designated as 3,2-enolone esters.[48, 113]
Accordingly, the corresponding 3,4-dideoxy derivatives can be referred to as carbohydrate
3,2-enones. In a pyranose system, an α,β-unsaturated carbonyl moiety can similarly be
established with the carbonyl functionality at C -1 (lactones), C -3 or C -4. Although
these regioisomers feature a comparably diverse chemistry[113, 223], this introduction
will focus on reactions of the relevant 3,2-enolones and the related 3,2-enones.
Carbohydrate 3,2-enones can be routinely obtained from simple 2-oxyglycals via a
Lewis acid-mediated Ferrier-type glycosylation/elimination cascade.[223] Due to this
convenient synthetic accessibility, carbohydrate 3,2-enones have been frequently applied
as building blocks for the synthesis of 4-C -branched sugars by means of conjugated
addition reactions to the Michael system. For example, Fraser-Reid and Coworkers
reported on the cuprate addition of the tritylated 3,2-enone EW, which provided the C -4
methylated product EX via selective axial attack of the reagent (Scheme 5.2).[224] A
similar strategy was employed by Tatsuta and Coworkers, who reacted enone EY with a
sulfonyl-stabilized carbanion. After intramolecular trapping of the enolate intermediate,
the glycoside-annulated hydroquinone EZ could be obtained.[225] Several contributions
to such conjugated addition reactions of carbohydrate 3,2-enones have been published
by Varela and Coworkers. Accordingly, in one example, enone FA was treated with
ethanethiol in the presence of a catalytic amine base to afford the corresponding 3,4-
dideoxy-4-thiohexopyranos-2-uloside FB in a thia-Michael reaction with selectivity for
axial attack.[226] Further examinations suggested that the configuration at the anomeric
position provided the steric bias for the diastereoselectivity, since otherwise similar
β-configured substrates resulted in selective equatorial attack at the C -4.[227]
Apart from conjugated addition reactions, other transformations of carbohydrate 3,2-
enones include, for example, Diels-Alder reactions. In this regard, Varela and Coworkers
reacted 3,2-enone FC with cyclopentadiene in toluene (Scheme 5.3, top).[228] The
cycloaddition occurred selectively from the β-face, and gave annulated 2-ulosides FD/FE
as an endo/exo mixture. Noteworthy, Diels-Alder reactions have also been investigated
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Scheme 5.2 C -4 functionalizations of carbohydrate 3,2-enones EW[224], EY[225] and
FA[226] via conjugated addition reactions.
with carbohydrate 3,2-enolone substrates, although these displayed a significantly
lower dienophilicity as compared to 3,2-enones. Lichtenthaler and Coworkers treated
3,2-enolone ester FF with cyclopentadiene in CH2Cl2 (Scheme 5.3, bottom).[229]
The thermal reaction required high temperatures (200 ◦C, 48 h), and therefore high
pressure (15 kbar) and Lewis acid-catalyzed (TiCl4) procedures were explored. Suitable
conditions could be found, and provided the endo-product FG via selective attack from
the α-face.
Other synthetically useful addition reactions to carbohydrate 3,2-enolones do exist,
however, these transformations frequently suffer from low predictability of the synthetic
outcome. Lichtenthaler and Coworkers performed a detailed investigation on the re-
activity of benzoylated 1,5-anhydro-3,2-enolone FH (Scheme 5.4).[53] The cuprate
addition (CuI, MeLi) to FH provided 4-C -methylated FI with equatorial selectiv-
ity, albeit in a mediocre 40% yield. In contrast, in the presence of lithium enolates,
1,2-addition occurred at the C -2, accompanied by an unexpected O-3–O-2 benzoyl
migration and formation of the 3-ulose product FJ. Unexpectedly, under nitroaldol
conditions, double addition occurred at the C -2, and the 2,2-bis(nitromethyl) product
FK was formed. Similar transformations involving the conventional 3,2-enolones (not
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the 1-deoxy derivatives like FH) seem to be underexplored. However, an examination of
the diverse degradation reactions of carbohydrate 3,2-enolones (Section 2.1.2) suggests
that under basic, as well as under acidic conditions, several potential side reactions
have to be considered.
In 2001, Zou and Coworkers reported on an interesting rearrangement reaction
of a carbohydrate 3,2-enolone.[230] When C -glycosidic α-allyl 3,2-enolone FL or the
corresponding β-isomer FM were subjected to basic conditions (K2CO3 or Et3N in
MeOH), from both substrates one identical product could be isolated and identified to
be the 5-hydroxycyclopent-2-enone (±)-FN, notably as a racemic mixture (Scheme
Zou 2001:
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Scheme 5.5 Top: published base-induced rearrangement reactions of dihydropyran-3-ones,
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reaction. B– = basic reagent. RDS = rate-determining step. Counter ion not
shown.
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5.5). Previously, Caddick and Coworkers published a comparable rearrangement of
the racemic enone (±)-FO. Upon treatment with Et3N in DMF, the dihydropyran-3-
one underwent rearrangement into 5-hydroxycyclopent-2-enone (±)-FP, which exhib-
ited a 4,5-trans-configuration comparable to (±)-FN.[231] Prior to these two reports,
Kolb and Hoffmann published a similar rearrangement of dihydropyran-3-ones into 5-
hydroxycyclopent-2-enones (not shown).[232] In their optimized procedure, the authors
treated the substrates with a buffer of PhCO2H/KOAc (1:2) in DMF at 80 °C to invoke
the rearrangement. However, following experiments indicated that the reaction was
dependent on proton catalysis, rather than a base-induced process.
For the rearrangements described by Zou[230] and Caddick[231], a generally ac-
cepted mechanism can be given by taking into account mechanistic considerations by
the authors, including following publications by the Caddick group.[233–238] Thus,
as exemplified for the transformation of (±)-FO, deprotonation at the C -2 of the
dihydropyran-3-one (related to the carbohydrate C -1) gives the enolate FO-a/FO-b
(Scheme 5.5, bottom). Subsequently, a 6pi disrotatory electrocyclic ring opening
would occur, putatively supported by the anionic enolate oxygen, giving the open-chain
vinylogous enolate FO-c/FO-d, notably an achiral intermediate. The final cyclization
would proceed either in the sense of an intramolecular aldol addition, or in a (charge-
promoted) 4pi conrotatory electrocyclic ring closure. Computational results reported
by the Caddick group suggested that the formation of FO-c/FO-d (the ring opening)
is the rate-determining step of the overall reaction.[238] For the following step FO-
d→(±)-FP, rotational isomerizations and the final cyclization step are energetically
advantageous for the formation of the 4,5-trans-isomer (±)-FP, which was found to be
both the kinetic and the thermodynamic product.
Notably, a comparison of this type of rearrangements with known base-induced
degradation reactions of 3,2-enolones (Scheme 2.7 on page 15) suggests that the initial
deprotonation/enolate formation step is crucial for the outcome of the reaction: thus,
deprotonation at the carbohydrate C -5 (C -6 in the pyran numbering) is associated with
elimination processes (represented by the formation of AS), whereas deprotonation at
the carbohydrate C -1 results in the described ring contraction to racemic cyclopent-
enones. However, the chemistry of dihydropyran-3-one systems seems to be complex,
and dependent on the individual substrate and the reaction conditions. Therefore,
other factors like the absence of a leaving group at the carbohydrate C -1 in substrates
(±)-FL/FM/FO have to be taken into account.
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Scheme 5.6 Schematic representation of the synthetic routes described in this chapter.
In preceding transformations, both allyl 2-uloside 2a and benzyl 2-uloside 2b were
observed to undergo elimination to the corresponding 3,2-enolones 3b and 40 in the
presence of bases (Scheme 5.6). Inspired by this, suitable conditions were examined
to deliberately invoke this elimination under basic conditions. As a third, structurally
simpler substrate, methyl 2-uloside 2c was included in these investigations. In following
experiments, the thus obtained 3,2-enolones 3b, 40 and 72 were reacted in the presence
of nucleophilic/basic reagents to explore their applicability as unsaturated carbohydrate
building blocks. Under optimized conditions, the formation of racemic C -4 quaternary
4-hydroxycyclopent-2-enones (±)-73, (±)-74 and (±)-75 occurred in a previously
undescribed rearrangement. Further investigations into this interesting transformation,
including effects of the solvent and of the nature of the base, were performed. A
plausible mechanistic picture for the title reaction was established in the context of
related published reactions. The results obtained along these lines are covered in this
chapter.
5.3. Results and Discussion
Initial experiments for the formation of 3,2-enolones 3b, 40 and 72 from the corre-
sponding 2-ulosides 2a,b,c startet with an examination of conditions decribed in the
literature for similar transformations (comp. Section 2.1.2 on page 13). These early
investigations, including the preliminary observation of the title reaction, were in part
elaborated by R. M. Oechsner in the course of a bachelor thesis.[239]
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5.3.1. Synthesis of 3,2-Enolone Substrates
In general, ester-protected 2-ulosides undergo elimination to the 3,2-enolone esters
cleanly under a variety of conditions. A protocol frequently applied, in this regard,
involves simple heating of the acylated 2-ulosides in wet benzene in the presence of
NaHCO3 as a weak base (comp. formation of AQ, Scheme 2.6 on page 14).[38, 51,
56] Starting from these conditions in the case of benzylated 2-ulosides 2a,b,c, minor
variations were required. To account for the poor benzyloxide leaving group at position
4, a stronger base (K2CO3) was applied. Furthermore, the solvent was changed from
benzene to toluene for toxicity reasons. Thus, when 2-ulosides 2b,c were stirred in wet
toluene in the presence of K2CO3 at 80–95 ◦C, smooth elimination to 3,2-enolones 40
and 72 was observable, and the products could be isolated in 85–90% yield (Scheme
5.7). In the transformation of the sensitive allyl 2-uloside 2a to 3b, crude material as
obtained from the Dess-Martin oxidation of 7 was subjected to the elimination, since
chromatographic purification of 2a resulted in a severe loss of material.
K2CO3, H2O, O
BnO
OBn
O
OR
3b: R = All (70%, 2 steps, from 7)
40: R = Bn (90%)
72: R = Me (85%)
OBnO
BnO
OBn
O
OR
2a: R = All (crude)
2b: R = Bn
2c: R = Me
PhCH3, 80 to 95 °C, 
18 to 22 h
Scheme 5.7 Formation of 3,2-enolones 3b, 40 and 72 from 2-ulosides 2a,b,c.
Analytical data obtained for 3,2-enolones 3b, 40 and 72 were largely comparable to
published data on similar systems. In this regard, the determination of the J 4,5 coupling
constant of the H -4 (a doublet) allowed for a conformational analysis. Dihydropyran-3-
ones usually occupy either envelope conformations with the ring oxygen above or below
the plane (OE or EO), or half-chair conformations (OH 2 or 2HO).[229] Lichtenthaler and
Coworkers deduced the following circumstances from spectroscopic data on a set of α-
and β-configured 3,2-enolones (Scheme 5.8, top).[56, 229] Accordingly, α-configured
3,2-enolones FQ and AQ feature coupling constants J 4,5 in the range 1.8–2.0Hz. These
values are in agreement with a 90° orientation of the quasi-axial H -5 with respect to
the five-carbon envelope plane as established in an OE conformation. Possibly, for
α-3,2-enolones, this conformation is favorable owing to the anomeric effect. In contrast,
for β-configured 3,2-enolone FF, J 4,5=3.5Hz was found, relating to a quasi-equatorial
orientation of H -5 as realized in an EO conformation. Furthermore, the authors proposed
a slight distortion of the envelope conformation, caused by steric repulsions between the
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Scheme 5.8 Top: proposed conformations of α-3,2-enolones FQ/AQ (OE ; H -5 quasi-
axial) and β-3,2-enolone FF (EO; H -5 quasi-equatorial) by Lichtenthaler and
Coworkers.[56, 229] Published values of the significant coupling constant J 4,5
are given in CDCl3. Bottom: proposed EO conformation for β-3,2-enolones
3b, 40 and 72. Values for J 4,5 are given in CDCl3 (3b) or acetone-D6 (40
and 72).
bis(quasi-axial) substituents at positions 1 and 5. For β-3,2-enolones 3b, 40 and 72,
values for J 4,5 in the range 3.4–3.6Hz (Scheme 5.8, bottom) were in good agreement
with these suggestions, and thus indicated the preference for an EO conformation of
these 3,2-enolone intermediates in the respective NMR solvent.
5.3.2. Base-induced Rearrangement: Formation of
Cyclopent-2-enones
Further investigations into the chemistry of the obtained 3,2-enolones 3b, 40 and 72
started with the benzyl derivative 40, which was subjected to standard thia-Michael
conditions[227] involving ethanethiol and a catalytic amine base in CH2Cl2 to explore
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possible reactivities with nucleophilic reagents (Scheme 5.9, top). Surprisingly, 40
was found to be unreactive even under forcing conditions (100 ◦C, sealed vessel). Obvi-
ously, the α,β-unsaturated carbonyl moiety in carbohydrate 3,2-enolone ethers of this
type is no suitable electrophile for conjugated addition reactions, most certainly due to
the presence of a donor oxygen substituent at the α-position (C -3). Next, 40 was reacted
in the presence of highly nucleophilic sodium thiophenolate in DMF at 80 ◦C (Scheme
5.9, bottom). Under these conditions, the formation of a single product was observable
by TLC. After workup and chromatographic purification of the crude product, the
obtained mass spectra suggested a molecular weight identical to the substrate 40, and
thus, a product probably originating from a rearrangement reaction. Albeit, the isolated
material exhibited no significant optical rotation, which was indicative of a racemic
mixture or of an achiral product. Eventually, by means of 2D NMR experiments, the
structure of 2,5-bis(benzyloxy)-4-benzyloxymethyl-4-hydroxycyclopent-2-enone (±)-74
could be established, which was obviously formed in the reaction as a racemic mixture in
70% yield. In addition, chiral column HPLC experiments provided further confirmation
for a racemic mixture by the presence of two detectable species with near-identical
integration (Appendix B).
A literature survey for comparable rearrangements revealed transformations published
by Caddick[231] and Zou[230], which afforded cyclopent-2-enones from dihydropyran-
3-ones in putatively similar reactions (Scheme 5.5 on page 147). However, in the
published procedures, the formation of the 5-hydroxy-substituted cyclopentenones
occurred, whereas the transformation of 40 afforded the 4-hydroxy-substituted cy-
clopentenone (±)-74. NMR Spectroscopically, this difference was evident from the
EtSH, Et3N cat.,O
BnO
OBn
O
OBn
40
CH2Cl2, 100 °C, 26 h,
sealed vessel
no conversion
NaSPh (1.2 equiv.),O
BnO
OBn
O
OBn
40
DMF, 80 °C, 3 h
(±)-74 (70%)
O
OBn
HO
BnO
BnO
Scheme 5.9 Preliminary experiments for the reaction of 3,2-enolone 40 with nucleophilic
reagents, and initial formation of cyclopent-2-enone (±)-74.[239]
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cyclopentenone ring protons. For literature compound (±)-FN, the olefinic proton
H -3 (6.30 ppm in CDCl3) appeared as a doublet due to vicinal coupling with the
adjacent tertiary H -4 (J 3,4=2.0Hz).[230] For (±)-74, in contrast, both the olefinic
H -3 (6.35 ppm in acetone-D6 ) as well as the tertiary H -5 (4.14 ppm) appeared as clean
singlets.
Synthetic strategies for cyclopent-2-enones, and especially for the prominent 4-
hydroxycyclopent-2-enone motif, are of interest. For example, various compounds
carrying this framework have been extracted from natural sources, and the cyclopen-
tenone pharmacophore is frequently associated with interesting biological activities.[240–
245] In this context, biological and chemical properties of cyclopent-2-enones have been
outlined in a large number of review articles.[246–250] For this reason, the observed un-
expected formation of cyclopentenones from carbohydrate 3,2-enolone synthons seemed
to be an interesting addition to the available synthetic methods. Therefore, a systematic
examination of this reaction was performed.
An initial experiment was designed based on the following observation reported by Zou
and Coworkers[230]: β-configured 2-uloside BU underwent rapid elimination in 1 h to
3,2-enolone FM by using 1% K2CO3 or 10% Et3N as a base in methanol (Scheme 5.10,
top). Under the same conditions, upon extending the reaction time to 3 d, the described
rearrangement into (±)-FN occurred. Related to this transformation, 2-uloside 2b
was subjected to identical conditions (Scheme 5.10, bottom) to examine if a similar
Zou 2001:
O
O
OBn
BnO (±)-FN (78%)
O
FM (87%)
All
1% K2CO3, or:
10% Et3N,
MeOH, 20 °C, 1 h
OBn
All
HO
BnO
OBnO
BnO
OBn
O
All
BU
3 d
same conditions,
OBnO
BnO
OBn
O
OBn
2b
1% K2CO3, or:
10% Et3N,
MeOH, r.t.
complex mixture
Scheme 5.10 Top: published procedure by Zou and Coworkers, including base-induced
elimination of 2-uloside BU towards 3,2-enolone FM, followed by rearrange-
ment into cyclopent-2-enone (±)-FN upon prolonged reaction time.[230]
Bottom: unoptimized transformation of 2-uloside 2b under similar conditions,
resulting in a complex mixture.
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cascade of elimination and rearrangement was feasible. However, TLC control suggested
the formation of plentiful products, and likewise 1H NMR analysis of the crude reaction
mixture was indicative of a complex mixture. Obviously, the conditions published by
Zou and Coworkers were unsuitable for O-glycosidic substrates of type 2 (or the derived
3,2-enolones). In addition, this finding emphasized a strong influence of the solvent
on the elimination and the following rearrangement reactions. In this context, it is
noteworthy that in the elimination reaction (formation of 40 from 2b) K2CO3 was also
used as the base, albeit in nonpolar toluene at 80 ◦C. Under these conditions, clean
elimination to 40 occurred without observable premature rearrangement into (±)-74.
In contrast, with K2CO3 in the highly polar protic methanol, fast reaction of 2b to
multiple products can be observed even at ambient temperature.
As a consequence of these preliminary experiments, further variations started from
the initially identified conditions (NaSPh in DMF). A reaction screening for the trans-
formation of 40 into (±)-74 included a selection of various basic/nucleophilic reagents
and solvents (Table 5.1). Starting from the initial procedure, which utilized NaSPh
as a stoichiometric reagent (1.2 equiv.) in DMF (entry 1), the possibility of a catalytic
reaction seemed to be plausible. Under similar conditions, using 0.15 equiv. of NaSPh
(entry 2), the reaction proceeded cleanly, but with only low conversion to (±)-74 after
48 h. In extended examinations on the rearrangement reaction described by Caddick
and Coworkers, catalytic amounts of DABCO (1,4-diazabicyclo[2.2.2]octane) as a nucle-
ophilic amine base in t-BuOH were identified as appropriate conditions.[238] Related to
this, 40 was reacted in the presence of catalytic DABCO (entry 3) in DMF. Although
formation of (±)-74 occurred, the reaction proceeded in an unclean manner and several
side products were formed. To further include an alkoxide base in the reaction screening,
catalytic amounts of KOtBu (entry 4) were examined in the reaction of 40. In this
case, the clean transformation was observable at 40 ◦C, and (±)-74 was isolated in 64%
yield after 5 h, together with 26% of unreacted 40. An extension of the reaction time to
8 h, however, resulted in a complex mixture and diminished yield (entry 5), indicating
that the product (±)-74 was unstable under the conditions of its formation. Similar
experiments involving the basic reagents NaSPh, DABCO and KOtBu were conducted
in protic solvents like t-BuOH (entries 6–8), or in the more polar 2,2,2-trifluoroethanol
(TFE, entries 9–11), but in these cases only low conversions or multiple side products
could be observed. Concluding experiments involved the most promising reagent KOtBu
in different solvents. Thus, in MeCN (entry 12), decomposition of the substrate 40
was observed at room temperature. In THF at 60 ◦C (entry 13), the product (±)-74
was formed, albeit in only low amounts (4%) after 24 h. Finally, fast conversion was
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Table 5.1 Reaction screening on the rearrangement of 3,2-enolone 40 into 4-
hydroxycyclopent-2-enone (±)-74.a
reagents,O
BnO
OBn
O
OBn
40 (±)-74
O
OBn
HO
BnO
BnO
conditions
# reagent (equiv.) solvent T, t recov. 40b (±)-74b
1 NaSPh (1.2) DMF 80 ◦C, 3 h – 70%
2 NaSPh (0.15) DMF 80 ◦C, 48 h 62% 22%
3 DABCO (0.15) DMF 80 ◦C, 6 h – 53%c
4 KOtBu (0.15) DMF 40 ◦C, 5 h 26% 64%
5 KOtBu (0.15) DMF 40 ◦C, 8 h – 47%c
6 NaSPh (0.15) t-BuOH 80 ◦C, 4 h – no react.
7 DABCO (0.15) t-BuOH 80 ◦C, 24 h 4%c,d 21%c,d
8 KOtBu (0.15) t-BuOH 80 ◦C, 48 h 51% 8%
9 NaSPh (0.15) TFE 70 ◦C, 24 h – no react.
10 DABCO (0.15) TFE 70 ◦C, 24 h 71%c,d 9%c,d
11 KOtBu (0.15) TFE 70 ◦C, 24 h 65%c,d 3%c,d
12 KOtBu (0.15) MeCN r.t., 24 h – decomp.c
13 KOtBu (0.15) THF 60 ◦C, 24 h 66% 4%
14 KOtBu (0.15) DMSO r.t., 1 h – 45%c
a Reactions were run under an atmosphere of nitrogen with 50mg of 40 in 1.7mL of anhydrous
solvent. When TLC control indicated completion, quenching (acetate buffer pH 5), aqueous
workup (CH2Cl2/H2O), drying (Na2SO4), filtration and evaporation gave the crude product.
For DMF: co-evaporation with n-heptane. For DMSO: addition of 5mL H2O followed by
repeated freeze-drying. Purification by automated flash column chromatography (20 g SiO2;
n-hexane/i-PrOH, 20:1; 14mL/min; UV detection at 260 nm) gave the product. DABCO =
1,4-diazabicyclo[2.2.2]octane. TFE = 2,2,2-trifluoroethanol.
b Chromatographically isolated. Average value of two independent identical experiments.
c Complex mixture of products.
d Estimated by 1H NMR integration of a chromatographically inseparable mixture.
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observed in DMSO (entry 14) at room temperature. However, after 1 h, the product
was obtained as a mixture including several side products.
These results suggested that, in general, polar aprotic solvents are beneficial for the
reaction. Highly polar solvents (DMSO, MeCN) can be associated with fast conversion of
the substrate at ambient temperature, however, the reactions proceed unclean and with
several side products, probably resulting from partial degradation of the cyclopentenone
product (±)-74 under these conditions. The initially utilized DMF seems to be a
suitable solvent, with KOtBu as the base suggesting a promising tradeoff between fast
conversion and negligible product degradation, provided the reaction is stopped at
major conversion. It should be noted that purified KOtBu (see Section 6.3.1 on page
180), in these and the following experiments, was added in the form of a solution in
DMF (2mg/mL). Upon standing of the stock solution for longer than 30min, base-
mediated degradation of DMF[251] resulted in a decreased concentration of the base,
therefore exhibiting weakly reproducible and slow conversions in the rearrangement
reaction when using this reagent. As a consequence, freshly prepared solutions of
KOtBu in DMF had to be employed. This seems to suggest that, under the conditions
of the rearrangement (80 ◦C in DMF), KOtBu similarly reacts with the solvent. A
plausible explanation could involve a (partially) autocatalytic mechanism, in which a
deprotonated 4-hydroxycyclopentenone product (an alkoxide base), originating from
the reaction induced under sufficiently high starting concentration of KOtBu, functions
as a base in the transformation of a second substrate molecule.
Starting from the identified conditions (KOtBu in DMF, entries 4 and 5), 3,2-enolone
substrates 3b, 40 and 72 were next subjected to the rearrangement reaction (Table
5.2). Furthermore, to explore a possible two-step reaction cascade involving elimination
and skeletal rearrangement, 2-ulosides 2b,c were reacted under similar conditions. In
the case of the sensitive allyl 2-uloside 2a, which could not be obtained in purified
form without substantially diminished yield, only the two-step reaction (rearrangement
of 3b) was investigated. For the transformation of 40 (entry 1), a smaller amount of
KOtBu was applied (0.05 equiv.) to prevent extensive product degradation. Elevated
temperatures (90 ◦C) were required in this case, but the product (±)-74 was obtained
in good yield (78%). In a similar manner, 2-uloside 2b underwent the reaction cascade
into (±)-74 in a 85% two-step yield (entry 2). In this case, at 50 ◦C, TLC suggested
the clean formation of the intermediate 40, which was converted to the cyclopentenone
product upon raising the temperature to 90 ◦C. The allyl derivative 3b (entry 3) was
found to be more reative, and the reaction in the presence of KOtBu (0.05 equiv.)
proceeded at r.t. However, (±)-73 was isolated in a mediocre 55% yield, most probably
due to base-induced double bond migration of the allyl moiety, which was also observed
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Table 5.2 Optimized conditions for the formation of (±)-73,74,75.a
reagents,
O
OBn
HO
BnO
RO
conditions
O
BnO
OBn
O
OR
3b: R = All 
40: R = Bn 
72: R = Me
OBnO
BnO
OBn
O
OR
2b: R = Bn
2c: R = Me
or
(±)-73: R = All
(±)-74: R = Bn
(±)-75: R = Me
# substrate (R) reagent (equiv.) solvent T, tb product (yield)c
1 40 (Bn) KOtBu (0.05) DMF 90 ◦C, 28 h (±)-74 (78%)
2 2b (Bn) KOtBu (0.05) DMF 50 to 90 ◦C, 30 h (±)-74 (85%)
3 3b (All) KOtBu (0.05) DMF r.t., 2 h (±)-73 (55%)
4 3b (All) NaSPh (0.50) DMF 90 ◦C, 22 h (±)-73 (66%)
5 72 (Me) KOtBu (0.05) DMF 90 ◦C, 75min (±)-75 (71%),
(±)-76 (8%)
6 2c (Me) KOtBu (0.10) DMF 50 to 90 ◦C, 42 h (±)-75 (61%)
a Experimental procedures are given in Chapter 6.
b Reaction time until total consumption of the starting material (TLC).
c Chromatographically isolated.
by Zou and Coworkers.[230] For that reason, a substoichiometric amount (0.50 equiv.) of
NaSPh at 90 ◦C (entry 4) was applied, and in this way (±)-73 could be isolated in 66%
yield. Methyl 3,2-enolone 72 (entry 5) underwent rearrangement into (±)-75 in 71%
yield under the established conditions with KOtBu as the base. For this transformation,
a side product could be isolated in minor amounts (8%) and NMR spectroscopically
identified to be the 4,5-cis-configured C -5 epimerization product (±)-76 (Scheme
5.11). In a similar manner but with 0.1 equiv. of the base (entry 6), 2-uloside 2c was
transformed in the cascade reaction to give (±)-75 in an acceptable 61% yield. In this
case, the epimerization product (±)-76 was not identified in significant amounts.
An analysis of the H,H-NOESY spectra for isomers (±)-75 and (±)-76 (Scheme
5.11; for spectra, see Appendix D) provided further confirmations for the assigned
structures and, specifically, for the C -4/5 relative configurations. Accordingly, (±)-75
exhibited a correlation between the C -4-OH (clearly visible in acetone-D6) and the
H -5. On the other hand, (±)-76 showed the expected correlations between the C -4-OH
and the C -5-OMe, and between the C -4-CH2 and H -5, respectively. Apart from these
spectroscopic properties, an additional structural proof could be obtained for major
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Scheme 5.11 Significant NOE contacts observed for cyclopentenones (±)-75 and (±)-76
in acetone-D6 at 600.1MHz. For H,H-NOESY spectra, see Appendix D.
isomer (±)-75, which could be crystallized from a solution in toluene/n-pentane. X-ray
structural analysis of the racemic compound (orthorhombic space group Pna21; Z  4
formula units in the unit cell) gave further confirmation for the assigned structure, and for
the 4,5-trans-configuration (Fig. 5.1). The torsion angle involving the α,β-unstaturated
carbonyl (O1-C1-C2-C3 167.4°) as well as the torsion angle involving C -4/5 (O1-C1-C5-
C4−157.1°) both indicated a distortion of the cyclopentenone framework. In comparison,
structurally related, but C -4-monosubstituted/C -5-unsubstituted cyclopent-2-enones
feature torsion angles significantly closer to 180° (e.g. O1-C1-C2-C3 −177.6°, O1-C1-
Figure 5.1 X-ray structure of compound (±)-75. Hydrogen atoms of the benzyl ethers
are omitted for clarity. Ellipsoids are drawn at the 50% probability level.
Red = oxygen, gray = carbon, white = hydrogen. Significant torsion angles:
O1-C1-C2-C3 167.4°, O1-C1-C5-C4 −157.1°.
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C5-C4 −178.0° for 2-hydroxy-4-methoxymethylcyclopent-2-enone[252]). Most probably,
higher deviations from 180°, as found for (±)-75, can be explained by considering
unfavorable steric repulsions, caused by the C -4/5 functionalizations of the compound.
5.3.3. Mechanistic Considerations
In the published rearrangements by Zou and Caddick, the formation of 5-hydroxy-
substituted cyclopent-2-enones is observed. An explanation can be obtained from the
generally accepted mechanism for these transformations (Scheme 5.12, b).[230, 231,
233–238] Thus, in the final ring closure step, the formal C -5 to C -1 addition of the
enolate intermediate FO-d provides the corresponding 5-hydroxycyclopent-2-enones.
Inspired by this, a plausible mechanistic picture for the here described rearrangement
was developed (Scheme 5.12, a). According to this, deprotonation/enolization would
occur at the C -5, giving the vinylogous enolate 40-a/40-b. Putatively, deprotonation at
the anomeric C -1 might be unfavorable due to repulsive interactions with the anomeric
oxygen substituent, which is not present in Caddick’s 1-deoxy system (±)-FO or Zou’s
C -glycosides FL/FM (comp. Scheme 5.5 on page 147). Subsequently, a 6pi disrotatory
electrocyclic ring opening can give the achiral cyclic enolate 40-c/40-d. In the final
step, 4pi conrotatory electrocyclic ring closure or an intramolecular aldol addition would
result in the formation of (±)-74. Notably, this final step features a formal C -1 to C -5
addition, and therefore gives the 4-hydroxy-substituted cyclopent-2-enones as observed.
Apart from the related rearrangements by Zou and Caddick[230, 231, 233–238], several
other reactions published in the literature are supportive for the proposed mechanism.
For the 6pi electrocyclic ring opening step (40-a/40-b to 40-c/40-d), analogous pro-
cesses have been described for the formation of other donor-acceptor-substituted diene
intermediates.[232] Notably, in some published examples, a complex chemistry involving
equilibria between electrocyclization and retro-cyclization processes was observed.[253,
254] Focussing on the second step (40-c/40-d to (±)-74), similar processes, both base-
or acid-catalyzed, are usually referred to as a Nazarov-type conrotatory 4pi electrocyclic
process.[254–257] As an experimental evidence, such transformations frequently proceed
with high diastereoselectivities associated with an electrocyclic reaction. In this context,
Nieto Faza and Coworkers performed computational studies on oxygenated pentadienyl
cation intermediates, as for example traversed in the Piancatelli rearrangement[255],
to gain insight into the mechanistic nature of the cyclization reactions.[256] Accord-
ing to these theoretical studies, such cyclization processes probably proceed in a 4pi
electrocyclic ring closure supported by charge polarization.
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It should be noted that the rearrangement reaction described here exhibited some
experimental distinctions from the literature transformations. Caddick and Coworkers,
in later studies on the rearrangement of (±)-FO, found that the use of protic solvents
(DABCO in t-BuOH) provided an improved yield of the product (±)-FP.[238] This
beneficial effect was attributed to the stabilization of enolate intermediates by the protic
solvent. However, for the described reaction of 40, protic solvents were found to be
unsuitable for the formation of (±)-74 (Table 5.1 on page 155, entries 6–11), although
the proposed mechanism involves similar anionic enolate intermediates. Owing to these
contradictory observations, alternative mechanistic pathways for the transformation of
40 to (±)-74 were considered.
A possible alternative to the proposed mechanism could involve initial conjugated
addition of the nucleophilic base, and formation of the C -4 branched intermediate
40-e, which could undergo elimination to the common vinylogous enolate intermediate
40-b (Scheme 5.13, a). However, this pathway seems unlikely since no intermediate
addition products could be isolated or observed by TLC or NMR analysis of the crude
reaction mixtures. Furthermore, the reactivity trends for the nucleophilic reagents
(rapid conversion of 40 with KOtBu, significantly slower conversion with NaSPh), and
the fact that 40 was inert under thia-Michael conditions, seem to be contradictive
for such a pathway. In addition, mechanisms involving radical intermediates can be
discussed. Thus, reaction of 40 with the base acting as a single electron reductant could
provide, after α-cleavage and α-hydrogen abstraction, common intermediate 40-c (b).
Furthermore, the reaction of open-chain enolate 40-c could proceed via an intramolecular
single electron transfer (SET), giving diradical 40-h and, after radical recombination,
the product (±)-74 (c). Finally, a cyclic intermediate, for example vinylogous enolate
40-a, could undergo homolytic cleavage of the O-5–C -1 bond and formation of diradical
40-i (d). A following intramolecular electron transfer step could give diradical 40-h
and, after recombination, (±)-74. Comparable diradical intermediates, similar to 40-h,
have in part been discussed as intermediates by Caddick and Coworkers.[235, 238]
To gain further insight into mechanistic features of the title reaction towards
cyclopent-2-enones of type (±)-74, a series of additional experiments was performed.
In these reactions 3,2-enolone 40 was subjected to the rearrangement under a variety of
conditions involving other reagent/solvent combinations, or in the presence of additives.
162 5. Cyclopent-2-enones from 2-Uloside Precursors
O
BnO
OBn
O
OBn
O
BnO
OBn
O OBn
(a)
40-a
40-c
conjugate addition/elimination pathway:
O
BnO
OBn
O
OBn
40
B
O
BnO
OBn
O
OBn
B
- BH
40-e
H
40-b
(b)
single electron transfer pathway:
O
BnO
OBn
O
OBn
40
B
O
BnO
OBn
O OBn
40-f
- BH
O
BnO
OBn
O
OBn α-cl.
H
B
(c)
diradical pathway: IM single electron transfer
40-g
BH
SET
SET O
BnO
OBn
O OBn
40-c
(d)
diradical pathway: homolytic cleavage
hom. cl.
40-h
O
BnO
OBn
O OBn
40-i
- B
SET
40-h
(see above)
(see above)
(see above)
O
OBn
HO
BnO
BnO
(±)-74
Scheme 5.13 Alternatively considered mechanisms for the formation of (±)-74 from 40.
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single electron transfer. Counter ion not shown.
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Radical-Scavenging Experiments
In mechanistic studies performed by Caddick and Coworkers, dihydropyran-3-one (±)-
FO was subjected to the rearrangement into (±)-FP in the presence of the radical
scavenger TEMPO (1 equiv., 2.5 equiv. DABCO in N,N -dimethylacetamide at 40 ◦C)
.[238] Simultaneous GC monitoring of the formation of (±)-FP confirmed that the
reaction with TEMPO proceeded with practically the same rate as a control reaction
without TEMPO. Thus, the authors concluded that a mechanism involving radical
intermediates was unlikely.
A similar experiment with 40 in the presence of TEMPO, under the optimized
reaction conditions, was designed. Due to the base-induced solvent degradation, as
discussed above, the rearrangement processes exhibited significant variations concerning
the reaction rate of identical reactions. Thus, time-dependent monitoring of the product
formation, similar to the experiment by Caddick[238], seemed to be inappropriate to
determine the influence of the radical scavenger TEMPO. However, ESI-MS studies
of TEMPO addition products have been applied to track radical intermediates in
biologically relevant reactions of proteins.[258] Inspired by this, the analysis of TEMPO
scavenging products in reactions of 40 by ESI-MS analysis seemed to be a suitable
method. Accordingly, after reacting 40 under the established conditions in the presence
of TEMPO (Scheme 5.14, a), 1H NMR integration of the crude product was applied
to determine the yield of unreacted 40 (11%) and of the product (±)-74 (30%), which
was obviously formed in a somewhat diminished yield. The following ESI-MS analysis
of the crude product (Scheme 5.14, (b), spectrum i) exhibited the expected signals
of substrate/product mass ([M+Na]+ m/z 453; [M+K]+ m/z 469). In addition, signals
in conformity with TEMPO adduct species of potential diradical intermediates were
observable, as exemplified by m/z 588 ([M+H˙+TEMPO˙+H+] or [M+H-TEMPO+H+])
and by m/z 743 ([M+2TEMPO˙+H+]). However, suitable reference samples containing
TEMPO as a neat unreacted mixture with 40 and (±)-74 (spectrum ii), or obtained in
a similar reaction in the absence of the base (spectrum iii) also exhibited the signal at
m/z 588. Concludingly, this signal can most likely be attributed to be a spectrometer
adduct of TEMPO-H, which is formed by hydrogen abstraction of a closed-shell species.
In contrast, m/z 743 could only be observed for the original reaction. A following high
resolution ESI-TOF-MS analysis for the corresponding signal (calcd. for C45H63N2O7
[M+2TEMPO˙+H+]: 743.4630, found: 743.4628) was also found to be in agreement
with a potential double TEMPO adduct. It was furthermore observed that handling of
the TEMPO-containing crude reaction samples at ambient temperature resulted in an
observable signal, reduced by two mass units, at m/z 586. Observation of this species
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Scheme 5.14 Radical scavenging experiments. (a) Reaction of 40 in the presence of
TEMPO. Yields determined by 1H NMR integration with benzaldehyde as
an internal standard. (b) ESI-MS spectra of radical scavenging products and
reference samples. Material obtained as stated below was dissolved in MeOH
(35 µg/mL) and injected. Conditions for reactions: anhydrous, degassed
DMF, 90 ◦C, 14 h. Sample preparation: i)-scavenging sample: substrate
40 (36mg; 0.084mmol) and TEMPO (0.084mmol) in DMF (2.5mL) was
reacted with 235 µL of KOtBu in DMF (2mg/mL; 4.2µmol). Workup as
described for the synthetic scale provided the crude sample. ii)-not reacted:
a neat mixture of 40, (±)-74 and TEMPO (1:1:7) was analyzed. iii)-no
base: substrate 40 (17mg; 0.039mmol) and TEMPO (0.039mmol) in DMF
(1.3mL) were reacted. iv)-no TEMPO: substrate 40 (44mg; 0.102mmol)
in DMF (2.7mL) with 285 µL of KOtBu in DMF (2mg/mL; 5.0µmol) were
reacted.
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could, most likely, be attributed either to dehydrogenation (double hydrogen abstraction)
of 40/(±)-74 by residual TEMPO, or to an adduct containing the TEMPO-derived
oxoammonium ion ([M+TEMPO+]).
Based on the described results of radical scavenging experiments, involving a dimin-
ished yield in the formation of (±)-74 in the presence of TEMPO together with the
identification of potential TEMPO adduct species by ESI-MS, a mechanism featuring
radical intermediates cannot be ruled out. However, especially under the forceful con-
ditions of the reaction (90 ◦C in DMF), the inertness of TEMPO towards closed-shell
species like the substrate/product or the solvent seems to be questionable. In this
regard, TEMPO-induced side reactions like hydrogen abstractions or single electron
oxidation reactions have to be considered, since such side reactions would diminish the
significance of the obtained results for the general mechanism of the reaction.[139, 259,
260]
Several attempts were undertaken to track potential radical intermediates by EPR
monitoring of the reaction of 40. However, in this regard, all efforts remained unfruitful.
Direct EPR-monitoring of the prototype transformation of 40 (for experimental details,
see Chapter 6.1 on page 179) in the temperature range 20–100 ◦C only provided
unreproducible and unspecific signals of weak intensity (not shown). Following analogous
experiments were performed utilizing N -tert-butyl-α-phenylnitrone[261, 262] (PBN)
as a spin trapping agent (0.25 or 1.0 equiv.; 20–100 ◦C). These experiments resulted,
albeit also weakly reproducible, in low-intensity signals associated with nitroxyl radical
products (after 2–3 h at 40 ◦C, or after 5min at 100 ◦C). However, similar signals were
observable for a reference sample containing no substrate 40, but PBN and KOtBu
(1:1) in DMF, thus indicating an origin related to the base-induced decomposition of
PBN or degradation reactions involving the solvent DMF.
Concludingly, the radical scavenging results described here seem to be ambiguous.
TEMPO radical scavenging in combination with ESI-MS analysis provided signals in
conformity with TEMPO adduct species of radical/diradical intermediates. However,
due to the questionable inertness of TEMPO under the forcing reaction conditions, and
since no radical intermediates could be directly observed via EPR spectroscopy, the
proposed mechanism involving non-radical intermediates (Scheme 5.12, (a) on page
160) seems to be the most plausible mechanism.
Isolation of Colored Side Products
The rearrangement reactions described here exhibited a striking property: reaction
conditions which displayed significant formation of the cyclopentenone product (Table
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Figure 5.2 (a) Red coloring of the reaction mixture in the transformation of 40 into
(±)-74. The picture refers to the reaction in Scheme 5.15, (a). (b) Colored
residue upon column chromatography (SiO2) of the crude product obtained
from the reaction in Scheme 5.15, (a).
5.1 on page 155, entries 1, 4, 5, 14) were accompanied by an instant, clearly visible deep
red coloring of the homogeneous reaction mixtures (Fig. 5.2, a). Likewise, reactions
in which only slow conversion to the product (±)-74 occurred (entries 2 and 7), the
coloring appeared with a delay of several hours. A suitable reference sample (2mg/mL
KOtBu in DMF at 90 ◦C) without the substrate 40 did not display a coloration, thereby
precluding an effect related to the solvent degradation. In the comparable literature
reactions towards 5-hydroxycyclopent-2-enones, Zou and Coworkers did not report on
any coloration of the reaction mixtures.[230] On the other hand, for the transformation
of (±)-FO with Et3N in DMF, Caddick and Coworkers reported on a black reaction
mixture. In light of the proposed mechanism for the formation of 4-hydroxycyclopent-
2-enones, involving the highly conjugated open-chain intermediates of type 40-c/40-d
(Scheme 5.12, (a) on page 160), it seemed likely that the observed intense coloring
might originate from such donor-acceptor-substituted diene intermediates, or from
derived condensation/degradation products.
In a prototype reaction of 3,2-enolone 40 (Scheme 5.15, a) with an increased
amount of KOtBu (0.15 equiv.) in DMF, after neutralization (acetate buffer pH 5)
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(b)
40-m
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exact mass: 367.18
proposed: [40-m + H]+
Figure 5.3 (a) UV/Vis spectrum of the extracted chromatography residue from the reaction
of 40 in Scheme 5.15, (a). (b) ESI-MS spectrum of the extracted residue.
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Scheme 5.15 Reactions for the extraction of colored side products. (a) Reaction of 40
with KOtBu in DMF. The structure of proposed side product 40-m is shown.
(b) Reaction utilizing Me2NH as the sole base in DMSO. (c) Reaction with
KOtBu in DMSO. Yields were determined by 1H NMR integration with
benzaldehyde as an internal standard.
and following complete evaporation of the volatile components, a dark brown oil was
obtained as the crude product. 1H NMR integration was used to determine the yield of
(±)-74 (73%), followed by chromatographic purification of the crude oil. Upon silica
gel chromatography, a brownish-red residue was obtained (Fig. 5.2, b), which did
not display chromatographic mobility even in increasingly polar solvents (toluene/ethyl
acetate, 10:1 to 1:1, then 100% ethyl acetate, then 100% acetonitrile). By extraction of
this residue from the silica gel layer with methanol, filtration and evaporation, a brownish
residue could be obtained. Extraction of the colored parts with acetone provided, after
evaporation, traces of a red oil (1mg from 78mg of 40). NMR spectroscopic analysis
of the sample was not feasible, and provided only weakly reproducible spectra with
unspecific broad signals in several solvents. However, UV/Vis spectra in acetonitrile
could be obtained (Fig. 5.3, a). As compared to the substrate 40 and the product
(±)-74, an increased absorbance starting around 650 nm was noticeable, together with
shoulders at 394 nm and 282 nm, respectively.
ESI-MS analysis of the same extracted material provided a remarkably simple spec-
trum, featuring essentially one high intensity signal at m/z 368 (Fig. 5.3, b). This
mass-to-charge ratio seemed to be consistent with a species of substrate/product mass,
undergoing substitution of one benzyloxy group with a dimethylamino group. High
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Scheme 5.16 Mechanistic suggestions for the formation of side product 40-m (proposed
structure) via reaction with Me2NH from base-induced DMF decomposition.
resolution ESI-TOF-MS analysis was, likewise, found to be compatible with these
results (calcd. for C22H26NO4 [M+H]+: 368.1856, found: 368.1858). To account for
these considerations, the following mechanistic explanation is proposed (Scheme 5.16).
Basic hydrolysis of the solvent DMF by KOtBu[251] results in the formation of dimethy-
lamine, thus present in the reaction mixture. Substrate 40 undergoes explusion of the
anomeric benzyloxide group and formation of the glycosyl cation 40-j (the tautomeric
form of a 3-oxidopyrylium ion). The anomeric cation is trapped by dimethylamine,
giving the N -glycoside 40-k. Subsequent ring opening and tautomerization reactions
could provide the conjugated iminium ion 40-m (or a tautomeric form of it) as the
proposed side product. Notably, the structure of 40-m is purely tentative. However, it
seemed to be in good agreement with the observation that the colored residue remained
chromatographically immobile when basic eluents (10% Et3N in EtOAc) were employed,
which seemed to be suggestive for a zwitterionic iminium species of type 40-m, rather
than for anomeric amine 40-k of the same molar mass.
To find further evidence for the suggested role of DMF-derived dimethylamine, two
additional experiments were performed. When a reaction of 40 was conducted with
dimethylamine as the sole base in DMSO (Scheme 5.15, b), the same product (±)-74
was formed in good yield (66%). Extraction of the chromatographic residue as described
above and analysis by ESI-MS gave a similarly intensive signal at m/z 368, thereby
suggesting the formation of the same low-yield side product. In contrast, when the
reaction was run with KOtBu in DMSO (Scheme 5.15, c), and thus in the absence
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of a source of dimethylamine, the derived ESI-MS spectrum exhibited no corresponding
signal at m/z 368. In this case, from the visually comparable brownish-red residue, only
mass-to-charge ratios consistent with dehydration products of the substrate/product
mass could be obtained.
The proposed structure of the donor-substituted conjugated iminium ion 40-m is
closely related to the Stenhouse salts (or: pyridinium dyes/pentamethine dyes), a
highly colored family of pentadienyl iminium dyes.[263, 264] In connection with the
title reaction, this class of compounds is widely known to undergo 4pi electrocyclic
ring closure reactions to amino-substituted cyclopent-2-enone derivatives, for example
in processes like the aza-Piancatelli reaction (the acid-catalyzed reaction of furfuryl
alcohols with amines), or in the ring opening/ring closure cascade of furfural-derived
imines.[257, 265] Likewise, 4pi electrocyclic ring closures of the corresponding 1-oxo
derivatives of stenhouse salt species (the non-iminium derivatives) are ubiquitously
discussed in processes like the original Piancatelli rearrangement, the acid-catalyzed
transformation of furfuryl alcohols into 4-hydroxycyclopent-2-enones.[249, 255, 264, 266]
In this regard, the given considerations can be regarded as an initial classification of
the title reaction within the complex field of the isomerization chemistry of unsaturated
five- and six-membered rings.
Isomerization Studies
The proposed mechanism for the described transformation of 3,2-enolones into 4-
hydroxycyclopent-2-enones (Scheme 5.12, (a) on page 160) suggests equilibria between
all intermediate species. Thus, the reaction of product (±)-74 in a 4pi electrocyclic
ring opening or in a retro-aldol reaction, followed by 6pi electrocyclic ring closure, could
potentially afford the original substrate 40, albeit as a racemic mixture. In this context,
in mechanistically comparable transformations published in the literature, complex
quilibria involving five- and six-membered cyclic products have been observed.[254]
Thus, in order to gain insight into the reversibility of the described transformation,
cyclopent-2-enone (±)-74 was reacted under conditions similar to its original formation
(Scheme 5.17, top). The reaction proceeded reluctantly even in the presence of
increased amounts of KOtBu (0.15 equiv.) at 70 ◦C. After 24 h, the reaction mixture
contained large amounts of unreacted substrate (±)-74 (43%), together with two
minor products (±)-77 (20%) and (±)-78 (16%). Chromatographic purification of
the mixture provided pure samples of (±)-77 and (±)-78 in 17% and 16% isolated
yields, respectively, and both isomers were determined to be of the same molar mass like
(±)-74 by ESI-MS analysis and, likewise, obtained in racemic form. Following NMR
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Scheme 5.17 Top: reaction of cyclopentenone (±)-74 under the rearrangement condi-
tions, affording diastereoisomeric (±)-77 and regioisomeric (±)-78. Yields
were determined by 1H NMR integration with benzaldehyde as an internal
standard. Bottom: plausible mechanism for the isomerizations.
analyses fully disclosed the structure of the C -5 isomerized 4,5-cis-configured (±)-77
(comparable to the methyl derivative (±)-76). Remarkably, (±)-78 was established
to be the corresponding regioisomeric 3-benzyloxy derivative. As compared to (±)-74,
the 13C NMR spectrum of (±)-78 featured a significantly deshielded signal for the C -3
(183.2 vs. 127.3 ppm) associated with a vinylogous ester, and a high-field signal for C -2
(104.3 vs. 155.2 ppm).
From a mechanistic perspective (Scheme 5.17, bottom), the formation of the
C -5 epimerization product (±)-77 can, in a straightforward manner, be explained by
formation of the intermediate enolate 74-a, which can undergo tautomerization to
minor isomer (±)-77 or back to major isomer (±)-74. Alternatively, deprotonation
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of the free hydroxyl group in (±)-74 gives the alkoxide 74-b. From this intermediate,
ring opening (either in an electrocyclic reaction or in a retro-aldol reaction) gives the
enolate 40-c proposed as the open chain intermediate in the original rearrangement
process. 40-c can cyclize to the originally unfavored 4,5-cis-isomer (±)-77, or back to
major isomer 74-b. To account for the formation of the 3-benzyloxy isomer, the double
keto-enol tautomerization of 40-c could give enolate 74-c, followed by ring closure
to (±)-78. In this way, the observed formation of (±)-78 serves as a good evidence
for the existence of open-chain intermediate species of the type 40-c/74-c within the
overall mechanistic picture.
Concluding Remarks
As a clarification, the title reaction for the transformation of carbohydrate-derived
3,2-enolones into 4-hydroxycyclopent-2-enones can be discussed in the context of widely
known related transformations of five- and six-membered unsaturated carbocycles and
heterocycles (Scheme 5.18). Thus, furfuryl alcohols, available from the reduction of
biomass-derived furfural, can be converted into 4-hydroxycyclopent-2-enones in the
Piancatelli rearrangement under Lewis or Brønsted acid catalysis.[249, 255, 264, 266]
Alternatively, furfuryl alcohols can undergo ring expansion into dihydropyran-3-one
systems, a process initiated under oxidative conditions (e.g. Br2 or NBS) which is
referred to as the Achmatowicz reaction.[267, 268] Highly functionalized (oxygenated)
dihydropyran-3-one systems can further be obtained from carbohydrate sources by
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Scheme 5.18 Schematic representation of the title reaction in the context of related trans-
formations.
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multistep carbohydrate transformations, resulting in enantiopure dihydropyran-3-ones
(carbohydrate 3,2-enolones). As previously described, Caddick and Coworkers demon-
strated that such dihydropyran-3-ones can undergo a base-induced rearrangement
into 5-hydroxycyclopent-2-enones.[231] In a similar transformation using carbohydrate-
derived enantiopure dihydropyran-3-ones, Zou and Coworkers demonstrated a similar
rearrangement to 5-hydroxycyclopent-2-enones, albeit also in racemic form due to a
proposed achiral open chain intermediate.[230] Comparable rearrangements by Kolb
and Hoffmann, which proceeded under Brønsted acid catalysis, suggest that a wide
array of conditions can initiate such a rearrangement.[232] In this context, the title
reaction constitutes a novel method for the synthesis of the corresponding regioisomeric
4-hydroxycyclopent-2-enones from dihydropyran-3-ones.
However, the developed rearrangement comprises some drawbacks: a) Since the
literature reactions towards 5-hydroxycyclopent-2-enones proceed under very similar
conditions as compared to the title reaction (basic reagents in polar protic or aprotic
solvents), it seems likely that the rearrangement is restricted to a narrow substrate scope
of O-glycosidic 3,2-enolones. Furthermore, the highly basic conditions can be expected
to be incompatible with ester-protected carbohydrate substrates, which constitute the
majority of published potential carbohydrate 3,2-enolone substrates. b) A cumbersome
multistep synthesis is required to obtain the carbohydrate substrates for the rearrange-
ment (from d-glucose: 6 steps towards the 2-uloside substrates, 7 steps towards the
3,2-enolones). c) Only racemic products can be obtained. Putatively, an achiral open
chain intermediate is formed, resulting in complete loss of stereoinformation present
in the carbohydrate substrate. Since carbohydrates are frequently employed as chiral
building blocks towards enantiopure products in what is referred to as the chiral pool
approach, this can be regarded as a severe disadvantage.
With the goal of developing an asymmetric protocol of their rearrangement towards
5-hydroxycyclopent-2-enones, Caddick and Coworkers employed chiral cinchona alkaloid
bases like quinine or quinidine. However, only a low level of enantioselectivity was
observed (ee<6%).[237] In contrast, the lipase-based kinetic resolution provided the
acetylated and the non-acetylated products in good enanomeric excesses (ee> 95%).[238]
Apart from this, multiple approaches towards chiral cyclopent-2-enones in general have
been published, including an asymmetric Piancatelli rearrangement employing chiral
BINOL-derived Brønsted acids.[250, 265] This seems to suggest that extended investiga-
tions into the title rearrangement, including hitherto unexplored acidic conditions, could
potentially facilitate an asymmetric reaction. In this regard, the results described here
offer a detailed examination of this transformation which might be valuable concerning
further investigations.
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5.3.4. Antimicrobial Activity Screenings
Compounds featuring the cyclopent-2-enone structural motif have been isolated from
natural sources, for example represented by the clavulone prostanoids.[242, 243, 269] In
part, such structures been associated with biological activities, including antibiotic[241,
245] and cytotoxic[244, 246, 270] properties.[248] Likewise, a number of dihydropyran-3-
one systems with interesting biological activities have been identified.[271–274] From
this perspective, a screening for potential activities of the 3,2-enolone substrates, and
of the derived cyclopent-2-enones formed in the title reaction, was of interest.
Antimicrobial screenings involving the 3,2-enolones 3b, 40 and 72, as well as the
racemic cyclopent-2-enones (±)-73, (±)-74, (±)-75 and (±)-76, were performed by
the CO-ADD initiative (The Community for Open Antimicrobial Drug Discovery),
located at the University of Queensland, Australia (for screening details and results,
see Appendix C). The antimicrobial activity was determined by the measurement
of the percentage of growth inhibition, and included the following selection of five
bacteria and two fungi: Staphylococcus aureus (ATCC 43300), Escherichia coli (ATCC
25922), Klebsiella pneumoniae (ATCC 700603), Acinetobacter baumannii (ATCC 19606),
Pseudomonas aeruginosa (ATCC 27853), Candida albicans (ATCC 90028), Cryptococcus
neoformans var. grubii (H99, ATCC 208821). The screening samples were prepared
using stock solutions of the respective compound in DMSO (32µg/mL). Albeit, no
significant antimicrobial activity of the tested compounds against the involved bacterial
and fungal strains could be found.
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Scheme 5.19 Synthetic routes described in this chapter. Formation of racemic cyclopent-
2-enones (±)-73, (±)-74 and (±)-75 from 2-ulosides 2a,b,c by a sequence
of elimination and base-mediated rearrangement.
Treatment of 2-uloside precursors 2a,b,c with K2CO3 in wet toluene allowed for the
clean formation of the carbohydrate 3,2-enolones 3b, 40 and 72 via elimination of
benzyl alcohol (Scheme 5.19). In reactivity studies involving these intermediates,
the α-oxygenated α,β-unsaturated carbonyl moiety was found to be inert towards the
conjugated addition of nucleophilic reagents. In contrast, by employing catalytic
amounts of basic KOtBu or NaSPh in the polar aprotic solvent DMF, a previously
undescribed rearrangement reaction afforded racemic 2-benzyloxy-4-hydroxycyclopent-
2-enones (±)-73,74,75 in generally good yields (61–85%). Likewise, 2-ulosides 2b and
2c could be directly converted into the respective cyclopent-2-enone products in an
elimination-rearrangement cascade reaction. The structures of the racemic products
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could be fully established by using multiple methods including 2D NMR spectroscopy,
chiral column HPLC, and X-ray crystallography on a crystalline sample obtained for
the methyl derivative (±)-75.
In contrast to the described title reaction, affording the 4-hydroxycyclopent-2-enones,
similar published rearrangements of dihydropyran-3-ones provide the corresponding 5-
hydroxycyclopent-2-enone products. To explain these differences, a plausible mechanism
was developed and discussed in the context of literature transformations. Further exper-
imental studies gave insight into potential side products formed in the reaction. In this
regard, an analysis of downstream isomerization processes from (±)-73,74,75 towards
diastereo- and regioisomeric cyclopent-2-enones completed the proposed mechanistic
picture involving achiral, open chain enolate intermediates.
6. Experimental Part
6.1. Instruments and Techniques
For the isolation, purification and characterization of the compounds described in this
thesis, the following instruments and techniques were used:
Analytical Thin-layer Chromatography (TLC): Reactions were monitored by TLC
on Polygram Sil G/UV plates from Macherey-Nagel and the detection of spots was
affected by inspection of the plates under UV light, by charring with H2SO4 (5% in
EtOH), by staining with an alkaline aqueous solution of KMnO4, or by staining with
(NH4)2MoO4/Ce(SO4)2 in dilute sulfuric acid.
Preparative Flash Column Chromatography: Preparative Chromatography for pu-
rification of the compounds was performed on silica gel (0.032–0.063mm mesh) from
Macherey-Nagel. For a typical chromatography procedure, the mass of silica gel used
was equal to 50–200 times the mass of the crude product subjected to chromatography.
Spherical SiO2 (Reprosil 70 Si, 50µm) was purchased from Dr. Maisch GmbH. This
material was used for challenging purifications of compound mixtures with similar chro-
matographic mobility. Typically, the amount of spherical SiO2 was equal to 200–300
times the mass of the crude product (ca. 50–200mg of crude material in combination
with 15–50 g of spherical SiO2). After purification, the columns were rinsed with THF
and acetone, and this way used ca. 5–10 times. RP-C18 silica gel 100 (fully endcapped)
was purchased from Sigma-Aldrich. For all described RP-chromatographic purifications,
columns with 10 g of RP material were used.
Chiral High-Performance Liquid Chromatography (HPLC): Chiral HPLC exper-
iments of compounds (±)-73, (±)-74 and (±)-75 were performed with a Sykam
S 1121 HPLC machine in combination with the column Reprosil Chiral-NR (8 µm,
150× 4.6mm) by Dr. Maisch GmbH. Isocratic n-hexane/iso-propyl alcohol ((±)-73
and (±)-74: 90:10; (±)-75: 100:7) was used as the eluent with a flow of 1.6mL/min (for
(±)-73 and (±)-74) or 2mL/min ((±)-75). Detection of compounds was performed
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by UV detection at 254 nm. Samples of 1.8mg of the compound were dissolved in 1mL
of the eluent (for (±)-75: addition of 200 µL CHCl3) and injected into the system
((±)-73 and (±)-74: 5 µL; (±)-75: 10 µL). Data processing and integration was done
with the software PeakSimple 4.49 64 bit. Chromatograms are given in Appendix B.
Melting Points: Melting points were determined with a Büchi Melting Point M-560
apparatus.
Optical Rotations: Optical rotations were measured with a Perkin-Elmer Polarimeter
341 in a 10 cm glass cuvette at 20 ◦C and at a wavelength of 589 nm.
Mass Spectrometry (MS): The following spectrometers were used for the measure-
ment of the corresponding mass spectra: FAB-MS: Finnigan model TSQ 70. ESI-MS:
Bruker Daltonics ESQUIRE 3000 Plus. ESI-TOF-HRMS: Bruker Daltonics maXis 4g.
ESI-FTICR-HRMS: Bruker Daltonics Apex II.
Nuclear Magnetic Resonance (NMR): NMR spectra were recorded with the follow-
ing spectrometers: Bruker Avance III HD 400 (1H: 400.2MHz; 13C: 100.6MHz), Bruker
Avance III HDX 600 (1H: 600.2MHz; 13C: 150.9MHz), Bruker Avance III HDX 700 (1H:
700.3MHz; 13C: 176.1MHz). Values of the chemical shift δ [ppm] are given in relation
to tetramethylsilane. Solvent residual signals were used for referencing[275]: acetone-D6:
2.05 (1H) and 29.84 (13C), CDCl3: 7.26 (1H) and 77.16 (13C), CD3OD: 3.31 (1H) and
49.00 (13C), DMSO-D6: 2.50 (1H) and 39.52 ppm (13C). Spectra measured in D2O were
calibrated for residual or added (0.5%) MeOH (1H: 3.34 ppm, 13C: 49.50 ppm). 13C NMR
spectra were measured with broadband decoupling. The assignment of signals was sup-
ported by DEPT-135 spectra and 2D NMR spectra, including H,H-COSY, C,H-HSQC,
F2-coupled C,H-HSQC, C,H-HMBC, H,H-NOESY, H,H-TOCSY and TOCSY-HSQC.
The following abbreviations are used for the splitting patterns of signals: s (singlet),
bs (broad singlet), d (doublet), t (triplet), q (quartet), dd (doublet of doublets), ddd
(doublet of doublet of doublets), dddd (doublet of doublet of doublet of doublets),
dt (doublet of triplets), m (multiplet). For diastereotopic methylene protons like the
carbohydrate H -6, the signal appearing at a higher chemical shift was designated Ha,
the one appearing at lower chemical shift Hb. In isomeric mixtures, corresponding
signals are marked with an asterisk, if observable. For isomeric mixtures of complex
carbohydrates, signal assignments, splitting patterns and integrations are only given
where possible. Copies of 1H and 13C spectra are given in Appendix E.
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Elemental Analysis (Combustion Analysis): Elemental analyses were performed
with a HEKAtech Euro 3000 CHN analyzer.
UV/Vis Spectroscopy: UV/Vis spectra were recorded on a PerkinElmer Lambda 35
spectrometer using a 1 cm quartz glass cuvette.
X-ray Crystallography: X-ray data were collected on a Bruker SMART APEX II
DUO diffractometer (for 11: Bruker APEX II CCD) equipped with an IµS micro-
focus sealed tube and QUAZAR optics, using CuK α radiation (λ = 1.54178Å) or
MoK α radiation (λ = 0.71073Å). Corrections for absorption effects were applied using
SADABS.[276] The structures were solved by direct methods using SHELXS[277] and
SHELXL/SHELXLE[278] for structure refinement. Complete crystallographic data have
been deposited with the Cambridge Crystallographic Data Centre. This information can
be obtained free of charge from https://www.ccdc.cam.ac.uk via the corresponding
CCDC numbers of the structures. The CCDC numbers, techniques used for crys-
tallization and crystal structure data/refinement parameters are given in Appendix
A.
Electron Paramagnetic Resonance (EPR): EPR spectra were recorded with a
Bruker EMX micro spectrometer in the X-band range. In a typical reaction, the
substrate 40 (24mg; 0.056mmol) was dissolved in anhydrous, degassed DMF (290 µL)
at 0 ◦C. A freshly prepared solution of KOtBu 4mg/mL in DMF (250 µL) was added,
and the sample was stored at 0 ◦C until the EPR measurement of aliquotic samples was
performed in quick succession. During measurement, the aliquotic sample was heated
in the range 20–100 ◦C (20 ◦C steps; 5min resting time at each temperature). In spin
trapping experiments, a solution of 40 (16mg; 0.037mmol) in anhydrous degassed DMF
(525µL) at 0 ◦C was treated with N -tert-butyl-α-phenylnitrone (PBN; 0.25 equiv. or 1.0
equiv.), and then with a freshly prepared solution of KOtBu 4mg/mL in DMF (255 µL).
The sample was stored at 0 ◦C until the EPR measurement of aliquotic samples as
described above commenced.
6.2. General Methods
Non-aqueous reactions were run in oven-dried glassware and in anhydrous solvents
using standard Schlenk techniques in combination with nitrogen as an inert gas for the
exclusion of oxygen and humidity. If not stated otherwise, the given yields correspond
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to isolated yields of solvent-free material obtained after the respective method of
purification (flash column chromatography, recrystallization or distillation).
6.3. Reagents and Materials
Commercial chemicals were purchased from the following suppliers: abcr, Acros Organ-
ics, Alfa Aesar, AppliChem, Carbolution, Carl Roth, euriso-top, Fisher Scientific, Fluka,
Glycon Biochemicals, Merck, Riedel-de-Haën, Sigma-Aldrich, Strem Chemicals, TCI,
Th. Geyer. If not mentioned otherwise below, all reagents were used as received. Dry
solvents were either purchased in anhydrous form, or in technical grade and dried via the
following standard methods: acetone (CaSO4), acetonitrile (purchased from Acros), ben-
zene (CaH2), CH2Cl2 (P4O10), CHCl3 (P4O10), 1,4-dioxane (Na/benzophenone), DMF
(P4O10), DMSO (purchased from Sigma-Aldrich), EtOAc (CaSO4), MeOH (Mg/I2),
n-hexane (Na/benzophenone), nitromethane (CaCl2), toluene (purchased from Acros),
THF (Na/benzophenone). After drying with the described method and distillation,
solvents were stored under an atmosphere of nitrogen over activated molecular sieves
3Å (not for acetone). Degassed solvents were obtained by using the freeze-pump-thaw
technique.
6.3.1. Key Reagents, Prepared Reagents and Purified Reagents
The following list comprises a selection of critical reagents for key reactions and the
corresponding commercial supplier. Furthermore, prepared reagents as well as purchased
reagents that were purified prior to use are included.
− acetate buffer pH 5: NaOAc (1.6 g) and AcOH (337µL) dissolved in water
(200mL).
− allyl alcohol: commercial material (Fluka) was stirred over CaH2 at r.t. for 12 h
followed by distillation.
− benzyl chloride: commercial material (Fluka) was dried over MgSO4, filtered and
distilled.
− n-BuLi: purchased from Acros Organics.
− tert-butyl hydroperoxide: purchased from Sigma-Aldrich.
− camphanoyl chloride: purchased from Sigma-Aldrich.
− Dess-Martin periodinane: prepared via the KBrO3 route.[279]
− DIBAL-H: purchased from Sigma-Aldrich.
− dimethylsulfide: purchased from Acros Organics.
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− diphosgene: purchased from Acros Organics.
− Hoveyda-Grubbs catalyst 2nd generation: purchased from Sigma-Aldrich.
− KOtBu: commercial material (Acros Organics) was suspended in anhydrous THF
(25 m%), filtered, and the filtrate was evaporated to dryness to give pure material.
− Lindlar catalyst: contains 5% Pd; purchased from Sigma-Aldrich.
− m-CPBA: commercial material (Sigma-Aldrich) was washed with phosphate buffer
pH 7.4 and water, then dried.
− MOPS: purchased from Carl Roth.
− OsO4: purchased from Riedel-de-Haën.
− Pd 10% on activated charcoal: purchased from Acros Organics.
− propiolaldehyde dibenzyl acetal: prepared via the route by Fliegel et al.[175]
− 2-(2-propynyloxy)tetrahydropyran: prepared via the route by McCune et al.[280]
− pyridine: anhydrous material was purchased from Sigma-Aldrich.
− SnCl2: purchased from Fluka.
− TEMPO: purchased from abcr.
− TCICA: commercial material (Sigma-Aldrich) was recrystallized from 1,2-dichloroethane.
− TMSOAc: purchased from Acros Organics.
− tri-iso-propyl(prop-2-yn-1-yloxy)silane: prepared via the route by Barros et al.[281]
− vinylmagnesium bromide: purchased from Acros Organics.
− VO(acac)2: purchased from Acros Organics.
6.4. Numbering, Nomenclature and Fischer Projections
In 2-C -branched carbohydrate precursors, the side chain is numbered in the order
C2-C7-C8-C9, and this numbering is also used for the given NMR assignments. For
the bicyclic carbohydrates in Chapter 3, the nomenclature is, in accordance with
IUPAC recommendations[16] for fused systems (2-Carb-35.2), in the following form:
substituents-(carbohydrate)[connection]annulation. Substituents on the annulated ring
precede the name, and the locants of the separated systems, and not those of the
total system numbering, are used. Substituents on the parent carbohydrate are given
within the parentheses. As a major difference of this method as compared to standard
heterocyclic nomenclature, the carbohydrate moiety is always cited first. For clarity,
the NMR assignment numbering of the 2-C -branched carbohydrates was retained
for the annulated compounds (side chain: C2-C7-C8-C9). The described procedure
is illustrated in Scheme 6.1, (a). The nomenclature of spirocyclic carbohydrate
intermediates of Chapter 4 is in conformity with IUPAC recommendations[16] for
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Scheme 6.1 (a) Clarification of numbering and nomenclature of annulated carbohydrate
derivatives of Chapter 3, exemplified for compounds 17 and 18. (b) Number-
ing and nomenclature of spirocyclic carbohydrates of Chapter 4, exemplified
for compound α,β-48.
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spirocyclic carbohydrates (2-Carb-35.3) and follows the general pattern substituents-
spiro[carbohydrate-connection-heterocycle] which is illustrated in Scheme 6.1, (b).
Substituents of the carbohydrate moiety are given in carbohydrate numbering, followed
by heterocycle substituents with accentuated heterocycle numbering. The determination
of the anomeric configurations of the spirocyclic carbohydrates is based on the Fischer
projections of the spiro-compounds as depicted in Scheme 6.2, (a). The numbering and
nomenclature of deprotected target octoses of Chapter 4 is in accordance with IUPAC
recommendations[16] for aldoses with multiple configurational prefixes (2-Carb-8.3).
This procedure is based on the Fischer projections of the compounds as illustrated in
Scheme 6.2, (b). For these higher carbohydrates, the numbering for NMR assignment
is consistent with carbohydrate numbering, in which the longest chain is numbered
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first, with position 1 being the higher oxidized carbon atom at the top position in the
Fischer projection. Consequently, following the synthetic route for these compounds,
the former side chain C -9 in α,β-48 equals the C -1 in syn-50 after deprotection.
6.5. Synthetic Procedures
Allyl 3,4,6-tri-O-benzyl-β-d-arabino-hexopyranoside-2-ulose (2a):
O
O
BnO
BnO
OBn
OAll
Via Koenigs-Knorr glycosylation of AD: to a suspension of MS 3 Å (1.1 g) and
Ag2CO3 (2.59 g; 9.39mmol) in dry CH2Cl2 (16mL) was added first allyl alcohol (0.49mL;
7.11mmol) and then dropwise a solution of 3,4,6-tri-O-benzyl-α-d-arabino-hexopyranos-
2-ulosyl bromide AD[43] (1.45 g; 2.84 mmol) in dry CH2Cl2 (8mL). The reaction
was stirred for 5min. Filtration through a pad of Celite and evaporation of the
solvent yielded a clear oil which was purified by flash column chromatography (SiO2,
chloroform/methanol, 100:1). The slightly impurified product (875mg) was purified by
multiple chromatography steps (SiO2, 100% chloroform) to yield pure 2a as a colorless
solid in minor yields (< 10%).
Via optimized Dess-Martin oxidation of 7: to a solution of allyl glucoside 7[61]
(1.70 g; 3.47mmol) in anhydrous CH2Cl2 (55mL) was added NaHCO3 (2.9 g). Next,
Dess-Martin reagent (5.88 g; 13.86mmol) was portionwise added over 30min. The
reaction was stirred for 24 h at r.t. and diluted with CH2Cl2 (260mL). The solution was
washed with water (130mL), sat. NaHCO3/0.2m Na2S2O3 (1:1, 3 × 210mL) and water
(210mL). The organic phase was dried over Na2SO4. Filtration and evaporation of the
solvent yielded crude 2a (83% crude yield), which was used for following transformations
without further purification. Repeated flash column chromatography (SiO2, 100%
chloroform) resulted in diminished yields (typically < 10%) of pure 2a as a colorless
solid. Analytical data corresponded fully to those obtained from 2a via glycosylation
of AD (see above).[
α
]20
D −38.7 (c= 1.0, CHCl3); 1H NMR (400.2MHz, CDCl3) δ: 7.43–7.29 (m, 13H,
HAr), 7.23–7.20 (m, 2H, HAr), 6.01–5.92 (m, 1H, allyl: O-CH2-CH=CH2), 5.35 (dd,
1H, J trans = 17.2, J gem = 1.2Hz, allyl: O-CH2-CH=CHH), 5.26 (d, 1H, J cis = 10.4Hz,
allyl: O-CH2-CH=CHH ), 5.01 (d, 1H, J = 11.4Hz, CH2Ph), 4.92–4.82 (m, 2H, CH2Ph,
H-1), 4.65–4.53 (m, 4H, CH2Ph), 4.42 (dd, 1H, J gem = 12.7, J vic = 5.0Hz, allyl:
O-CHH-CH=CH2), 4.27–4.19 (m, 2H, H-3, allyl: O-CHH -CH=CH2), 3.96–3.84 (m,
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2H, H-4, H-5), 3.80–3.72 (m, 2H, H-6a, H-6b); 13C NMR (100.6MHz, CDCl3) δ: 197.4
(C-2), 138.0, 137.8, 137.4 (3 × CAr,q.), 133.2 (allyl: O-CH2-CH=CH2), 128.6–127.8
(CAr), 118.8 (allyl: O-CH2-CH=CH2), 98.0 (C-1), 85.7 (C-3), 80.1 (C-4), 75.9 (C-5),
75.0 (CH2Ph), 73.6 (CH2Ph), 73.6 (CH2Ph), 69.9 (allyl: O-CH2-CH=CH2), 69.1 (C-6);
FAB-MS m/z 511 [M+Na]+; HR-ESI-FTICR calcd. for C31H36O7Na [M+Na+MeOH]+:
543.2353. Found: 543.2350; Anal. calcd. for C30H32O6: C, 73.75; H, 6.60. Found: C,
73.57; H, 6.64.
Benzyl 3,4,6-tri-O-benzyl-β-d-arabino-hexopyranoside-2-ulose (2b):
O
O
BnO
BnO
OBn
OBn
To a solution of glucoside 11[62] (1.65 g; 3.05mmol) in CH2Cl2 (100mL) was added Dess-
Martin periodinane (2.85 g; 6.71mmol) in portions over 15min at r.t., and the mixture
was stirred until TLC (toluene/ethyl acetate, 4:1) indicated complete transformation
of the starting material (16 h). The solution was diluted with CH2Cl2 (100mL) and
washed with water (80mL), sat. NaHCO3/0.2m Na2S2O3 (1:1, 3 × 210mL) and with
water (80mL). The organic layer was dried with Na2SO4, filtered and concentrated to
dryness. The crude product was suspended in toluene/acetone (20mL/15mL), and the
suspension was purified by flash column chromatography (SiO2, toluene/acetone, 20:1)
to afford pure ketone 2b (1.58 g; 96%) as a colorless solid. Crystals suitable for X-ray
structural analysis were obtained from n-pentane/ethyl acetate/chloroform. Analytical
data corresponded to published data.[37]
Additional characterization data: 13C NMR (100.6MHz, CDCl3) δ: 197.4 (C-2),
138.1, 137.8, 137.4, 136.2 (4 × CAr,q.), 128.6–127.8 (CAr), 97.4 (C-1), 85.8 (C-3), 80.1
(C-4), 75.9 (C-5), 75.0, 73.6, 73.6, 70.3 (4 × CH2Ph), 69.1 (C-6); Anal. calcd. for
C34H34O6: C, 75.82; H, 6.36. Found: C, 75.54; H, 6.35.
Methyl 3,4,6-tri-O-benzyl-β-d-arabino-hexopyranoside-2-ulose (2c):
O
O
BnO
BnO
OBn
OMe
To a solution of methyl glucoside 8[67, 69] (0.80 g; 1.72mmol) in anhydrous CH2Cl2
(56mL) was added Dess-Martin periodinane (1.61 g; 3.79mmol) portionwise over 15min
at r.t. After 18 h, TLC (toluene/ethyl acetate, 4:1) indicated complete consumption
of the starting material. The reaction mixture was diluted with CH2Cl2 (60mL) and
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washed with water (150 mL), sat. NaHCO3/0.2m Na2S2O3 (1:1, 3 × 50mL) and water
(50mL). The organic phase was dried over Na2SO4, filtered, and evaporated to dryness.
The crude oil was purified by flash column chromatography (SiO2, toluene/acetone, 10:1)
to give pure ketone 2c (0.77 g; 96%) as a colorless solid. Analytical data corresponded
to published data.[69]
Additional characterization data: 1H NMR (400.2MHz, CDCl3) δ: 7.43–7.38 (m,
2H, HAr), 7.37–7.25 (m, 12H, HAr), 7.22–7.15 (m, 2H, HAr), 4.99 (d, 1H, J gem = 11.5
Hz, CH2Ph), 4.86 (d, 1H, J gem = 10.9 Hz, CH2Ph), 4.72 (s, 1H, H-1), 4.63–4.53 (m, 4H,
CH2Ph), 4.24 (d, 1H, J 3,4 = 8.4 Hz, H-3), 3.93–3.82 (m, 2H, H-4, H-5), 3.80–3.70 (m,
2H, H-6a, H-6b), 3.60 (s, 3H, CH3); 13C NMR (100.6MHz, CDCl3) δ: 197.3 (C-2), 138.0,
137.8, 137.4 (3 × CAr,q.), 128.6–127.9 (CAr), 100.2 (C-1), 85.7 (C-3), 80.2 (C-4), 75.9
(C-5), 75.1 (CH2Ph), 73.7 (2 × CH2Ph), 69.0 (C-6), 57.0 (CH3); HR-ESI-TOF calcd.
for C28H30O6Na [M+Na]+: 517.2197. Found: 517.2201; Anal. calcd. for C28H30O6: C,
72.71; H, 6.54. Found: C, 72.42; H, 6.69.
Allyl 3,6-di-O-benzoyl-4-deoxy-β-d-glycero-hex-3-enopyranoside-2-ulose (3a):
O
BzO
OBz
O
OAll
Isolated from the Koenigs-Knorr glycosylation of AB: a suspension of 3,4,6-tri-O-
benzoyl-α-d-arabino-hexopyranos-2-ulosyl bromide AB[42] (1.52 g; 2.75mmol), MS 3 Å
(2 g) and Ag2CO3 (1.14 g; 4.12mmol) in dry CH2Cl2 (30mL) was stirred for 30min at
r.t. Allyl alcohol (0.56mL; 8.25mmol) was added, and the suspension was stirred for
3 h until TLC (toluene/ethyl acetate, 4:1) showed complete conversion of the starting
material. Filtration through a layer of Celite, evaporation of the solvent and flash
column chromatography (SiO2, toluene/ethyl acetate, 10:1) of the residue afforded
3,2-enolone 3a (346mg; 31%) as a colorless solid.
Rf = 0.22 (toluene/ethyl acetate, 60:1); 1H NMR (400.2MHz, CDCl3) δ: 8.15–8.07
(m, 4H, HAr), 7.65–7.57 (m, 2H, HAr), 7.52–7.44 (m, 4H, HAr), 6.92 (d, 1H, J 4,5 =
3.3Hz, H-4), 6.02–5.89 (m, 1H, allyl: O-CH2-CH=CH2), 5.36 (dddd, 1H, J trans = 17.2,
J gem = 1.5, 2 × 4J = 1.5Hz, allyl: O-CH2-CH=CHH), 5.26 (dddd, 1H, J cis = 10.4,
J gem = 1.3, 2 × 4J = 1.3Hz, allyl: O-CH2-CH=CHH ), 5.17 (s, 1H, H-1), 5.10 (ddd,
1H, J 5,6a = 6.9, J 5,6b = 6.0, J 4,5 = 3.5Hz, H-5), 4.74 (dd, 1H, J 6a,6b = 11.1, J 5,6a =
7.0Hz, H-6a), 4.65 (dd, 1H, J 6a,6b = 11.4, J 5,6b = 6.1Hz, H-6b), 4.43 (dddd, 1H, J gem
= 12.6, 3J = 5.3, 2 × 4J = 1.5Hz, allyl: O-CHH-CH=CH2), 4.26 (dddd, 1H, J gem
= 12.9, 3J = 6.3, 2 × 4J = 1.3Hz, allyl: O-CHH -CH=CH2); 13C NMR (100.6MHz,
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CDCl3) δ: 182.6 (C-2), 166.2, 163.9 (2 x benzoyl C=O), 142.3 (C-3), 134.2, 133.6 (2
× CAr), 133.0 (allyl: O-CH2-CH=CH2), 132.6 (C-4), 130.5–128.3 (CAr), 118.9 (allyl:
O-CH2-CH=CH2), 97.8 (C-1), 71.2 (C-5), 70.0 (allyl: O-CH2-CH=CH2), 66.3 (C-6);
FAB-MS m/z 431 [M+Na]+; HR-ESI-TOF calcd. for C23H20O7Na [M+Na]+: 431.1101.
Found: 431.1102.
Allyl 3,6-di-O-benzyl-4-deoxy-β-d-glycero-hex-3-enopyranoside-2-ulose (3b):
O
BnO
OBn
O
OAll
As a side product: Isolated in the unoptimized unbuffered Dess-Martin oxidation
of 7 and subsequent unoptimized Grignard addition: to a solution of glucoside 7[61]
(0.95 g; 1.93mmol) in anhydrous CH2Cl2 (30mL) was added Dess-Martin reagent (1.06 g;
2.50mmol) portionwise over 15min at r.t. The reaction was stirred for 2 h and then
diluted with CH2Cl2 (70mL). The solution was washed with a half-saturated K2CO3
solution (3 × 25mL) and water (3 × 25mL). The organic phase was dried over Na2SO4,
filtered and evaporated. The crude solid (1.4 g) was extracted with n-hexane/CHCl3 6:1
and filtered. Evaporation of the filtrate afforded a colorless solid (1.1 g), which was
purified by flash column chromatography (SiO2, n-hexane/chloroform, 2:1) to yield
1.01 g of slightly impurified 2a. The product was dissolved in anhydrous THF and
cooled to −78 ◦C. 2.1mL (2.1mmol) of vinylmagnesium bromide 1m in THF was added
over 10min, and after 45min another 0.3mL (0.3mmol) of the vinylmagnesium bromide
solution was added. After 15min TLC (toluene/ethyl acetate, 4:1) showed no more
progression of the reaction. At −78 ◦C, 5mL of sat. NH4Cl was added dropwise and
the reaction was allowed to warm to r.t. The suspension was diluted with CH2Cl2
(120mL) and washed with water (3 × 50mL). Drying of the organic phase over Na2SO4,
filtration and evaporation of the solvent yielded a colorless oil, which was purified by
flash column chromatography (SiO2, toluene/acetone, 25:1). 3b (110mg; 15%) was
isolated as the component with higher chromatographic mobility alongside with 16
(575mg; 58%).
Synthesized from 7: To allyl glucoside 7[61] (607mg; 1.24mmol) in anhydrous
CH2Cl2 (25mL) was portionwise added Dess-Martin periodinane (765mg; 1.80mmol)
over 10 min at r.t. After 15 h TLC control (toluene/ethyl acetate, 4:1) indicated com-
pletion of the reaction, and the suspension was diluted with CH2Cl2 (100mL), washed
with sat. NaHCO3/0.2m Na2S2O3 (1:1, 3 × 50mL) and water (50mL). The organic
phase was dried over Na2SO4, filtered, and evaporated to dryness to give 608mg of
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crude 2a. The crude product was dissolved in toluene (25mL) and water (0.75mL).
K2CO3 (288mg; 2.08mmol) was added, and the suspension was stirred at 80 ◦C for
18 h, when TLC (toluene/ethyl acetate, 4:1) indicated complete consumption of the
starting material. The reaction mixture was diluted with toluene (50mL), allowed to
cool to r.t., washed with water (2 × 20mL) and dried over Na2SO4. Filtration and
evaporation of the solvents yielded a colorless oil, which was purified by flash column
chromatography (SiO2, toluene/ethyl acetate, 8:1) to give 3,2-enolone 3b (325mg; 70%
over two steps) as a colorless oil.
Rf = 0.67 (toluene/ethyl acetate, 4:1);
[
α
]20
D −95.5 (c=1.0, CHCl3); UV (ace-
tonitrile) λmax (log ) 263 (3.90), 326 nm (sh, 2.13); 1H NMR (400.2MHz, CDCl3) δ:
7.40–7.29 (m, 10H, HAr), 5.99 (d, 1H, J 4,5 = 3.5Hz, H-4), 5.90 (dddd, 1H, J trans =
17.2, J cis = 10.4, J vic = 6.1, J vic = 5.3Hz, allyl: O-CH2-CH=CH2), 5.31 (dddd, 1H,
J trans = 17.2, J gem = 1.5, 2 × 4J = 1.4Hz, allyl: O-CH2-CH=CHH), 5.23 (dddd, 1H,
J cis = 10.4, J gem = 1.5, 2 × 4J = 1.4Hz, allyl: O-CH2-CH=CHH ), 5.00 (s, 1H, H-1),
4.91 (d, 1H, J = 12.1Hz, CH2Ph), 4.87 (d, 1H, J = 12.1Hz, CH2Ph), 4.75 (ddd, 1H,
J 4,5 = 3.5, J 5,6b = 6.9, J 5,6a = 6.5Hz, H-5), 4.57 (d, 1H, J = 12.0Hz, CH2Ph), 4.53 (d,
1H, J = 12.0Hz, CH2Ph), 4.31 (dddd, 1H, J gem = 12.7, J vic = 5.3, 2 × 4J = 1.5Hz,
allyl: O-CHH-CH=CH2), 4.16 (dddd, 1H, J gem = 12.7, J vic = 6.1, 2 × 4J = 1.4Hz,
allyl: O-CHH -CH=CH2), 3.80 (dd, 1H, J 6a,6b = 9.2, J 5,6a = 6.5Hz, H-6a), 3.60 (dd,
1H, J 6a,6b = 9.2, J 5,6b = 6.9Hz, H-6b); 13C NMR (100.6MHz, CDCl3) δ: 184.6 (C-2),
147.0 (C-3), 137.8, 135.6 (2 × CAr,q.), 133.3 (allyl: O-CH2-CH=CH2), 128.8–127.5
(CAr), 118.3 (allyl: O-CH2-CH=CH2), 116.8 (C-4), 97.9 (C-1), 73.6 (CH2Ph), 73.1
(C-6), 72.0 (C-5), 70.0 (CH2Ph), 69.5 (allyl: O-CH2-CH=CH2); HR-ESI-TOF calcd.
for C23H24O5Na [M+Na]+: 403.1516. Found: 403.1515; Anal. calcd. for C23H24O5: C,
72.61; H, 6.36. Found: C, 72.67; H, 6.53.
2,3,5-Tri-O-benzyl-d-arabino-1,4-lactone (4):
O O
OBn
OBn
BnO
A solution of 3,4,6-tri-O-benzyl-α-d-arabino-hexopyranos-2-ulosyl bromide AD[43]
(950mg; 1.86mmol) in dry CH2Cl2 (8mL) was slowly added to a suspension of allyl
alcohol (314µL; 4.65mmol), MS 3Å (700mg) and Ag2CO3 (1.79 g; 6.14mmol) in dry
CH2Cl2 (12mL) and the mixture was stirred at r.t. for 5min. Filtration through a
layer of Celite and evaporation of the volatile components gave a complex mixture
of compounds as observed by TLC (toluene/ethyl acetate, 20:1). Chromatographic
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purification of the residue (toluene/ethyl acetate, 20:1) afforded 4 (80mg; 10%) as a
colorless solid. Analytical data corresponded to published data.[59, 60] The formation
of 4 could not be reproduced.
3,4,6-Tri-O-acetyl-1,2-O-(1-methoxyethylidene)-α-d-glucopyranose (5):
OAcO
AcO
OAc
O
O
OMe
Based on a method published by Nepogodiev et al.[62] for the synthesis of 9, a solution
of 2,3,4,6-tetra-O-acetyl-α-d-glucopyranosyl bromide AV (15.2 g; 37.0mmol) in dry
MeNO2 (45mL) at r.t. was treated with 2,4,6-collidine (9.80mL; 73.92 mmol), MeOH
(7.47mL; 184.8mmol) and n-Bu4NBr (2.50 g; 7.76mmol). After 28 h, TLC control
(toluene/ethyl acetate, 4:1, + 1% Et3N) confirmed completion of the reaction, and a
white precipitate had formed. Dilution with CHCl3 (300mL), washing with water (3
× 300mL), drying (Na2SO4), filtration and evaporation of the volatile parts gave a
yellow oil. Purification by flash column chromatography (SiO2, toluene/ethyl acetate,
25:1 to 16:1, + 2% Et3N) gave orthoester 5 (12.41 g; 93%) in the form of a colorless oil
as an isomeric mixture (exo/endo=12:1). Analytical data corresponded to published
data.[63].
3,4,6-Tri-O-benzyl-1,2-O-(1-methoxyethylidene)-α-d-glucopyranose (6):
OBnO
BnO
OBn
O
O
OMe
According to a similar reaction as published by Nepogodiev et al.[62] for the synthesis
of 10, acetylated orthoester 5 (6.63 g; 18.29mmol) was dissolved in anhydrous benzyl
chloride (50mL) and treated with NaOH (11.46 g; 286.50 mmol). The vigorously
stirred mixture was heated to 135 ◦C for 3 h, when TLC control (toluene, + 2% Et3N)
confirmed complete conversion. The reaction was allowed to cool to r.t., diluted with
Et2O (500mL) and washed with water (3 × 200mL, addition of brine to facilitate phase
separation). Drying (Na2SO4), filtration and evaporation of the volatile parts gave a
yellow oil. Purification by flash column chromatography (SiO2, toluene/petroleum ether
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60–90, 2:1, + 2% Et3N) gave orthoester 6 (6.0 g; 65%) as a colorless oil as an isomeric
mixture (exo/endo: n. d.). Analytical data corresponded to published data.[282, 283]
Allyl 3,4,6-tri-O-benzyl-β-d-glucopyranoside (7):
O
OH
BnO
BnO
OBn
OAll
As described by Draghetti et al.[61], benzylated orthoester 6 (9.54 g; 18.83mmol) in
anhydrous allyl alcohol (41mL) was cooled to 0 ◦C and treated with TMSOTf (255 µL;
1.41 mmol). The solution was stirred at 0 ◦C for 30min, when TLC (toluene/ethyl
acetate, 4:1) indicated absence of the starting material. The reaction was quenched
at 0 ◦C by the dropwise addition of Et3N (2mL) in CH2Cl2 (20 mL), allowed to warm
to r.t., and diluted with CH2Cl2 (250mL). Washing with sat. NaHCO3 (2 × 75mL)
and water (2 × 75mL), drying (Na2SO4), filtration and evaporation of the volatile
parts provided a brown oil. The crude product was dissolved in MeOH (120mL), and
NaOMe 25% in MeOH (750µL) was added dropwise at r.t. After a reaction time of
18 h, neutralization with Dowex H+ ion exchange resin, filtration and evaporation to
dryness gave a brown oil. Flash column chromatography (SiO2, toluene/ethyl acetate,
12:1) gave allyl glucoside 7 (6.10 g; 66%, 2 steps) as a colorless oil. Analytical data
corresponded to published data.[284]
Methyl 3,4,6-tri-O-benzyl-β-d-glucopyranoside (8):
O
OH
BnO
BnO
OBn
OMe
As described by Draghetti et al.[61] for the synthesis of 7, benzylated orthoester 6
(1.26 g; 2.48mmol) in anhydrous MeOH (5.5mL) was cooled to 0 ◦C, and TMSOTf
(40µL; 0.22mmol) was added. The solution was stirred at 0 ◦C for 30min, when TLC
(toluene/ethyl acetate, 4:1) indicated absence of the starting material. The reaction was
quenched at 0 ◦C by the dropwise addition of Et3N (0.5mL) in CH2Cl2 (5mL), allowed
to warm to r.t., and diluted with CH2Cl2 (40mL). Washing with sat. NaHCO3 (2 ×
15mL) and water (2 × 15mL), drying (Na2SO4), filtration and evaporation to dryness
gave a brown oil. The crude oil was dissolved in MeOH (20mL), and NaOMe 25% in
MeOH (100 µL) was added dropwise at r.t. After a reaction time of 18 h, neutralization
with Dowex H+ ion exchange resin, filtration and evaporation of the solvent gave a
brown oil, which was purified by flash column chromatography (SiO2, toluene/ethyl
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acetate, 12:1) to give methyl glucoside 8 (920mg; 80%, 2 steps) as a colorless solid.
Analytical data corresponded to published data.[67]
3,4,6-Tri-O-acetyl-1,2-O-(1-benzyloxyethylidene)-α-d-glucopyranose (9):
OAcO
AcO
OAc
O
O
OBn
According to Nepogodiev et al.[62], 2,3,4,6-tetra-O-acetyl-α-d-glucopyranosyl bromide
AV (23.20 g; 56.41mmol) was dissolved in anhydrous MeNO2 (75mL) and was treated
with 2,4,6-collidine (15.0mL; 113.14mmol) and benzyl alcohol (29.3mL; 282.1mmol).
Next, n-Bu4NBr (3.78 g; 11.72mmol) was added, and the mixture was stirred at r.t. for
24 h, when a white precipitate had formed and TLC (toluene/ethyl acetate, 4:1, + 2%
Et3N) confirmed complete consumption of the starting material. Dilution with CHCl3
(700mL), washing with water (3 × 350mL), drying (Na2SO4), filtration and evaporation
of the volatile parts gave an oil. Purification by flash column chromatography (SiO2,
toluene to toluene/ethyl acetate 10:1, + 2% Et3N) gave orthoester 9 (20.49 g; 83%) in
the form of a colorless oil as an isomeric mixture (exo/endo=25:1). Analytical data
corresponded to published data.[62]
3,4,6-Tri-O-benzyl-1,2-O-(1-benzyloxyethylidene)-α-d-glucopyranose (10):
OBnO
BnO
OBn
O
O
OBn
As described by Nepogodiev et al.[62], to acetylated orthoester 9 (25.50 g; 58.16mmol)
in anhydrous benzyl chloride (150mL) was added NaOH (36.50 g; 912.5mmol), and
the vigorously stirred mixture was heated to 135 ◦C for 5 h, when TLC (toluene, + 2%
Et3N) confirmed complete transformation. The suspension was allowed to cool to r.t.,
diluted with water (300mL) and extracted with Et2O (2 × 300mL). The combined
organic extracted were washed with water (3 × 300mL), dried (Na2SO4), and filtered.
Evaporation of the volatile parts, followed by evaporation of benzyl chloride at 65 ◦C to
complete dryness, gave a crude brown oil. Purification by flash column chromatography
(SiO2, toluene, + 2% Et3N) gave benzylated orthoester 10 (28.27 g; 83%) as an isomeric
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mixture (exo/endo=25:1) in the form of a brownish oil. Analytical data corresponded
to published data.[62]
Benzyl 3,4,6-tri-O-benzyl-β-d-glucopyranoside (11):
O
OH
BnO
BnO
OBn
OBn
According to a protocol published by Nepogodiev et al.[62], benzylated orthoester 10
(28.27 g; 48.52mmol) in anhydrous MeNO2 (150mL) was treated with HgBr2 (1.23 g;
3.41mmol). The mixture was heated to 93 ◦C for 5.5 h, when TLC (toluene/ethyl
acetate, 4:1) indicated complete conversion. The reaction was allowed to cool to r.t.,
and CHCl3 (500mL) was added. Washing of the mixture with water (4 × 200mL),
drying (Na2SO4), filtration and evaporation of the solvents gave a crude brown oil
(41.4 g). Of this crude product, a fraction of 21.90 g (53 m%) was suspended in
MeOH (100mL), and CH2Cl2 (100mL) was added. To the clear solution was added
NaOMe 25% in MeOH (500µL) at r.t. After 5 d, a second portion of NaOMe was added
(200µL). After a total reaction time of 7 d, the reaction mixture was neutralized by the
addition of Dowex H+ ion exchange resin, filtered and evaporated to dryness. Flash
column chromatography (SiO2, toluene/ethyl acetate, 15:1) provided benzyl glucoside
11 (11.82 g; 85%, 2 steps, based on reacted fraction of the crude product). Analytical
data corresponded to published data.[62]
Allyl 3,4,6-tri-O-benzoyl-2-C-vinyl-β-d-mannopyranoside (12):
OBzO
BzO
OBz
O
OH
A suspension of benzoylated ulosyl bromide AB[42] (801mg; 1.45mmol), MS 3Å
(650mg) and Ag2CO3 (400mg; 1.45mmol) in anhydrous CH2Cl2 (15mL) was stirred at
r.t. for 30min. Subsequently, allyl alcohol (108 µL; 1.60mmol) was added, and stirring
was continued for 3 h until TLC (toluene/ethyl acetate, 4:1) showed complete conversion
of the starting material. The suspension was filtered through a layer of Celite and
concentrated under reduced pressure to give crude 1a. The crude material was dissolved
in anhydrous THF (25mL) and cooled to −80 ◦C. Vinylmagnesium bromide 0.7m in
THF (2.49mL; 1.74mmol) was added dropwise and the reaction was stirred for 30min
at −80 ◦C until TLC (toluene/ethyl acetate, 12:1) showed complete conversion of the
starting material. Sat. NH4Cl (5ml) was added dropwise, and the mixture was allowed
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to warm to r.t. The suspension was extracted with CH2Cl2 (3 × 15mL), and the
combined organic extracts were washed with brine (20mL), dried (Na2SO4), filtered
and concentrated in vacuo. Flash column chromatography (SiO2, toluene/ethyl acetate,
25:1) of the residue gave diene 12 (236mg; 29% over two steps) as a white foam. An
analytical sample was recrystallized from cyclohexane.
M.p. 118 ◦C (cyclohexane); Rf = 0.14 (toluene/ethyl acetate, 18:1);
[
α
]20
D −186.2 (c
= 0.5, CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 8.06–8.01 (m, 2H, HAr), 7.95–7.85
(m, 4H, HAr), 7.65–7.36 (m, 9H, HAr), 5.95–5.85 (m, 3H, H-4, allyl: -CH2-CH=CH2,
vinyl: -CH=CH2), 5.70 (d, 1H, J 3,4 = 9.9Hz, H-3), 5.51 (dd, 1H, J trans = 17.2, J gem
= 1.8Hz, vinyl: -CH=CHH), 5.28 (dddd, 1H, J trans = 17.2, J gem = 1.8Hz, 2 × 4J
= 1.8Hz, allyl: -CH2-CH=CHH), 5.19–5.11 (m, 2H, allyl: -CH2-CH=CHH, vinyl:
-CH=CHH ), 5.01 (s, 1H, H-1), 4.61 (dd, 1H, J 6a,6b = 11.9, J 5,6a = 3.0Hz, H-6a), 4.52
(dd, 1H, J 6a,6b = 11.9, J 5,6b = 5.3Hz, H-6b), 4.38–4.29 (m, 2H, allyl: O-CHH-CH=CH2,
H-5), 4.27 (d, 1H, J = 1.0Hz, OH), 4.18 (dddd, 1H, J gem = 13.2, 3J = 5.9, 2 × 4J =
1.6Hz, allyl: O-CHH -CH=CH2); 13C NMR (100.6MHz, acetone-D6) δ: 166.5, 166.3,
166.1 (3 × benzoyl C=O), 137.9 (vinyl: -CH=CH2), 135.1 (allyl: -CH2-CH=CH2),
134.2, 134.0, 134.0 (3 × CAr,q.), 131.0–129.3 (CAr), 117.3 (allyl: -CH2-CH=CH2), 117.0
(vinyl: -CH=CH2), 102.0 (C-1), 77.9 (C-2), 75.2 (C-3), 72.8 (C-5), 70.6 (allyl: -CH2-
CH=CH2), 69.5 (C-4), 64.3 (C-6); FAB-MS m/z 581 [M+Na]+; HR-ESI-TOF calcd.
for C32H30O9Na [M+Na]+: 581.1782. Found: 581.1780; Anal. calcd. for C32H30O9: C,
68.81; H, 5.41. Found: C, 68.99; H, 5.39.
3,6-Dihydro(3,4,6-tri-O-benzoyl-1-deoxy-β-d-mannopyranoso)[1,2-b]-2H -
pyran (13):
OBzO
BzO
OBz
O
OH
7 8
9
1
6
A mixture of diene 12 (513mg; 0.92mmol) and Hoveyda-Grubbs catalyst 2nd gen.
(50mg; 9mol%) in CH2Cl2 (50mL) was stirred at r.t. while a thin stream of nitrogen
was slowly conducted through the mixture. After a total reaction time of 28 h, TLC
(toluene/acetone, 20:1) showed complete conversion of the starting material. Concen-
tration of the mixture under reduced pressure and flash column chromatography (SiO2,
toluene/acetone, 20:1) of the residue gave alkene 13 (431mg; 88%) as a colorless solid.
An analytical sample was recrystallized from n-hexane/ethyl acetate.
M.p. 129–135 ◦C (n-hexane/ethyl acetate, decomp.); Rf = 0.11 (toluene/acetone,
20:1);
[
α
]20
D −43.0 (c= 1.0, CHCl3); 1H NMR (400.2MHz, CDCl3) δ: 8.07–8.00 (m, 4H,
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HAr), 7.90–7.85 (m, 2H, HAr), 7.55–7.43 (m, 3H, HAr), 7.41–7.28 (m, 6H, HAr) 6.07 (dd,
1H, J 4,5 = J 3,4 = 9.7Hz, H-4), 5.98–5.90 (m, 2H, H-7, H-8), 5.52 (d, 1H, J 3,4 = 9.5Hz,
H-3), 4.80 (s, 1H, H-1), 4.66 (dd, 1H, J 6a,6b = 12.3, J 5,6a = 2.9Hz, H-6a), 4.53–4-46 (m,
3H, H-6b, H-9a, H-9b), 4.18 (ddd, 1H, J 4,5 = 9.9, J 5,6b = 5.2, J 5,6a = 2.9Hz, H-5), 2.44
(bs, 1H, OH); 13C NMR (100.6MHz, CDCl3) δ: 166.6, 166.4, 165.4 (3 × benzoyl C=O),
133.6, 133.4, 133.1 (CAr,q.), 130.1 (C-8), 130.0–128.4 (CAr), 125.1 (C-7), 99.1 (C-1),
74.1 (C-3), 74.1 (C-5), 68.3 (C-4), 67.8 (C-2), 67.1 (C-9), 63.5 (C-6); FAB-MS m/z
553 [M+Na]+, 531 [M+H]+; HR-ESI-TOF calcd. for C30H26O9Na [M+Na]+: 553.1469.
Found: 553.1478; Anal. calcd. for C30H26O9: C, 67.92; H, 4.94. Found: C, 68.04; H,
5.37.
(3S,4R)-3,4-Dihydroxytetrahydro(3,4,6-tri-O-benzoyl-1-deoxy-β-d-manno-
pyranoso)[2,1-e]-2H -pyran (14):
7 8 9
1
6
OBzO
BzO
OBz
O
OH
HO OH
NMO (190mg; 1.65mmol) was added to a solution of alkene 13 (673mg; 1.27mmol) in
a mixture of acetone (15mL), water (5mL) and t-BuOH (2mL), followed by 100µL
of an aqueous 2% OsO4 solution. The mixture was stirred at 45 ◦C for several days,
until TLC (toluene/ethyl acetate, 4:1) indicated no further progress of the reaction. A
second portion of NMO (190mg; 1.65mmol) and OsO4 solution (125µL) was added,
and stirring was continued (in total 12 d) until TLC showed complete conversion of
the starting material. Na2S2O3 (0.6 g) was added at r.t., the mixture was stirred for
30min and diluted with water (80mL). The resulting solution was extracted with
ethyl acetate (3 × 80mL) and the combined extracts were washed with 1 m HCl (2 ×
100mL), sat. NaHCO3 (2 × 100mL) and brine (100mL), dried over Na2SO4, filtered
and concentrated in vacuo. Recrystallization of the residue from toluene/acetone gave
triol 14 (531mg; 74%) as a colorless solid.
M.p. 193–194 ◦C (toluene/acetone, decomp.); Rf = 0.13 (toluene-ethyl acetate, 4:1);[
α
]20
D −28.8 (c= 1.0, acetone); 1H NMR (400.2MHz, acetone-D6) δ: 8.07–7.91 (m, 6H,
HAr), 7.65–7.54 (m, 3H, HAr), 7.51–7.39 (m, 6H, HAr), 6.00–5.93 (m, 2H, H-4, H-3),
5.05 (s, 1H, H-1), 4.58 (dd, 1H, J 6a,6b = 12.1, J 5,6a = 2.8Hz, H-6a), 4.50 (dd, 1H,
J 6a,6b = 12.1, J 5,6b = 5.1Hz, H-6b), 4.46 (bs, 1H, C-2-OH ), 4.38–4.29 (m, 2H, C-5-OH,
H-5), 4.24–4.15 (m, 1H, H-8), 3.98–3.92 (m, 1H, H-7), 3.86–3.80 (m, 1H, C-8-OH ),
3.76 (dd, 1H, J 9a,9b = 10.9, J 8,9a = 5.8Hz, H-9a), 3.67 (dd, 1H, J 9a,9b = 10.9, J 8,9b =
10.9Hz, H-9b); 13C NMR (100.6MHz, acetone-D6) δ: 166.7, 166.4, 166.2 (3 × C=O),
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134.2, 134.2, 133.9 (CAr,q.), 130.9–129.3 (CAr), 98.4 (C-1), 74.1 (C-2), 73.8 (C-5), 73.6
(C-4), 70.0 (C-7), 69.8 (C-3), 65.8 (C-9), 64.7 (C-8), 64.1 (C-6); FAB-MS m/z 587
[M+Na]+, 565 [M+H]+; HR-ESI-TOF calcd. for C30H28O11Na [M+Na]+: 587.1524.
Found: 587.1524; Anal. calcd. for C30H28O11: C, 63.83; H, 5.00. Found: C, 63.42; H,
5.16.
(3S,4R)-3,4-Dihydroxytetrahydro(1-deoxy-β-d-mannopyranoso)[2,1-e]-2H -
pyran (syn-15):
7 8 9
1
6
OHO
HO
OH
O
OH
HO OH
From 14: A catalytic amount of NaOMe 25% in MeOH (80µL) was added to a solution
of tribenzoate 14 (258mg; 0.46mmol) in MeOH (15mL) and the solution was stirred at
r.t. for 15–20min until TLC (toluene/ethyl acetate, 8:1) indicated complete conversion
of the starting material. The solution was neutralized by the addition of Dowex H+
ion exchange resin, filtered and concentrated under reduced pressure. Washing of the
remaining colorless oil several times with n-hexane/ethyl acetate (1:1), followed by
co-evaporation with toluene and washing of the residue with CHCl3, gave syn-15
(88mg, 76%) as a colorless solid.
From 18: Pd 10% on activated charcoal (60mg; 43wt%) was added to a solution
of 18 (141mg; 0.27mmol) in MeOH (10mL). The suspension was stirred under an
atmosphere of hydrogen at r.t. for 18 h. When TLC (chloroform/methanol, 5:1) showed
completion of the reaction the solvent was evaporated and the residue was suspended
in MeCN/H2O 4:1 (24mL). The suspension was centrifuged and the clear phase was
separated. The solid residue was again suspended in MeCN/H2O and centrifuged again.
The combined clear phases were evaporated and the residual oil was purified by RP-C18
chromatography (MeCN/H2O, 2:1) to provide pure hexol syn-15 (68mg; quant.) as
an oil. Crystals suitable for X-ray structural analysis were obtained from a saturated
solution of syn-15 in methanol/water.
M.p. 240 ◦C (methanol/water, decomp.); Rf = 0.17 (chloroform/methanol, 5:1);[
α
]20
D 22.5 (c= 0.93, D2O); 1H NMR (400.2MHz, D2O) δ: 4.74 (s, 1H, H-1), 4.18 (ddd,
1H, J 8,9ab = 11.3, 5.6, J 7,8 = 3.2Hz, H-8), 4.06 (d, 1H, J 7,8 = 3.1Hz, H-7), 3.92–3.82
(m, 3H, H-6a, H-9a, H-3), 3.75 (dd, 1H, J 6a,6b = 12.5, J 5,6b = 5.9Hz, H-6b), 3.69–3.62
(m, 2H, H-4, H-9b), 3.46 (ddd, 1H, J 4,5 = 10.0, J 5,6b = 5.9, J 5,6a = 2.2Hz, H-5); 13C
NMR (100.6MHz, D2O) δ: 97.5 (C-1), 78.0 (C-5), 73.8 (C-2), 71.9 (C-3), 68.5 (C-7),
68.2 (C-4), 64.7 (C-9), 64.3 (C-8), 61.3 (C-6); ESI-MS m/z 286 [M+Cl]-; HR-ESI-TOF
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calcd. for C9H16O8Na [M+Na]+: 275.0737. Found: 275.0741; Anal. calcd. for C9H16O8:
C, 42.86; H, 6.39. Found: C, 42.53; H, 6.46.
Allyl 3,4,6-tri-O-benzyl-2-C-vinyl-β-d-mannopyranoside (16):
OBnO
BnO
OBn
O
OH
Crude 2a as described above from the Dess-Martin oxidation of 1.70 g (3.47mmol) of
7 was dissolved in anhydrous THF (65mL) and cooled to −78 ◦C. Vinylmagnesium
bromide 1m in THF (6.97mL; 6.97mmol) was constantly added dropwise over 2 h by
using a programmable syringe pump. After completion of the addition, the solution
was stirred for another 30min at −78 ◦C, neutralized by the dropwise addition of sat.
NH4Cl (4mL) and allowed to warm to r.t. The reaction mixture was diluted with
CH2Cl2 (260mL), washed with water (3 × 130mL) and dried over Na2SO4. Filtration
and evaporation of the solvents gave a colorless oil which was purified by flash column
chromatography (SiO2, toluene/acetone, 25:1) to provide diene 16 (1.49 g; 83% over
two steps) in the form of a colorless oil.
Rf=0.56 (toluene/ethyl acetate, 4:1);
[
α
]20
D −30.4 (c=1.0, CHCl3); 1H NMR
(400.2MHz, CDCl3) δ: 7.39–7.26 (m, 13H, HAr), 7.22–7.19 (m, 2H, HAr), 5.89 (dddd,
1H, J trans = 17.2, J cis = 10.4, J vic = 6.4, 4.9Hz, allyl: O-CH2-CH=CH2), 5.79 (dd, 1H,
J trans = 17.1, J cis = 10.5Hz, vinyl: -CH=CH2), 5.62 (dd, 1H, J trans = 17.1, J gem =
1.5Hz vinyl: -CH=CHH), 5.37 (dd, 1H, J cis = 10.5, J gem = 1.5Hz, vinyl: -CH=CHH ),
5.29 (dddd, 1H, J trans = 17.2, J gem = 1.6, 2 × 4J = 1.6Hz, allyl: O-CH2-CH=CHH),
5.20 (dddd, 1H, J cis = 10.4, J gem = 1.6, 2 × 4J = 1.4Hz, allyl: O-CH2-CH=CHH ),
4.83 (d, 1H, J gem = 10.4Hz, CH2Ph), 4.76 (d, 1H, J gem = 10.6Hz, CH2Ph), 4.71
(d, 1H, J gem = 10.6Hz, CH2Ph), 4.66 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.62–4.54
(m, 2H, CH2Ph), 4.43–4.35 (m, 2H, H-1, allyl: O-CHH-CH=CH2, visible coupling
constants: J gem = 13.1, J vic = 4.8, 2 × 4J = 1.5Hz), 4.13 (dddd, 1H, J gem = 13.1,
J vic = 6.5, 2 × 4J = 1.2Hz, allyl: O-CHH -CH=CH2), 3.91 (dd, J 4,5 = J 3,4 = 9.5Hz,
H-4), 3.81 (dd, 1H, J 6a,6b = 10.9, J 5,6a = 2.1Hz, H-6a), 3.75 (dd, 1H, J 6a,6b = 10.9,
J 5,6b = 5.1Hz, H-6b), 3.55–3.49 (m, 2H, H-5, H-3, visible coupling constants: J 3,4 =
9.1Hz), 2.56 (bs, 1H, OH); 13C NMR (100.2MHz, CDCl3) δ: 138.4, 138.2, 137.8 (3 ×
CAr,q.), 137.6 (vinyl: -CH=CH2), 133.8 (allyl: O-CH2-CH=CH2), 128.5–127.7 (CAr),
117.9 (allyl: O-CH2-CH=CH2), 117.0 (vinyl: -CH=CH2), 100.3 (C-1), 84.3 (C-3),
77.3 (C-2), 76.0 (C-4), 76.0 (CH2Ph), 75.4 (C-5), 75.2 (CH2Ph), 73.6 (CH2Ph), 69.9
(allyl: O-CH2-CH=CH2), 69.2 (C-6); HR-ESI-TOF calcd. for C32H36O6Na [M+Na]+:
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539.2404. Found: 539.2404; Anal. calcd. for C32H36O6: C, 74.40; H, 7.02. Found: C,
73.94; H, 7.17.
3,6-Dihydro(3,4,6-tri-O-benzyl-1-deoxy-β-d-mannopyranoso)[1,2-b]-2H -
pyran (17):
OBnO
BnO
OBn
O
OH
7 8
9
1
6
To a solution of diolefin 16 (705mg; 1.36mmol) in dry CH2Cl2 (35mL) was added
Hoveyda-Grubbs catalyst 2nd gen. (14mg; 0.022mmol; 1.6mol%) and the green solution
was stirred for 24 h at r.t. When TLC (toluene/ethyl acetate, 4:1) indicated complete
consumption of the starting material, the solvent was evaporated. To the brown residue
in 5mL CH2Cl2, di(ethylene glycol) vinyl ether was added as a ruthenium scavenger[126]
and the solution was stirred at r.t. for 1.5 h. The solvent was evaporated and the brown
oil was purified by flash column chromatography (SiO2, toluene/ethyl acetate, 5:1) to
yield bicyclic alkene 17 (629mg; 94%) as a colorless solid. Crystals of 17 suitable for
X-ray structural analysis were obtained from n-hexane/ethyl acetate.
M.p. 118 ◦C (n-hexane/ethyl acetate); Rf=0.11 (toluene/ethyl acetate, 4:1);
[
α
]20
D
17.7 (c= 1.0, CHCl3); 1H NMR (400.2MHz, CDCl3) δ: 7.40–7.25 (m, 13H, HAr), 7.22–
7.15 (m, 2H, HAr), 5.96 (ddd, 1H, J 7,8 = 10.0, J 7,9a = 2.0, J 7,9b = 2.0Hz, H-7), 5.80
(ddd, 1H, J 7,8 = 10.0, J 8,9a = 3.1, J 8,9b = 1.8Hz, H-8), 4.99 (d, 1H, J gem = 11.5Hz,
CH2Ph), 4.82 (d, 1H, J gem = 10.8Hz, CH2Ph), 4.73–4.67 (m, 2H, CH2Ph), 4.62–4.55
(m, 2H, CH2Ph), 4.44–4.37 (m, 2H, H-1, H-9a), 4.33 (ddd, 1H, J 9a,9b = 17.3, J 8,9b = 2.1,
J 7,9b = 2.1Hz, H-9b), 4.17 (dd, 1H, J 4,5 = 9.7, J 3,4 = 9.0Hz, H-4), 3.84–3.76 (m, 2H,
H-6a, H-6b), 3.61 (ddd, 1H, J 4,5 = 9.8, J 5,6a = 4.2, J 5,6b = 2.5Hz, H-5), 3.39 (d, 1H,
J 3,4 = 9.0Hz, H-3), 2.22 (bs, 1H, OH); 13C NMR (100.6MHz, CDCl3) δ: 138.3, 138.1,
138.1 (3 × CAr,q.), 129.3 (C-8), 128.6–127.7 (CAr), 126.0 (C-7), 99.3 (C-1), 82.6 (C-3),
77.2 (C-5), 76.8 (C-4), 75.9 (CH2Ph), 75.3 (CH2Ph), 73.7 (CH2Ph), 68.9 (C-6), 68.3
(C-2), 66.9 (C-9); HR-ESI-TOF calcd. for C30H32O6Na [M+Na]+: 511.2091. Found:
511.2092; Anal. calcd. for C30H32O6: C, 73.75; H, 6.60. Found: C, 73.64; H, 6.60.
(3S,4R)-3,4-Dihydroxytetrahydro(3,4,6-tri-O-benzyl-1-deoxy-β-d-manno-
pyranoso)[2,1-e]-2H -pyran (18):
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OBnO
BnO
OBn
O
OH
HO OH
A solution of alkene 17 (139mg; 0.28mmol) in THF (4mL) and water (1.5mL) was
treated with pyridine (23µL; 0.28mmol) and trimethylamine N -oxide (63mg; 0.57mmol).
Then, 80µL of a solution of OsO4 (1% in water) was added and the reaction mixture
was stirred at 60 ◦C. When TLC (toluene/ethyl acetate, 1:1) indicated no further
progress of the reaction after 3 d, 20µL of OsO4 1% solution and 15mg (0.14mmol) of
trimethylamine N -oxide was added and heating was continued. After 5 d TLC showed
complete transformation of the substrate and the reaction mixture was allowed to cool
to r.t. Na2S2O3 (50mg) was added and the solution was stirred for 30min. Dilution
with water/brine (30mL/10mL), extraction with EtOAc (3 × 30mL), drying (Na2SO4),
filtration and evaporation of the volatile parts provided a colorless oil. Purification by
flash column chromatography (SiO2, toluene/ethyl acetate, 1:1) yielded triol 18 (141mg;
95%) as a colorless foam. An analytical sample was recrystallized from n-hexane/ethyl
acetate.
M.p. 143 ◦C (n-hexane/ethyl acetate); Rf=0.17 (toluene/ethyl acetate, 1:1);
[
α
]20
D
45.0 (c=1.0, CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.43–7.23 (m, 15H, HAr),
4.93–4.88 (m, 2H, CH2Ph), 4.82 (d, 1H, J gem = 11.1Hz, CH2Ph), 4.68 (s, 1H, H-1),
4.65–4.59 (m, 2H, CH2Ph), 4.53 (d, 1H, J gem = 12.1 Hz, CH2Ph), 4.24–4.16 (m, 1H,
H-8), 4.15–4.11 (m, 1H, H-7), 4.09–4.03 (m, 1H, OH), 4.01–3.91 (m, 3H, OH, H-3, H-4),
3.77–3.73 (m, 2H, H-6a, H-6b), 3.69 (dd, 1H, J 9a,9b = 10.9, J 8,9a = 5.6Hz, H-9a), 3.61
(dd, 1H, J 9a,9b = 10.9, J 8,9b = 10.8Hz, H-9b), 3.54 (ddd, 1H, J 4,5 = 9.3, J 5,6a = 3.3,
J 5,6b = 3.3Hz, H-5), 3.44 (bs, 1H, C-2-OH); 13C NMR (100.6MHz, acetone-D6) δ:
142.2, 139.8, 139.7 (3 × CAr,q.), 129.0–128.1 (CAr), 98.4 (C-1), 81.8 (C-3), 77.3 (C-4),
77.1 (C-5), 75.7 (CH2Ph), 75.4 (CH2Ph), 74.4 (C-2), 73.7 (CH2Ph), 70.4 (C-7), 70.1
(C-6), 65.5 (C-9), 65.1 (C-8); HR-ESI-TOF calcd. for C30H34O8Na [M+Na]+: 545.2146.
Found: 545.2146; Anal. calcd. for C30H34O8: C, 68.95; H, 6.56. Found: C, 69.25; H,
6.72.
(3R,4S)-3,4-Epoxytetrahydro(3,4,6-tri-O-benzyl-1-deoxy-β-d-mannopyra-
noso)[2,1-e]-2H -pyran (19):
7 8
9
1
6
OBnO
BnO
OBn
O
OH
O
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Alkene 17 (92mg; 0.188mmol) was dissolved in anhydrous toluene (6mL) and VO(acac)2
(2mg; 0.008mmol; 4mol%) was added. The blue solution was treated with t-BuOOH
5.5m in decane (41µL; 0.226mmol) upon which the solution turned red immediately,
and was then stirred at 60 ◦C for 18 h when TLC (petroleum ether 60–90/ethyl acetate,
1:1, + 2% Et3N) indicated no further progress of the reaction. A second portion of
t-BuOOH solution (10 µL; 0.055mmol) was added, and stirring at 60 ◦C was continued.
After a total reaction time of 48 h the reaction was diluted with toluene (30mL) and
allowed to cool to r.t. The solution was washed with ice-cold half-sat. Na2S2O3 (3
× 15mL) and water (20mL). Drying over Na2SO4, filtration and evaporation of the
solvent afforded a colorless oil which was recrystallized from n-hexane/ethyl acetate to
yield 57mg of epoxide 19 as a colorless crystalline solid. Chromatographic purification
(SiO2, petroleum ether 60–90/ethyl acetate, 1.5:1, + 0.25% Et3N) of the residue from
the evaporated mother liquor yielded an additional 11mg of epoxide 19 (68mg; 72%
total yield).
M.p. 142 ◦C (n-hexane/ethyl acetate); Rf=0.35 (petroleum ether 60–90/ethyl
acetate, 1.5:1, + 2% Et3N);
[
α
]20
D 53.7 (c= 1.0, CHCl3); 1H NMR (400.2MHz, CDCl3)
δ: 7.42–7.25 (m, 13H, HAr), 7.24–7.17 (m, 2H, HAr), 5.08 (d, 1H, J gem = 11.9Hz,
CH2Ph), 4.85 (d, 1H, J gem = 10.8Hz, CH2Ph), 4.74 (d, 1H, J gem = 11.9Hz, CH2Ph),
4.69 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.61 (d, 1H, J gem = 10.8Hz, CH2Ph), 4.56 (d, 1H,
J gem = 12.2Hz, CH2Ph), 4.31–4.19 (m, 2H, H-4, H-9a), 4.01–3.94 (m, 2H, H-9b, H-1),
3.82–3.74 (m, 2H, H-6a, H-6b), 3.56 (dddd, 1H, J 4,5 = 9.9, J 5,6a = 2.3, J 5,6b = 2.3, 4J
= 2.3Hz, H-5), 3.47 (d, 1H, J 3,4 = 9.1Hz, H-3), 3.11–3.05 (m, 2H, H-8, H-7), 2.85 (bs,
1H, OH); 13C NMR (100.6MHz, CDCl3) δ: 138.2, 137.9, 137.8 (3 × CAr,q.), 128.7–127.7
(CAr), 99.6 (C-1), 80.3 (C-3), 77.2 (C-5), 76.9 (C-4), 75.4 (CH2Ph), 75.3 (CH2Ph), 73.8
(CH2Ph), 68.7 (C-6), 67.2 (C-2), 64.8 (C-9), 52.5 (C-7), 51.6 (C-8); HR-ESI-TOF calcd.
for C30H32O7Na [M+Na]+: 527.2040. Found: 527.2043; Anal. calcd. for C30H32O7: C,
71.41; H, 6.39. Found: C, 71.45; H, 6.57.
(3R,4R)-3,4-Dihydroxytetrahydro(3,4,6-tri-O-benzyl-1-deoxy-β-d-manno-
pyranoso)[2,1-e]-2H -pyran (20):
7 8 9
1
6
OBnO
BnO
OBn
O
OH
HO
OH
To a solution of epoxide 19 (225mg; 0.446mmol) in DMSO (16mL) and water (4mL)
was added KOH (349mg) and the reaction mixture was stirred at 35 ◦C for 7 d, when
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TLC (toluene/ethyl acetate, 1:3) indicated complete conversion of the starting material.
After cooling to r.t., NH4Cl (333mg) was added and the solution was stirred for 15min.
Brine (40mL) was added and the solution was extracted with ethyl acetate (4 × 40mL).
The combined organic extracts were washed with water (5 × 40mL) and dried over
Na2SO4, filtered and evaporated to provide a yellow oil. Flash column chromatography
(SiO2, toluene/ethyl acetate, 1.5:1) yielded 20 (145mg; 62%) as a colorless solid. An
analytical sample was recrystallized from n-hexane/ethyl acetate.
M.p. 150 ◦C (n-hexane/ethyl acetate); Rf=0.32 (toluene/ethyl acetate, 1:3);
[
α
]20
D
75.8 (c=1.0, CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.44–7.24 (m, 15H, HAr),
4.94–4.84 (m, 2H, CH2Ph), 4.81 (d, 1H, J gem = 11.1Hz, CH2Ph), 4.70–4.59 (m, 5H, 2
× OH, H-1, 2 × CH2Ph), 4.55 (d, 1H, J gem = 12.0Hz, CH2Ph), 4.27 (bs, 1H, C -2-OH),
4.19–4.15 (m, 1H, H-7), 4.04 (dd, 1H, J 9a,9b = 12.3, J 8,9a = 1.3Hz, H-9a), 4.00–3.91
(m, 2H, H-3, H-4), 3.87 (ddd, 1H, J 9a,9b = 12.2, J 8,9b = 1.3, 4J = 1.3Hz, H-9b),
3.79–3.73 (m, 2H, H-6a, H-6b), 3.68–3.62 (m, 1H, H-8), 3.58–3.52 (m, 1H, H-5); 13C
NMR (100.6MHz, acetone-D6) δ: 140.2, 139.7, 139.7 (3 × CAr,q.), 129.0–128.1 (CAr),
98.8 (C-1), 81.6 (C-3), 77.2 (C-4), 77.1 (C-5), 75.6 (CH2Ph), 75.3 (CH2Ph), 74.5 (C-2),
73.7 (CH2Ph), 70.8 (C-8), 70.1 (C-6), 68.7 (C-7), 68.6 (C-9); HR-ESI-TOF calcd. for
C30H34O8Na [M+Na]+: 545.2146. Found: 545.2152; Anal. calcd. for C30H34O8: C,
68.95; H, 6.56. Found: C, 68.67; H, 6.70.
(3R,4R)-3,4-Dihydroxytetrahydro(1-deoxy-β-d-mannopyranoso)[2,1-e]-2H -
pyran (anti-21):
7 8 9
1
6
OHO
HO
OH
O
OH
HO
OH
Triol 20 (90mg; 0.172mmol) was dissolved in MeOH (6.4mL). Pd 10% on activated
charcoal (38mg; 42wt%) was added, and the suspension was stirred at r.t. under an
atmosphere of hydrogen for 20 h. TLC control (chloroform/methanol, 5:1) indicated
complete transformation of the starting material. After evaporation of the solvent,
the residue was suspended in MeCN/H2O 4:1, centrifuged, and the clear phase was
separated. The solid residue was suspended in MeCN/H2O and centrifuged again.
Evaporation of the combined clear phases yielded a colorless oil. Purification by RP-C18
chromatography (MeCN/H2O, 2:1) gave anti-21 (39mg; 90%) as a colorless solid.
Rf=0.08 (chloroform/methanol, 5:1);
[
α
]20
D 19.4 (c=1.0, H2O); 1H NMR (400.2
MHz, D2O) δ: 4.72 (s, 1H, H-1), 4.10–3.99 (m, 3H, H-7, H-9a, H-9b), 3.91 (dd, 1H,
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J 6a,6b = 12.5, J 5,6a = 2.2Hz, H-6a), 3.82–3.79 (m, 1H, H-8), 3.78–3.72 (m, 2H, H-3,
H-6b), 3.65 (dd, 1H, J 3,4 = 9.7, J 4,5 = 9.7Hz, H-4), 3.47 (ddd, 1H, J 4,5 = 9.9, J 5,6b =
6.2, J 5,6a = 2.2Hz, H-5); 13C NMR (100.6MHz, D2O) δ: 97.9 (C-1), 78.0 (C-5), 73.4
(C-2), 71.8 (C-3), 69.3 (C-8), 68.2 (C-4), 68.0 (C-9), 67.1 (C-7), 61.4 (C-6); HR-ESI-TOF
calcd. for C9H16O8Na [M+Na]+: 275.0737. Found: 275.0740; HR-ESI-TOF calcd. for
C9H15O8 [M–H]-: 251.0772. Found: 251.0773; Anal. calcd. for C9H16O8: C, 42.86; H,
6.39. Found: C, 42.67; H, 6.82.
Benzyl 3,4,6-tri-O-benzyl-2-C-(3,3-dibenzyloxypropyn-1-yl)-β-d-manno-
pyranoside (22):
7
8
9
OBnO
BnO
OBn
OBn
OH
BnO
OBn
Propiolaldehyde dibenzyl acetal[175] (1.02 g; 4.04mmol) was dissolved in anhydrous
THF (35mL) and cooled to −80 ◦C. n-BuLi (1.50mL; 4.04mmol; 2.7m in n-heptane)
was added dropwise, and stirring at −80 ◦C was continued for 2.5 h. Next, benzyl
2-uloside 2b[37] (1.98 g; 3.67mmol) in 30mL THF was added dropwise over 15min.
After stirring for another 15min, the reaction was quenched by the dropwise addition
of brine (25mL) at −80 ◦C. The mixture was diluted with CHCl3 (200mL) and washed
with water, sat. NH4Cl, sat. NaHCO3 and water (100mL each). Drying of the organic
phase (Na2SO4), filtration, evaporation of the solvents and purification of the residue by
flash column chromatography (SiO2, toluene/acetone, 20:1) afforded alkyne 22 (2.47 g;
85%) as a colorless solid. An analytical sample was recrystallized from n-hexane/ethyl
acetate.
M.p. 85 ◦C (n-hexane/ethyl acetate); Rf=0.65 (toluene/ethyl acetate, 4:1);
[
α
]20
D
3.5 (c= 1.0, CHCl3); 1H NMR (400.2MHz, CDCl3) δ: 7.50–7.21 (m, 30H, HAr), 5.57 (s,
1H, H-9), 5.14 (d, 1H, J gem = 10.6Hz, CH2Ph), 5.04 (d, 1H, J gem = 12.1Hz, CH2Ph),
4.95 (d, 1H, J gem = 10.6Hz, CH2Ph), 4.88 (d, 1H, J gem = 11.1Hz, CH2Ph), 4.85–4.78
(m, 3H, CH2Ph), 4.74–4.63 (m, 4H, CH2Ph), 4.59 (d, 1H, J gem = 10.9Hz, CH2Ph),
4.56 (s, 1H, H-1), 3.91–3.76 (m, 3H, H-4, H-6a, H-6b), 3.71 (d, 1H, J 3,4 = 9.1Hz, H-3),
3.52 (ddd, 1H, J 4,5 = 9.9, J 5,6ab = 5.1, 1.9Hz, H-5), 3.10 (bs, 1H, OH); 13C NMR
(100.6MHz, CDCl3) δ: 138.2, 138.1, 137.8 137.4, 137.3, 136.7 (6 × CAr,q.), 128.5–127.7
(CAr), 99.7 (C-1), 90.7 (C-9), 85.3 (C-3), 85.1 (C-7), 80.8 (C-8), 76.1 (CH2Ph), 75.3
(C-5), 75.2 (CH2Ph), 75.0 (C-4), 73.6 (CH2Ph), 71.6 (C-2), 70.8 (CH2Ph), 69.0 (C-6),
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67.5 (C-9-O-CH2Ph), 67.4 (C-9-O-CH2Ph); HR-ESI-TOF calcd. for C51H50O8Na
[M+Na]+: 813.3398. Found: 813.3384; Anal. calcd. for C51H50O8: C, 77.45; H, 6.37.
Found: C, 77.21; H, 6.40.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(Z)-3,3-dibenzyloxyprop-1-en-1-yl}-β-d-
mannopyranoside (23):
7
89
OBnO
BnO
OBn
OBn
OH
BnO
BnO
A solution of alkyne 22 (129mg; 0.163mmol) in anhydrous DMF (2mL) was treated
with Lindlar catalyst (64mg; 50wt%). The mixture was stirred under an atmosphere
of hydrogen at r.t. for 48 h, when TLC (toluene/ethyl acetate, 4:1) indicated complete
conversion. Dilution with CH2Cl2, filtration through a layer of Celite, evaporation of
the volatile parts and co-evaporation of residual DMF with n-heptane gave a crude
oil. Flash column chromatography (SiO2, toluene/acetone, 20:1) gave (Z )-alkene 23
(120mg; 93%) as a colorless solid. An analytical sample was recrystallized from n-
hexane/ethyl acetate. Crystals suitable for X-ray structural analysis were obtained
from n-pentane/ethyl acetate.
M.p. 95 ◦C (n-hexane/ethyl acetate); Rf=0.76 (toluene/ethyl acetate, 4:1);
[
α
]20
D
−34.0 (c=0.5, CHCl3); 1H NMR (400.2MHz, DMSO-D6) δ: 7.40–7.15 (m, 30H, HAr),
6.19 (d, 1H, J 8,9 = 6.8Hz, H-9), 5.74 (dd, 1H, J 7,8 = 12.4, J 8,9 = 6.8Hz, H-8), 5.67
(d, J 7,8 = 12.4Hz, H-7), 4.80 (d, J gem = 12.4Hz, CH2Ph), 4.76–4.46 (m, 11H, CH2Ph,
H-1), 4.43 (d, J gem = 11.6Hz, CH2Ph), 4.34 (bs, 1H, OH), 3.78–3.63 (m, 4H, H-3, H-4,
H-6a, H-6b), 3.58–3.52 (m, 1H, H-5); 13C NMR (100.6 MHz, DMSO-D6) δ: 138.5, 138.5,
138.4, 138.4, 138.3, 137.7 (6 × CAr,q.), 133.2 (C-7), 129.8 (C-8), 128.2–127.2 (CAr),
100.7 (C-1), 97.5 (C-9), 84.3 (C-3), 78.7 (C-2), 75.6 (C-4), 74.9 (CH2Ph), 74.5 (C-5),
74.1 (CH2Ph), 72.3 (CH2Ph), 70.2 (CH2Ph), 69.1 (C-6), 67.5 (CH2Ph), 66.3 (CH2Ph);
HR-ESI-TOF calcd. for C51H52O8Na [M+Na]+: 815.3554. Found: 815.3544; Anal.
calcd. for C51H52O8: C, 77.25; H, 6.61. Found: C, 77.31; H, 6.56.
Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-2-C-(3,3-dibenzyloxypropyn-1-yl)-β-d-
mannopyranoside (24):
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7
8
9
OBnO
BnO
OBn
OBn
OAc
BnO
OBn
A solution tertiary alcohol 22 (394mg; 0.50mmol) in CHCl3 (4mL) was treated with
Ac2O (4mL), Et3N (76 µL; 0.548mmol) and DMAP (122mg; 1.0mmol). The mixture
was heated to 65 ◦C for 4 d, when TLC (toluene/ethyl acetate, 4:1) indicated complete
conversion of the starting material. The reaction mixture was diluted with CHCl3
(50mL) and poured onto ice-cold sat. NaHCO3 (50mL). The organic layer was separated
and washed with sat. NaHCO3 and water (20mL each), then dried (Na2SO4), filtered,
concentrated in vacuo and co-evaporated with toluene (2 × 10mL). Flash column
chromatography of the residue (SiO2, toluene/acetone, 50:1) gave acetate 24 (335mg;
81%) in the form of a colorless oil.
Rf=0.70 (toluene/ethyl acetate, 4:1);
[
α
]20
D −11.7 (c=0.85, CHCl3); 1H NMR
(400.2MHz, CDCl3) δ: 7.43–7.18 (m, 28H, HAr), 7.15–7.10 (m, 2H, HAr), 5.53 (s, 1H,
H-9), 5.30 (d, 1H, J gem = 10.9Hz, CH2Ph), 4.97 (d, 1H, J gem = 12.4Hz, CH2Ph),
4.87–4.62 (m, 8H, CH2Ph), 4.56 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.51–4.44 (m, 2H,
H-1, CH2Ph), 3.79–3.67 (m, 4H, H-6a, H-6b, H-3), 3.49 (ddd, 1H, J 4,5 = 9.6, J 5,6 =
4.5, 2.5Hz, H-5), 2.18 (s, 3H, CH3); 13C NMR (100.6MHz, CDCl3) δ: 168.3 (acetyl
C=O), 138.3, 138.2, 138.0, 137.6, 137.6, 136.7 (6 × CAr,q.), 128.7–127.7 (CAr), 100.6
(C-1), 91.0 (C-9), 86.1 (C-3), 84.4 (C-7), 82.2 (C.8), 75.7 (C-5), 75.4 (CH2Ph), 2 ×
75.2 (CH2Ph, C-2), 74.7 (C-4), 73.6 (CH2Ph), 71.2 (CH2Ph), 69.2 (C-6), 67.6 (CH2Ph),
67.6 (CH2Ph), 22.2 (CH3); HR-ESI-TOF calcd. for C53H52O9Na [M+Na]+: 855.3504.
Found: 855.3505; Anal. calcd. for C53H52O9: C, 76.42; H, 6.29. Found: C, 76.36; H,
6.32.
Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-2-C-{(Z)-3,3-dibenzyloxyprop-1-en-1-
yl}-β-d-mannopyranoside (25):
7
89
OBnO
BnO
OBn
OBn
OAc
BnO
BnO
Alkyne 24 (249mg; 0.299mmol) in anhydrous DMF (3mL) was treated with Lindlar
catalyst (113mg; 45wt%). The mixture was stirred under an atmosphere of hydrogen
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at r.t. for 3 d, when TLC (toluene/ethyl acetate, 4:1) indicated complete conversion.
Dilution with CH2Cl2, filtration through a layer of Celite, evaporation of the volatile
parts and co-evaporation of residual DMF with n-heptane gave alkene 25 (220mg; 88%)
as a colorless oil in high purity without further purification.
Rf=0.78 (toluene/ethyl acetate, 2:1);
[
α
]20
D −18.6 (c= 1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.35–7.16 (m, 30H, HAr), 6.21 (d, 1H, J 7,8 = 12.4Hz, H-7), 5.76 (dd,
1H, J 7,8 = 12.4, J 8,9 = 7.8Hz, H-8), 5.67 (d, 1H, J 8,9 = 7.8Hz, H-9), 5.27 (s, 1H,
H-1), 4.87 (d, 1H, J gem = 11.6Hz, CH2Ph), 4.65–4.55 (m, 3H, CH2Ph), 4.51–4.46 (m,
3H, CH2Ph), 4.44–4.37 (m, 5H, CH2Ph), 4.95–4.82 (m, 4H, H-5, H-3, H-6a, H-4), 3.77
(dd, 1H, J 6a,6b = 9.6, J 5,6b = 5.8Hz, H-6b), 1.83 (s, 3H, CH3); 13C NMR (100.6MHz,
CDCl3) δ: 169.4 (acetyl C=O), 138.5, 138.4, 138.2, 138.1, 138.0, 137.8 (6 × CAr,q.),
133.1 (C-7), 128.6–127.5 (CAr), 127.1 (C-8), 99.8 (C-1), 95.8 (C-9), 80.2 (C-2), 79.7
(C-3), 75.1 (*C-4), 74.9 (*C-5; assignments may be interchanged), 74.8 (CH2Ph), 73.3
(CH2Ph), 72.3 (CH2Ph), 71.1 (CH2Ph), 70.6 (C-6), 66.9 (CH2Ph), 65.2 (CH2Ph), 22.2
(CH3); HR-ESI-TOF calcd. for C53H54O9Na [M+Na]+: 857.3660. Found: 857.3663;
Anal. calcd. for C53H54O9: C, 76.24; H, 6.52. Found: C, 76.14; H, 6.48.
Benzyl 3,4,6-tri-O-benzyl-2-C-(3,3-dimethoxypropyn-1-yl)-β-d-manno-
pyranoside (26):
7
8
9
OBnO
BnO
OBn
OBn
OH
MeO
OMe
Dibenzyl acetal 22 (301mg; 0.38mmol) was dissolved in anhydrous MeOH (20mL) and
I2 (200mg; 0.79mmol) was added. The solution was stirred at 60 ◦C for 48 h until TLC
(toluene/ethyl acetate, 4:1) indicated complete consumption of the starting material.
The reaction mixture was cooled to 0 ◦C, treated with solid Na2S2O3 (1.0 g), stirred
for 15min and allowed to warm to r.t. Next, CHCl3 (100mL) was added, and the
organic layer was washed with water (2 × 30mL) and brine (30mL). The solution was
dried (Na2SO4), filtered and concentrated in vacuo. Flash column chromatographic
purification of the residue (SiO2, toluene/acetone, 20:1) afforded dimethyl acetal 26
(213mg; 88%) as a colorless oil.
Rf=0.30 (toluene/ethyl acetate, 4:1);
[
α
]20
D −6.7 (c=1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.48–7.27 (m, 18H, HAr), 7.22–7.15 (m, 2H, HAr), 5.18 (s, 1H, H-9),
5.08 (d, 1H, J gem = 10.9Hz, CH2Ph), 5.00 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.90 (d,
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1H, J gem = 10.9Hz, CH2Ph), 4.85–4.74 (m, 2H, CH2Ph), 4.70–4.51 (m, 4H, CH2Ph,
H-1), 3.86–3.67 (m, 4H, H-4, H-6a, H-6b, H-3, visible coupling constants: J 3,4 = 9.1Hz),
3.52–3.45 (m, 1H, H-5), 3.36 (s, 6H, 2 × CH3), 3.04 (bs, 1H, OH); 13C NMR (100.6MHz,
CDCl3) δ: 138.3, 138.1, 137.9 136.8 (4 × CAr,q.), 128.5–127.7 (CAr), 99.9 (C-1), 93.1
(C-9), 85.4 (C-3), 84.9 (C-7), 80.5 (C-8), 76.1 (CH2Ph), 75.4 (C-5), 75.2 (CH2Ph), 75.0
(C-4), 73.6 (CH2Ph), 71.7 (C-2), 70.9 (CH2Ph), 69.1 (C-6), 52.8 (CH3), 52.6 (CH3);
HR-ESI-TOF calcd. for C39H42O8Na [M+Na]+: 661.2772. Found: 661.2777; Anal.
calcd. for C39H42O8: C, 73.33; H, 6.63. Found: C, 73.04; H, 6.65.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(Z)-3,3-dimethoxyprop-1-en-1-yl}-β-d-
mannopyranoside (27):
7
89
OBnO
BnO
OBn
OBn
OH
MeO
MeO
Alkyne 26 (95mg; 0.149mmol) in anhydrous DMF (3mL) was treated with Lindlar
catalyst (71mg; 75wt%) and stirred under an atmosphere of hydrogen for 5 d when
TLC (toluene/ethyl acetate, 4:1) indicated complete conversion. Dilution with CH2Cl2,
filtration through a layer of Celite, evaporation of the volatile parts and co-evaporation
of residual DMF with n-heptane gave the crude product. Flash column chromatographic
purification (SiO2, toluene, + 2% Et3N) provided alkene 27 (87mg; 91%) in the form
of a colorless, amorphous solid.
Rf=0.23 (toluene, + 2% Et3N);
[
α
]20
D −57.0 (c= 1, CHCl3); 1H NMR (400.2MHz,
DMSO-D6) δ: rotameric isomerism, significant signals: 5.69 (d, 1H, J 8,9 = 6.3Hz, H-9),
5.59 (d, 1H, J 7,8 = 12.4Hz, H-7), 5.54 (dd, 1H, J 7,8 = 12.4, J 8,9 = 6.3Hz, H-8), 3.14 (s,
6H, 2 × CH3); 13C NMR (100.6MHz, DMSO-D6) δ: rotameric isomerism, significant
signals: 133.2 (C-7), 129.8 (C-8), 100.7 (C-1), 99.0 (C-9), 74.5 (C-5), 52.8, 51.6 (2 ×
CH3); HR-ESI-TOF calcd. for C39H44O8Na [M+Na]+: 663.2928. Found: 663.2933;
Anal. calcd. for C39H44O8: C, 73.10; H, 6.92. Found: C, 72.97; H, 7.01.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1,3-dioxan-2-yl)ethynyl}-β-d-manno-
pyranoside (28):
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7
8
9
OBnO
BnO
OBn
OBn
OH
O
O
To a solution of dibenzyl acetal 22 (465mg; 0.59mmol) in anhydrous toluene (15mL) was
added 1,3-dihydroxypropane (426 µL; 5.88mmol) and a catalytic amount of p-TsOH·H2O
(14mg). The solution was stirred at 100 ◦C for 22 h, when TLC (toluene/ethyl acetate,
4:1) indicated the complete transformation of the starting material. The reaction mixture
was diluted with toluene (20mL) and washed with sat. NaHCO3 (20mL) and water
(20mL). After drying (Na2SO4), filtration and concentration in vacuo, flash column
chromatographic purification of the residue (SiO2, toluene/ethyl acetate, 7:1) afforded
dioxane 28 (320mg; 84%) as a colorless amorphous solid.
Rf=0.26 (toluene/ethyl acetate, 4:1);
[
α
]20
D −2.4 (c=1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.48–7.42 (m, 4H, HAr), 7.40–7.26 (m, 14H, HAr), 7.21–7.16 (m, 2H,
HAr), 5.46 (s, 1H, H-9), 5.10 (d, 1H, J gem = 10.9Hz, CH2Ph), 5.01 (d, 1H, J gem =
12.4Hz, CH2Ph), 4.91 (d, 1H, J gem = 10.9Hz, CH2Ph), 4.85–4.76 (m, 2H, CH2Ph),
4.69–4.52 (m, 4H, CH2Ph, H-1), 4.22–4.15 (m, 2H, -CH 2-CH2-CH2-), 3.86–3.69 (m,
6H, -CH2-CH2-CH 2-, H-6a, H-6b, H-4, H-3, visible coupling constants: J 3,4 = 8.8Hz),
3.48 (ddd, 1H, J 4,5 = 9.8, J 5,6 = 5.1, 2.0Hz, H-5), 3.07 (bs, 1H, OH), 1.81–1.67 (m,
2H, -CH2-CH 2-CH2-); 13C NMR (100.6MHz, CDCl3) δ: 138.3, 138.1, 137.9, 136.9 (4 ×
CAr,q.), 128.5–127.7 (CAr), 99.9 (C-1), 90.2 (C-9), 85.4 (C-3), 85.1 (C-7), 80.7 (C-8), 76.1
(CH2Ph), 75.4 (C-5), 75.2 (CH2Ph), 75.0 (C-4), 73.6 (CH2Ph), 71.7 (C-2), 70.9 (CH2Ph),
69.1 (C-6), 64.6 (-CH2-CH2-CH2-), 64.6 (-CH2-CH2-CH2-), 25.7 (-CH2-CH2-CH2-);
HR-ESI-TOF calcd. for C40H42O8Na [M+Na]+: 673.2772. Found: 673.2777; Anal.
calcd. for C40H42O8: C, 73.83; H, 6.51. Found: C, 73.67; H, 6.66.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(Z)-2-(1,3-dioxan-2-yl)vinyl}-β-d-manno-
pyranoside (29):
7
89
OBnO
BnO
OBn
OBn
OH
O
O
Alkyne 28 (239mg; 0.367mmol) in anhydrous DMF (5mL) was treated with Lindlar
catalyst (144mg; 60wt%) and stirred under an atmosphere of hydrogen for 3 d, when
6.5. Synthetic Procedures 207
TLC (toluene/ethyl acetate, 4:1) suggested the completion of the reaction. Dilution
with CH2Cl2, filtration through a layer of Celite, evaporation of the volatile parts and
co-evaporation of residual DMF with n-heptane gave pure alkene 29 (194mg; 81%) as
a colorless, amorphous solid.
Rf=0.65 (toluene/ethyl acetate, 2:1);
[
α
]20
D –61.2 (c= 1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.41–7.25 (m, 18H, HAr), 7.23–7.17 (m, 2H, HAr), 5.80 (d, 1H, J 8,9 =
5.1Hz, H-9), 5.70 (dd, 1H, J 7,8 = 12.1, J 8,9 = 5.2Hz, H-8), 5.33 (d, 1H, J 7,8 = 12.1Hz,
H-7), 4.93 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.86 (d, 1H, J gem = 10.9Hz, CH2Ph),
4.76–4.52 (m, 6H, CH2Ph), 4.26 (s, 1H, H-1), 4.10–4.01 (m, 2H, -CH 2-CH2-CH2-),
3.92–3.72 (m, 6H, H-4, OH, -CH2-CH2-CH 2-, H-6a, H-6b), 3.49–3.43 (m, 1H, H-5),
3.40 (d, 1H, J 3,4 = 9.1Hz, H-3), 2.17–2.03 (m, 1H, -CH2-CHaHb-CH2-), 1.31 (d, 1H,
J vic = 13.4Hz, -CH2-CHaHb-CH2-); 13C NMR (100.6MHz, CDCl3) δ: 138.5, 138.4,
138.0, 137.2 (4 × CAr,q.), 133.2 (C-7), 132.2 (C-8), 128.8–127.7 (CAr), 99.8 (C-1), 98.5
(C-9), 84.6 (C-3), 78.7 (C-2), 2 × 76.1 (C-4, CH2Ph), 75.5 (C-5), 75.2 (CH2Ph), 73.7
(CH2Ph), 70.4 (CH2Ph), 69.5 (C-6), 66.7 (-CH2-CH2-CH2-), 66.6 (-CH2-CH2-CH2-
), 25.6 (CH2-CH2-CH2-); HR-ESI-TOF calcd. for C40H44O8Na [M+Na]+: 675.2932.
Found: 675.2928; Anal. calcd. for C40H44O8: C, 73.60; H, 6.79. Found: C, 73.65; H,
6.88.
Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-2-C-{(1,3-dioxan-2-yl)ethynyl}-β-d-
mannopyranoside (30):
7
8
9
OBnO
BnO
OBn
OBn
OAc
O
O
The tertiary alcohol 28 (128mg; 0.197mmol) was dissolved in anhydrous toluene
(2mL) and treated with Ac2O (2mL), Et3N (30µL; 0.22mmol) and DMAP (24mg;
0.197mmol). The mixture was heated to 45 ◦C for 5 h, when TLC (toluene/ethyl
acetate, 4:1) suggested complete conversion of the starting material. The reaction
mixture was allowed to cool to r.t., and was next diluted with toluene (30mL) and
poured onto ice-cold sat. NaHCO3 (20mL). After stirring for 1 h, the organic layer was
separated and washed with sat. NaHCO3 (2 × 15mL, to neutral solution) and water
(20mL). Drying (Na2SO4), filtration and evaporation of the solvents in vacuo gave a
brown oil, which was purified by flash column chromatography (SiO2, toluene/acetone,
60:1) to give acetate 30 (85mg; 72%) as a yellowish oil.
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Rf=0.76 (toluene/ethyl acetate, 4:1);
[
α
]20
D −28.3 (c= 1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.48–7.27 (m, 18H, HAr), 7.17–7.12 (m, 2H, HAr), 5.54 (s, 1H, H-9), 5.31
(d, 1H, J gem = 10.6Hz, CH2Ph), 5.00 (d, 1H, J gem = 12.4Hz, CH2Ph), 4.83–4.78 (m, 2H,
CH2Ph), 4.75 (d, 1H, J gem = 12.4Hz, CH2Ph), 4.68 (d, 1H, J gem = 12.1Hz, CH2Ph),
4.61–4.55 (m, 2H, CH2Ph, H-1), 4.49 (d, 1H, J gem = 10.9Hz, CH2Ph), 4.36–4.26 (m,
2H, -CHaHb-CH2-CH2-, -CH2-CH2-CHaHb-), 3.87–3.70 (m, 6H, -CHaHb-CH2-CH2-,
-CH2-CH2-CHaHb-, H-3, H-4, H-6a, H-6b), 3.53 (ddd, 1H, J 4,5 = 9.9, J 5,6 = 4.3, 2.5Hz,
H-5), 2.20 (s, 3H, CH3), 1.91–1.80 (m, 1H, -CH2-CHaHb-CH2-), 1.71–1.61 (m, 1H,
-CH2-CHaHb-CH2-); 13C NMR (100.6MHz, CDCl3) δ: 168.5 (acetyl C=O), 138.3, 138.1,
138.0, 136.8 (4 × CAr,q.), 128.7–127.7 (CAr), 100.8 (C-1), 89.7 (C-9), 86.1 (C-3), 84.0
(C-7), 82.4 (C-8), 75.6 (C-5), 75.4 (CH2Ph), 75.2 (C-2), 75.2 (CH2Ph), 74.6 (C-4),
73.5 (CH2Ph), 71.3 (CH2Ph), 69.1 (C-6), 2 × 63.7 (-CH2-CH2-CH2-, -CH2-CH2-CH2-),
25.9 (-CH2-CH2-CH2-), 22.2 (CH3); HR-ESI-TOF calcd. for C42H44O9Na [M+Na]+:
715.2878. Found: 715.2879; Anal. calcd. for C42H44O9: C, 72.81; H, 6.40. Found: C,
72.79; H, 6.47.
Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-2-C-{(Z)-2-(1,3-dioxan-2-yl)vinyl}-
β-d-mannopyranoside (31):
7
89
OBnO
BnO
OBn
OBn
OAc
O
O
To a solution of alkyne 30 (82mg; 0.118mmol) in anhydrous DMF (3mL) was added
Lindlar catalyst (44mg; 54wt%), and the mixture was stirred under an atmosphere
of hydrogen for 5 d, when no more conversion could be observed. TLC (toluene/ethyl
acetate, 4:1) suggested the presence of unreacted 30 and of a product with lower
chromatographic mobility. Dilution with CH2Cl2, filtration through a layer of Celite,
evaporation of the volatile parts and co-evaporation of residual DMF with n-heptane gave
a crude mixture. Flash column chromatographic purification (SiO2, toluene/acetone,
60:1) provided substrate 30 (48mg; 0.069mmol) together with alkene 31 (18mg; 22%;
53% brsm) in the form of a colorless oil.
Rf=0.45 (toluene/ethyl acetate, 4:1);
[
α
]20
D –20.9 (c= 1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.38–7.24 (m, 18H, HAr), 7.23–7.19 (m, 2H, HAr), 6.11 (dd, 1H, J 7,8 =
12.6, J 7,9 = 0.7Hz, H-7), 5.48 (dd, 1H, J 7,8 = 12.7, J 8,9 = 6.5Hz, H-8), 5.21 (dd, 1H,
J 8,9 = 6.6, J 7,9 = 0.6Hz, H-9), 5.12 (s, 1H, H-1), 4.90 (d, 1H, J gem = 12.7Hz, CH2Ph),
4.76 (d, 1H, J gem = 11.4Hz, CH2Ph), 4.69–4.63 (m, 2H, CH2Ph), 4.54 (d, 1H, J gem =
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11.9Hz, CH2Ph), 4.51–4.43 (m, 3H, CH2Ph), 4.06 (d, 1H, J 3,4 = 6.0Hz, H-3), 4.04–3.96
(m, 2H, -CHaHb-CH2-CH2-, -CH2-CH2-CHaHb-), 3.91–3.76 (m, 4H, H-6a, H-4, H-5,
H-6b), 3.54 (ddd, 1H, J = 11.9, 11.9, 2.4 Hz, -CHaHb-CH2-CH2-), 3.44 (ddd, 1H, J =
11.9, 11.9, 2.4 Hz, -CH2-CH2-CHaHb-), 2.11–1.97 (m, 4H, -CH2-CHaHb-CH2-, CH3),
1.26–1.20 (m, 1H, -CH2-CHaHb-CH2-); 13C NMR (100.6MHz, CDCl3) δ: 168.9 (acetyl
C=O), 138.6, 138.4, 138.1, 137.5 (4 × CAr,q.), 132.6 (C-7), 128.5–127.6 (CAr), 127.5
(C-8), 99.7 (C-1), 97.9 (C-9), 81.4 (C-2), 81.3 (C-3), 75.5 (*C-5), 75.0 (*C-4, assignments
may be interchanged), 74.9 (CH2Ph), 73.4 (CH2Ph), 73.2 (CH2Ph), 70.9 (CH2Ph), 70.5
(C-6), 66.6 (-CH2-CH2-CH2-), 66.6 (-CH2-CH2-CH2-), 25.6 (-CH2-CH2-CH2-), 21.9
(CH3); HR-ESI-TOF calcd. for C42H46O9Na [M+Na]+: 717.3034. Found: 717.3040;
Anal. calcd. for C42H46O9: C, 72.60; H, 6.67. Found: C, 72.27; H, 6.99.
Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-2-C-{(1,3-dioxolan-2-yl)acetyl}-β-d-
mannopyranoside (32):
7
8
9
OBnO
BnO
OBn
OBn
OAc
O
O
O
To acetylated dibenzyl acetal 24 (62mg; 0.074mmol) in ethylene glycol (5mL) was
added I2 (50mg), and the mixture was heated to 50 ◦C for 22 h. TLC (toluene/acetone,
20:1) indicated the presence of multiple products. The reaction mixture was cooled
to 0 ◦C by the addition of ice. Next, Na2S2O3 (90mg) was added, and the suspension
was stirred for 15min until it had completely decolorized. CHCl3 (50mL) and water
(20ml) were added, and the organic layer was separated. Washing with sat. NaHCO3
(20mL) and water (2 × 20mL), drying (Na2SO4), filtration and evaporation of the
volatile components in vacuo gave a crude oil. Flash column chromatography (SiO2,
toluene/acetone, 20:1) afforded ketone 32 (17mg; 33%) in the form of a colorless oil.
Rf=0.22 (toluene/acetone, 20:1);
[
α
]20
D −52.9 (c= 1, CHCl3); 1H NMR (400.2MHz,
CDCl3) δ: 7.37–7.22 (m, 18H, HAr), 7.11–7.06 (m, 2H, HAr), 5.15 (dd, 1H, J 8a,9 =
5.3, J 8b,9 = 4.2Hz, H-9), 4.93 (d, 1H, J gem = 11.4Hz, CH2Ph), 4.75–4.69 (m, 2H,
CH2Ph), 4.67–4.46 (m, 6H, CH2Ph, H-1, H-3), 4.43 (d, 1H, J gem = 10.9Hz, CH2Ph),
3.89–3.68 (m, 7H, 2 × dioxolane CH2, H-4, H-6a, H-6b), 3.58 (ddd, 1H, J 4,5 = 9.6,
J 5,6 = 4.6, 2.8Hz, H-5), 3.14 (dd, 1H, J 8a,8b = 16.9, J 8a,9 = 5.3Hz, H-8a), 3.07 (dd,
1H, J 8a,8b = 16.9, J 8b,9 = 4.2Hz, H-8b), 2.23 (s, 3H, CH3); 13C NMR (100.6MHz,
CDCl3) δ: 203.3 (C-7), 170.2 (acetyl C=O), 138.5, 138.3, 138.1, 136.4 (4 × CAr,q.),
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128.5–127.6 (CAr), 101.4 (C-9), 99.7 (C-1), 88.2 (C-2), 80.9 (C-3), 75.8 (C-4), 75.7
(C-5), 75.1 (CH2Ph), 74.9 (CH2Ph), 73.6 (CH2Ph), 71.4 (CH2Ph), 69.3 (C-6), 64.9
(dioxolane CH2), 64.8 (dioxolane CH2), 45.2 (C-8), 21.5 (CH3); HR-ESI-TOF calcd. for
C41H44O10Na [M+Na]+: 719.2827. Found: 719.2822.
Benzyl 3,4,6-tri-O-benzyl-2-C-(3-hydroxyprop-1-yn-1-yl)-β-d-mannopyra-
noside (33):
7
8
9
OBnO
BnO
OBn
OBn
OH
OH
From 2b: 43 µL of propargyl alcohol (0.74mmol) in anhydrous THF (5mL) was
dropwise treated with 1.49mL of ethylmagnesium bromide (1m in THF; 1.49mmol)
at r.t. The mixture was heated to 80 ◦C for 1.5 h, and then allowed to cool to r.t.
Next, this solution was added dropwise to benzyl 2-uloside 2b[37] (0.20 g; 0.37mmol)
in anhydrous THF (5mL) at r.t. with a programmable syringe pump (addition rate:
0.12mL/min). The reaction mixture was stirred for another 30min, when TLC control
(toluene/ethyl acetate, 4:1) showed complete consumption of the starting material. The
solution was cooled to 0 ◦C and dropwise treated with sat. NH4Cl (2mL). After dilution
with CHCl3 (100mL) and water (25mL), and washing of the organic part with sat.
NH4Cl (25mL), sat. NaHCO3 (25mL) and water (25mL), the organic phase was dried
(Na2SO4), filtered and evaporated to give a crude oil. Flash column chromatographic
purification (SiO2, toluene/ethyl acetate, 4:1) yielded alkynol 33 (138mg; 63%) as a
colorless resin. As side products with higher chromatographic mobility, gluco-derivative
39 (11mg; 5%) and 3,2-enolone 40 (9mg; 5%) were obtained.
From 22: A solution of dibenzyl acetal 22 (297mg; 0.38mmol) in anhydrous acetone
(20mL) was treated with a catalytic amount of p-TsOH·H2O (30mg). The solution was
stirred at 50 ◦C for 48 h. TLC (toluene/ethyl acetate, 4:1) suggested the presence of
multiple products, and the solution was neutralized by the addition of Et3N (50 µL) at
r.t., and was then evaporated to dryness. Flash column chromatographic purification
(SiO2, toluene/acetone, 20:1) gave a mixture of products as a yellow oil (170mg). This
crude mixture was dissolved in MeOH (10mL) and cooled to 0 ◦C. NaBH4 (19mg;
0.50mmol) was added, and stirring at 0 ◦C was continued for 30min. TLC control
(toluene/ethyl acetate, 4:1) confirmed the formation of a major product with lower
chromatographic mobility, and the mixture was neutralized by the addition of sat.
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NH4Cl (200µL). Stirring at 0 ◦C was continued until no further gas evolved from the
solution, which was then allowed to warm to r.t. Evaporation of all volatile components
in vacuo gave a crude product, which was dissolved in CH2Cl2 (50mL), washed with
water (2 × 20mL) and dried (Na2SO4). Filtration, evaporation of the solvents, and
flash column chromatographic purification (SiO2, toluene/ethyl acetate, 6:1 to 4:1) gave
alkynol 33 (121mg; 54% over two steps) as a colorless resin.
Rf=0.08 (toluene/ethyl acetate, 4:1);
[
α
]20
D −9.5 (c=1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.48–7.25 (m, 18H, HAr), 7.23–7.13 (m, 2H, HAr), 5.06–4.95 (m, 2H,
CH2Ph), 4.91 (d, 1H, J gem = 11.0Hz, CH2Ph), 4.81 (d, 1H, J gem = 10.9Hz, CH2Ph),
4.75 (d, 1H, J gem = 12.3Hz, CH2Ph), 4.66 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.59 (d,
1H, J gem = 12.1Hz, CH2Ph), 4.53 (d, 1H, J gem = 10.9Hz, CH2Ph), 4.48 (s, 1H, H-1),
4.20 (s, 2H, H-9a, H-9b), 3.85–3.70 (m, 3H, H-4, H-6a, H-6b), 3.64 (d, 1H, J 3,4 =
9.2Hz, H-3), 3.52–3.43 (m, 1H, H-5); 13C NMR (100.6MHz, CDCl3) δ: 138.2, 138.1,
138.1, 136.9 (4 × CAr,q.), 128.5–127.7 (CAr), 100.0 (C-1), 85.5 (C-3), 84.6 (C-7), 84.2
(C-8), 76.0 (CH2Ph), 75.3 (C-5), 75.2 (CH2Ph), 75.2 (C-4), 73.6 (CH2Ph), 71.7 (C-2),
70.9 (CH2Ph), 69.1 (C-6), 51.0 (C-9); HR-ESI-TOF calcd. for C37H38O7Na [M+Na]+:
617.2510. Found: 617.2506; Anal. calcd. for C37H38O7: C, 74.73; H, 6.44. Found: C,
74.67; H, 6.64.
Benzyl 3,4,6-tri-O-benzyl-2-C-{3-(tri-iso-propylsilyloxy)prop-1-yn-1-yl}-β-d-
mannopyranoside (34):
7
8
9
OBnO
BnO
OBn
OBn
OH
OTIPS
Tri-iso-propyl(prop-2-yn-1-yloxy)silane[281] (235µL; 0.93mmol) in anhydrous THF
(14mL) was cooled to −80 ◦C. Next, n-BuLi (2.5 m in n-hexane; 360µL; 0.19mmol)
was added dropwise, and the reaction mixture was stirred for 60min at −80 ◦C. Benzyl
2-uloside 2b[37] (387mg; 0.72mmol) in THF (6mL) was slowly added with a pro-
grammable syringe pump (addition rate: 0.17 mL/min), and the cooled solution was
stirred for 1 h. TLC reaction control (toluene/ethyl acetate, 4:1) showed complete
conversion, and the reaction was quenched by the dropwise addition of sat. NH4Cl
(3mL). The suspension was allowed to warm to r.t. and was diluted with CHCl3 (80mL)
and water (20mL). The organic phase was washed with sat. NaHCO3 (25mL) and
water (25mL), dried (Na2SO4), filtered and evaporated to dryness. Flash column chro-
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matographic purification (SiO2, toluene/acetone, 25:1) of the crude material provided
silyl ether 34 (293mg; 72%) as a colorless, highly viscous oil.
Rf=0.65 (toluene/ethyl acetate, 4:1);
[
α
]20
D −8.3 (c=1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.44–7.24 (m, 18H, HAr), 7.17–7.12 (m, 2H, HAr), 5.12 (d, 1H, J gem =
10.8Hz, CH2Ph), 4.98 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.87 (d, 1H, J gem = 10.8Hz,
CH2Ph), 4.79 (d, 1H, J gem = 10.9Hz, CH2Ph), 4.74 (d, 1H, J gem = 12.2Hz, CH2Ph),
4.64 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.57 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.53–4.47
(m, 2H, CH2Ph, H-1), 4.45–4.36 (m, 2H, H-9a, H-9b), 3.79–3.68 (m, 3H, H-4, H-6a,
H-6b), 3.66 (d, 1H, J 3,4 = 9.1Hz, H-3), 3.46 (ddd, 1H, J 4,5 = 9.9, J 5,6a = 5.4, J 5,6b =
2.0Hz, H-5), 1.11–1.01 (m, 21H, i-Pr); 13C NMR (100.6MHz, CDCl3) δ: 138.4, 138.2,
138.1, 137.0 (4 × CAr,q.), 128.5–127.7 (CAr), 100.3 (C-1), 85.8 (C-3), 84.6 (C-7), 83.4
(C-8), 76.1 (CH2Ph), 75.4 (C-5), 75.3 (CH2Ph), 75.1 (C-4), 73.7 (CH2Ph), 71.7 (C-2),
71.1 (CH2Ph), 69.2 (C-6), 52.1 (C-9), 18.1 ((H3C )2CH-Si), 12.1 ((H3C)2CH-Si); HR-
ESI-TOF calcd. for C46H58O7SiNa [M+Na]+: 773.3844. Found: 773.3840; Anal. calcd.
for C46H58O7Si: C, 73.56; H, 7.78. Found: C, 73.36; H, 7.73.
Benzyl 3,4,6-tri-O-benzyl-2-C-{3-[(2R/S)-tetrahydro-2H -pyran-2-yloxy]-
prop-1-yn-1-yl}-β-d-mannopyranoside (35):
7
8
9
OBnO
BnO
OBn
OBn
OH
OTHP
2-(2-Propynyloxy)tetrahydropyran[280](1.87mL; 13.32mmol) was dissolved in anhy-
drous THF (200mL) and cooled to −80 ◦C. Next, n-BuLi (5.55mL; 13.88mmol; 2.5m
in n-hexane) was added dropwise, and the reaction mixture was stirred at −80 ◦C for 1 h.
Benzyl 2-uloside 2b[37] (5.98 g; 11.10mmol) was dissolved in anhydrous THF (100mL)
at r.t. and was slowly added dropwise to the cooled solution via a cannula (addition over
50min). When the addition was complete, the mixture was stirred for another 10min
at −80 ◦C, when TLC (toluene/ethyl acetate, 4:1) indicated complete consumption of
the starting material. The reaction was quenched by the dropwise addition of brine
(50mL), and was then allowed to warm to r.t. Dilution with CH2Cl2 (700mL), washing
with water, sat. NaHCO3 and water (150mL each) and drying over Na2SO4 provided,
after filtration and evaporation, a colorless oil (8 g). Purification by flash column
chromatography (SiO2, toluene/ethyl acetate, 5.5:1) gave THP-protected alkynol 35
(7.0 g; 93%) as a diastereomeric mixture (ca. 1:1) in the form of a colorless oil.
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Rf =0.45 (toluene/ethyl acetate, 4:1); 1H NMR (400.2MHz, CDCl3): δ: 7.44–7.25
(m, 18H, HAr), 7.18–7.13 (m, 2H, HAr), 5.07 (d, 1H, J gem = 10.8Hz, CH2Ph), 4.98
(d, 1H, J gem = 12.4Hz, CH2Ph), 4.87 (d, 1H, J gem = 10.8Hz, CH2Ph), 4.82–4.72 (m,
3H, CH2Ph, pyran H-2), 4.64 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.57 (d, 1H, J gem =
12.1Hz, CH2Ph), 4.53–4.47 (m, 2H, CH2Ph, H-1), 4.35–4.22 (m, 2H, H-9ab), 3.84–3.74
(m, 3H, pyran H-6a, H-4, H-6a), 3.71 (dd, 1H, J 6a,6b = 10.9, J 5,6b = 5.3Hz, H-6b), 3.65
(d, 1H, J 3,4 = 9.1Hz, H-3), 3.52–3.42 (m, 2H, H-5, pyran H-6b), 2.96 (bs, 1H, OH),
1.83–1.41 (m, 6H, pyran H-3ab, pyran H-4ab, pyran H-5ab); 13C NMR (100.6MHz,
CDCl3) mixture of diastereoisomers(*): δ: 138.4, 138.2, 138.0, 137.0 (4 × CAr,q.), 128.5–
127.7 (CAr), 100.1 (C-1), 100.1 (C-1*), 96.9 (pyran C-2), 85.7 (C-3), 85.6 (C-3*), 85.0
(C-7), 84.9 (C-7*), 82.1 (C-8), 82.1 (C-8*), 76.1 (CH2Ph), 76.1 (CH2Ph*), 75.4 (C-5),
75.3 (CH2Ph), 75.2 (C-4), 75.1 (C4*), 73.7 (CH2Ph), 71.7 (C-2), 71.0 (CH2Ph), 70.9
(CH2Ph*), 69.2 (C-6), 62.2 (pyran C-6), 62.1 (pyran C-6*), 54.3 (C-9), 54.2 (C-9*), 30.3
(pyran C-3), 25.5 (pyran C-5), 19.2 (pyran C-4), 19.1 (pyran C-4*); HR-ESI-TOF calcd.
for C42H46O8Na [M+Na]+: 701.3085. Found: 701.3085; Anal. calcd. for C42H46O8: C,
74.31; H, 6.83. Found: C, 74.12; H, 6.85.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(Z)-3-hydroxyprop-1-en-1-yl}-β-d-manno-
pyranoside (36):
7
8
9
OBnO
BnO
OBn
OBn
OH
HO
To a solution of THP-protected allyl alcohol 38 (6.78 g; 9.96mmol) in MeOH (200mL)
was added a catalytic amount of p-TsOH·H2O (100mg) and the mixture was stirred at
r.t. for 10 h. TLC reaction monitoring (toluene/ethyl acetate, 4:1) indicated complete
conversion. After neutralization with Et3N (1mL) and stirring for 15min, evaporation
of the volatile parts yielded a colorless oil (6 g). Flash column chromatography (SiO2,
toluene/ethyl acetate, 2.5:1) gave pure allyl alcohol 36 (5.65 g; 95%) as a colorless oil.
Rf=0.21 (toluene/ethyl acetate, 4:1);
[
α
]20
D −59.2 (c=1, CHCl3); 1H NMR (400.2
MHz, acetone-D6) δ: 7.43–7.21 (m, 20H, HAr), 5.81 (ddd, 1H, J 7,8 = 12.0, J 8,9a =
5.9, J 8,9b = 5.9Hz, H-8), 5.43 (ddd, 1H, J 7,8 = 12.2, J 7,9a = 1.7, J 7,9b = 1.7Hz, H-7),
4.87 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.83–4.74 (m, 3H, CH2Ph), 4.69–4.55 (m, 5H,
CH2Ph, H-1), 4.51 (ddd, 1H, J 9a,9b = 14.1, J 8,9a = 6.0, J 7,9a = 1.6Hz, H-9a), 4.39
(ddd, 1H, J 9a,9b = 13.9, J 8,9b = 5.8, J 7,9b = 1.5Hz, H-9b), 3.96 (bs, 1H, OH), 3.89 (dd,
1H, J 3,4 = 9.4, J 4,5 = 9.4Hz, H-4), 3.83 (dd, 1H, J 6a,6b = 11.0, J 5,6a = 2.1Hz, H-6a),
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3.77 (dd, 1H, J 6a,6b = 11.0, J 5,6b = 5.3Hz, H-6b), 3.61–3.53 (m, 2H, H-3, H-5); 13C
NMR (100.6 MHz, acetone-D6) δ: 139.9, 139.9, 139.8, 138.9 (4 × CAr,q.), 135.7 (C-8),
130.5 (C-7), 129.1–128.2 (CAr), 102.2 (C-1), 86.2 (C-3), 79.2 (C-2), 76.9 (C-4), 76.4
(CH2Ph), 76.3 (C-5), 75.4 (CH2Ph), 73.8 (CH2Ph), 71.1 (CH2Ph), 70.3 (C-6), 59.7
(C-9); HR-ESI-TOF calcd. for C37H40O7Na [M+Na]+: 619.2666. Found: 619.2667;
Anal. calcd. for C37H40O7: C, 74.47; H, 6.76. Found: C, 74.17; H, 6.87.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(Z)-3-[tri-iso-propylsilyloxy]prop-1-en-1-yl}-
β-d-mannopyranoside (37):
7
8
9
OBnO
BnO
OBn
OBn
OH
TIPSO
To alkyne 34 (73mg; 0.098mmol) in 1,4-dioxane (3.5mL) was added Lindlar catalyst
(24mg; 33wt%) and the reaction mixture was stirred under an atmosphere of hydrogen
at r.t. After 21 h, when TLC (toluene/ethyl acetate, 4:1) indicated no further progression
of the reaction, another portion of Lindlar catalyst (15mg; 20wt%) was added, and
stirring under the hydrogen atmosphere was continued for another 22 h. The suspension
was diluted with EtOAc (20mL), filtered through a layer of Celite, and evaporated
in vacuo to give a crude oil. Flash column chromatographic purification (SiO2, 100%
toluene to toluene/ethyl acetate, 9:1) yielded TIPS-protected allyl alcohol 37 (64mg;
87%) in the form of a colorless oil.
Rf=0.83 (toluene/ethyl acetate, 4:1);
[
α
]20
D −45.8 (c=1, CHCl3); 1H NMR (400.2
MHz, CDCl3) δ: 7.39–7.25 (m, 18H, HAr), 7.18–7.12 (m, 2H, HAr), 5.81 (ddd, 1H,
J 7,8 = 12.2, J 8,9a = 5.3, J 8,9b = 5.3Hz, H-8), 5.10 (ddd, 1H, J 7,8 = 12.2, J 7,9a = 2.0,
J 7,9b = 2.0Hz, H-7), 4.91 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.82–4.70 (m, 4H, CH2Ph,
H-9a), 4.68–4.56 (m, 4H, CH2Ph, H-9b), 4.53 (d, 1H, J gem = 10.9Hz, CH2Ph), 4.29
(s, 1H, H-1), 3.86 (dd, 1H, J 3,4 = 9.4, J 4,5 = 9.4Hz, H-4), 3.80 (dd, 1H, J 6a,6b = 10.9,
J 5,6a = 2.0Hz, H-6a), 3.74 (dd, 1H, J 6a,6b = 10.9, J 5,6b = 5.3Hz, H-6b), 3.47–3.40 (m,
2H, H-5, H-3), 2.91 (bs, 1H, OH), 1.09–0.99 (m, 21H, i-Pr); 13C NMR (100.6MHz,
CDCl3) δ: 138.5, 138.3, 138.2, 137.2 (4 × CAr,q.), 137.0 (C-8), 128.5–127.7 (CAr), 127.6
(C-7), 100.3 (C-1), 85.3 (C-3), 78.6 (C-2), 76.1 (C-4), 76.0 (CH2Ph), 75.4 (C-5), 75.2
(CH2Ph), 73.7 (CH2Ph), 70.5 (CH2Ph), 69.4 (C-6), 60.9 (C-9), 18.2 ((H3C )2CH-Si), 12.1
((H3C)2CH-Si); HR-ESI-TOF calcd. for C46H60O7SiNa [M+Na]+: 775.4001. Found:
775.3997; Anal. calcd. for C46H60O7Si: C, 73.37; H, 8.03. Found: C, 73.23; H, 8.04.
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Benzyl 3,4,6-tri-O-benzyl-2-C-{(Z)-3-[(2R/S)-tetrahydro-2H -pyran-2-yl-
oxy]prop-1-en-1-yl}-β-d-mannopyranoside (38):
7
8
9
OBnO
BnO
OBn
OBn
OH
THPO
Alkyne 35 (7.0 g; 10.31mmol) in 1,4-dioxane (200mL) was treated with Lindlar catalyst
(3.5 g; 50wt%) and stirred under an atmosphere of hydrogen at r.t. After 20 h, TLC
(toluene/ethyl acetate, 4:1) showed complete conversion. Filtration through a layer
of Celite and evaporation of the solvent in vacuo gave a crude oil. Flash column
chromatography (SiO2, toluene/ethyl acetate, 8:1 to 5:1) provided THP-protected allyl
alcohol 38 (6.80 g; 97%) as a mixture of diastereoisomers (ca. 1:1) in the form of a
colorless oil.
Rf=0.61 (toluene/ethyl acetate, 4:1); 1H NMR (400.2MHz, CDCl3) mixture of
diastereoisomers(*): δ: 7.40–7.22 (m, 18H, HAr), 7.19–7.14 (m, 2H, HAr), 5.85–5.72
(m, 1H, H-8), 5.32–5.24 (m, 1H, H-7), 4.97–4.88 (m, 1H, CH2Ph), 4.85–4.76 (m, 2H,
CH2Ph), 4.74–4.58 (m, 6H, CH2Ph, H-9a, pyran H-2, pyran H-2*, H-9a*), 4.57–4.51 (m,
1H, CH2Ph), 4.45 (ddd, 0.5H, J gem = 13.5, J 8*,9b* = 6.7, J 7*,9b* = 1.4Hz, H-9b*), 4.37
(ddd, 0.5H, J gem = 13.4, J 8,9b = 5.6, J 7,9b = 1.6Hz, H-9b), 4.33 (s, 0.5H, H-1), 4.31
(s, 0.5H, H-1*), 3.93–3.85 (m, 1H, H-4), 3.84–3.72 (m, 3H, H-6a, H-6b, pyran H-6a),
3.68–3.51 (m, 1H, OH), 3.50–3.37 (m, 3H, H-5, pyran H-6b, H-3), 1.84–1.72 (m, 1H,
pyran H-4a), 1.69–1.40 (m, 5H, pyran H-3ab, pyran H-5ab, pyran H-4b); 13C NMR
(100.6MHz, CDCl3) mixture of diastereoisomers(*): δ: 138.5, 138.3, 138.2, 138.1, 137.3,
137.2 (CAr,q.), 132.2 (C-8), 131.6 (C-8*), 131.3 (C-7), 130.4 (C-7*), 128.5–127.7 (CAr),
100.8 (C-1), 100.5 (C-1*), 98.0 (pyran C-2), 97.1 (pyran C-2*), 85.3 (C-3), 85.1 (C-3*),
78.7 (C-2), 78.5 (C-2*), 76.2 (CH2Ph), 76.1 (C-4), 75.5 (C-5), 75.2 (CH2Ph), 73.7
(CH2Ph), 70.8 (CH2Ph), 70.7 (CH2Ph*), 69.5 (C-6), 64.3 (C-9*), 63.5 (C-9), 62.1 (pyran
C-6), 62.0 (pyran C-6*), 30.6 (pyran C-3), 30.5 (pyran C-3*), 25.5 (pyran C-5), 25.5
(pyran C-5*), 19.4 (pyran C-4), 19.3 (pyran C-4*); HR-ESI-TOF calcd. for C42H48O8Na
[M+Na]+: 703.3241. Found: 703.3243; Anal. calcd. for C42H48O8: C, 74.09; H, 7.11.
Found: C, 73.99; H, 7.18.
Benzyl 3,4,6-tri-O-benzyl-2-C-(3-hydroxyprop-1-yn-1-yl)-β-d-glucopyra-
noside (39):
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Isolated as a minor side product (11mg; 5%) in the formation of 33 from 2b (0.20 g;
0.37mmol) as described on page 210.
Rf=0.17 (toluene/ethyl acetate, 4:1); 1H NMR (400.2MHz, CDCl3) δ: 7.44–7.23
(m, 18H, HAr), 7.18–7.12 (m, 2H, HAr), 5.04–4.95 (m, 2H, CH2Ph), 4.88–4.79 (m, 2H,
CH2Ph), 4.71–4.64 (m, 2H, CH2Ph), 4.57–4.49 (m, 2H, CH2Ph), 4.29 (s, 3H, H-1, H-9a,
H-9b), 3.82–3.73 (m, 3H, H-4, H-6a, H-6b), 3.60 (d, 1H, J 3,4 = 9.2Hz, H-3), 3.50 (ddd,
1H, J 4,5 = 9.8, J 5,6a = 3.3, J 5,6b = 3.3Hz, H-5), 2.45 (bs, 2H, 2 × OH); 13C NMR
(100.6MHz, CDCl3) δ: 138.6, 138.3, 138.2, 136.8 (4 × CAr,q.), 128.6–127.8 (CAr), 101.6
(C-1), 86.2 (C-7), 85.8 (C-3), 82.1 (C-8), 76.9 (C-4), 76.0 (C-5), 75.5 (CH2Ph), 75.3
(CH2Ph), 75.0 (C-2), 73.6 (CH2Ph), 71.3 (CH2Ph), 69.0 (C-6), 51.4 (C-9); HR-ESI-TOF
calcd. for C37H38O7Na [M+Na]+: 617.2510. Found: 617.2509.
Benzyl 3,6-di-O-benzyl-4-deoxy-β-d-glycero-hex-3-enopyranoside-2-
ulose (40):
O
BnO
OBn
O
OBn
As a side product: Isolated as a minor product (9mg; 5%) in the formation of 33
from 2b (0.20 g; 0.37mmol) as described on page 210.
Synthesized from 2b: 2-Uloside 2b[37] (0.97 g; 1.80mmol) was dissolved in toluene
(38mL), and water (2.6mL) was added. Next, the mixture was treated with K2CO3
(0.50 g; 3.62mmol), and the suspension was stirred at 95 ◦C. After 22 h, TLC (toluene/
ethyl acetate, 4:1) suggested complete conversion of the substrate, and the reaction
mixture was diluted with toluene (50mL) and allowed to cool to r.t. The suspension
was washed with water (3 × 20mL), dried (Na2SO4), and filtered. The solvent was
evaporated in vacuo, and the resulting yellow oil was purified by flash column chro-
matography (SiO2, toluene/ethyl acetate, 8:1) to give benzyl 3,2-enolone 40 (0.71 g;
92%) as a colorless oil.
Rf=0.71 (toluene/ethyl acetate, 4:1);
[
α
]20
D −108.9 (c=1, CHCl3). UV (acetoni-
trile) λmax (log ) 263 (3.78), 337 nm (sh, 1.86); 1H NMR (400.2MHz, acetone-D6)
δ: 7.45–7.27 (m, 15H, HAr), 6.29 (d, 1H, J 4,5 = 3.6Hz, H-4), 5.07 (s, 1H, H-1), 4.92–
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4.85 (m, 4H, H-5, CH2Ph), 4.70 (d, 1H, J gem = 11.9Hz, CH2Ph), 4.62–4.55 (m, 2H,
CH2Ph), 3.88 (dd, 1H, J 6a,6b = 9.7, J 5,6a = 7.0Hz, H-6a), 3.71 (dd, 1H, J 6a,6b = 9.8,
J 5,6b = 6.1Hz, H-6b); 13C NMR (100.6MHz, acetone-D6) δ: 184.9 (C-2), 147.9 (C-3),
139.4, 138.3, 137.3 (3 × CAr,q.), 129.3–128.4 (CAr), 117.6 (C-4), 99.0 (C-1), 74.0 (C-6),
73.7 (CH2Ph), 73.0 (C-5), 70.8 (CH2Ph), 70.3 (CH2Ph). HR-ESI-TOF: calcd. for
C27H26O5Na [M+Na]+ 453.1672. Found 453.1675. Anal. calcd. for C27H26O5: calcd.
C, 75.33; H, 6.09. Found: C, 75.37; H, 6.15.
(2S)-1,3,4,6-Tetra-O-benzyl-4’7’-dihydrospiro[2-deoxy-β-d-mannopyranose-
2,4’-[1,3]-dioxepin-2-one] (41):
7 8
9 OBn
OBnO
BnO
OBn
O O
O
Diol 36 (205mg; 0.344mmol) in anhydrous CH2Cl2/pyridine (3:1, 40mL) was cooled to
0 ◦C. Subsequently, trichloromethyl chloroformate (diphosgene; 45µL; 0.378mmol) in
CH2Cl2 (2mL) was slowly added dropwise. When the addition was complete, stirring at
0 ◦C was continued for 2.5 h, when TLC (toluene/ethyl acetate, 4:1) suggested complete
conversion to a product of higher chromatographic mobility. The reaction mixture was
treated with water (1mL) and allowed to warm to r.t. The volatile components were
evaporated in vacuo, followed by co-evaporation of residual pyridine with toluene. The
crude product was dissolved in CH2Cl2 (80mL) and washed with sat. NaHCO3 (20mL)
and water (20mL). Drying (Na2SO4), filtration and evaporation gave a crude product,
which was purified by flash column chromatography (SiO2, toluene/ethyl acetate, 7:1)
to give spirocarbonate 41 (200mg; 93%) as a colorless solid. An analytical sample was
recrystallized from n-hexane/ethyl acetate (1:1). Single crystals for X-ray structural
analysis were obtained from n-pentane/acetone-D6.
M.p. 142–143 ◦C (n-hexane/ethyl acetate); Rf=0.62 (toluene/ ethyl acetate, 4:1);[
α
]20
D −77.3 (c=1, CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.46–7.19 (m, 20H,
HAr), 6.24 (ddd, 1H, J 7,8 = 11.1, J 8,9b = 5.9, J 8,9a = 4.9Hz, H-8), 5.89 (d, 1H, J 7,8
= 11.1Hz, H-7), 4.92–4.84 (m, 2H, CH2Ph), 4.79–4.59 (m, 8H, CH2Ph, H-1, H-9a),
4.54 (dd, 1H, J 9a,9b = 14.1, J 8,9b = 6.2Hz, H-9a), 4.13 (dd, 1H, J 3,4 = 9.5, J 4,5 =
9.5Hz, H-4), 3.90 (d, 1H, J 3,4 = 9.3Hz, H-3), 3.86–3.77 (m, 2H, H-6a, H-6b), 3.63 (ddd,
1H, J 4,5 = 9.9, J 5,6a = 4.9, J 5,6b = 2.1Hz, H-5); 13C NMR (100.6MHz, acetone-D6)
δ: 153.4 (OC(=O)O), 139.9, 139.6, 139.3, 138.6 (4 × CAr,q.), 131.3 (C-7), 129.1–129.0
(CAr), 128.9 (C-8), 128.8–128.2 (CAr), 100.4 (C-1), 89.2 (C-2), 85.4 (C-3), 76.8 (C-5),
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76.4 (CH2Ph), 75.9 (C-4), 75.6 (CH2Ph), 73.9 (CH2Ph), 71.2 (CH2Ph), 70.0 (C-6), 64.2
(C-9); HR-ESI-TOF calcd. for C38H38O8Na [M+Na]+: 645.2459. Found: 645.2467;
Anal. calcd. for C38H38O8: C, 73.29; H, 6.15. Found: C, 73.08; H, 6.21.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(Z)-3-chloroprop-1-en-1-yl}-β-d-manno-
pyranoside (42):
7
8
9
OBnO
BnO
OBn
OBn
OH
Cl
In a procedure similar to the synthesis of spirocarbonate 41 above, diol 36 (100mg;
0.168mmol) in anhydrous pyridine (20mL) was treated with neat trichloromethyl
chloroformate (22µL; 0.184mmol) at 0 ◦C. After a reaction time of 1 h at 0 ◦C, workup
and chromatography as described above provided allyl chloride 42 (2mg; 2%) as a
side product with higher chromatographic mobility, together with spirocarbonate 41
(103mg; 94%).
Rf=0.73 (toluene/ethyl acetate, 4:1);
[
α
]20
D −35.5 (c=0.27, CHCl3); 1H NMR
(600.1MHz, acetone-D6) δ: 7.43–7.21 (m, 20H, HAr), 5.75 (ddd, 1H, J 7,8 = 11.8, J 8,9a
= 6.8, J 8,9b = 6.8Hz, H-8), 5.89 (d, 1H, J 7,8 = 11.1Hz, H-7), 5.53 (ddd, 1H, J 7,8 =
11.6, 4J 7,9ab = 1.3, 1.3Hz, H-7), 4.87 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.83–4.72 (m,
4H, H-9a, CH2Ph), 4.68–4.58 (m, 5H, CH2Ph, H-1), 4.50 (ddd, 1H, J 9a,9b = 12.3, J 8,9b
= 6.8, 4J 7,9b = 1.3Hz, H-9b), 3.92 (dd, 1H, J 3,4 = 9.4, J 4,5 = 9.4Hz, H-4), 3.83 (dd,
1H, J 6a,6b = 11.0, J 5,6a = 2.0Hz, H-6a), 3.80–3.75 (m, 2H, H-6b, OH), 3.60 (d, 1H,
J 3,4 = 9.2Hz, H-3), 3.57 (ddd, 1H, J 4,5 = 9.8, J 5,6b = 5.1, J 5,6a = 1.8Hz, H-5); 13C
NMR (150.9MHz, acetone-D6) δ: 139.9, 139.7, 139.7, 138.7 (4 × CAr,q.), 132.6 (C-7),
132.1 (C-8), 129.1–128.2 (CAr), 101.9 (C-1), 85.8 (C-3), 79.3 (C-2), 76.9 (C-4), 76.4
(CH2Ph), 76.3 (C-5), 75.4 (CH2Ph), 73.8 (CH2Ph), 71.2 (CH2Ph), 70.2 (C-6), 42.7
(C-9); HR-ESI-TOF calcd. for C37H39ClO6Na [M+Na]+: 637.2327. Found: 637.2327.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1S,2S)-1,2,3-trihydroxyprop-1-yl}-β-d-
mannopyranoside [(7S,8S)-43]:
7
89
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
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From 36: Alkene 36 (406mg; 0.68mmol) in a mixture of t-BuOH (10mL), MeCN
(1mL) and H2O (1mL) was treated with citric acid (261mg; 1.36mmol) and NMO
(159mg; 1.36mmol). The solution was slightly heated to 27 ◦C. OsO4 1% aqueous
solution (150 µL; 0.9mol%) was added, and the mixture was stirred at 27 ◦C for 3 d.
TLC control (toluene/ethyl acetate, 1:1) showed reluctant further progression after this
time, and additional H2O (1mL) and OsO4 (100µL; 0.6mol%) was added. Stirring was
continued for 3 d. Next, Na2S2O3 (100mg) was added, and the solution was stirred for
60min, diluted with brine and sat. NaHCO3 (1:1, 30mL), extracted with CH2Cl2 (3
× 50mL), dried (Na2SO4), filtered and evaporated to dryness. The crude residue was
purified by flash column chromatography (SiO2, chloroform/acetonitrile, 6:1 to 4:1) to
give a mixture of syn-diols (7S,8S)-43 and (7R,8R)-44 (381mg; 89%; d.r.≈ 6.6:1)
as a colorless solid. Of this mixture of isomers, 262mg (69% of total material) was
subjected to fractional crystallization from n-hexane/CHCl3 (ca. 1:1). The major isomer
(7S,8S)-43 was obtained from the mother liquor collected after typically 18 h at r.t.
Repeated analogous crystallizations of the precipitated fractions and collection of the
mother liquor (NMR analysis for confirmation of purity) provided pure (7S,8S)-43
(184mg; 65% from 36, based on crystallized material fraction).
From (7S,8S)-45: Tribenzoate (7S,8S)-45 (528mg; 0.56mmol) in MeOH (18mL)
was dropwise treated with NaOMe (150 µL; 30% in MeOH) at r.t. After 14 h, TLC
reaction control (toluene/ethyl acetate, 4:1) confirmed complete conversion of the
starting material. The solution was neutralized by the addition of Dowex H+ ion
exchange resin, filtered, and evaporated in vacuo to give a crude oil. Purification by
flash column chromatography (SiO2, chloroform/acetonitrile, 4:1) provided (7S,8S)-
43 (322mg; 91%) as a colorless solid. An analytical sample was recrystallized from
n-hexane/CHCl3.
M.p. 140–141 ◦C (n-hexane/CHCl3). Rf=0.48 (toluene/ethyl acetate, 1:1);
[
α
]20
D
−9.9 (c=1, CHCl3); 1H NMR (400.2MHz, CD3OD) δ: 7.45–7.40 (m, 2H, HAr), 7.40–
7.24 (m, 16H, HAr), 7.20–7.16 (m, 2H, HAr), 4.95–4.89 (m, 2H, CH2Ph), 4.85 (s, 1H,
H-1), 4.81 (d, 1H, J gem = 11.0Hz, CH2Ph), 4.74 (d, 1H, J gem = 11.1Hz, CH2Ph), 4.68
(d, 1H, J gem = 11.6Hz, CH2Ph), 4.63–4.53 (m, 3H, CH2Ph), 4.28–4.21 (m, 1H, H-8),
4.02 (d, 1H, J 7,8 = 9.4Hz, H-7), 3.89 (d, 1H, J 3,4 = 9.4Hz, H-3), 3.84 (dd, 1H, J 3,4 =
9.4, J 4,5 = 9.4Hz, H-4), 3.79–3.68 (m, 3H, H-6a, H-6b, H-9a), 3.61 (dd, 1H, J 9a,9b =
11.4, J 8,9b = 5.0Hz, H-9b), 3.50–3.43 (m, 1H, H-5); 13C NMR (100.6MHz, CD3OD) δ:
139.9, 139.6, 139.5, 138.9 (4 × CAr,q.), 129.4–128.6 (CAr), 101.1 (C-1), 83.3 (C-3), 80.3
(C-2), 78.0 (C-4), 77.0 (CH2Ph), 76.2 (C-5), 75.8 (CH2Ph), 74.6 (C-8), 74.5 (CH2Ph),
72.0 (CH2Ph), 70.4 (C-6), 69.1 (C-7), 65.7 (C-9); HR-ESI-TOF calcd. for C37H42O9Na
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[M+Na]+: 653.2721. Found: 653.2725; Anal. calcd. for C37H42O9: C, 70.46; H, 6.71.
Found: C, 70.17; H, 6.90.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1R,2R)-1,2,3-trihydroxyprop-1-yl}-β-d-
mannopyranoside [(7R,8R)-44]:
7
89
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
To tribenzoate (7R,8R)-46 (270mg; 0.29mmol) in MeOH (10mL) was dropwise added
NaOMe (100 µL; 30% in MeOH) at r.t. After 16 h TLC (toluene/ethyl acetate, 4:1)
confirmed complete conversion of the starting material. Neutralization with Dowex
H+ ion exchange resin, filtration and evaporation of the volatile parts in vacuo gave a
crude oil. Purification by flash column chromatography (SiO2, chloroform/acetonitrile,
4:1) gave minor tetrol (7R,8R)-44 (160mg; 89%) in the form of a colorless solid. An
analytical sample was recrystallized from n-hexane/CHCl3.
M.p. 152 ◦C (n-hexane/CHCl3). Rf=0.46 (toluene/ethyl acetate, 1:1);
[
α
]20
D
−38.1 (c= 1, CHCl3); 1H NMR (600.1MHz, CD3OD) δ: 7.44–7.41 (m, 2H, HAr), 7.40–
7.36 (m, 2H, HAr), 7.36–7.22 (m, 14H, HAr), 7.17–7.13 (m, 2H, HAr), 4.94–4.90 (m, 2H,
CH2Ph), 4.83 (d, 1H, J gem = 11.4Hz, CH2Ph), 4.75 (s, 1H, H-1), 4.73 (d, 1H, J gem =
11.0Hz, CH2Ph), 4.67 (d, 1H, J gem = 11.5Hz, CH2Ph), 4.63 (d, 1H, J gem = 12.0Hz,
CH2Ph), 4.59–4.55 (m, 2H, CH2Ph), 4.06 (d, 1H, J 3,4 = 9.4Hz, H-3), 4.01–3.96 (m,
2H, H-7, H-8), 3.94 (dd, 1H, J 3,4 = 9.7, J 4,5 = 9.7Hz, H-4), 3.78 (dd, 1H, J 6a,6b =
10.9, J 5,6a = 2.1Hz, H-6a), 3.76–3.70 (m, 2H, H-6b, H-9a), 3.62–3.58 (m, 1H, H-9b),
3.47 (ddd, 1H, J 4,5 = 9.7, J 5,6b = 5.4, J 5,6a = 2.1Hz, H-5); 13C NMR (150.9MHz,
CD3OD) δ: 140.0, 139.6, 139.5, 138.9 (4 × CAr,q.), 129.4–128.4 (CAr), 101.7 (C-1), 82.6
(C-3), 79.3 (C-2), 78.8 (C-4), 76.3 (C-5), 75.9 (CH2Ph), 75.7 (CH2Ph), 74.5 (C-8), 74.5
(CH2Ph), 72.1 (CH2Ph), 70.3 (C-6), 70.1 (C-7), 65.7 (C-9); HR-ESI-TOF calcd. for
C37H42O9Na [M+Na]+: 653.2721. Found: 653.2733; Anal. calcd. for C37H42O9: C,
70.46; H, 6.71. Found: C, 70.23; H, 6.70.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1S,2S)-1,2,3-tribenzoyloxyprop-1-yl}-β-d-
mannopyranoside [(7S,8S)-45]:
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Alkene 36 (449mg; 0.75mmol) was subjected to the osmium-based dihydroxylation as
reported above on page 219 to give crude (7S,8S)-43 and (7R,8R)-44. After flash
column chromatographic purification (SiO2, chloroform/acetonitrile, 6:1 to 4:1) the
mixture of isomers (466mg; 0.74mmol) was dissolved in anhydrous pyridine (7mL)
and cooled to 0 ◦C. The solution was dropwise treated with benzoyl chloride (562 µL;
4.88mmol), stirred for 5min, and allowed to warm to r.t. Subsequently, the reaction
mixture was heated to 75 ◦C for 15 h. More benzoyl chloride (100 µL; 0.87mmol) was
added, and the temperature was elevated to 85 ◦C for 7 h. Next, MeOH (3mL) was slowly
added dropwise at r.t., and the reaction mixture was stirred for 15min. Evaporation of
the volatile parts, followed by co-evaporation of residual pyridine with toluene (10mL),
gave a crude product. Flash column chromatography (SiO2, toluene/ethyl acetate,
24:1 to 18:1) gave major tribenzoate (7S,8S)-45 (448mg; 63%, 2 steps) and minor
tribenzoate (7R,8R)-46 (110mg; 16%, 2 steps), both as a colorless foam. Analytical
data for major (7S,8S)-45:
Rf=0.64 (toluene/ethyl acetate, 4:1);
[
α
]20
D −70.9 (c= 1, CHCl3); 1H NMR (400.2
MHz, acetone-D6) δ: 8.02–7.98 (m, 2H, HAr), 7.86–7.80 (m, 4H, HAr), 7.63–7.24 (m,
29H, HAr), 6.50–6.45 (m, 1H, H-8), 6.28 (d, 1H, J 7,8 = 4.0Hz, H-7), 5.03 (d, 1H, J gem
= 11.6Hz, CH2Ph), 4.99–4.88 (m, 4H, H-1, H-9a, CH2Ph), 4.82–4.77 (m, 2H, CH2Ph),
4.72–4.65 (m, 2H, CH2Ph), 4.62 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.48 (dd, 1H, J 9a,9b
= 12.1, J 8,9b = 5.9Hz, H-9b), 4.21 (s, 1H, OH), 4.03 (dd, 1H, J vic = 9.7, 9.2Hz, H-4),
3.86 (dd, 1H, J 6a,6b = 11.1, J 5,6a = 2.1Hz, H-6a), 3.80 (dd, 1H, J 6a,6b = 11.1, J 5,6b
= 5.4Hz, H-6b), 3.68–3.59 (m, 2H, H-3, H-5); 13C NMR (100.6MHz, acetone-D6) δ:
166.5, 166.3, 166.1 (3 × benzoyl C=O), 139.8, 139.6, 139.5, 137.7 (4 × CAr,q.), 134.4,
133.9, 133.8 (CAr), 131.4–128.2 (CAr, CAr,q.), 99.2 (C-1), 82.3 (C-3), 78.5 (C-4), 77.0
(C-2), 76.1 (CH2Ph), 76.0 (C-5), 75.2 (CH2Ph), 73.8 (CH2Ph), 73.5 (C-7), 72.4 (C-8),
70.6 (CH2Ph), 70.0 (C-6), 64.1 (C-9); HR-ESI-TOF calcd. for C58H54O12Na [M+Na]+:
965.3508. Found: 965.3506; Anal. calcd. for C58H54O12: C, 73.87; H, 5.77. Found: C,
73.99; H, 5.85.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1R,2R)-1,2,3-tribenzoyloxyprop-1-yl}-β-d-
mannopyranoside [(7R,8R)-46]:
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Isolated as the minor component (110mg; 16%, 2 steps) as a colorless foam from the
benzoylation of (7S,8S)-43 and (7R,8R)-44 as described above.
Rf=0.69 (toluene/ethyl acetate, 4:1);
[
α
]20
D 41.8 (c= 1, CHCl3); 1H NMR (400.2MHz,
acetone-D6) δ: 8.12–8.06 (m, 2H, HAr), 8.01–7.95 (m, 2H, HAr), 7.86–7.81 (m, 2H, HAr),
7.66–7.44 (m, 9H, HAr), 7.43–7.18 (m, 20H, HAr), 6.53 (ddd, 1H, J 7,8 = 5.6, J 8,9b =
5.6, J 8,9a = 2.7Hz, H-8), 6.31 (d, 1H, J 7,8 = 5.6Hz, H-7), 5.16 (d, 1H, J gem = 11.6Hz,
CH2Ph), 5.03 (d, 1H, J gem = 11.6Hz, CH2Ph), 4.99 (d, 1H, J gem = 11.0Hz, CH2Ph),
4.95–4.88 (m, 2H, H-9a, H-1), 4.82–4.72 (m, 2H, CH2Ph), 4.70–4.63 (m, 2H, CH2Ph),
4.59 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.48 (dd, 1H, J 9a,9b = 12.2, J 8,9b = 5.6Hz,
H-9b), 4.19 (dd, 1H, J 3,4 = 9.2, J 4,5 = 9.2Hz, H-4), 4.07 (d, 1H, J 3,4 = 8.9Hz, H-3),
4.02 (s, 1H, OH), 3.86–3.78 (m, 2H, H-6a, H-6b), 3.68–3.62 (m, 1H, H-5); 13C NMR
(100.6MHz, acetone-D6) δ: 166.4, 166.2, 165.9 (3 × benzoyl C=O), 139.7, 139.5, 139.4,
138.5 (4 × CAr,q.), 134.3–128.0 (CAr, CAr,q.), 100.5 (C-1), 82.5 (C-3), 77.9 (C-4), 77.6
(C-2), 76.0 (C-5), 75.4 (CH2Ph), 75.1 (CH2Ph), 73.7 (CH2Ph), 73.0 (C-7), 72.3 (C-8),
71.9 (CH2Ph), 69.9 (C-6), 64.2 (C-9); HR-ESI-TOF calcd. for C58H54O12Na [M+Na]+:
965.3508. Found: 965.3509; Anal. calcd. for C58H54O12: C, 73.87; H, 5.77. Found C,
73.60; H, 6.08.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1S,2S)-3-[(1S,4R)-3-oxo-4,7,7-trimethyl-2-
oxabicyclo[2.2.1]heptane-1-carbonyl]oxy-1,2-dihydroxyprop-1-yl}-β-d-
mannopyranoside [(7S,8S)-47]:
1'
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Amixture of syn-tetrols (7S,8S)-43 and (7R,8R)-44 (154mg; 0.244mmol; d.r.≈ 6.6:1),
as obtained from the osmium-based dihydroxylation reported on page 219 after chro-
matography, was dissolved in anhydrous CH2Cl2 (10mL). Next, i-Pr2NEt (83 µL;
0.488mmol) was added at −20 ◦C, followed by the dropwise addition of (–)-(1S,4R)-
6.5. Synthetic Procedures 223
camphanoyl chloride (53mg; 0.244mmol) in CH2Cl2 (2mL). The solution was stirred
for 3 h at 0 ◦C, when TLC reaction control (toluene/ethyl acetate, 4:1) indicated com-
plete consumption of the starting materials and the formation of multiple products.
The reaction mixture was evaporated to dryness in vacuo. Multiple successive chro-
matographic purification steps (spherical SiO2, toluene/ethyl acetate, 5:1 to 4:1, and:
chloroform/acetonitrile, 30:1 to 18:1) provided major primary camphanate (7S,8S)-47
(107mg; 52%) as a colorless solid. Single crystals for X-ray structural analysis were
grown from diethyl ether/acetonitrile.
Rf=0.16 (toluene/ethyl acetate, 4:1);
[
α
]20
D −14.3 (c= 1, CHCl3); 1H NMR (400.2
MHz, acetone-D6) δ: 7.47–7.38 (m, 6H, HAr), 7.40–7.22 (m, 14H, HAr), 5.03 (d, 1H,
J gem = 11.5Hz, CH2Ph), 4.98–4.92 (m, 2H, CH2Ph, H-1), 4.87 (d, J gem = 11.5Hz,
CH2Ph), 4.79 (d, J gem = 11.1Hz, CH2Ph), 4.73–4.53 (m, 8H, CH2Ph, 3 × OH, H-8),
4.48 (dd, 1H, J 9a,9b = 11.5, J 8,9a = 2.6Hz, H-9a), 4.29 (dd, 1H, J 9a,9b = 11.5, J 8,9b
= 4.7Hz, H-9b), 4.19–4.13 (m, 1H, H-7), 4.02–3.94 (m, 2H, H-3, H-4), 3.85 (dd, 1H,
J 6a,6b = 11.0, J 5,6a = 2.2Hz, H-6a), 3.78 (dd, 1H, J 6a,6b = 11.0, J 5,6a = 5.3Hz, H-6b),
3.60–3.53 (m, 1H, H-5), 2.35–2.27 (m, 1H, H-6’a), 1.86–1.72 (m, 2H, H-6’b, H-5’a), 1.46
(ddd, 1H, J gem = 14.2, J vic = 10.2, 5.0Hz, H-5’b), 0.99 (s, 3H, C-4’-CH 3), 0.96 (s,
3H, C(CH 3)(CH3)), 0.84 (s, 3H, C(CH3)(CH 3)); 13C NMR (100.6MHz, acetone-D6) δ:
178.5 (C-3’=O), 167.9 ((C-1’)-C=O), 140.1, 139.9, 139.7, 138.9 (4 × CAr,q.), 129.1–128.0
(CAr), 100.6 (C-1), 92.0 (C-1’), 82.7 (C-3), 79.8 (C-2), 77.8 (C-4), 76.3 (C-5), 75.8
(CH2Ph), 75.2 (CH2Ph), 73.8 (CH2Ph), 72.2 (C-8), 71.2 (CH2Ph), 70.3 (C-6), 68.8
(C-7), 67.9 (C-9), 55.2 (C-7’), 54.6 (C-4’), 31.2 (C-6’), 29.6 (C-5’), 17.1 (C(CH3)(CH3)),
16.9 (C(CH3)(CH3)), 9.9 (C-4’-CH3); HR-ESI-TOF calcd. for C47H54O12Na [M+Na]+:
833.3508. Found: 833.3505; Anal. calcd. for C47H54O12: C, 69.61; H, 6.71. Found: C,
69.55; H, 6.79.
(2S,2’R/S,3’R,4’S)-1,3,4,6-Tetra-O-benzyl-2’,3’,4’-trihydroxyspiro[2-deoxy-
β-d-mannopyranose-2,5’-tetrahydrofuran] (α,β-48):
8
β-48α-48
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side chain: α-D-ribo side chain: β-D-ribo
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To major tetrol (7S,8S)-43 (139mg; 0.220mmol) in anhydrous EtOAc/toluene (2:1,
36mL) was added 3-(N -morpholino)propanesulfonic acid (MOPS; 554mg; 2.64mmol)
and the suspension was stirred vigorously. The mixture was cooled to −50 ◦C, and
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TEMPO 1mg/mL in EtOAc (1.0mL; 3mol%) was added. Next, trichloroisocyanuric
acid (TCICA) 10mg/mL in EtOAc (4.4mL; 0.187mmol) was slowly added dropwise
over 15min. After complete addition, the pale yellow mixture was stirred for 1 h, allowed
to warm to −35 ◦C, and stirred for 14 h at this temperature. TLC control (toluene/ethyl
acetate, 1:1) showed major conversion, and Me2S (44 µL; 0.60mmol) in EtOAc (1mL)
was added dropwise, upon which the yellowish reaction mixture decolorized rapidly.
Stirring of the suspension was continued for 15min at −35 ◦C. After dilution with
EtOAc (30mL) and washing with brine/sat. Na2S2O3 (10:1, 2 × 20mL), the organic
phase was dried (Na2SO4), filtered and evaporated in vacuo to give crude 48 (158mg).
Flash column chromatographic purification (spherical SiO2, toluene/n-hexane/acetone,
8:8:5, + 0.25% Et3N) gave α,β-48 (84mg; 61%; 72% brsm) as a colorless solid with
higher chromatographic mobility, along with recovered (7S,8S)-43 (21mg). Solid
α,β-48 contained α-48 as the major component (α/β≈ 11.1:1 in acetone-D6), and
at r.t. in acetone-D6, isomerization was observed, giving β-48 as the major isomer
after ca. 5–6 d (α/β≈ 1:2.7). An analytical sample of α,β-48 was recrystallized from
Et2O/CH2Cl2.
M.p. 162–164 ◦C (Et2O/CH2Cl2, decomp.); Rf=0.60 (toluene/ethyl acetate, 1:1);[
α
]20
D −16.2 (α/β≈ 2.7:1, c= 0.5, acetone-D6), −13.8 (α/β≈ 1:1.7, c= 0.5, acetone-D6);
selected signals for α-48: 1H NMR (400.2MHz, acetone-D6) δ: 7.49–7.24 (m, 20H,
HAr), 5.23 (dd, 1H, J 9,OH = 11.5, J 8,9 = 3.1Hz, H-9), 5.03 (d, 1H, J gem = 11.4Hz,
CH2Ph), 4.94 (d, 1H, J gem = 11.3Hz, CH2Ph), 4.69 (H-1), 4.56 (H-7), 4.15 (d, 1H,
J 7,OH = 7.1Hz, C-7-OH), 3.94 (d, 1H, J 8,OH = 10.8Hz, C-8-OH), 3.91–3.80 (m, 3H,
H-4, H-6a, H-6b), 3.77–3.72 (m, 1H, H-8), 3.66 (d, 1H, J 3,4 = 9.4Hz, H-3), 3.57 (ddd,
1H, J 4,5 = 9.8, J 5,6a = 4.9, J 5,6b = 2.1Hz, H-5); 13C NMR (100.6MHz, acetone-D6) δ:
139.8, 139.6, 139.6, 137.9 (4 × CAr,q.), 129.3–128.2 (CAr), 100.1 (C-1), 98.9 (C-9), 86.0
(C-2), 83.8 (C-3), 78.6 (C-4), 76.5 (CH2Ph), 76.3 (C-5), 75.3 (CH2Ph), 73.9 (CH2Ph),
72.8 (C-7), 72.6 (C-8), 72.1 (CH2Ph), 70.0 (C-6); selected signals for β-48: 1H NMR
(400.2MHz, acetone-D6) δ: 7.49–7.23 (m, 20H, HAr), 5.11 (d, 1H, J gem = 11.0Hz,
CH2Ph), 4.97–4.91 (m, 2H, H-9, CH2Ph), 4.85–4.79 (m, 2H, CH2Ph), 4.71 (H-1), 4.15
(d, 1H, J = 8.3Hz, OH), 3.88 (H-4), 3.75 (d, 1H, J 3,4 = 9.5Hz, H-3), 3.61 (H-5,
H-8); 13C NMR (100.6MHz, acetone-D6) δ: 139.7, 139.5, 138.4, 137.7 (4 × CAr,q.),
129.5–128.2 (CAr), 103.6 (C-9), 99.9 (C-1), 87.2 (C-2), 82.0 (C-3), 78.6 (C-4), 77.3 (C-8),
77.2 (CH2Ph), 76.2 (C-5), 75.3 (CH2Ph), 73.9 (CH2Ph), 72.1 (CH2Ph), 71.6 (C-7), 69.9
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(C-6); HR-ESI-TOF calcd. for C37H40O9Na [M+Na]+: 651.2565. Found: 651.2563;
Anal. calcd. for C37H40O9: C, 70.68; H, 6.41. Found: C, 70.37; H, 6.61.
(2S,3’S,4’S)-1,3,4,6-Tetra-O-benzyl-3’,4’-dihydroxyspiro[2-deoxy-β-d-
mannopyranose-2,2’-tetrahydrofuran] [(7S,8S)-49]:
OBnO
BnO
OBn
OBn
O
HO
OH
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Isolated as a colorless solid in low yields (<5%) from the synthesis of α,β-48 as
described above upon quenching with sat. Na2S2O5 (2mL) at −40 ◦C, aqueous workup
(brine), and chromatography as described.
Rf=0.65 (toluene/ethyl acetate, 1:1);
[
α
]20
D −15.7 (c=0.5, CHCl3); 1H NMR
(400.2MHz, acetone-D6) δ: 7.48–7.24 (m, 20H, HAr), 5.02 (d, 1H, J gem = 11.5Hz,
CH2Ph), 4.93 (d, 1H, J gem = 11.1Hz, CH2Ph), 4.77 (d, 1H, J gem = 11.1Hz, CH2Ph),
4.75–4.70 (m, 2H, CH2Ph), 4.70–4.64 (m, 3H, H-1, CH2Ph), 4.64–4.59 (m, 1H, CH2Ph),
4.56–4.51 (m, 1H, H-7), 4.00–3.85 (m, 4H, H-8, H-9a, H-4, OH), 3.85–3.78 (m, 2H,
H-6a, H-6b), 3.76–3.69 (m, 3H, H-9b, H-3, OH), 3.67 (d, 1H, J 3,4 = 9.3Hz, H-3), 3.56
(ddd, 1H, J 4,5 = 9.9, J 5,6ab = 4.8, 2.2Hz, H-5); 13C NMR (100.6MHz, acetone-D6) δ:
139.8, 139.7, 139.6, 137.9 (4 × CAr,q.), 129.5–128.1 (CAr), 100.4 (C-1), 85.3 (C-2), 84.3
(C-3), 78.7 (C-4), 76.6 (CH2Ph), 76.2 (C-5), 75.4 (C-9), 75.3 (CH2Ph), 74.3 (C-7), 73.9
(CH2Ph), 72.9 (C-8), 71.9 (CH2Ph), 70.0 (C-6); HR-ESI-TOF calcd. for C37H40O8Na
[M+Na]+: 635.2615. Found: 635.2618.
4-C-Formyl-d-erythro-l-talo-octose (syn-50):
(O)HC
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syn-50-B
(37%)
A solution of α,β-48 (64mg; 0.102mmol) in MeOH (6.5mL) was treated with Pd 10%
on activated charcoal (250mg), and the suspension was stirred under an atmosphere of
hydrogen for 4 d. TLC reaction control (chloroform/methanol, 2:1) showed complete
conversion to a mixture of products without observable fluorescence quenching, and
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with low chromatographic mobility. The reaction mixture was diluted with MeOH
(10mL), filtered through a layer of Celite, and the filter pad was thoroughly rinsed
with MeOH. The collected filtrate was evaporated to dryness to give a colorless oil.
RP-chromatographic purification (RP-C18 silica gel, methanol/water, 1:1) gave, after
partial evaporation and freeze-drying from residual water over several days, syn-50
(27mg; 99%) as a colorless foam. The compound was isolated as a mixture of isomers.
Rf=0.39 (chloroform/methanol, 2:1);
[
α
]20
D 10.6 (c= 0.5, H2O); identified isomers:
(1R,9S)-4-C-formyl-d-erythro-l-talo-octo-1,5-pyranose-9,7-pyranose (syn-
50-A, 49% isomeric contribution in D2O), selected signals: 1H NMR (700.3MHz, D2O)
δ: 5.29 (d, 1H, J 1,2 = 1.2Hz, H-1), 5.15 (s, 1H, H-9), 4.13 (d, 1H, J 5,6 = 8.7Hz,
H-5), 4.07 (d, 1H, J 2,3 = 3.4Hz, H-3), 3.91 (dd, 1H, J 2,3 = 3.4, J 1,2 = 1.5Hz, H-2),
3.90–3.82 (m, H-6, H-7), 3.79–3.75 (m, 2H, H-8a, H-8b); 13C NMR (176.1MHz, D2O) δ:
95.4 (C-1), 93.0 (C-9), 75.8 (C-4), 73.2 (C-7), 71.7 (C-2), 70.9 (C-5), 65.5 (C-6), 64.7
(C-3), 61.5 (C-8); (1S,9S)-4-C-formyl-d-erythro-l-talo-octo-1,5-pyranose-9,7-
pyranose (syn-50-B, 37% isomeric contribution in D2O), selected signals: 1H NMR
(700.3MHz, D2O) δ: 5.15 (s, 1H, H-9), 4.86 (d, 1H, J 1,2 = 0.7Hz, H-1), 3.96 (dd, 1H,
J 2,3 = 3.3, J 1,2 = 0.7Hz, H-2), 3.93 (d, 1H, J 2,3 = 3.3Hz, H-3), 3.90–3.82 (m, H-6,
H-7, H-8a, H-8b), 3.58 (d, 1H, J 5,6 = 9.3Hz, H-5); 13C NMR (176.1MHz, D2O) δ: 94.7
(C-1), 93.2 (C-9), 75.7 (C-5), 74.7 (C-4), 73.0 (C-7), 72.4 (C-2), 68.1 (C-3), 65.6 (C-6),
61.5 (C-8); HR-ESI-TOF calcd. for C9H16O9Na [M+Na]+: 291.0687. Found: 291.0688;
HR-ESI-TOF calcd. for C9H15O9 [M–H]–: 267.0722. Found: 267.0726; Anal. calcd. for
C9H16O9·H2O: C, 37.77; H, 6.34. Found: C, 37.64; H, 6.37.
(2S,2’R/S,3’S,4’R)-1,3,4,6-Tetra-O-benzyl-2’,3’,4’-trihydroxyspiro[2-deoxy-
β-d-mannopyranose-2,5’-tetrahydrofuran] (α,β-51):
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To minor tetrol (7R,8R)-44 (158 mg; 0.251 mmol) in anhydrous EtOAc/toluene (2:1,
40.5 mL) was added MOPS (629mg; 3.01mmol), and the vigorously stirred suspension
was cooled to −50 ◦C. TEMPO 1mg/mL in EtOAc (1.2mL; 3mol%) was added,
followed by the dropwise addition of TCICA 10mg/mL in EtOAc (5.0mL; 0.213mmol)
over 15min. The yellowish mixture was stirred for 15 h at −50 ◦C, after which time
TLC control (toluene/ethyl acetate, 1:1) indicated major conversion. Me2S (66 µL;
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0.90mmol) in EtOAc (1mL) was added dropwise, and the decolorized reaction mixture
was stirred for 15min at −50 ◦C. Dilution with EtOAc (20mL), washing with brine/sat.
Na2S2O3 (10:1, 2 × 20mL), drying (Na2SO4), filtration and evaporation of the volatile
parts gave crude 51 (158mg). Purification by flash column chromatography (spherical
SiO2, toluene/n-hexane/acetone, 8:5:8, + 0.25% Et3N) gave α,β-51 (101mg; 64%;
80% brsm) as a colorless solid with higher chromatographic mobility, alongside with
recovered (7R,8R)-44 (31mg). The product α,β-51 was initially isolated as a mixture
with α/β≈ 1.4:1 in acetone-D6, and at r.t. in solution epimerization to α/β≈ 1:1 was
observable. An analytical sample was recrystallized from Et2O/CH2Cl2.
M.p. 193 ◦C (Et2O/CH2Cl2, decomp.); Rf=0.60 (toluene/ethyl acetate, 1:1);
[
α
]20
D
−42.4 (α/β≈ 1:1, c= 0.5, acetone-D6); selected signals for α-51: 1H NMR (400.2MHz,
acetone-D6) δ: 7.46–7.23 (m, 20H, HAr), 4.92 (H-9), 4.70 (H-1), 4.69 (H-7), 4.44–4.40
(m, 1H, C-7-OH), 4.20 (d, 1H, J 8,OH = 11.9Hz, C-8-OH), 4.05–3.92 (m, H-4, C-9-
OH), 3.89–3.80 (m, H-6a, H-6b), 3.75 (H-3), 3.66–3.60 (m, 2H, H-5, H-8); 13C NMR
(150.9MHz, acetone-D6) δ: 138.9–137.0 (CAr,q.), 128.5–127.3 (CAr), 102.6 (C-9), 98.5
(C-1), 87.6 (C-2), 79.7 (C-3), 77.8 (C-4), 76.4 (C-8), 75.3 (C-5), 70.8 (C-7), 69.0 (C–6);
selected signals for β-51: 1H NMR (400.2MHz, acetone-D6) δ: 7.46–7.23 (m, 20H,
HAr), 5.17–5.11 (m, 1H, H-9), 4.62 (H-1), 4.56 (C-9-OH), 4.53 (H-7), 4.05–3.92 (m,
H-4), 3.89–3.80 (m, H-6a, H-6b), 3.78 (H-8), 3.75 (H-3), 3.57 (ddd, 1H, J 4,5 = 9.8,
J 5,6a = 4.3, J 5,6b = 2.3Hz, H-5); 13C NMR (150.9MHz, acetone-D6) δ: 138.9–137.0
(CAr,q.), 128.5–127.3 (CAr), 100.6 (C-1), 97.9 (C-9), 86.4 (C-2), 80.3 (C-3), 77.9 (C-4),
75.2 (C-5), 71.9 (C-7), 71.8 (C-8), 69.0 (C-6); HR-ESI-TOF calcd. for C37H40O9Na
[M+Na]+: 651.2565. Found: 651.2565; Anal. calcd. for C37H40O9: C, 70.68; H, 6.41.
Found: C, 70.50; H, 6.47.
4-C-Formyl-d-erythro-l-gulo-octose (syn-52):
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(66%)
To α,β-51 (54mg; 0.086mmol) in MeOH (7.5mL) was added Pd 10% on activated
charcoal (211mg), and the suspension was stirred under an atmosphere of hydrogen
for 5 d. After this time, TLC (chloroform/methanol, 2:1) showed complete conversion
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to a mixture of products without detectable fluorescence quenching, and with low
chromatographic mobility. The suspension was diluted with MeOH (10mL), filtered
through Celite, and the filter pad was thoroughly rinsed with MeOH. The obtained
filtrate was evaporated to dryness in vacuo to give a colorless oil. RP-chromatographic
purification (RP-C18 silica gel, methanol/water, 1:1) gave, after partial evaporation
and freeze-drying from residual water, syn-52 (23mg; 99%) as a colorless foam. The
compound was isolated as a mixture of isomers.
Rf=0.39 (chloroform/methanol, 2:1);
[
α
]20
D −4.4 (c=0.5, H2O); identified iso-
mer: (1S,9R)-4-C-formyl-D-erythro-L-gulo-octo-1,5-pyranose-9,7-pyranose
(syn-52-A, 66% isomeric contribution in D2O), selected signals: 1H NMR (700.3MHz,
D2O) δ: 4.99 (s, 1H, H-9), 4.86 (d, 1H, J 1,2 = 8.4Hz, H-1), 3.97 (d, 1H, J 2,3 =
3.4Hz, H-3), 3.91–3.88 (m, H-8a), 3.78 (d, 1H, J 5,6 = 9.7Hz, H-5), 3.76–3.69 (m, 3H,
H-8b, H-6, H-2), 3.44–3.40 (m, 1H, H-7); 13C NMR (176.1MHz, D2O) δ: 95.1 (C-1),
93.9 (C-9), 77.0 (C-7), 75.6 (C-5), 74.0 (C-4), 70.6 (C-3), 70.1 (C-2), 65.7 (C-6), 61.4
(C-8); HR-ESI-TOF calcd. for C9H16O9Na [M+Na]+: 291.0687. Found: 291.0685;
HR-ESI-TOF calcd. for C9H15O9 [M–H]–: 267.0722. Found: 267.0724; Anal. calcd. for
C9H16O9·2H2O: C, 35.53; H, 6.63. Found: C, 35.69; H, 6.54.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(2S,3S)-2-hydroxymethyloxiran-3-yl}-β-d-
mannopyranoside [(7S,8S)-53]:
7
8
9
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Alkene 36 (190mg; 0.318mmol) was dissolved in anhydrous CH2Cl2 (12mL), and
purified m-CPBA 100mg/mL in CH2Cl2 (0.714mL; 71.4mg; 0.414mmol) was slowly
added dropwise at r.t. After 24 h, TLC (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N)
suggested complete consumption of the substrate, and the reaction was quenched by
the addition of sat. Na2S2O3 (1mL). After stirring for 15min, the reaction mixture was
diluted with CH2Cl2 (30mL), and washed with sat. NaHCO3 (2 × 10mL) and water
(10mL). Drying of the organic layer (Na2SO4), filtration and evaporation of the volatile
parts yielded the crude product as a mixture of diastereoisomers (d.r.≈ 5:1). Purification
by flash column chromatography (spherical SiO2, toluene/n-hexane/acetone, 1:1:0.2 to
1:1:0.25, + 2% Et3N) gave pure major epoxide (7S,8S)-53 (140mg; 72%) as a colorless
oil, alongside with minor (7R,8R)-57 (25mg; 13%) with higher chromatographic
mobility.
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Rf=0.18 (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N);
[
α
]20
D −37.2 (c=1,
CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.49–7.17 (m, 20H, HAr), 4.94–4.87 (m,
2H, CH2Ph), 4.82–4.76 (m, 2H, CH2Ph), 4.75–4.58 (m, 5H, H-1, CH2Ph), 4.06–3.97
(m, H-9a, H-4), 3.87–3.75 (m, 3H, H-9b, H-6a, H-6b), 3.71 (d, 1H, J 3,4 = 9.3Hz, H-3),
3.66–3.56 (m, 2H, H-5, OH), 3.29 (s, 1H, OH), 3.00 (ddd, 1H, J 8,9ab = 7.3, 2.7, J 7,8 =
4.3Hz, H-8), 2.94 (d, 1H, J 7,8 = 4.3Hz, H-7); 13C NMR (100.6MHz, acetone-D6) δ:
139.8, 139.6, 139.4, 138.9 (4 × CAr,q.), 129.1–128.2 (CAr), 102.6 (C-1), 82.7 (C-3), 77.1
(C-4), 76.3 (C-5), 76.2 (CH2Ph), 75.5 (C-2), 75.4 (CH2Ph), 73.8 (CH2Ph), 71.0 (CH2Ph),
70.1 (C-6), 61.5 (C-9), 58.2 (C-8), 57.9 (C-7); HR-ESI-TOF calcd. for C37H40O8Na
[M+Na]+: 635.2615. Found: 635.2615; Anal. calcd. for C37H40O8: C, 72.53; H, 6.58.
Found: C, 72.52; H, 6.75.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(2S,3S)-2-acetoxymethyloxiran-3-yl}-β-d-
mannopyranoside [(7S,8S)-54]:
7
8
9
OBnO
BnO
OBn
OBn
OH
AcO
O
A solution of epoxyalcohol (7S,8S)-53 (217mg; 0.354mmol) in anhydrous MeCN
(20mL) was treated with catalytic amounts of DMAP (8mg) at 0 ◦C. Then, Et3N
in MeCN (1.48mL; 50µL/mL; 0.531mmol) was added dropwise, followed by Ac2O
in MeCN (1.0mL; 50 µL/mL; 0.531mmol), and the mixture was slowly allowed to
warm to r.t. After 20 h, TLC control (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N)
indicated completion of the reaction, and the solution was neutralized by the addition
of NaHCO3 (300mg), followed by stirring for 15min. Dilution with CH2Cl2 (50mL),
washing with sat. NaHCO3 (15mL) and sat. NaCl (15mL), drying (Na2SO4), filtration
and evaporation of the solvents gave a colorless oil. Purification of the crude product
by flash column chromatography (SiO2, toluene/n-hexane/acetone, 1:1:0.2, + 2% Et3N)
yielded pure epoxyacetate (7S,8S)-54 (222mg; 96%) as a colorless oil.
Rf=0.76 (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N);
[
α
]20
D −52.2 (c=1,
CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.48–7.19 (m, 20H, HAr), 4.96–4.88 (m,
2H, CH2Ph), 4.85–4.75 (m, 2H, CH2Ph), 4.75–4.63 (m, 4H, H-1, CH2Ph), 4.60 (d,
1H, J gem = 12.2Hz, CH2Ph), 4.54 (dd, 1H, J 9a,9b = 13.0, J 8,9a = 7.6Hz, H-9a), 4.42
(dd, 1H, J 9a,9b = 13.1, J 8,9b = 1.8Hz, H-9b), 4.02 (dd, 1H, J 3,4 = 9.5, J 4,5 = 9.5Hz,
H-4), 3.87–3.78 (m, 2H, H-6a, H-6b), 3.75 (d, 1H, J 3,4 = 9.4Hz, H-3), 3.60 (ddd, 1H,
J 4,5 = 9.7, J 5,6ab = 4.7, 2.3Hz, H-5), 3.40 (d, 1H, J = 1.2Hz, OH), 3.06–2.98 (m,
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2H, H-8, H-7), 1.94 (s, 3H, CH3); 13C NMR (100.6MHz, acetone-D6) δ: 170.7 (acetyl
C=O), 139.8, 139.6, 139.2, 138.8 (4 × CAr,q.), 129.1–128.2 (CAr), 102.3 (C-1), 82.5
(C-3), 77.1 (C-4), 76.3 (C-5), 76.3 (CH2Ph), 75.4 (CH2Ph), 75.3 (C-2), 73.8 (CH2Ph),
70.9 (CH2Ph), 70.1 (C-6), 64.8 (C-9), 57.4 (C-7), 54.5 (C-8); HR-ESI-TOF calcd. for
C39H42O9Na [M+Na]+: 677.2721. Found: 677.2721; Anal. calcd. for C39H42O9: C,
71.54; H, 6.47. Found: C, 71.34; H, 6.52.
(2S,3’S,4’R)-1,3,4,6-Tetra-O-benzyl-3’,4’-bis(acetoxy)spiro[2-deoxy-β-d-
mannopyranose-2,2’-tetrahydrofuran] [(7S,8R)-55]:
OBnO
BnO
OBn
OBn
O
AcO
OAc
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Epoxyacetate (7S,8S)-54 (101mg; 0.154mmol) in 5mL of degassed HOAc/Ac2O (1:1,
preheated at 75 ◦C for 18 h) was treated with TMSOAc (46 µL; 0.309mmol), and the
solution was heated to 105 ◦C for 19 h. TLC reaction control (toluene/n-hexane/acetone,
2:2:1, + 0.5% Et3N) indicated complete conversion. The mixture was poured onto
ice-cold sat. NaHCO3 (30mL), stirred for 15min and diluted with CH2Cl2 (30mL).
After separation of the phases, the aqueous phase was extracted with CH2Cl2 (2 ×
20mL), and the combined organic extracts were washed with sat. NaHCO3 and water
(15mL each). Drying (Na2SO4), filtration and evaporation of the solvents in vacuo gave
a yellow oil. Flash column chromatography (SiO2, toluene/n-hexane/acetone, 2:2:0.25
to 2:2:0.35) yielded spiro-tetrahydrofuran (7S,8R)-55 (91mg; 85%) as a colorless oil.
Rf=0.60 (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N);
[
α
]20
D −40.4 (c=1,
CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.52–7.24 (m, 20H, HAr), 5.94 (d, 1H,
J 7,8 = 6.2Hz, H-7), 5.49 (ddd, 1H, J 8,9a = 7.7, J 7,8 = 6.1, J 8,9b = 6.1Hz, H-8), 4.97 (d,
1H, J gem = 10.8Hz, CH2Ph), 4.93–4.86 (m, 2H, CH2Ph), 4.81 (d, 1H, J gem = 11.1Hz,
CH2Ph), 4.74 (d, 1H, J gem = 11.6Hz, CH2Ph), 4.68–4.63 (m, 3H, H-1, CH2Ph), 4.59
(d, 1H, J gem = 12.1Hz, CH2Ph), 4.42 (dd, 1H, J 9a,9b = 8.9, J 8,9a = 7.7Hz, H-9a),
3.87–3.74 (m, 3H, H-4, H-6a, H-6b), 3.69 (d, 1H, J 3,4 = 9.5Hz, H-3), 3.64 (dd, 1H,
J 9a,9b = 8.9, J 8,9b = 6.0Hz, H-9b), 3.50 (ddd, 1H, J 4,5 = 9.8, J 5,6ab = 5.0, 2.1Hz, H-5),
2.03 (s, 3H, CH3), 1.97 (s, 3H, CH3); 13C NMR (100.6MHz, acetone-D6) δ: 171.1, 170.9
(2 × acetyl C=O), 139.8, 139.8, 139.6, 138.6 (4 × CAr,q.), 129.2–128.2 (CAr), 101.0
(C-1), 85.1 (C-2), 81.8 (C-3), 78.2 (C-4), 78.0 (C-8), 76.5 (C-7), 76.2 (CH2Ph), 76.0
(C-5), 75.3 (CH2Ph), 73.8 (CH2Ph), 71.8 (CH2Ph), 71.4 (C-9), 70.0 (C-6), 20.8, 20.7 (2
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× CH3); HR-ESI-TOF calcd. for C41H44O10Na [M+Na]+: 719.2827. Found: 719.2827;
Anal. calcd. for C41H44O10: C, 70.67; H, 6.37. Found: C, 70.45; H, 6.44.
(2S,3’S,4’R)-1,3,4,6-Tetra-O-benzyl-3’,4’-dihydroxyspiro[2-deoxy-β-d-
mannopyranose-2,2’-tetrahydrofuran] [(7S,8R)-56]:
OBnO
BnO
OBn
OBn
O
HO
OH
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A solution of diacetate (7S,8R)-55 (89mg; 0.128mmol) in MeOH (3mL) was treated
with cat. NaOMe (30µL; 25% in MeOH). The mixture was stirred at r.t. for 1 h, when
TLC (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N) indicated formation of a single
product. Neutralization with Dowex H+ ion exchange resin, filtration and evaporation
yielded a colorless solid. Flash column chromatography (SiO2, chloroform/acetonitrile,
4:1) gave diol (7S,8R)-56 (73mg; 93%) as a colorless solid.
Rf=0.28 (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N);
[
α
]20
D −50.1 (c=1,
CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.50–7.22 (m, 20H, HAr), 5.00 (d, 1H,
J gem = 11.3Hz, CH2Ph), 4.89 (d, 1H, J gem = 11.5Hz, CH2Ph), 4.81–4.74 (m, 2H,
CH2Ph), 4.72 (s, 1H, H-1), 4.69–4.51 (m, 5H, CH2Ph, H-8), 4.46 (dd, 1H, J 7,8 = 6.4,
J 7,OH = 6.4Hz, H-7), 4.39 (d, 1H, J 7,OH = 6.4Hz, OH), 4.18 (d, 1H, J 8,OH = 5.4Hz,
OH), 4.06 (dd, 1H, J 8,9a = 7.7, J 9a,9b = 7.7Hz, H-9a), 3.89–3.75 (m, 3H, H-4, H-6a,
H-6b), 3.65 (d, 1H, J 3,4 = 9.5Hz, H-3), 3.56 (dd, 1H, J 8,9b = 7.8, J 9a,9b = 7.8Hz,
H-9b), 3.50 (ddd, 1H, J 4,5 = 9.7, J 5,6ab = 5.0, 2.1Hz, H-5); 13C NMR (100.6MHz,
acetone-D6) δ: 139.8, 139.8, 139.7, 139.3 (4 × CAr,q.), 129.1–128.2 (CAr), 101.9 (C-1),
85.5 (C-2), 82.6 (C-3), 79.1 (C-7), 78.3 (C-4), 76.4 (C-8), 76.4 (CH2Ph), 76.1 (C-5),
75.2 (CH2Ph), 73.8 (CH2Ph), 72.7 (C-9), 71.7 (CH2Ph), 70.2 (C-6); HR-ESI-TOF calcd.
for C37H40O8Na [M+Na]+: 635.2615. Found: 635.2616; Anal. calcd. for C37H40O8: C,
72.53; H, 6.58. Found: C, 72.56; H, 6.66.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(2R,3R)-2-hydroxymethyloxiran-3-yl}-β-d-
mannopyranoside [(7R,8R)-57]:
7
8
9
OBnO
BnO
OBn
OBn
OH
HO
O
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To alkene 36 (1.85 g; 3.10mmol) in anhydrous benzene (115mL) was added VO(acac)2
(24mg; 2.9mol%) at r.t. The blue solution was treated with t-BuOOH (5.5m in nonane;
620µL; 3.41mmol), upon which the solution turned deep red. The reaction mixture
was stirred for 17 h at r.t., after which time TLC (toluene/n-hexane/acetone, 1:1:1,
+ 0.5% Et3N) indicated complete conversion. The reaction was quenched by the
addition of sat. Na2S2O3 (5mL) and stirred for 15min. Dilution with toluene (300mL),
washing with water (3 × 100mL), drying (Na2SO4), filtration and evaporation of
the volatile components yielded the crude product as a mixture of diastereoisomers
(d.r.≈ 2.5:1). Purification by flash column chromatography (spherical SiO2, toluene/n-
hexane/acetone, 1:1:0.2 to 1:1:0.25, + 2% Et3N) provided pure major epoxide (7R,8R)-
57 (1.1 g; 58%) as a colorless solid, together with minor (7S,8S)-53 (342mg; 18%)
with lower chromatographic mobility. An analytical sample was crystallized from
toluene/n-hexane/chloroform.
M.p. 119 ◦C (toluene/n-hexane/chloroform); Rf=0.22 (toluene/n-hexane/acetone,
2:2:1, + 0.5% Et3N);
[
α
]20
D −60.9 (c=1, CHCl3); 1H NMR (400.2MHz, acetone-D6)
δ: 7.48–7.22 (m, 20H, HAr), 4.96 (d, 1H, J gem = 10.3Hz, CH2Ph), 4.89 (d, 1H, J gem
= 11.9Hz, CH2Ph), 4.80 (d, 1H, J gem = 11.1Hz, CH2Ph), 4.77–4.71 (m, 2H, CH2Ph,
H-1), 4.70–4.56 (m, 4H, CH2Ph), 3.99 (dd, 1H, J 9a,9b = 13.0, J 8,9a = 7.0Hz, H-9a),
3.94–3.73 (m, 5H, H-9b, H-3, H6a, H-6b, H-4), 3.63 (bs, 1H, OH), 3.58 (ddd, 1H, J 4,5
= 9.7, J 5,6ab = 5.3, 2.0Hz, H-5), 3.34 (bs, 1H, OH), 3.10 (d, 1H, J 7,8 = 4.3Hz, H-7),
3.08–3.03 (m, 1H, H-8); 13C NMR (100.6MHz, acetone-D6) δ: 139.8, 139.8, 139.7, 138.5
(4 × CAr,q.), 129.2–128.2 (CAr), 100.1 (C-1), 87.2 (C-3), 76.9 (C-4), 76.3 (C-5), 75.7
(CH2Ph), 75.5 (CH2Ph), 74.7 (C-2), 73.8 (CH2Ph), 71.3 (CH2Ph), 70.2 (C-6), 61.4
(C-9), 59.2 (C-7), 58.9 (C-8); HR-ESI-TOF calcd. for C37H40O8Na [M+Na]+: 635.2615.
Found: 635.2613; Anal. calcd. for C37H40O8: C, 72.53; H, 6.58. Found: C, 72.40; H,
6.62.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(2R,3R)-2-acetoxymethyloxiran-3-yl}-β-d-
mannopyranoside [(7R,8R)-58]:
7
8
9
OBnO
BnO
OBn
OBn
OH
AcO
O
To epoxyalcohol (7R,8R)-57 (186mg; 0.304mmol) in anhydrous MeCN (17mL) was
added a catalytic amount of DMAP (8mg) at 0 ◦C. Next, Et3N in MeCN (1.26mL;
50 µL/mL; 0.456mmol), followed by Ac2O in MeCN (0.86mL; 50µL/mL; 0.456mmol)
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was added dropwise, and the reaction mixture was allowed to warm to r.t. After 20 h,
TLC (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N) indicated complete conversion,
and the solution was neutralized by the addition of NaHCO3 (300mg) and was stirred for
15min. Dilution with CH2Cl2 (50mL), washing with sat. NaHCO3 (15mL) and brine
(15mL), drying (Na2SO4), filtration and evaporation of the volatile components gave a
colorless oil. Purification of the crude product by flash column chromatography (SiO2,
toluene/n-hexane/acetone, 1:1:0.2, + 2% Et3N) yielded pure epoxyacetate (7R,8R)-58
(182mg; 91%) as a colorless solid.
Rf=0.76 (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N);
[
α
]20
D −30.8 (c=1,
CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.48–7.21 (m, 20H, HAr), 4.95 (d, 1H,
J gem = 10.4Hz, CH2Ph), 4.89 (d, 1H, J gem = 12.0Hz, CH2Ph), 4.82–4.72 (m, 3H,
CH2Ph, H-1), 4.71–4.50 (m, 6H, CH2Ph, H9a, H-9b), 3.89 (d, 1H, J 3,4 = 8.9Hz, H-3),
3.86–3.74 (m, 3H, H-4, H6a, H-6b), 3.59 (ddd, 1H, J 4,5 = 9.7, J 5,6ab = 5.1, 2.0Hz, H-5),
3.44 (bs, 1H, OH), 3.17 (d, 1H, J 7,8 = 4.4Hz, H-7), 3.16–3.11 (m, 1H, H-8), 2.00 (s, 3H,
CH3); 13C NMR (100.6MHz, acetone-D6) δ: 170.8 (acetyl C=O), 139.8, 139.7, 139.5,
138.4 (4 × CAr,q.), 129.2–128.2 (CAr), 99.8 (C-1), 86.9 (C-3), 76.9 (C-4), 76.3 (C-5),
75.7 (CH2Ph), 75.5 (CH2Ph), 74.5 (C-2), 73.8 (CH2Ph), 71.3 (CH2Ph), 70.2 (C-6),
64.7 (C-9), 58.7 (C-7), 55.5 (C-8), 20.8 (CH3); HR-ESI-TOF calcd. for C39H42O9Na
[M+Na]+: 677.2721. Found: 677.2727; Anal. calcd. for C39H42O9: C, 71.54; H, 6.47.
Found: C, 71.59; H, 6.54.
(2S,3’R,4’S)-1,3,4,6-Tetra-O-benzyl-3’,4’-bis(acetoxy)spiro[2-deoxy-β-d-
mannopyranose-2,2’-tetrahydrofuran] [(7R,8S)-59]:
78
9 OBnO
BnO
OBn
OBn
O
AcO OAc
To epoxyacetate (7R,8R)-58 (182mg; 0.278mmol) in 9mL of degassed HOAc/Ac2O
(1:1, preheated at 75 ◦C for 18 h) was added TMSOAc (83µL; 0.556mmol) at r.t., and
the solution was then heated to 105 ◦C for 20 h. TLC control (toluene/n-hexane/acetone,
2:2:1, + 0.5% Et3N) indicated complete conversion. The mixture was poured onto ice-
cold sat. NaHCO3 (50mL), stirred for 15min and diluted with CH2Cl2 (50mL). After
separation of the phases, and extraction of the aqueous phase with CH2Cl2 (20mL), the
combined organic parts were washed with sat. NaHCO3 (2 × 50mL) and water (50mL).
The organic phases were dried (Na2SO4), filtered and evaporated in vacuo to give a
yellow oil. Flash column chromatography (SiO2, toluene/n-hexane/acetone, 2:2:0.20 to
2:2:0.25) yielded spirotetrahydrofuran (7R,8S)-59 (143mg; 72%) as a colorless oil.
234 6. Experimental Part
Rf=0.63 (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N);
[
α
]20
D −3.4 (c= 1, CHCl3);
1H NMR (400.2MHz, acetone-D6) δ: 7.50–7.23 (m, 20H, HAr), 5.87 (d, 1H, J 7,8 =
6.9Hz, H-7), 5.54 (ddd, 1H, J 8,9a = 7.2, J 8,9b = 7.2, J 7,8 = 7.2Hz, H-8), 4.99–4.89 (m,
3H, CH2Ph), 4.78 (d, 1H, J gem = 11.0Hz, CH2Ph), 4.73–4.63 (m, 4H, CH2Ph, H-1),
4.59 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.41–4.35 (m, 1H, H-9a), 3.95 (dd, 1H, J 3,4 = 9.7,
J 4,5 = 9.7Hz, H-4), 3.85–3.76 (m, 2H, H-6a, H-6b), 3.68–3.61 (m, 2H, H-3, H-9b), 3.50
(ddd, 1H, J 4,5 = 9.9, J 5,6ab = 4.2, 2.7Hz, H-5), 2.20 (s, 3H, CH3), 1.97 (s, 3H, CH3);
13C NMR (100.6MHz, acetone-D6) δ: 170.8, 170.8 (2 × acetyl C=O), 139.8, 139.7,
139.5, 138.9 (4 × CAr,q.), 129.2–128.2 (CAr), 101.1 (C-1), 86.2 (C-2), 82.1 (C-3), 78.5
(C-4), 77.6 (C-8), 77.1 (C-7), 76.1 (C-5), 75.4 (CH2Ph), 75.4 (CH2Ph), 73.8 (CH2Ph),
72.2 (CH2Ph), 70.6 (C-9), 69.8 (C-6), 21.1, 20.6 (2 × CH3); HR-ESI-TOF calcd. for
C41H44O10Na [M+Na]+: 719.2827. Found: 719.2826; Anal. calcd. for C41H44O10: C,
70.67; H, 6.37. Found: C, 70.72; H, 6.44.
(2S,3’R,4’S)-1,3,4,6-Tetra-O-benzyl-3’,4’-dihydroxyspiro[2-deoxy-β-d-
mannopyranose-2,2’-tetrahydrofuran] [(7R,8S)-60]:
78
9 OBnO
BnO
OBn
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O
HO OH
A solution of diacetate (7R,8S)-59 (132mg; 0.189mmol) in MeOH (4.5mL) was
treated with NaOMe (50µL; 25% in MeOH) and stirred at r.t. for 1.5 h. After this time,
TLC (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N) indicated complete consumption
of the starting material, and the mixture was neutralized by the addition of Dowex H+
ion exchange resin. Filtration and evaporation to dryness gave a colorless solid, which
was purified by flash column chromatography (SiO2, chloroform/acetonitrile, 4:1) to
give diol (7R,8S)-60 (105mg; 91%) as a colorless solid.
Rf=0.25 (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N);
[
α
]20
D −44.0 (c=1,
CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.44–7.19 (m, 20H, HAr), 5.06 (d, 1H,
J gem = 11.0Hz, CH2Ph), 4.92 (d, 1H, J gem = 12.1Hz, CH2Ph), 4.84 (d, 1H, J gem =
10.9Hz, CH2Ph), 4.81–4.76 (m, 2H, CH2Ph, OH), 4.69–4.57 (m, 5H, H-1, CH2Ph),
4.53–4.43 (m, 2H, H-7, H-8), 4.20 (d, 1H, J 8,OH = 5.3Hz, OH), 4.10–4.03 (m, 1H, H-9a),
3.91–3.72 (m, 4H, H-4, H-6a, H-6b, H-3), 3.58–3.52 (m, 1H, H-9b), 3.48 (ddd, 1H, J 4,5 =
9.8, J 5,6ab = 5.0, 2.0Hz, H-5); 13C NMR (100.6MHz, acetone-D6) δ: 140.6, 139.8, 139.8,
139.1 (4 × CAr,q.), 129.1–127.8 (CAr), 101.3 (C-1), 86.5 (C-2), 81.9 (C-3), 79.1 (C-7
or C-8), 78.5 (C-4), 76.9 (C-7 or C-8), 76.1 (C-5), 75.4 (CH2Ph), 74.3 (CH2Ph), 73.8
(CH2Ph), 72.4 (C-9), 71.3 (CH2Ph), 70.2 (C-6); HR-ESI-TOF calcd. for C37H40O8Na
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[M+Na]+: 635.2615. Found: 635.2617; Anal. calcd. for C37H40O8: C, 72.53; H, 6.58.
Found: C, 72.22; H, 6.66.
(2S,5’R,6’R)-1,3,4,6-Tetra-O-benzyl-spiro[2-deoxy-β-d-mannopyranose-2,4’-
(oxirano[2,3-e]-[1,3]-dioxepan-2-one)] [(7R,8R)-61]:
8
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O
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Epoxide (7R,8R)-57 (82mg; 0.134mmol) in anhydrous CH2Cl2/pyridine (10:1, 11mL)
was cooled to−20 ◦C, and trichloromethyl chloroformate (diphosgene; 18 µL; 0.147mmol)
in CH2Cl2 (1mL) was added dropwise. After the addition, stirring at −20 ◦C was
continued for 3.5 h, and the reaction was then allowed to warm to r.t. After a total
reaction time of 4 h, TLC (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N) indicated
completion of the reaction. The reaction mixture was dropwise treated with water
(0.5mL), diluted with CH2Cl2 (30mL), washed with brine (3 × 10mL) and dried
(Na2SO4). Filtration and evaporation yielded a crude solid, which was co-evaporated
with toluene (10mL) prior to recrystallization from toluene/acetone (2.4:1) to give
(7R,8R)-61 (69mg; 81%) as a colorless crystalline solid. Single crystals for X-ray
structural analysis were obtained from diethyl ether/acetone-D6.
M.p. 158 ◦C (toluene/acetone); Rf=0.77 (toluene/n-hexane/acetone, 1:1:1, + 0.5%
Et3N);
[
α
]20
D −91.9 (c= 1, CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.47–7.16 (m,
20H, HAr), 5.11 (d, 1H, J gem = 10.8Hz, CH2Ph), 4.98–4.91 (m, 2H, CH2Ph, H-1),
4.76–4.68 (m, 4H, CH2Ph), 4.65 (dd, 1H, J 9a,9b = 13.1, J 8,9a = 1.4Hz, H-9a), 4.62–4.57
(m, 2H, CH2Ph), 4.33 (dd, 1H, J 9a,9b = 13.1, J 8,9b = 4.4Hz, H-9b), 4.13–4.05 (m, 2H,
H-3, H-4), 3.84 (dd, 1H, J 6a,6b = 11.3, J 5,6a = 2.0Hz, H-6a), 3.80 (dd, 1H, J 6a,6b =
11.3, J 5,6b = 5.3Hz, H-6b), 3.72–3.64 (m, 1H, H-5), 3.52–3.45 (m, 2H, H-8, H-7); 13C
NMR (100.6MHz, acetone-D6) δ: 151.4 (OC(=O)O), 139.9, 139.8, 139.5, 138.3 (4 ×
CAr,q.), 129.3–127.9 (CAr), 100.7 (C-1), 85.2 (C-3), 83.6 (C-2), 76.9 (C-5), 76.5 (C-4),
75.8 (CH2Ph), 75.8 (CH2Ph), 73.9 (CH2Ph), 71.5 (CH2Ph), 70.0 (C-6), 64.0 (C-9), 56.7
(C-7), 51.1 (C-8); HR-ESI-TOF calcd. for C38H38O9Na [M+Na]+: 661.2408. Found:
661.2412; Anal. calcd. for C38H38O9: C, 71.46; H, 6.00. Found: C, 71.18; H, 6.19.
(2S,2’R/S,3’R,4’S)-1,3,4,6-Tetra-O-benzyl-2’-hydroxyspiro[2-deoxy-β-d-
mannopyranose-2,5’-(oxirano[2,3-c]-tetrahydrofuran)] (α,β-62):
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side chain: α-D-ribo side chain: β-D-ribo
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OBn
OBn
OHO
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Epoxy alcohol (7S,8S)-53 (260mg; 0.424mmol) in anhydrous EtOAc/toluene (2:1,
67mL) was treated with MOPS (1.06 g; 5.09mmol), and the vigorously stirred mixture
was cooled to −50 ◦C. TEMPO 1mg/mL in EtOAc (2.0mL; 3mol%) was added,
followed by dropwise addition of TCICA 20mg/mL in EtOAc (7.4mL; 0.636mmol)
over 15min. The pale yellow suspension was vigorously stirred for 3 h at −50 ◦C, after
which time TLC (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N) showed complete
conversion of the starting material. Next, Me2S (150µL; 2.0mmol) in EtOAc (2mL)
was added dropwise to the reaction mixture at −50 ◦C, and stirring of the decolorized
mixture continued for 15min. After dilution with EtOAc (50mL) and washing with
sat. NaHCO3/sat. Na2S2O3 (10:1, 2 × 30mL), the organic phase was dried (Na2SO4),
filtered and the solvents evaporated to dryness to give crude 62 (260mg). Flash column
chromatographic purification (spherical SiO2, toluene/n-hexane/acetone, 10:10:1, +
2% Et3N) gave α,β-62 (211mg; 82%) as a colorless oil. The major component of the
isomeric mixture was determined to be β-62 in acetone-D6 (α/β≈ 6:94 to 8:92).
Rf=0.69 (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N);
[
α
]20
D −9.2 (α/β≈ 8:92,
c=0.5, acetone-D6); selected signals for α-62: 1H NMR (400.2MHz, acetone-D6) δ:
5.49 (H-9), 4.83 (H-1), 4.76 (OH), 3.58 (H-5); 13C NMR (100.6MHz, acetone-D6) δ:
99.9 (C-1); selected signals for β-62: 1H NMR (400.2MHz, acetone-D6) δ: 7.49–7.20 (m,
20H, HAr), 5.11 (d, 1H, J 9,OH = 12.2Hz, H-9), 4.98 (d, 1H, J gem = 10.4Hz, CH2Ph),
4.92 (s, 1H, H-1), 4.89–4.82 (m, 3H, CH2Ph), 4.73–4.67 (m, 2H, CH2Ph), 4.65 (d, 1H,
J gem = 12.2Hz, CH2Ph), 4.58 (d, 1H, J gem = 12.2Hz, CH2Ph), 4.53 (d, 1H, J 9,OH =
12.2Hz, OH), 3.96 (d, 1H, J 3,4 = 9.3Hz, H-3), 3.88–3.78 (m, 4H, H-4, H-6a, H-6b, H-7),
3.65 (ddd, 1H, J 4,5 = 9.1, J 5,6ab = 4.7, 2.5Hz, H-5), 3.53 (d, 1H, J 7,8 = 2.7Hz, H-8); 13C
NMR (100.6MHz, acetone-D6) δ: 139.7, 139.5, 139.4, 137.9 (4 × CAr,q.), 129.9–128.0
(CAr), 99.9 (C-1), 97.4 (C-9), 85.0 (C-2), 82.6 (C-3), 77.6 (C-4), 77.1 (CH2Ph), 76.6
(C-5), 75.3 (CH2Ph), 73.8 (CH2Ph), 70.6 (CH2Ph), 70.1 (C-6), 56.9 (C-8), 56.5 (C-7);
HR-ESI-TOF calcd. for C37H38O8Na [M+Na]+: 633.2459. Found: 633.2459; Anal.
calcd. for C37H38O8: C, 72.77; H, 6.27. Found: C, 72.73; H, 6.37.
(2S,2’R/S,3’S,4’R)-1,3,4,6-Tetra-O-benzyl-2’-hydroxyspiro[2-deoxy-β-d-
mannopyranose-2,5’-(oxirano[2,3-c]-tetrahydrofuran)] (α,β-63):
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To epoxy alcohol (7R,8R)-57 (303mg; 0.496mmol) in anhydrous EtOAc/toluene (2:1,
78mL) was added MOPS (1.25 g; 5.95mmol), and the vigorously stirred suspension
was cooled to −50 ◦C. TEMPO 1mg/mL in EtOAc (2.3mL; 3mol%) was added, and
then dropwise TCICA 20mg/mL in EtOAc (8.7mL; 0.744mmol) slowly over 15min.
The pale yellow suspension was stirred for 3 h at −50 ◦C, when TLC control (toluene/n-
hexane/acetone, 1:1:1, + 0.5% Et3N) showed complete consumption of the starting
material. Me2S (170µL; 2.3mmol) in EtOAc (2mL) was added dropwise at −50 ◦C, and
stirring of the cooled decolorized mixture was continued for 15min. Dilution with EtOAc
(50mL), washing with sat. NaHCO3/sat. Na2S2O3 (10:1, 2 × 30mL), drying of the
organic layer (Na2SO4), filtration and evaporation to dryness gave crude 63 (260mg).
Flash column chromatographic purification (spherical SiO2, toluene/n-hexane/acetone,
10:10:3, + 2% Et3N) gave α,β-63 (280mg; 92%) as a colorless foam. The major
component of the isomeric mixture was identified to be α-63 in acetone-D6 (α/β≈ 91:9
to 97:3). Single crystals of α-63 suitable for X-ray structural analysis were obtained
from toluene/CH2Cl2.
Rf=0.67 (toluene/n-hexane/acetone, 1:1:1, + 0.5% Et3N);
[
α
]20
D −68.4 (α/β≈ 97:3,
c= 0.5, acetone-D6); selected signals for α-63: 1H NMR (400.2MHz, acetone-D6) δ:
7.50–7.20 (m, 20H, HAr), 5.20 (d, 1H, J 9,OH = 12.0Hz, H-9), 5.01 (d, 1H, J gem =
11.5Hz, CH2Ph), 4.91 (d, 1H, J gem = 10.4Hz, CH2Ph), 4.83 (s, 1H, H-1), 4.82–4.74 (m,
2H, CH2Ph), 4.65–4.52 (m, 4H, CH2Ph), 4.32 (d, 1H, J 9,OH = 12.0Hz, OH), 4.01 (d,
1H, J 3,4 = 8.9Hz, H-3), 3.94 (d, 1H, J 7,8 = 2.7Hz, H-7), 3.85 (H-6a), 3.79–3.71 (m, 2H,
H-6b, H-4), 3.64 (ddd, 1H, J 4,5 = 9.3, J 5,6b = 5.4, J 5,6a = 2.2Hz, H-5), 3.58 (d, 1H,
J 7,8 = 2.7Hz, H-8); 13C NMR (100.6MHz, acetone-D6) δ: 139.9, 139.8, 139.8, 137.6 (4
× CAr,q.), 129.5–128.1 (CAr), 99.4 (C-1), 97.3 (C-9), 83.6 (C-2), 82.5 (C-3), 76.7 (C-4),
76.7 (C-5), 75.4 (CH2Ph), 75.2 (CH2Ph), 73.8 (CH2Ph), 72.0 (CH2Ph), 70.4 (C-6), 57.3
(C-7), 56.9 (C-8); selected signals for β-63: 1H NMR (400.2MHz, acetone-D6) δ: 5.47
(H-9), 4.96 (H-1), 4.71 (OH), 4.23 (d, 1H, J 3,4 = 9.1Hz, H-3), 3.67 (H-5); 13C NMR
(100.6MHz, acetone-D6) δ: 98.9 (C-1), 98.0 (C-9), 81.7 (C-3); HR-ESI-TOF calcd. for
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C37H38O8Na [M+Na]+: 633.2459. Found: 633.2447; Anal. calcd. for C37H38O8: C,
72.77; H, 6.27. Found: C, 72.61; H, 6.29.
(2S,4’R)-1,3,4,6-Tetra-O-benzyl-2’,2’-dimethyl-4’-{(1S)-1,2-O-isoprop-
ylidene-1,2-dihydroxyethyl}spiro[2-deoxy-β-d-mannopyranose-2,5’-[1,3]-
dioxolane] [(7R,8S)-64]:
8
7
9
OBnO
BnO
OBn
O
OBn
O
O
O
To epoxide (7R,8R)-57 (1.39 g; 2.26mmol) in anhydrous acetone (115mL) at r.t. was
dropwise added a freshly prepared solution of SnCl2 10mg/mL in acetone (12.9mL;
30mol%). The solution was heated to 55 ◦C for 1.5 h, after which time TLC (toluene/n-
hexane/acetone, 2:2:1, + 0.5% Et3N) indicated complete conversion of the substrate
epoxide, and the formation of multiple products. The reaction mixture was allowed to
cool to r.t. and was slowly treated with sat. NaHCO3 (4mL). Next, the mixture was
diluted with water (100mL), extracted with CH2Cl2 (3 × 150mL), and the combined
organic extracts were dried (Na2SO4). Filtration and evaporation of the volatile parts in
vacuo yielded a crude oil. Flash column chromatographic purification (SiO2, toluene/n-
hexane/acetone, 2:2:0.4 to 2:2:0.8) gave, eluting in this order, (7R,8S)-64 (446mg;
28%) as a yellowish oil with high chromatographic mobility, (7R,8S)-66 (223mg; 15%)
as a colorless oil with medium mobility and (7R,8S)-65 (667mg; 44%) as a colorless
oil with low chromatographic mobility. Analytical data for (7R,8S)-64:
Rf=0.58 (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N);
[
α
]20
D −47.4 (c=0.5,
CHCl3); 1H NMR (600.1MHz, acetone-D6) δ: 7.49–7.23 (m, 20H, HAr), 5.03 (d, 1H,
J gem = 11.4Hz, CH2Ph), 4.90 (d, 1H, J gem = 11.7Hz, CH2Ph), 4.80 (d, 1H, J gem =
11.0Hz, CH2Ph), 4.72–4.65 (m, 3H, CH2Ph), 4.61 (d, 1H, J gem = 11.9Hz, CH2Ph),
4.42–4.38 (m, 2H, H-8, H-1), 4.25 (d, 1H, J 7,8 = 8.4Hz, H-7), 3.89–3.84 (m, 3H, H-9a,
H-4, H-6a), 3.80 (dd, 1H, J 6a,6b = 11.0, J 5,6b = 5.2Hz, H-6b), 3.64 (dd, 1H, J 9a,9b =
8.0, J 8,9b = 8.0Hz, H-9b), 3.58 (ddd, 1H, J 4,5 = 9.9, J 5,6b = 5.3, J 5,6a = 2.0Hz, H-5),
3.47 (d, 1H, J 3,4 = 9.4Hz, H-3), 1.44 (s, 3H, CH3), 1.35 (s, 3H, CH3), 1.30 (s, 3H, CH3),
1.23 (s, 3H, CH3); 13C NMR (150.9MHz, acetone-D6) δ: 139.8, 139.5, 139.5, 138.4 (4
× CAr,q.), 129.3–128.3 (CAr), 110.4 (Me2CO2), 109.2 (Me2CO2), 99.9 (C-1), 85.7 (C-2),
81.7 (C-3), 79.3 (C-7), 79.2 (C-4), 76.6 (CH2Ph), 76.0 (C-5), 75.5 (C-8), 75.3 (CH2Ph),
73.9 (CH2Ph), 70.6 (CH2Ph), 70.0 (C-6), 66.1 (C-9), 27.2 (CH3), 27.2 (CH3), 27.1
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(CH3), 25.9 (CH3); HR-ESI-TOF calcd. for C43H50O9Na [M+Na]+: 733.3347. Found:
733.3352. Anal. calcd. for C43H50O9: C, 72.65; H, 7.09. Found: C, 72.72; H, 7.20.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1R,2S)-1,2-O-isopropylidene-1,2,3-trihydr-
oxyprop-1-yl}-β-d-mannopyranoside [(7R,8S)-65]:
OBnO
BnO
OBn
OH
OBn
HO
O
O
8
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9
Isolated as the major product (667mg; 44%) in the form of a colorless oil in the SnCl2-
mediated epoxide opening of (7R,8R)-57 as described above.
Rf=0.28 (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N);
[
α
]20
D −34.6 (c=0.5,
CHCl3); 1H NMR (600.1MHz, acetone-D6) δ: 7.43–7.21 (m, 20H, HAr), 4.99 (d, 1H,
J gem = 11.0Hz, CH2Ph), 4.91–4.85 (m, 2H, CH2Ph), 4.79–4.74 (m, 2H, H-8, CH2Ph),
4.72–4.64 (m, 3H, CH2Ph), 4.63–4.59 (m, 2H, H-1, CH2Ph), 4.29 (d, 1H, J 7,8 = 8.3Hz,
H-7), 4.16 (s, 1H, OH), 4.04 (dd, J 4,5 = 9.7, J 3,4 = 9.4Hz, H-4), 3.95–3.91 (m, 2H,
H-3, OH), 3.83 (dd, 1H, J 6a,6b = 11.0, J 5,6a = 2.0Hz, H-6a), 3.80 (dd, 1H, J 6a,6b =
11.0, J 5,6b = 4.8Hz, H-6b), 3.67 (ddd, 1H, J 9a,9b = 11.0, J 9a,OH = 6.2, J 8,9a = 4.8Hz,
H-9a), 3.64–3.59 (m, 1H, H-9b), 3.55 (ddd, 1H, J 4,5 = 9.7, J 5,6b = 4.8, J 5,6a = 2.2Hz,
H-5), 1.46 (s, 3H, CH3), 1.35 (s, 3H, CH3); 13C NMR (150.9MHz, acetone-D6) δ: 139.8,
139.7, 139.6, 138.8 (4 × CAr,q.), 129.1–128.1 (CAr), 109.0 (Me2CO2), 101.0 (C-1), 81.6
(C-3), 79.2 (C-7), 78.7 (C-8), 78.4 (C-4), 76.1 (C-2), 76.1 (C-5), 75.3 (CH2Ph), 75.0
(CH2Ph), 73.8 (CH2Ph), 71.1 (CH2Ph), 70.1 (C-6), 64.7 (C-9), 27.7 (CH3), 27.1 (CH3);
HR-ESI-TOF calcd. for C40H46O9Na [M+Na]+: 693.3034. Found: 693.3027. Anal.
calcd. for C40H46O9: C, 71.62; H, 6.91. Found: C, 71.78; H, 7.07.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1R,2S)-2,3-O-isopropylidene-1,2,3-trihydr-
oxyprop-1-yl}-β-d-mannopyranoside [(7R,8S)-66]:
8
7
9
OBnO
BnO
OBn
OH
OBn
O
OH
O
Isolated as the minor product (223mg; 15%) in the form of a colorless oil in the SnCl2-
mediated epoxide opening of (7R,8R)-57 as described above.
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Rf=0.39 (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N);
[
α
]20
D +7.8 (c=0.5,
CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.44–7.24 (m, 20H, HAr), 5.01 (d, 1H,
J gem = 11.5Hz, CH2Ph), 4.92 (d, 1H, J gem = 11.7Hz, CH2Ph), 4.85–4.78 (m, 3H, H-1,
CH2Ph), 4.70–4.65 (m, 3H, CH2Ph), 4.60 (d, 1H, J gem = 12.4Hz, CH2Ph), 4.45 (ddd,
1H, J 8,9b = 7.8, J 8,9a = 6.3, J 7,8 = 6.3Hz, H-8), 4.04 (dd, J 4,5 = 9.5, J 3,4 = 9.5Hz,
H-4), 3.95–3.88 (m, 3H, H-3, H-9a, H-7), 3.87–3.80 (m, 3H, OH, H-6a, H-6b), 3.74 (dd,
1H, J 8,9b = 8.1, J 9a,9b = 8.1Hz, H-9b), 3.58–3.53 (m, 2H, H-5, OH), 1.26 (s, 3H, CH3),
1.16 (s, 3H, CH3); 13C NMR (100.6MHz, acetone-D6) δ: 139.9, 139.9, 139.7, 138.9 (4
× CAr,q.), 129.1–128.2 (CAr), 108.5 (Me2CO2), 101.6 (C-1), 81.4 (C-3), 78.4 (C-4), 77.8
(C-2), 77.3 (C-8), 76.2 (C-5), 75.4 (CH2Ph), 75.1 (CH2Ph), 73.8 (C-7), 73.8 (CH2Ph),
71.5 (CH2Ph), 70.1 (C-6), 68.0 (C-9), 27.0 (CH3), 26.1 (CH3); HR-ESI-TOF calcd. for
C40H46O9Na [M+Na]+: 693.3034. Found: 693.3034. Anal. calcd. for C40H46O9: C,
71.62; H, 6.91. Found: C, 71.33; H, 6.91.
Benzyl 3,4,6-tri-O-benzyl-2-C-{(1R,2S)-1,2,3-trihydroxyprop-1-yl}-β-d-
mannopyranoside [(7R,8S)-67]:
7
89
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
From (7R,8S)-64: Diacetonide (7R,8S)-64 (446mg; 0.627mmol) in a mixture of
formic acid (21.5mL) and water (3.8mL) was heated to 35 ◦C for 4 d. Simultaneous
reaction monitoring of aliquotic samples via ESI-MS confirmed the absence of acetonide
species after this time. The solution was allowed to cool to r.t., diluted with water
(20mL), extracted with CH2Cl2 (3 × 50mL), saturated with NaCl and once more
extracted with CH2Cl2 (50mL). The combined organic extracts were washed with sat.
NaHCO3 (2 × 50mL) and water (50mL), dried (Na2SO4), filtered and evaporated
to give a crude brown oil. This crude product was dissolved in MeOH (25mL), and
NH3 7n in MeOH (10mL) was added. After 18 h at r.t., TLC (toluene/ethyl acetate,
1:1) confirmed complete saponification of formate species and formation of one major
product of low chromatographic mobility. The reaction mixture was evaporated to
dryness, and the crude product was purified by flash column chromatography (SiO2,
chloroform/acetonitrile, 4:1) to give tetrol (7R,8S)-67 (167mg; 42% over 2 steps) as
a colorless solid.
From (7R,8S)-65: In an analogous procedure with (7R,8S)-65 (667mg; 0.994mmol),
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reaction in formic acid/water at r.t. for 3 d, and then at 35 ◦C for 1 d gave, after formate
cleavage as described above, tetrol (7R,8S)-67 (339mg; 54% over 2 steps).
From (7R,8S)-66: In an analogous procedure with (7R,8S)-66 (223mg; 0.332mmol),
reaction in formic acid/water at r.t. for 1 d gave, after formate cleavage as described
above, tetrol (7R,8S)-67 (141mg; 67% over 2 steps).
Rf=0.21 (toluene/ethyl acetate, 1:1);
[
α
]20
D −9.2 (c=1, CHCl3); 1H NMR (400.2
MHz, CD3OD) δ: 7.45–7.23 (m, 18H, HAr), 7.18–7.13 (m, 2H, HAr), 4.95–4.87 (m,
3H, CH2Ph, H-1), 4.79 (d, 1H, J gem = 11.0Hz, CH2Ph), 4.71 (d, 1H, J gem = 11.0Hz,
CH2Ph), 4.66–4.61 (m, 2H, CH2Ph), 4.60–4.53 (m, 2H, CH2Ph), 4.04 (d, 1H, J 7,8 =
2.5Hz, H-7), 4.02–3.94 (m, 2H, H-4, H-8), 3.82–3.73 (m, 3H, H-3, H-6a, H-6b), 3.64–3.49
(m, 3H, H-9a, H-9b, H-5); 13C NMR (100.6MHz, CD3OD) δ: 139.7, 139.5, 139.4, 138.9
(4 × CAr,q.), 129.5–128.6 (CAr), 102.7 (C-1), 82.1 (C-3), 78.5 (C-2), 78.5 (C-4), 76.2
(C-5), 76.0 (CH2Ph), 75.8 (CH2Ph), 74.5 (CH2Ph), 72.6 (C-7), 72.5 (CH2Ph), 71.2
(C-8), 70.2 (C-6), 65.0 (C-9); HR-ESI-TOF calcd. for C37H42O9Na [M+Na]+: 653.2721.
Found: 653.2722; Anal. calcd. for C37H42O9: C, 70.46; H, 6.71. Found: C, 70.31; H,
6.82.
(2S,2’R/S,3’R,4’R)-1,3,4,6-Tetra-O-benzyl-2’,3’,4’-trihydroxyspiro[2-deoxy-
β-d-mannopyranose-2,5’-tetrahydrofuran] (α,β-68):
8 7
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side chain: α-D-xylo side chain: β-D-xylo
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From (7R,8S)-67: To (7R,8S)-67 (100mg; 0.159mmol) in anhydrous EtOAc/toluene
(2:1, 25.5mL) was added MOPS (399mg; 1.90mmol), and the vigorously stirred suspen-
sion was cooled to −65 ◦C. Next, TEMPO 1mg/mL in EtOAc (1.49mL; 6mol%) was
added, followed by the dropwise addition of a solution of TCICA 10mg/mL in EtOAc
(3.1mL; 0.135mmol) over 15min. The resulting pale yellow mixture was stirred for 3 h at
−65 ◦C. Next, Me2S (70 µL; 0.85mmol) in EtOAc (1mL) was added dropwise at −65 ◦C,
and stirring of the decolorized reaction mixture continued for 15min. After dilution with
EtOAc (20mL) and washing with brine/sat. Na2S2O3 (10:1, 2 × 15mL), the organic
layer was dried (Na2SO4), filtered and evaporated to dryness to give crude 68 (111mg).
Flash column chromatographic purification (spherical SiO2, toluene/n-hexane/acetone,
4:4:3, + 0.5% Et3N) gave α,β-68 (18mg; 18%; 36% brsm) as a colorless solid with
higher chromatographic mobility, along with recovered (7R,8S)-67 (50mg).
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From (7R,8R)-69: A solution of lactone (7R,8R)-69 (89mg; 0.142mmol) in anhy-
drous THF (6mL) was cooled to −78 ◦C, and a solution of DIBAL-H (1.42mL; 1m in
THF; 1.42mmol) was slowly added dropwise. The reaction mixture was stirred at −78 ◦C
for 1 h, allowed to warm to −50 ◦C, and stirred for another 1 h. TLC (toluene/ethyl
acetate, 1:1) showed major conversion of the substrate lactone, and MeOH (0.5mL)
was added dropwise at −50 ◦C. Next, 10% HCl (0.5mL) was also added dropwise, and
the mixture was stirred for 10min at −50 ◦C. CH2Cl2 (10mL) was added, and the
mixture was allowed to warm to r.t. Water (5mL) was added, followed by extraction
with EtOAc (2 × 20mL) and CH2Cl2 (2 × 20mL). The combined organic extracts were
dried (Na2SO4), filtered and evaporated to give a crude solid (85mg). Purification by
flash column chromatography (SiO2, toluene/n-hexane/acetone, 2:2:0.8 to 2:2:1) gave
α,β-68 (61mg; 68%; 76% brsm) along with recovered substrate (7R,8R)-69 (9mg).
α,β-68 was isolated as a mixture of isomers with α/β≈ 1:1 in acetone-D6.
Rf=0.46 (toluene/ethyl acetate, 1:1);
[
α
]20
D −21.8 (α/β≈ 1:1, c= 0.5, acetone-D6);
selected signals for α-68: 1H NMR (600.1MHz, acetone-D6) δ: 7.45–7.23 (m, 20H,
HAr), 5.14 (dd, 1H, J 9,OH = 6.1, J 8,9 = 6.1Hz, H-9), 4.90 (C-7-OH), 4.61 (H-1), 4.40
(m, 1H, visible: J = 8.1, 4.8Hz, H-7), 4.26–4.20 (m, 2H, H-8, C-9-OH), 3.89 (dd, 1H,
J 3,4 = 9.7, J 4,5 = 9.7Hz, H-4), 3.85–3.77 (m, 3H, H-6a, H-6b, H-3), 3.55–3.48 (m,
2H, H-5, C-8-OH); 13C NMR (150.9MHz, acetone-D6) δ: 99.5 (C-1), 96.0 (C-9), 86.1
(C-2), 81.2 (C-3), 78.4 (C-4), 78.4 (C-8), 76.6 (C-7), 76.3 or 76.1 (C-5), 70.1 (C-6);
selected signals for β-68: 1H NMR (600.1MHz, acetone-D6) δ: 7.45–7.23 (m, 20H,
HAr), 4.94 (H-9), 4.90 (C-7-OH), 4.61 (H-1), 4.59 (C-9-OH), 4.47 (dd, 1H, J = 7.0,
5.0Hz, H-7), 4.44–4.38 (m, 1H, C-8-OH), 4.10–4.06 (m, 1H, H-8), 3.93 (dd, 1H, J 3,4 =
9.0, J 4,5 = 9.0Hz, H-4), 3.85–3.77 (m, 3H, H-6a, H-6b, H-3), 3.55–3.48 (m, 1H, H-5);
13C NMR (150.9MHz, acetone-D6) δ: 103.5 (C-9), 100.5 (C-1), 86.9 (C-2), 84.2 (C-8),
81.3 (C-3), 78.4 (C-4), 77.8 (C-7), 76.3 or 76.1 (C-5), 70.1 (C-6); HR-ESI-TOF calcd.
for C37H40O9Na [M+Na]+: 651.2565. Found: 651.2559; Anal. calcd. for C37H40O9: C,
70.68; H, 6.41. Found: C, 70.47; H, 6.62.
(2S,3’R,4’R)-1,3,4,6-Tetra-O-benzyl-3’,4’-dihydroxyspiro[2-deoxy-β-d-
mannopyranose-2,5’-tetrahydrofuran-2-one] (7R,8R)-69:
8 7
9
OBnO
BnO
OBn
OBn
OO
HO OH
A solution of (7R,8S)-67 (199mg; 0.316mmol) in anhydrous EtOAc/toluene (2:1,
50mL) was treated with MOPS (794mg; 3.79mmol), and the vigorously stirred mixture
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was cooled to −50 ◦C. Next, TEMPO 1mg/mL in EtOAc (1.48mL; 3mol%) was
added. Subsequently, TCICA 20mg/mL in EtOAc (5.9mL; 0.506mmol) was slowly
added dropwise over 15min, and the resulting pale yellow mixture was stirred for
30min at −50 ◦C. The reaction was allowed to slowly warm to −35 ◦C and stirred at
this temperature for 17 h, after which time TLC (toluene/ethyl acetate, 1:1) showed
essentially complete conversion. Next, Me2S (175 µL; 2.37mmol) in EtOAc (2mL) was
added dropwise, and stirring of the rapidly decolorizing reaction mixture continued
for 15min at −35 ◦C. After dilution with EtOAc (50mL) and washing with brine/sat.
Na2S2O3 (10:1, 3 × 30mL) and water (30mL), the organic phase was dried (Na2SO4),
filtered and evaporated to dryness to give crude (7R,8R)-69 (220mg). Flash column
chromatographic purification (SiO2, toluene/n-hexane/acetone, 10:10:4 to 10:10:5.5)
gave pure lactone (7R,8R)-69 (166mg; 84%) as a colorless solid with higher chro-
matographic mobility, along with α,β-68 (12mg; 6%) as a side product. An analytical
sample was recrystallized from n-hexane/ethyl acetate.
M.p. 172 ◦C (n-hexane/ethyl acetate, decomp.). Rf=0.72 (toluene/ethyl acetate,
1:1);
[
α
]20
D −43.7 (c=1, CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.45–7.20 (m,
20H, HAr), 5.59 (d, 1H, J 7,OH = 5.1Hz, C-7-OH), 5.15 (d, 1H, J 8,OH = 5.8Hz, C-8-OH),
5.05 (d, 1H, J gem = 11.0Hz, CH2Ph), 4.97–4.88 (m, 2H, CH2Ph), 4.82–4.77 (m, 2H,
H-1, CH2Ph), 4.73–4.59 (m, 5H, CH2Ph, H-7), 4.58 (dd, 1H, J 7,8 = 8.4, J 8,OH =
5.9Hz, H-8), 4.08 (d, 1H, J 3,4 = 9.5Hz, H-3), 3.91 (dd, J 4,5 = 9.8, J 3,4 = 9.8Hz, H-4),
3.88–3.81 (m, 2H, H-6a, H-6b), 3.63 (ddd, 1H, J 4,5 = 9.8, J 5,6ab = 4.3, 2.4Hz, H-5);
13C NMR (100.6MHz, acetone-D6) δ: 174.4 (C-9), 139.7, 139.5, 139.4, 138.3 (4 ×
CAr,q.), 129.2–128.0 (CAr), 98.7 (C-1), 86.0 (C-2), 80.0 (C-3), 78.3 (C-4), 76.1 (C-5),
75.6 (CH2Ph), 75.3 (C-7), 74.8 (CH2Ph), 74.7 (C-8), 73.9 (CH2Ph), 71.6 (CH2Ph), 69.7
(C-6); HR-ESI-TOF calcd. for C37H48O9Na [M+Na]+: 649.2408. Found: 649.2409;
Anal. calcd. for C37H38O9: C, 70.91; H, 6.11. Found: C, 70.68; H, 6.36.
4-C-Formyl-d-erythro-l-ido-octose (anti-70):
(O)HC
CHO
OH
HO
OH
OH
CH2OH
OH
HO
9
8
1
4
2
3
5
6
7
9
anti-70-A
(47%)
anti-70-B
(10%)
OHO
HO
OH
OH
OHO
HO OH
OHO
HO
OH
OH
OHO
HO OH
1
2 3
7
8
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To a solution of α,β-68 (29mg; 0.045mmol) in MeOH (4mL) was added Pd 10% on
activated charcoal (112mg), and the suspension was stirred under an atmosphere of
hydrogen for 4 d. TLC control (chloroform/methanol, 2:1) indicated complete conversion
to a mixture of products without observable fluorescence quenching. The reaction
mixture was diluted with MeOH (5mL), filtered through a layer of Celite, and the
filter pad was thoroughly rinsed with MeOH. The collected filtrate was evaporated to
dryness to give a colorless oil. RP-chromatographic purification (RP-C18 silica gel,
methanol/water, 1:1) gave, after partial evaporation and freeze-drying from residual
water over several days, anti-70 (12mg; 99%) as a colorless foam. The compound was
isolated as a mixture of isomers.
Rf=0.14–0.64 (chloroform/methanol, 2:1);
[
α
]20
D 42.8 (c=0.5, H2O); identified
isomers: (1S,9S)-4-C-formyl-d-erythro-l-ido-octo-1,4-furanose-9,7-pyranose
(anti-70-A, 47% isomeric contribution in D2O), selected signals: 1H NMR (700.3MHz,
D2O) δ: 5.27 (d, 1H, J 1,2 = 4.7Hz, H-1), 5.01 (s, 1H, H-9), 4.25 (dd, 1H, J 2,3 = 9.0, J 1,2
= 4.7Hz, H-2), 4.14 (d, 1H, J 2,3 = 9.0Hz, H-3), 3.94 (d, 1H, J 5,6 = 9.7Hz, H-5), 3.86
(H-8a), 3.82 (H-7), 3.73 (dd, 1H, J 8a,8b = 11.8, J 7,8b = 6.0Hz, H8b), 3.53 (dd, 1H, J 5,6
= 9.7, J 6,7 = 9.7Hz, H-6); 13C NMR (176.1MHz, D2O) δ: 97.4 (C-9), 94.8 (C-1), 84.2
(C-4), 77.4 (C-3), 76.4 (C-2), 72.3 (C-7), 69.6 (C-5), 68.8 (C-6), 61.6 (C-8); (1S,9R)-
4-C-formyl-d-erythro-l-ido-octo-1,4-furanose-9,7-pyranose (anti-70-B, 10%
isomeric contribution in D2O), selected signals: 1H NMR (700.3MHz, D2O) δ: 5.31 (d,
1H, J 1,2 = 5.0Hz, H-1), 4.75 (s, 1H, H-9), 4.30 (dd, 1H, J 2,3 = 8.8, J 1,2 = 5.0Hz, H-2),
4.25 (H-3), 3.76 (H-5), 3.41 (H-7); 13C NMR (176.1MHz, D2O) δ: 94.4 (C-1), 93.5 (C-9),
76.4 (C-2), 76.4 (C-7), 74.8 (C-3), 71.2 (C-5), 68.5 (C-6), 61.5 (C-8); HR-ESI-TOF
calcd. for C9H16O9Na [M+Na]+: 291.0687. Found: 291.0689; HR-ESI-TOF calcd. for
C9H15O9 [M-H]–: 267.0722. Found: 267.0723; Anal. calcd. for C9H16O9·H2O: C, 37.77;
H, 6.34. Found: C, 37.69; H, 6.56.
1,3,6-Tri-O-benzyl-2-C,4-O-{(1R,2S)-2,3-O-isopropylidene-2,3-dihydroxy-n-
prop-1-ylidene}-β-d-mannopyranose-1C4 (7R,8S)-71:
8
9
O
OBnOBn
BnO
OH
O H
O O
7
Method a: To a solution of epoxide (7S,8S)-53 (91mg; 0.149mmol) in anhydrous
acetone (4mL) was dropwise added a freshly prepared solution of SnCl2 in acetone
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(141µL; 10mg/mL; 5mol%), and the mixture was heated to 45 ◦C for 24 h. A second
portion of SnCl2 in acetone (5mol%) was added, and the solution was heated to 55 ◦C
for another 22 h. TLC reaction control (toluene/n-hexane/acetone, 2:2:1, + 0.5% Et3N)
confirmed the formation of one major product, and the reaction mixture was allowed to
cool to r.t. Next, sat. NaHCO3 (1mL) was added dropwise, the solution was diluted
with water (10mL) and extracted with CH2Cl2 (3 × 20mL). Drying (Na2SO4) of the
organic parts, filtration and evaporation of the volatile components gave a yellow oil,
which was purified by flash column chromatography (SiO2, toluene/n-hexane/acetone,
2:2:1) to give acetonide (7R,8S)-71 (57mg; 68%) as a colorless solid. An analytical
sample was recrystallized from n-hexane/acetone.
Method b: Starting from epoxide (7S,8S)-53 (71mg; 0.116mmol) in acetone (3mL)
with SnCl2 in acetone (2.2mL; 10mg/mL; 1 equiv.), reaction for 2 h at 0 ◦C, workup
and chromatography as described above gave (7R,8S)-71 (39mg; 60%).
M.p. 134 ◦C (n-hexane/acetone); Rf=0.45 (toluene/n-hexane/acetone, 2:2:1, +
0.5% Et3N);
[
α
]20
D −15.1 (c= 1, CHCl3); 1H NMR (400.2MHz, acetone-D6) δ: 7.37–7.19
(m, 15H, HAr), 4.94 (d, 1H, J gem = 11.7Hz, CH2Ph), 4.86–4.82 (m, 2H, CH2Ph, H-1),
4.70–4.67 (m, 2H, OH, CH2Ph), 4.51 (d, 1H, J 3,4 = 5.7Hz, H-3), 4.46 (d, 1H, J gem =
11.7Hz, CH2Ph), 4.38–4.30 (m, 3H, H-4, CH2Ph, visible coupling constants: J 4,5 =
2.6Hz), 4.23 (ddd, 1H, J 8,9b = 7.6, J 8,9a = 6.8, J 7,8 = 5.3Hz, H-8), 4.10–4.00 (m, 3H,
H-5, H-9a, H-6a), 3.94 (d, 1H, J 7,8 = 5.3Hz, H-7), 3.87 (dd, 1H, J 6a,6b = 9.9, J 5,6b =
5.3Hz, H-6b), 3.79 (dd, 1H, J 9a,9b = 8.3, J 8,9b = 7.9Hz, H-9b), 1.34 (s, 3H, CH3), 1.31
(s, 3H, CH3); 13C NMR (150.9MHz, acetone-D6) δ: 139.7, 139.6, 139.4 (3 × CAr,q.),
129.0–127.9 (CAr), 109.3 (Me2CO2), 104.9 (C-1), 81.7 (C-7), 80.0 (C-3), 77.5 (C-5), 76.7
(C-8), 76.1 (C-2), 73.9 (C-4), 73.6 (CH2Ph), 73.5 (CH2Ph), 71.2 (C-6), 70.7 (CH2Ph),
66.7 (C-9), 26.6 (CH3), 26.1 (CH3); HR-ESI-TOF calcd. for C33H38O8Na [M+Na]+:
585.2459. Found: 585.2464; Anal. calcd. for C33H38O8: C, 70.44; H, 6.81. Found: C,
70.48; H, 6.81.
Methyl 3,6-di-O-benzyl-4-deoxy-β-d-glycero-hex-3-enopyranoside-2-ulose
(72):
O
BnO
OBn
O
OMe
To methyl 2-uloside 2c[69] (229mg; 0.50mmol) in toluene (10mL) and water (0.33mL)
was added K2CO3 (110mg; 0.80mmol), and the mixture was stirred at 80 ◦C for 20 h.
TLC control (toluene/ethyl acetate, 4:1) indicated complete conversion, and the emulsion
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was diluted with toluene (30mL), allowed to cool to r.t., and washed with water (2
× 10mL). Drying of the organic phase (Na2SO4), filtration and evaporation of the
volatile parts gave a colorless oil. Purification by flash column chromatography (SiO2,
toluene/ethyl acetate, 6:1) yielded methyl 3,2-enolone 72 (150mg; 85%) as a colorless
oil.
Rf=0.51 (toluene/ethyl acetate, 4:1);
[
α
]20
D −81.0 (c = 1, CHCl3). UV (acetonitrile)
λmax (log ) 263 (3.70), 317 nm (sh, 1.10); 1H NMR (400.2MHz, acetone-D6) δ: 7.45–
7.27 (m, 10H, HAr), 6.27 (d, 1H, J 4,5 = 3.4Hz, H-4), 4.94–4.87 (m, 2H, CH2Ph), 4.86 (s,
1H, H-1), 4.83 (ddd, 1H, J 5,6a = 6.4, J 5,6b = 6.4, J 4,5 = 3.4Hz, H-5), 4.64–4.57 (m, 2H,
CH2Ph), 3.81 (dd, 1H, J 6a,6b = 9.7, J 5,6a = 6.9Hz, H-6a), 3.67 (dd, 1H, J 6a,6b = 9.7,
J 5,6b = 6.1Hz, H-6b), 3.47 (s, 3H, CH3); 13C NMR (100.6MHz, acetone-D6) δ: 185.0
(C-2), 147.9 (C-3), 139.4, 137.3 (2 × CAr,q.), 129.3, 129.2, 128.9, 128.6, 128.4 (CAr),
117.5 (C-4), 100.9 (C-1), 74.0 (C-6), 73.7 (CH2Ph), 72.9 (C-5), 70.3 (CH2Ph), 56.2
(CH3); HR-ESI-TOF calcd. for C21H22O5Na [M+Na]+: 377.1359. Found: 377.1360.
Anal. calcd. for C21H22O5: C, 71.17; H, 6.26. Found: C, 70.81; H, 6.39.
rac-(4R/S,5R/S)-5-Allyloxy-2-benzyloxy-4-benzyloxymethyl-4-hydroxy-
cyclopent-2-enone [(±)-73]:
(±)
O
OBn
HO
BnO
AllO
To allyl 3,2-enolone 3b (170mg; 0.447mmol) in anhydrous DMF (8.0mL) was added
NaSPh (30mg; 0.223mmol) at r.t., and after 25min the reaction mixture was heated to
90 ◦C for 22 h. TLC reaction control (toluene/ethyl acetate, 4:1) confirmed completion
of the reaction, and the red solution was allowed to cool to r.t. and neutralized with
acetate buffer pH 5 (1mL). Dilution with CH2Cl2 (70mL), washing with water (20mL),
drying (Na2SO4), filtration and evaporation in vacuo gave a brown oil. Residual DMF
was removed by co-evaporation with n-heptane (10mL), and purification by flash
column chromatography (SiO2, toluene/ethyl acetate, 11:1) gave cyclopentenone (±)-
73 (113mg; 66%) as a colorless oil.
Rf=0.47 (toluene/ethyl acetate, 4:1);
[
α
]20
D 0 (c= 1, CHCl3); UV (acetonitrile) λmax
(log ) 248 (3.90), 323 nm (1.67); 1H NMR (700.3MHz, acetone-D6) δ: 7.42–7.40 (m, 2H,
HAr), 7.39–7.35 (m, 2H, HAr), 7.35–7.29 (m, 5H, HAr), 7.27–7.24 (m, 1H, HAr), 6.33 (s,
1H, H-3), 5.94 (dddd, 1H, J trans = 17.3, J cis = 10.5, 2 × J vic = 5.2Hz, H2C=CH -CH2-),
5.36 (dddd, 1H, J trans = 17.3, J gem = 1.8, 2 × 4J = 1.8Hz, HaHbC=CH-CH2-), 5.16–
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5.14 (m, 1H, visible coupling constant: J cis = 10.5Hz, HaHbC=CH-CH2-), 5.03–4.98 [m,
2H, PhCH 2O-(C-2)], 4.81 (bs, 1H, OH), 4.52–4.48 (m, 2H, PhCH 2O-CH2), 4.43 (dddd,
1H, J gem = 13.3, J vic = 5.2, 2 × 4J = 1.6Hz, H2C=CH-CHaHb-), 4.32 (dddd, 1H, J gem
= 13.3, J vic = 5.2, 2 × 4J = 1.6Hz, H2C=CH-CHaHb-), 4.06 (s, 1H, H-5), 3.63 (d, 1H,
J gem = 9.3Hz, PhCH2O-CHaHb), 3.57 (d, 1H, J gem = 9.3Hz, PhCH2OCHaHb); 13C
NMR (176.1MHz, acetone-D6) δ: 196.1 (C-1), 155.2 (C-2), 139.6, 137.0 (2 × CAr,q.),
135.7 (H2C=CH-CH2-), 129.3, 129.0, 129.0, 128.6, 128.2, 128.1 (CAr), 127.1 (C-3), 116.8
(H2C=CH-CH2-), 87.0 (C-5), 77.9 (C-4), 74.3 (PhCH2O-CH2), 73.8 (PhCH2O-CH2),
73.1 (H2C=CH-CH2-), 71.8 [PhCH2O-(C-2)]; HR-ESI-TOF calcd. for C23H24O5Na
[M+Na]+: 403.1516. Found: 403.1518; Anal. calcd. for C23H24O5: C, 72.61; H, 6.36.
Found: C, 72.65; H, 6.59.
rac-(4R/S,5R/S)-2,5-Bis(benzyloxy)-4-benzyloxymethyl-4-hydroxycyclo-
pent-2-enone [(±)-74]:
(±)
O
OBn
HO
BnO
BnO
From 40: Benzyl 3,2-enolone 40 (195mg; 0.453mmol) was dissolved in anhydrous
DMF (11.8mL), and a freshly prepared solution of KOtBu 2mg/mL in DMF (1.25mL;
0.023mmol) was dropwise added. The resulting yellow solution was heated to 90 ◦C,
upon which the color of the solution changed into a deep red. After 28 h, TLC
(toluene/ethyl acetate, 4:1) indicated complete consumption of the starting material,
and the reaction was allowed to cool to r.t. The reaction mixture was neutralized
by the addition of acetate buffer pH 5 (1mL). Next, the solution was diluted with
CH2Cl2 (50mL), washed with water (2 × 15mL), dried (Na2SO4), filtered, and evapo-
rated to dryness. Residual DMF was removed by co-evaporation with n-heptane (10mL)
to give a brown oil. Purification by flash column chromatography (SiO2, toluene/ethyl
acetate, 10:1) gave cyclopentenone (±)-74 (153mg; 78%) as a colorless oil.
From 2b: To a solution of benzyl 2-uloside 2b[37] (243mg; 0.451mmol) in anhydrous
DMF (14.8mL) was dropwise added a freshly prepared solution of KOtBu 2mg/mL in
DMF (1.25mL; 0.023mmol). The solution was heated to 50 ◦C and stirred for 3 h. TLC
(toluene/ethyl acetate, 4:1) indicated complete conversion of the starting material to
the intermediate 3,2-enolone 40, and the temperature was elevated to 90 ◦C. The dark
red solution was stirred at this temperature for 30 h, after which time TLC suggested
completion of the reaction. The solution was allowed to cool to r.t., and was then
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neutralized by the addition of acetate buffer pH 5 (1mL). Dilution with CH2Cl2 (50mL),
washing with water (2 × 15mL), drying (Na2SO4), filtration and evaporation gave a
brown oil, which was co-evaporated with n-heptane (10mL) to remove residual DMF.
The crude product was purified by flash column chromatography (SiO2, toluene/ethyl
acetate, 10:1) to yield cyclopentenone (±)-74 (166mg; 85%) as a colorless oil.
Rf=0.52 (toluene/ethyl acetate, 4:1).
[
α
]20
D 0 (c= 1, CHCl3). UV (acetonitrile) λmax
(log ) 239 (3.62), 246 (3.61), 284 (sh, 2.57), 316 nm (sh, 2.09). 1H NMR (700.3MHz,
acetone-D6) δ: 7.45–7.40 (m, 4H, HAr), 7.39–7.33 (m, 5H, HAr), 7.31–7.28 (m, 5H,
HAr), 7.26–7.23 (m, 1H, HAr), 6.35 (s, 1H, H-3), 5.03–4.98 [m, 3H, PhCH 2O-(C-
2), PhCHaHbO-(C-5)], 4.89–4.85 [m, 2H, PhCHaHbO-(C-5), OH], 4.52–4.48 (m, 2H,
PhCH 2O-CH2), 4.14 (s, 1H, H-5), 3.67 (d, 1H, J gem = 9.3Hz, PhCH2O-CHaHb), 3.63
(d, 1H, J gem = 9.3Hz, PhCH2O-CHaHb); 13C NMR (176.1MHz, acetone-D6) δ: 196.2
(C-1), 155.2 (C-2), 139.5, 139.3, 137.0 (3 × CAr,q.), 129.3, 129.1, 129.0, 129.0, 128.6,
128.4, 128.3, 128.2, 128.1 (CAr), 127.1 (C-3), 87.1 (C-5), 78.0 (C-4), 74.3 (PhCH2O-CH2),
74.0 [PhCH2O-(C-5)], 73.8 (PhCH2O-CH2), 71.8 [PhCH2O-(C-2)]; HR-ESI-TOF calcd.
for C27H26O5Na [M+Na]+: 453.1672. Found: 453.1675. Anal. calcd. for C27H26O5: C,
75.33; H, 6.09. Found: C, 75.01; H, 6.25.
rac-(4R/S,5R/S)-2-Benzyloxy-4-benzyloxymethyl-4-hydroxy-5-methoxy-
cyclopent-2-enone [(±)-75]:
O
OBn
HO
BnO
MeO
(±)
From 72: To a solution of methyl 3,2-enolone 72 (83mg; 0.234mmol) in anhydrous
DMF (8.3mL) was added a freshly prepared solution of KOtBu 2mg/mL in DMF
(0.65mL; 0.012mmol), and the yellow solution was heated to 90 ◦C. The resulting deep
red reaction mixture was stirred at 90 ◦C for 75min, after which time TLC (toluene/ethyl
acetate, 4.1) indicated complete conversion of the starting material. The solution was
allowed to cool to r.t. and was then neutralized with acetate buffer pH 5 (1mL).
Dilution with CH2Cl2 (50mL), washing with water (20mL), drying (Na2SO4), filtration
and evaporation of the volatile parts gave a yellow oil. Residual DMF was removed
by co-evaporation of the crude product with n-heptane (10mL). Purification by flash
column chromatography (SiO2, toluene/ethyl acetate, 10:1) yielded, as a side product,
(±)-76 (7mg; 8%) with higher chromatographic mobility, together with (±)-75 (59mg;
71%) as the major isomer in the form of a colorless oil.
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From 2c: A solution of methyl 2-uloside 2c[69] (113mg; 0.244mmol) in anhydrous
DMF (8mL) at r.t. was treated with a freshly prepared solution of KOtBu 2mg/mL in
DMF (0.68mL; 0.012mmol), and the yellow reaction mixture was stirred for 24 h at r.t.
TLC reaction control (toluene/ethyl acetate, 4:1) indicated the complete formation of
the intermediate 72. Next, the temperature was elevated to 50 ◦C, and two additional
portions of KOtBu 2mg/mL in DMF (2 × 0.68mL; 0.024mmol) were added when
TLC showed reluctant further progression of the reaction. After stirring at 50 ◦C for a
total reaction time of 18 h, the red solution was allowed to cool to r.t. The mixture
was neutralized with acetate buffer pH 5 (1mL), diluted with CH2Cl2 (50mL), washed
with water (2 × 25mL), dried (Na2SO4), filtered and evaporated. The resulting
brown oil was co-evaporated with n-heptane (10mL), and purified by flash column
chromatography (SiO2, toluene/ethyl acetate, 9:1) to provide (±)-75 (53mg; 61%) as a
colorless oil. Single crystals of (±)-75 suitable for X-ray crystallography were obtained
from toluene/n-pentane. Analytical data for (±)-75:
Rf=0.52 (toluene/ ethyl acetate, 4:1);
[
α
]20
D 0 (c= 1, CHCl3); UV (acetonitrile) λmax
(log ) 248 (3.99), 323 nm (sh, 1.90); 1H NMR (600.1MHz, acetone-D6) δ: 7.43–7.40 (m,
2H, HAr), 7.39–7.28 (m, 7H, HAr), 7.28–7.24 (m, 1H, HAr), 6.32 (s, 1H, H-3), 5.03–4.97
[m, 2H, PhCH2O(C-2)], 4.75 (bs, 1H, OH), 4.52–4.47 (m, 2H, PhCH 2O-CH2), 3.88
(s, 1H, H-5), 3.64 (s, 3H, CH3), 3.61 (d, 1H, J gem = 9.3Hz, PhCH2O-CHaHb), 3.53
(d, 1H, J gem = 9.3Hz, PhCH2O-CHaHb); 13C NMR (100.6MHz, acetone-D6) δ: 196.2
(C-1), 155.1 (C-2), 139.6, 137.0 (2 × CAr,q.), 129.3, 129.0, 129.0, 128.6, 128.2, 128.1
(CAr), 127.1 (C-3), 89.4 (C-5), 77.8 (C-4), 74.3 (PhCH2O-CH2), 73.8 (PhCH2O-CH2),
71.8 [PhCH2O-(C-2)], 60.4 (CH3); HR-ESI-TOF calcd. for C21H22O5Na [M+Na]+:
377.1359. Found: 377.1361; Anal. calcd. for C21H22O5: C, 71.17; H, 6.26. Found: C,
71.35; H 6.47.
rac-(4R/S,5S/R)-2-Benzyloxy-4-benzyloxymethyl-4-hydroxy-5-methoxy-
cyclopent-2-enone [(±)-76]:
O
OBn
HO
BnO
MeO
(±)
Isolated as the minor diastereoisomer (7mg; 8%) in the formation of (±)-75 from 72
as described above:
Rf=0.55 (toluene/ethyl acetate, 4:1);
[
α
]20
D 0 (c= 1, CHCl3). 1H NMR (600.1MHz,
acetone-D6) δ: 7.44–7.41 (m, 2H, HAr), 7.40–7.33 (m, 7H, HAr), 7.31–7.27 (m, 1H, HAr),
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6.42 (s, 1H, 3H), 5.02-4.98 [m, 2H, PhCH 2O-(C-2)], 4.62–4.56 (m, 2H, PhCH 2OCH2),
3.96 (bs, 1H, OH), 3.82 (s, 1H, H-5), 3.65 (d, 1H, J gem = 9.4Hz, PhCH2O-CHaHb),
3.60–3.57 (m, 4H, PhCH2O-CHaHb, CH3); 13C NMR (100.6MHz, acetone-D6) δ: 198.3
(C-1), 156.9 (C-2), 139.4, 137.0 (2 × CAr,q.), 129.3, 129.2, 129.0, 128.7, 128.6, 128.6,
128.5 (CAr), 128.4 (C-3), 81.2 (C-5), 75.3 (PhCH2O-CH2), 74.0 (PhCH2O-CH2), 72.1
[PhCH2O-(C-2)], 60.0 (CH3); HR-ESI-TOF calcd. for C21H22O5Na [M+Na]+: 377.1359.
Found: 377.1358.
rac-(4R/S,5S/R)-2,5-Bis(benzyloxy)-4-benzyloxymethyl-4-hydroxycyclo-
pent-2-enone [(±)-77]:
(±)
O
OBn
HO
BnO
BnO
To a solution of 5-benzyloxycyclopent-2-enone (±)-74 (69mg; 0.160mmol) in anhydrous
DMF (3.3mL) was added a freshly prepared solution of KOtBu 2mg/mL in DMF
(1.35mL; 0.024mmol), and the reaction mixture was heated to 70 ◦C. After 24 h, the
mixture was allowed to cool to r.t., and acetate buffer pH 5 (1mL) was added to the
dark brown solution. All volatile components were evaporated in vacuo. Benzaldehyde
(19.2mg) was added to the crude product mixture as an internal integration standard
to determine the amount of unreacted (±)-74 (43%), of diastereoisomer (±)-77 (20%),
and of regioisomer (±)-78 (16%) by 1H NMR integration. Chromatographic purification
(SiO2, toluene/ethyl acetate, 12:1 to 10:1) afforded (±)-77 (12mg, 17%) as a yellow oil
as the product with higher chromatographic mobility, along with (±)-78 (11mg, 16%).
Analytical data for (±)-77:
Rf=0.54 (toluene/ethyl acetate, 4:1);
[
α
]20
D 0 (c= 1, CHCl3); 1H NMR (600.1MHz,
acetone-D6) δ: 7.45–7.27 (m, 15H, HAr), 6.43 (s, 1H, H-3), 5.02–5.00 [m, 2H, PhCH 2O-
(C-2)], 4.90 [d, 1H, J gem = 11.9Hz, PhCHaHbO-(C-5)], 4.85 [d, 1H, J gem = 11.9Hz,
PhCHaHbO-(C-5)], 4.53 (d, 1H, J gem = 12.1Hz, PhCHaHbO-CH2), 4.50 (d, 1H, J gem
= 11.9Hz, PhCHaHbO-CH2), 4.10 (bs, 1H, OH), 4.08 (s, 1H, H-5), 3.60 (d, 1H, J gem =
9.4Hz, PhCH2O-CHaHb), 3.57 (d, 1H, J gem = 9.4Hz, PhCH2O-CHaHb); 13C NMR
(150.9MHz, acetone-D6) δ: 198.6 (C-1), 157.0 (C-2), 139.3, 139.1, 137.0 (3 × CAr,q.),
129.4, 129.1, 129.1, 129.1, 128.9, 128.7 (CAr), 128.7 (C-3), 128.6, 128.5, 128.4 (CAr),
78.9 (C-5), 75.1 (PhCH2O-CH2), 74.7 (C-4), 74.0 (PhCH2O-CH2), 73.8 [PhCH2O-(C-
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5)], 72.1 [PhCH2O-(C-2)]; HR-ESI-TOF calcd. for C27H26O5Na [M+Na]+: 453.1672.
Found: 453.1674.
rac-(4R/S,5R/S)-3,5-Bis(benzyloxy)-4-benzyloxymethyl-4-hydroxycyclo-
pent-2-enone [(±)-78]:
(±)
O
HO
BnO
BnO
OBn
Cyclopent-2-enone (±)-78 (11mg; 16%) was isolated as a minor regioisomer, together
with (±)-77, in the transformation of (±)-74 as described above. Analytical data for
(±)-78:
Rf=0.42 (toluene/ethyl acetate, 4:1);
[
α
]20
D 0 (c= 1, CHCl3); 1H NMR (600.1MHz,
acetone-D6) δ: 7.47–7.44 (m, 4H, HAr), 7.40–7.32 (m, 5H, HAr), 7.29–7.21 (m, 6H,
HAr), 5.46 (s, 1H, H-2), 5.19–5.13 [m, 2H, PhCH 2O-(C-3)], 5.07–5.04 [m, 2H, OH,
PhCHaHbO-(C-5)], 4.87 [d, 1H, J gem = 12.1 Hz, PhCHaHbO-(C-5)], 4.54 (d, 1H,
J gem = 12.1 Hz, PhCHaHbO-CH2), 4.48 (d, 1H, J gem = 12.1 Hz, PhCHaHbO-CH2),
4.16 (s, 1H, H-5), 3.78–3.76 (m, 2H, PhCH2O-CH 2); 13C NMR (150.9MHz, acetone-
D6) δ: 197.9 (C-1), 183.2 (C-3), 139.6, 139.5, 136.2 (3 × CAr,q.), 129.4, 129.2, 129.0,
129.0, 128.8, 128.3, 128.3, 128.2, 128.1 (CAr), 104.3 (C-2), 87.0 (C-5), 80.2 (C-4), 74.1
[PhCH2-O-(C-5)], 73.9 (PhCH2O-CH2), 73.7 [PhCH2O-(C-3)], 71.6 (PhCH2O-CH2);
HR-ESI-TOF calcd. for C27H26O5Na [M+Na]+: 453.1672. Found: 453.1672.

7. Summary of Results
In the course of this thesis, synthetic and structural studies have been performed on
complex carbohydrate scaffolds of interest. In this regard, the results described here offer
a contribution to the chemistry of higher-carbon sugars with structural relations to either
naturally occurring complex sugars, or to carbohydrate analogs with potential biological
applications. Detailed investigations into the reactivities of the synthetic intermediates
provided further insight into widely employed classes of carbohydrate building blocks.
Compound classes with special relevance to the synthetic routes described here are
2-keto-sugars (2-ulosides) and 2-C -branched sugars. Consequently, this thesis contains
contributions to the chemistry of these important carbohydrate frameworks.
As universal intermediates towards the target structures of this thesis, 3,4,6-O-
benzylated β-2-ulosides of type 2 were required. In this regard, preliminary examinations
focussed on the synthesis of the unknown allyl 2-uloside 2a, a sensitive intermediate
prone to elimination of the 4-benzyloxy group. Whereas glycosylation-based methods
with the corresponding 2-ulosyl bromide donor met with failure, Dess-Martin oxidation
of the respective 2-O-unprotected glucoside 7 proved to be suitable and provided the
sensitive 2-keto-sugar 2a reliably. The corresponding benzyl 2-uloside 2b and methyl
2-uloside 2c, which have both been prepared previously by other methods, could also
be obtained in this way from the known 2-O-unprotected glucosides 8 and 11. X-ray
structural analyses on both the known glucoside 11 and the corresponding known
2-uloside 2b provided insight into structural features of 2-keto-sugars, and confirmed
that 2b occupied a distorted 4C 1 conformation.
OBnO
BnO
OBn
O
OR
OBnO
BnO
OBn
OH
OR
2a: R = All
2b: R = Bn
2c: R = Me
Dess-Martin 
periodinane
D-Glc
5 steps (known)
via carbohydrate-
1,2-orthoesters
  7: R = All
11: R = Bn
  8: R = Me
(83 to 96%)
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β-2-Ulosides structurally similar to intermediates 2a,b,c have been shown to undergo
carbonyl addition reactions with equatorial selectivity, giving the respective carbon-
branched mannoside products. In this way, derived from ketones 2a,b, various novel
2-C -branched mannosides could be synthesized by the reaction with Grignard reagents
or alkynyllithium nucleophiles. The obtained products included the vinyl-branched
allyl mannoside 16, as well as 2-C -(Z )-alkenyl branched mannosides 23 or 36, both
derived from Lindlar hydrogenation of the respective alkynes. This set of unsaturated
branched mannosides could be extended by routine protecting group transformations,
or by reacting substrates 2 with other metalated alkynes in a similar manner. The
Lindlar hydrogenations of alkynes of type 22 required optimized conditions, and DMF
as the solvent was found to significantly accelerate the semihydrogenations of these
sterically crowded branched alkynes. The structure of 23, which exhibited rotameric
isomerism in NMR experiments, was furthermore confirmed by X-ray crystallography.
Apart from serving as intermediates in the target-oriented syntheses as described below,
these molecular scaffolds can be expected to be useful carbohydrate building blocks
due to the straightforward functionalization of the introduced unsaturations.
OBnO
BnO
OBn
O
OR
2a: R = All
2b: R = Bn
OBnO
BnO
OBn
OAll
OH
16
(83%, 2 steps from 7)
vinyl-MgBr
OBnO
BnO
OBn
OBn
OH
BnO
OBn
OBnO
BnO
OBn
OBn
OH
BnO
BnO
alkynyl-Li
alkynyl-Li
22
23
(79%, 2 steps)
OBnO
BnO
OBn
OBn
OH
OTHP
1. Lindlar
    hydrogenation
2. deprotection
OBnO
BnO
OBn
OBn
OH
HO
35
36
(86%, 3 steps)
Lindlar
hydrogenation
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OBnO
BnO
OBn
OAll
OH
16
OBnO
BnO
OBn
O
OH
17 (94%)
OHO
HO
OH
O
OH
HO OH
anti-21 
(40%, 3 steps,
11 steps from D-Glc)
OHO
HO
OH
O
OH
HO
OH
RCM
1. syn-dihydrox.
2. deprotection
1. epoxidation
2. epoxide opening
3. deprotection
syn-15 
(95%, 2 steps,
10 steps from D-Glc)
In one target-oriented synthetic project, the synthesis of 1,2-annulated bicyclic carbo-
hydrates was explored. Such rigid, conformationally fixed sugar derivatives have been
shown to act as carbohydrate mimetic inhibitors for several natural glycosidases, an
enzyme class widely associated with severe diseases, and thus, medicinally relevant.
Starting from vinyl-branched mannoside 16, a synthetic strategy involving ring-closing
metathesis followed by syn-dihydroxylation or epoxidation/epoxide opening provided
target structures syn-15 and anti-21, which can be described as polyhydroxylated
2,10-dioxadecalin derivatives. Both highly polar bicyclic sugars exhibited a trans-decalin
core structure, and were amenable to full NMR characterization in D2O. The structure
of syn-15 could additionally be confirmed by X-ray crystallography, which provided
insight into a dense network of hydrogen-bonding interactions of the hydroxyl-rich
sugar hybrid in the solid state. Structurally related 1,2-annulated sugars have been
reported before. However, the developed synthetic strategy involving allyl 2-uloside 2a
facilitated the synthesis of such frameworks with the traditionally challenging β-manno-
configuration. In this regard, the results discussed here are a valuable contribution to
synthetic strategies for bicyclic carbohydrate mimetics.
In contrast to these conformationally rigid annulated sugars, a second project targeted
the synthesis of structurally diverse reducing sugars with multiple cyclic hemiacetal
forms. Inspired by the annulated major isomer of the unusual natural monosaccharide
bradyrhizose (structure K), the synthesis of similar cyclic hemiacetals with a con-
ventional pyranose (β-mannose) instead of the carbasugar moiety was pursued. The
natural bradyrhizose K was isolated from Gram-negative nitrogen-fixing soil bacteria,
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syn-dihydrox. 1. epoxidation 
2. epoxide opening
3. deprotections
OBnO
BnO
OBn
OBn
OH
HO 36
(7S,8S)-43
(major)
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
OBnO
BnO
OBn
OBn
OH
HO
OH
OH
(7R,8R)-44
(minor)
(7R,8S)-67
(26%, 4 steps)
OBnO
BnO
OBn
OBn
OHO
HO
OH
OBnO
BnO
OBn
OBn
OHO
HO OH
OBnO
BnO
OBn
OBn
OHO
HO OH
oxidation oxidation 1. oxidation2. DIBAL-H
side chain: D-ribo side chain: D-lyxo side chain: D-xylo
α,β-48 (61%) α,β-51 (64%) α,β-68 (63%, 2 steps)
(up to 96%,
d.r. up to 6.6:1)
and its unusual structure is believed to play a role in the initiation of symbiosis with
legume host plants. Due to these biological aspects, and due to an interesting equi-
librium of hemiacetal isomers of K, the synthesis of these higher sugar analogs was
desirable. In an optimized synthetic approach towards such structures, side chain allyl
alcohol 36 was transformed into the fully hydroxylated propyl-branched mannosides
(7S,8S)-43, (7R,8R)-44 and (7R,8S)-67 via osmium-based syn-dihydroxylation or
via an epoxidation/epoxide opening sequence. The configurations of the hydroxylated
side chains of these intermediates could be fully established by NMR experiments and
X-ray structural analyses of suitable derivatization products. Subsequently, selective
oxidation of the primary alcohol functionalities gave spirofuranose-pyranoses α,β-48,
α,β-51 and α,β-68 with diverse stereochemical configurations of the furanose moieties
(d-ribo, -lyxo and -xylo, respectively). Selective oxidation methods utilizing catalytic
TEMPO under reported conditions failed to give these intermediates in a clean manner.
Therefore, a novel oxidation protocol involving TEMPO/trichloroisocyanuric acid in
connection with an optimized solvent/buffer system had to be established, and proved
to be an effective and mild oxidation method for other sensitive substrates. In the
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transformation of the anti-isomer (7R,8S)-67, overoxidation to the lactone occurred,
and therefore a following reduction step was required to provide the wanted hemiacetal
α,β-68. The obtained spirofuranose-pyranose hybrid molecules constituted a new class
of structurally interesting complex carbohydrates, and could be fully characterized as
α/β-mixtures via 2D NMR experiments. In the final global debenzylation step, these
spirofuranoses liberated the target molecules, represented by the 4-C -formyl branched
octoses syn-50, syn-52 and anti-70 in the open-chain forms. Detailed NMR-based
structural investigations into the major cyclic hemiacetal forms in D2O revealed that the
anticipated bradyrhizose-type acetal-hemiacetal-isomers (see bottom) did not represent
major isomeric forms of the compounds. Instead, the respective bis(hemiacetal) forms
HO
HO
OH
O
OH
HO
OH
OH
(bradyrhizose)
OHO
HO
OH
O
OH
HO OH
OH
K
(not observed)
5
1
23
145
9
7
9,7-pyr-1,9-pyr
related to:target structures:
(anticipated)
(O)HC
CHO
OH
HO
OH
OH
CH2OH
OH
OH9
8
1
4
2
3
5
6
7
syn-50
(30%, 9 steps from 2b,
14 steps from D-glc)
(O)HC
CHO
OH
HO
OH
OH
CH2OH
HO
HO
syn-52
(8%, 9 steps from 2b,
14 steps from D-glc)
(O)HC
CHO
OH
HO
OH
OH
CH2OH
OH
HO
9
anti-70
(13%, 11 steps from 2b,
16 steps from D-glc)
OHO
HO
OH
OH
OHO
HO OH
1
2 3
7
8
debenzylation debenzylation debenzylation
major isomers in D2O:
(> 50% contrib.) OHO
O
OH
OH
HO OH1
OH
2
3
7
8
9
OH
1,5-pyr-9,7-pyr 1,4-fur-9,7-pyr
(for syn-50/syn-52) (for anti-70)
side chain: D-ribo side chain: D-lyxo side chain: D-xylo
α,β-48 α,β-51 α,β-68
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(1,5-pyranose-9,7-pyranoses or spiro-1,4-furanose-9,7-pyranoses) were identified to be the
major species in solution. These results indicated a distinct alteration of the preferred
hemiacetal isomeric forms upon changing the carbasugar motif of bradyrhizose into a
conventional β-mannoside structure. Although this suggested that the obtained target
structures were no suitable analogs for the natural bradyrhizose monosaccharide, the
presented work is an addition to the chemistry of higher-carbon sugars, to selective
oxidation reactions of polyhydroxylated substrates, and to the complex stereochemistry
of carbohydrate structures in general.
In a concluding project, basic reactivities were explored starting from the 2-keto-
sugars 2a,b,c. Treatment of these substrates with basic reagents (K2CO3) invoked an
elimination of benzyl alcohol and formation of the carbohydrate 3,2-enolones 3b/40/72.
Similar observations have been described in the literature as a universal degradation
reaction of 2-keto-sugars which is particularly frequent for ester-protected substrates.
Upon subjecting these α,β-unsaturated carbonyl compounds to basic conditions in polar
aprotic solvents (e.g. KOtBu in DMF), a novel rearrangement into racemic 2-benzyloxy-
4-benzyloxymethyl-4-hydroxy-2-alkoxycyclopent-2-enones was initiated. Mechanistic
considerations suggested a cascade involving electrocyclic ring-opening to an achiral
open-chain enolate species, followed by electrocyclic or intramolecular aldol-type ring
closure towards the products (±)-73,74,75. Additionally, under the conditions of the re-
arrangement, 2-ulosides 2b,c could be transformed into the respective cyclopent-2-enone
products in an elimination-rearrangement cascade process. Comparable rearrangements
have been reported previously, however, these reactions resulted in the formation
of the regioisomeric 5-hydroxycyclopent-2-enones. Mechanistic explanations for this
experimental difference could be established. Furthermore, close investigations into
observable side products and isomerization processes of the rearrangement reaction
OBnO
BnO
OBn
O
OR
2a: R = All
2b: R = Bn
2c: R = Me
(elimination)
O
BnO
OBn
O
OR
3b: R = All
40: R = Bn
72: R = Me
KOtBu cat. or 
NaSPh cat.,
O
OBn
HO
BnO
RO
(±)-73: R = All
(±)-74: R = Bn
(±)-75: R = Me
(rearrangement)
elimination-rearrangement cascade
DMF
(70 to 90%) (61 to 85%)
KOtBu cat., DMF
(for 2b/2c)
K2CO3,
PhCH3, H2O
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provided an additional understanding of this interesting transformation in the context
of the molecular diversity of unsaturated carbohydrates and the derived carbocyclic
products.

List of Abbreviations and Symbols
1,2-DCE 1,2-dichloroethane
2,2-DMP 2,2-dimethoxypropane
α specific rotation
α anomeric descriptor in carbohydrate structures
β anomeric descriptor in carbohydrate structures
Å Angstrom; 0.1 nm
Ac acetyl
acac acetylacetonate
AD asymmetric dihydroxylation
AIBN azobisisobutyronitrile
Aliquat 336 N -methyl-N,N,N -trioctylammonium chloride
All allyl
Ar aryl
ATCC American Type Culture Collection
BINOL 1,1’-bi-2-naphthol
Bn benzyl
Boc tert-butyloxycarbonyl
BQ benzoquinone
Bz benzoyl
brsm based on recovered starting material
bs broad singlet (NMR)
C chair conformation
calcd. calculated
262 List of Abbreviations and Symbols
cl. cleavage
CLB para-chlorobenzoate
CM cytoplasmic membrane
COSY correlation spectroscopy (NMR)
CSA camphorsulfonic acid
δ chemical shift in NMR spectroscopy [ppm]
d doublet (NMR)
DABCO 1,4-diazabicyclo[2.2.2]octane
dd doublet of doublets (NMR)
DEPT distortionless enhancement by polarization transfer (NMR)
DHQ dihydroquinine
DHQD dihydroquinidine
DIBAL-H diisobutylaluminium hydride
DIC N,N’-diisopropylcarbodiimide
diglyme bis(2-methoxyethyl) ether
DMAP 4-dimethylaminopyridine
DMDO dimethyldioxirane
DMF dimethylformamide
DMP Dess-Martin periodinane
DMSO dimethyl sulfoxide
DNJ 1-deoxynojirimycin
d.r. diastereomeric ratio
 molar attenuation coefficient
E envelope conformation
EC Enzyme Commission number
ee enantiomeric excess
EPR electron paramagnetic resonance
equiv. equivalents
ESI electrospray ionization
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FAB fast atom bombardment
FTICR fourier-transform ion cyclotron resonance
Fuc l-fucose
FUR furanose
Gal d-galactose
GC gas chromatography
gem geminal
GH glycoside hydrolase, glycosidase
Glc d-glucose
GlcN d-glucosamine
GlcNAc N -acetyl-d-glucosamine
GlcOS d-glucosone
GT glycosyltransferase
H half-chair conformation
H.-G. Hoveyda-Grubbs catalyst
HMBC heteronuclear multiple bond correlation (NMR)
HMDS hexamethyldisilazide
HPLC high-performance liquid chromatography
HQ hydroquinone
HR high resolution
HSQC heteronuclear single quantum coherence (NMR)
i-Bu isobutyl
IM intramolecular
IND indolinyl
i-Pr isopropyl
IUPAC International Union for Pure and Applied Chemistry
J coupling constant in NMR spectroscopy [Hz]
Kdo 3-deoxy-α-d-manno-oct-2-ulosonic acid
LA Lewis acid
264 List of Abbreviations and Symbols
LDA lithium diisopropylamide
LDmanHep l-glycero-d-manno-heptose
LPS lipopolysaccharides
m multiplet (NMR)
m-CPBA meta-chloroperoxybenzoic acid
Me methyl
MMPP magnesium monoperoxyphthalate
MOPS 3-(N -morpholino)propanesulfonic acid
M.p. melting point
MS mass spectrometry
MS molecular sieves
MTPA α-methoxy-α-(trifluoromethyl)phenylacetic acid
NBS N -bromosuccinimide
n-Bu n-butyl
Neu neuraminic acid
NMO N -methylmorpholine N -oxide
NOE nuclear overhauser effect (NMR)
NOESY nuclear overhauser spectroscopy (NMR)
OM outer membrane
OMP outer membrane proteins
ox. oxidation
PBN N -tert-butyl-α-phenylnitrone
PDH pyranose 2-dehydrogenase
Pg protecting group
PHAL phthalazine
POx pyranose 2-oxidase
Py pyridine
PYR pyranose
q. quaternary
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RCM ring-closing metathesis
RDS rate-determining step
red. reduction
Rf retention factor (TLC)
RP reversed phase
r.t. room temperature
s singlet (NMR)
sat. saturated
SET single electron transfer
sh shoulder (UV/Vis spectroscopy)
Sug sugar
t triplet (NMR)
TBAF tetra-n-butylammonium fluoride
TBDPS tert-butyldiphenylsilyl
TBS tert-butyldimethylsilyl
t-Bu tert-butyl
TCICA trichloroisocyanuric acid
TEMPO 2,2,6,6-tetramethylpiperidin-N -oxyl
Tf trifluoromethanesulfonyl
TFA trifluoroacetic acid
TFAA trifluoroacetic acid anhydride
TFE 2,2,2-trifluoroethanol
THF tetrahydrofuran
THP tetrahydro-2H -pyran-2-yl
TIPS triisopropylsilyl
TLC thin-layer chromatography
TMS trimethylsilyl
TOCSY total correlation spectroscopy (NMR)
TOF time of flight ion separation
266 List of Abbreviations and Symbols
TS transition state
Ts toluenesulfonyl
UV ultraviolet radiation
vic vicinal
Vis visible light
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Given below is a list of all numbered compounds, and cross-references to the corres-
ponding reaction schemes are included. For compounds isolated multiple times from
different reactions, the respective highest yield synthesis is referenced. Additionally,
literature references are given for known compounds.
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X-ray Data of Compound 2b
O
O
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2b
Colorless needles of 2b were grown by slow diffusion of n-pentane into a solution of the
compound (20mg) in ethyl acetate/chloroform (2:1, 750µL) at r.t.
For structural data: CCDC 1505647 via https://www.ccdc.cam.ac.uk.
Figure A.1 X-ray structure of compound 2b. Hydrogen atoms of the benzyl ethers and a
disorder involving the O51 benzyl group are omitted for clarity. Ellipsoids are
drawn at the 50% probability level. Red = oxygen, gray = carbon, white =
hydrogen.
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Table A.1 Crystal data and refinement parameters for compound 2b. Estimated standard
deviations are given in parentheses.
parameter 2b
Empirical formula C34H34O6
Formula weight (g/mol) 538.61
Temperature (K) 100(2)
Radiation type CuKα
Wavelength (Å) 1.54178
Crystal system Monoclinic
Space group P21
a (Å) 12.5198(4)
b (Å) 7.6052(3)
c (Å) 15.2218(5)
α (°) 90
β (°) 102.2180(10)
γ (°) 90
Cell volume (Å3) 1416.52(9)
Z 2
Density (calculated) (Mg/m3) 1.263
Crystal size (mm3) 0.430 × 0.066 × 0.052
θ range (°) 2.970 to 66.615
Reflections collected 12973
Independent reflections (Rint) 4840 (0.0196)
Goodness-of-fit on F2 1.057
Final R indices [I>2σ(I)] R1=0.0295, wR2=0.0754
R indices (all data) R1=0.0302, wR2=0.0760
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X-ray Data of Compound 11
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Crystals of 11 were obtained by evaporation of a solution of the compound in n-
hexane/ethyl acetate. Upon drying, the residual oil crystallized to give colorless prisms.
For structural data: CCDC 1909188 via https://www.ccdc.cam.ac.uk.
Figure A.2 X-ray structure of compound 11. Hydrogen atoms of the benzyl ethers are
omitted for clarity. Ellipsoids are drawn at the 50% probability level. Red =
oxygen, gray = carbon, white = hydrogen.
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Table A.2 Crystal data and refinement parameters for compound 11. Estimated standard
deviations are given in parentheses.
parameter 11
Empirical formula C34H36O6
Formula weight (g/mol) 540.63
Temperature (K) 110(2)
Radiation type MoKα
Wavelength (Å) 0.71073
Crystal system Orthorhombic
Space group P212121
a (Å) 8.0111(2)
b (Å) 10.8059(2)
c (Å) 32.7521(6)
α (°) 90
β (°) 90
γ (°) 90
Cell volume (Å3) 2835.26(10)
Z 4
Density (calculated) (Mg/m3) 1.267
Crystal size (mm3) 0.14 × 0.12 × 0.10
θ range (°) 1.985 to 27.890
Reflections collected 31154
Independent reflections (Rint) 6733 (0.0201)
Goodness-of-fit on F2 1.008
Final R indices [I>2σ(I)] R1=0.0322, wR2=0.0771
R indices (all data) R1=0.0366, wR2=0.0798
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X-ray Data of Compound syn-15
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Colorless plates of syn-15 were obtained by adding water dropwise to a suspension
of the compound (36mg) in boiling methanol (1mL) to a clear solution. Subsequent
cooling to 4 ◦C over several days resulted in crystallization.
For structural data: CCDC 1427168 via https://www.ccdc.cam.ac.uk.
Figure A.3 X-ray structure of compound syn-15. A second molecule in the asymmetric
unit is omitted. Ellipsoids are drawn at the 50% probability level. Red =
oxygen, gray = carbon, white = hydrogen.
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Table A.3 Crystal data and refinement parameters for compound syn-15. Estimated
standard deviations are given in parentheses.
parameter syn-15
Empirical formula C9H16O8
Formula weight (g/mol) 252.22
Temperature (K) 100(2)
Radiation type CuKα
Wavelength (Å) 1.54178
Crystal system Monoclinic
Space group P21
a (Å) 9.0765(3)
b (Å) 10.3405(3)
c (Å) 10.7638(3)
α (°) 90
β (°) 90.0570(10)
γ (°) 90
Cell volume (Å3) 1010.24(5)
Z 4
Density (calculated) (Mg/m3) 1.658
Crystal size (mm3) 0.298 × 0.187 × 0.072
θ range (°) 4.107 to 66.664
Reflections collected 6541
Independent reflections (Rint) 3016 (0.0149)
Goodness-of-fit on F2 1.032
Final R indices [I>2σ(I)] R1=0.0220, wR2=0.0561
R indices (all data) R1=0.0220, wR2=0.0561
278 Appendix A. X-Ray Crystallography
Table A.4 Selected bond lengths, angles and torsion angles for syn-15. Estimated standard
deviations are given in parentheses.
bond (Å) bond (Å) bond (Å)
C1-C2 1.535(5) C3-C4 1.527(4) C6-O6 1.429(4)
C1-O1 1.405(3) C3-O3 1.421(4) C1’-O1’ 1.446(3)
C1-O1’ 1.411(3) C4-C5 1.534(4) C1’-C2’ 1.524(4)
C2-C3 1.535(4) C4-O4 1.425(3) C2’-C3’ 1.526(4)
C2-C3’ 1.533(4) C5-C6 1.507(4) C2’-O2’ 1.438(3)
angle (°) angle (°) torsion (°)
O1-C1-O1’ 104.2(2) C4-C5-C6 112.5(2) O1’-C1-C2-O2 58.6(3)
C1-O1’-C1’ 111.4(2) C4-C5-O1 111.1(2) O1-C1-C2-O2 -56.6(3)
C1-O1-C5 110.5(2) C6-C5-O1 107.3(2) O1-C1-O1’-C1’ -179.9(2)
C1-C2-C3 106.7(2) C1’-C2’-C3’ 111.4(2) O2-C2-C3’-O3’ 172.6(2)
C3’-C2-O2 104.8(2) O2’-C2’-C3’ 110.0(2) O3’-C3’-C2’-O2’ -53.7(3)
C3-C2-C3’ 113.7(2) C2-C3’-C2’ 108.3(2) O1’-C1-O1-C5 174.2(2)
C2-C3-C4 109.7(2) O3’-C3’-C2’ 110.6(2)
C3-C4-C5 109.7(2)
Table A.5 Hydrogen-bonding interactions of syn-15 for dO···H < 3.0Å and θO−H···O > 90◦.
Type: 2c (two-centered classical, including type: H···O···H’), bif. (bifurcated,
type: O···H(-O)···O’).
contact O···O (Å) H···O (Å) O-H···O (°) type symm. op.
O22’-H22A···O1 2.97 2.19 154.9 2c x,y,1+z
O3’-H3B···O1 3.21 2.90 103.7 bif. 2-x,-1/2+y,-z
O3-H3C···O1’ 2.73 1.90 172.8 2c 2-x,-1/2+y,-z
O2-H2C···O3’ 2.82 2.08 145.8 2c 2-x,-1/2+y,-z
O2’-H2B···O21 2.89 2.06 166.6 bif. x,y,z
O2’-H2B···O23 3.40 2.92 118.1 bif. 1-x,1/2+y,1-z
O4-H4A···O2’ 2.84 2.03 161.7 2c 1+x,y,z
O3’-H3B···O6 2.74 1.91 169.5 bif. 2-x,-1/2+y,-z
O6-H6···O23 2.73 1.90 173.0 2c 1+x,y,-1+z
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Table A.5 Continued: hydrogen-bonding interactions of syn-15.
contact O···O (Å) H···O (Å) O-H···O (°) type symm. op.
O23-H23D···O21 3.01 2.24 152.1 bif. 1-x,-1/2+y,1-z
O22-H22C···O24 2.83 2.04 154.9 2c 1-x,-1/2+y,1-z
O23-H23D···O26 3.12 2.46 136.5 bif. 1-x,-1/2+y,1-z
O23’-H23B···O26 2.81 2.03 155.4 2c 1-x,-1/2+y,1-z
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X-ray Data of Compound 17
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Colorless needles of 17 were obtained by slow concentration of a solution of the com-
pound in n-hexane/ethyl acetate at r.t.
For structural data: CCDC 1497333 via https://www.ccdc.cam.ac.uk.
Figure A.4 X-ray structure of compound 17. Hydrogen atoms of the benzyl ethers are
omitted for clarity. Ellipsoids are drawn at the 50% probability level. Red =
oxygen, gray = carbon, white = hydrogen.
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Table A.6 Crystal data and refinement parameters for compound 17. Estimated standard
deviations are given in parentheses.
parameter 17
Empirical formula C30H32O6
Formula weight (g/mol) 488.55
Temperature (K) 100(2)
Radiation type MoKα
Wavelength (Å) 0.71073
Crystal system Monoclinic
Space group P21
a (Å) 13.4668(7)
b (Å) 5.4807(3)
c (Å) 17.8748(10)
α (°) 90
β (°) 107.555(3)
γ (°) 90
Cell volume (Å3) 1257.85(12)
Z 2
Density (calculated) (Mg/m3) 1.290
Crystal size (mm3) 0.430 × 0.090 × 0.030
θ range (°) 1.586 to 26.683
Reflections collected 13024
Independent reflections (Rint) 5731 (0.0534)
Goodness-of-fit on F2 1.017
Final R indices [I>2σ(I)] R1=0.0482, wR2=0.0869
R indices (all data) R1=0.0720, wR2=0.0981
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X-ray Data of Compound 23
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Colorless needles of 23 were grown by vapor diffusion of n-pentane into a solution of
the compound (20mg) in ethyl acetate/chloroform (2:1, 750µL) at r.t.
For structural data: CCDC 1505648 via https://www.ccdc.cam.ac.uk.
Figure A.5 X-ray structure of compound 23. One out of four molecules in the asymmetric
unit is shown. Hydrogen atoms of the benzyl ethers are omitted for clarity.
Ellipsoids are drawn at the 50% probability level. Red = oxygen, gray =
carbon, white = hydrogen.
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Table A.7 Crystal data and refinement parameters for compound 23. Estimated standard
deviations are given in parentheses.
parameter 23
Empirical formula C51H52O8
Formula weight (g/mol) 792.92
Temperature (K) 101(2)
Radiation type MoKα
Wavelength (Å) 0.71073
Crystal system Triclinic
Space group P1
a (Å) 9.7674(7)
b (Å) 15.2213(10)
c (Å) 29.934(2)
α (°) 90.647(3)
β (°) 93.386(3)
γ (°) 108.083(3)
Cell volume (Å3) 4221.1(5)
Z 4
Density (calculated) (Mg/m3) 1.248
Crystal size (mm3) 0.432 × 0.096 × 0.077
θ range (°) 1.364 to 27.300
Reflections collected 127433
Independent reflections (Rint) 36514 (0.1116)
Goodness-of-fit on F2 0.971
Final R indices [I>2σ(I)] R1=0.0675, wR2=0.1343
R indices (all data) R1=0.1392, wR2=0.1693
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X-ray Data of Compound 41
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Colorless needles of 41 were grown by vapor diffusion of n-pentane into a solution of
the compound (10mg) in acetone-D6 (500µL) at r.t.
For structural data: CCDC 1895600 via https://www.ccdc.cam.ac.uk.
Figure A.6 X-ray structure of compound 41. Hydrogen atoms of the benzyl ethers are
omitted for clarity. Ellipsoids are drawn at the 50% probability level. Red =
oxygen, gray = carbon, white = hydrogen.
Appendix A. X-Ray Crystallography 285
Table A.8 Crystal data and refinement parameters for compound 41. Estimated standard
deviations are given in parentheses.
parameter 41
Empirical formula C38H38O8
Formula weight (g/mol) 622.68
Temperature (K) 100(2)
Radiation type MoKα
Wavelength (Å) 0.71073
Crystal system Monoclinic
Space group P21
a (Å) 8.5680(4)
b (Å) 10.1981(5)
c (Å) 18.5348(9)
α (°) 90
β (°) 98.016(2)
γ (°) 90
Cell volume (Å3) 1603.70(13)
Z 2
Density (calculated) (Mg/m3) 1.290
Crystal size (mm3) 0.272 × 0.062 × 0.047
θ range (°) 2.219 to 28.885
Reflections collected 31261
Independent reflections (Rint) 8389 (0.0473)
Goodness-of-fit on F2 1.017
Final R indices [I>2σ(I)] R1=0.0405, wR2=0.0776
R indices (all data) R1=0.0558, wR2=0.0845
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X-ray Data of Compound (7S,8S)-47
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Colorless needles of (7S,8S)-47 were grown by vapor diffusion of diethyl ether into a
solution of the compound (20mg) in acetonitrile (450µL) at r.t.
For structural data: CCDC 1895601 via https://www.ccdc.cam.ac.uk.
Figure A.7 X-ray structure of compound (7S,8S)-47. Hydrogen atoms of the benzyl
ethers are omitted for clarity. Ellipsoids are drawn at the 50% probability level.
Red = oxygen, gray = carbon, white = hydrogen.
Appendix A. X-Ray Crystallography 287
Table A.9 Crystal data and refinement parameters for compound (7S,8S)-47. Estimated
standard deviations are given in parentheses.
parameter (7S,8S)-47
Empirical formula C47H54O12
Formula weight (g/mol) 810.90
Temperature (K) 100(2)
Radiation type CuKα
Wavelength (Å) 1.54178
Crystal system Monoclinic
Space group P21
a (Å) 11.0987(2)
b (Å) 6.02780(10)
c (Å) 30.6688(4)
α (°) 90
β (°) 91.6070(10)
γ (°) 90
Cell volume (Å3) 2050.96(6)
Z 2
Density (calculated) (Mg/m3) 1.313
Crystal size (mm3) 0.474 × 0.106 × 0.070
θ range (°) 1.441 to 66.626
Reflections collected 32675
Independent reflections (Rint) 7017 (0.0292)
Goodness-of-fit on F2 1.060
Final R indices [I>2σ(I)] R1=0.0266, wR2=0.0658
R indices (all data) R1=0.0279, wR2=0.0665
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X-ray Data of Compound (7R,8R)-61
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Colorless plates of (7R,8R)-61 were obtained by vapor diffusion of diethyl ether into
a solution of the compound (12mg) in acetone-D6 (600µL) at r.t.
For structural data: CCDC 1895599 via https://www.ccdc.cam.ac.uk.
Figure A.8 X-ray structure of compound (7R,8R)-61. Hydrogen atoms of the benzyl
ethers are omitted for clarity. Ellipsoids are drawn at the 50% probability level.
Red = oxygen, gray = carbon, white = hydrogen.
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Table A.10 Crystal data and refinement parameters for compound (7R,8R)-61. Esti-
mated standard deviations are given in parentheses.
parameter (7R,8R)-61
Empirical formula C38H38O9
Formula weight (g/mol) 638.68
Temperature (K) 100(2)
Radiation type MoKα
Wavelength (Å) 0.71073
Crystal system Monoclinic
Space group P21
a (Å) 8.5337(3)
b (Å) 10.1228(4)
c (Å) 18.6351(7)
α (°) 90
β (°) 99.1070(10)
γ (°) 90
Cell volume (Å3) 1589.50(10)
Z 2
Density (calculated) (Mg/m3) 1.3340
Crystal size (mm3) 0.273 × 0.176 × 0.140
θ range (°) 1.107 to 29.074
Reflections collected 30538
Independent reflections (Rint) 8504 (0.0502)
Goodness-of-fit on F2 1.042
Final R indices [I>2σ(I)] R1=0.0392, wR2=0.0849
R indices (all data) R1=0.0468, wR2=0.0896
290 Appendix A. X-Ray Crystallography
X-ray Data of Compound α-63
α-63
side chain: α-D-lyxo
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Colorless needles of α-63 were obtained by slow concentration of a solution of α,β-63
(16mg) in toluene/CH2Cl2 (3:2; 1mL) at r.t.
For structural data: CCDC 1895602 via https://www.ccdc.cam.ac.uk.
Figure A.9 X-ray structure of compound α-63. Hydrogen atoms of the benzyl ethers and
a disorder involving the O6 benzyl group are omitted for clarity. Ellipsoids are
drawn at the 50% probability level. Red = oxygen, gray = carbon, white =
hydrogen.
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Table A.11 Crystal data and refinement parameters for compound α-63. Estimated
standard deviations are given in parentheses.
parameter α-63
Empirical formula C37H38O8
Formula weight (g/mol) 610.67
Temperature (K) 173(2)
Radiation type MoKα
Wavelength (Å) 0.71073
Crystal system Monoclinic
Space group P21
a (Å) 12.082(2)
b (Å) 9.8858(17)
c (Å) 13.502(2)
α (°) 90
β (°) 93.491(2)
γ (°) 90
Cell volume (Å3) 1609.7(5)
Z 2
Density (calculated) (Mg/m3) 1.260
Crystal size (mm3) 0.720 × 0.110 × 0.069
θ range (°) 2.197 to 28.925
Reflections collected 16500
Independent reflections (Rint) 8045 (0.0533)
Goodness-of-fit on F2 1.026
Final R indices [I>2σ(I)] R1=0.0533, wR2=0.1182
R indices (all data) R1=0.1003, wR2=0.1440
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X-ray Data of Compound (±)-75
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Colorless needles of (±)-75 were obtained by vapor diffusion of n-pentane into a solution
of the compound (25mg) in toluene (200 µL) at r.t.
For structural data: CCDC 1553837 via https://www.ccdc.cam.ac.uk.
Figure A.10 X-ray structure of compound (±)-75. Hydrogen atoms of the benzyl ethers
are omitted for clarity. Ellipsoids are drawn at the 50% probability level.
Red = oxygen, gray = carbon, white = hydrogen.
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Table A.12 Crystal data and refinement parameters for compound (±)-75. Estimated
standard deviations are given in parentheses.
parameter (±)-75
Empirical formula C21H22O5
Formula weight (g/mol) 354.38
Temperature (K) 100(2)
Radiation type CuKα
Wavelength (Å) 1.54178
Crystal system Orthorhombic
Space group Pna21
a (Å) 22.3577(5)
b (Å) 14.3796(3)
c (Å) 5.53140(10)
α (°) 90
β (°) 90
γ (°) 90
Cell volume (Å3) 1778.32(6)
Z 4
Density (calculated) (Mg/m3) 1.324
Crystal size (mm3) 1.161 × 0.081 × 0.036
θ range (°) 3.655 to 72.392
Reflections collected 17136
Independent reflections (Rint) 3200 (0.0492)
Goodness-of-fit on F2 1.016
Final R indices [I>2σ(I)] R1=0.0320, wR2=0.0778
R indices (all data) R1=0.0356, wR2=0.0796
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Antimicrobial screenings were performed by the CO-ADD initiative (The Community
for Open Antimicrobial Drug Discovery), located at the University of Queensland, 306
Carmody Rd, St. Lucia, QLD, 4072, Australia. Screenings involved the compounds 3b,
40, 72, (±)-73, (±)-74, (±)-75 and (±)-76. Given below is the employed standard
protocol as described by CO-ADD:
Inhibition of bacterial growth (against Staphylococcus aureus (Sa; ATCC
43300), Escherichia coli (Ec; ATCC 25922), Klebsiella pneumoniae (Kp;
ATCC 700603), Acinetobacter baumannii (Ab; ATCC 19606) and Pseu-
domonas aeruginosa (Pa; ATCC 27853)) was determined by measuring the
absorbance at 600 nm (OD600), using a Tecan M1000 Pro monochromator
plate reader. The percentage of growth inhibition was calculated for each
well, using the negative control (media only) and positive control (bacteria
without inhibitors) on the same plate as references. Growth inhibition
of Candida albicans (Ca; ATCC 90028) was determined by measuring ab-
sorbance at 530 nm (OD530), while the growth inhibition of Cryptococcus
neoformans var. grubii (Cn; H99, ATCC 208821) was determined by mea-
suring the difference in absorbance between 600 and 570 nm (OD600-570),
after the addition of resazurin (0.001% final concentration) and incubation
at 35 ◦C for an additional 2 h. The absorbance was measured using a Biotek
Synergy HTX plate reader. The percentage of growth inhibition was cal-
culated for each well, using the negative control (media only) and positive
control (fungi without inhibitors) on the same plate as references.
Negative inhibition values indicate that the growth rate is higher compared
to the negative control (bacteria/fungi only, set to 0% inhibition). The
growth rates for all bacteria and fungi has a variation of ± 10%. Any
significant variation (or outliers/hits) is identified by the modified Z-Score,
and actives are selected by a combination of inhibition value and Z-Score.
The Z-Score is calculated based on the sample population using a modified
Z-Score method which accounts for possible skewed sample population. The
modified method uses median and MAD (median average derivation) instead
of average and sd, and a scaling factor[285]:
M
(
i
)
 0.6745 · (x (i)−median (x)MAD). M (i) values of > 2.5 label out-
liers or hits. Active samples: equal or above 80% and Z-score above 2.5 for
either replicate (n = 2 on different plates). Partial active samples: inhibition
values between 50.9% and 79.9% or abs(Z-score) below 2.5. Inactive samples:
inhibition values below 50% and/or abs(Z-score) below 2.5.
Appendix C. Antimicrobial Screenings 301
Table C.1 Results of the antimicrobial screening of compounds 3b, 40, 72, (±)-73, (±)-74,
(±)-75 and (±)-76.
3b 40 72 (±)-73 (±)-74 (±)-75 (±)-76
Sa inhib. 1 18.72 16.01 12.53 12.37 10.95 12.97 1.10
Sa Z-score 1 0.12 0.31 0.56 0.57 0.67 0.53 1.36
Sa inhib. 2 10.86 15.27 15.47 13.04 10.85 16.37 15.79
Sa Z-score 2 0.80 0.46 0.45 0.63 0.80 0.38 0.43
Ec inhib. 1 10.72 10.04 7.57 8.20 8.43 7.35 –0.95
Ec Z-score 1 0.27 0.38 0.76 0.67 0.63 0.80 2.08
Ec inhib. 2 4.57 6.60 4.31 7.25 7.42 8.69 9.47
Ec Z-score 2 1.37 1.02 1.41 0.90 0.87 0.65 0.52
Kp inhib. 1 14.06 12.26 11.07 10.53 13.63 16.20 17.26
Kp Z-score 1 0.18 0.38 0.51 0.56 0.23 –0.04 –0.15
Kp inhib. 2 8.00 6.68 9.74 8.88 7.53 13.79 8.44
Kp Z-score 2 0.11 0.28 –0.11 0.00 0.17 –0.63 0.05
Pa inhib. 1 1.28 9.78 4.26 8.47 6.83 8.78 4.73
Pa Z-score 1 1.49 0.24 1.05 0.43 0.67 0.39 0.98
Pa inhib. 2 9.88 6.85 7.35 7.17 5.46 13.90 0.72
Pa Z-score 2 –0.66 –0.21 –0.28 –0.25 0.00 –1.26 0.70
Ab inhib. 1 5.07 13.45 3.25 4.03 11.02 6.61 –0.99
Ab Z-score 1 0.72 –0.62 1.02 0.89 –0.23 0.47 1.70
Ab inhib. 2 1.69 8.94 4.75 –0.43 15.36 6.59 0.51
Ab Z-score 2 0.91 –0.43 0.34 1.31 –1.63 0.00 1.13
Ca inhib. 1 14.01 4.56 15.35 7.12 14.78 6.67 2.90
Ca Z-score 1 –1.22 0.04 –1.40 –0.30 –1.33 –0.24 0.26
Ca inhib. 2 12.44 6.99 15.28 10.35 2.31 4.77 4.14
Ca Z-score 2 –1.11 –0.21 –1.57 –0.76 0.54 0.14 0.24
Cn inhib. 1 –48.81 –37.46 –59.63 –45.11 –51.71 –60.42 –33.77
Cn Z-score 1 0.27 0.02 0.51 0.18 0.33 0.52 –0.06
Cn inhib. 2a – – – – – – –
Cn Z-score 2a – – – – – – –
a For Cn sample 2: quality test not passed.
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Figure D.1 Section of the H,H-NOESY spectrum of 36 at 400.2MHz in acetone-D6.
Significant signals are labeled, and dashed arrows indicate NOE contacts
between the axial H -1/H -3 and the alkene H -7. The shown spectrum is
symmetrized.
Appendix D. Selected 2D NMR Spectra 305
(acetone-D6,
α/β   6.7:1)
H-9-H-8 H-8-H-7
H-7-H-3
OH OH OH
H-9
H-8H-7
H-3
α-48
OBnO
BnO
OBn
OBn
OHO
HO
OH
side chain: α-D-ribo
78
9
5.0 4.5 4.0 3.5
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
~
~
Figure D.2 Section of the H,H-NOESY spectrum of α,β-48 (α/β≈ 6.7:1) at 400.2MHz in
acetone-D6. Significant signals of the α-isomer are labeled, and dashed arrows
refer to NOE contacts between the side chain H -7/H -8/H -9 and the axial
carbohydrate H -3. The shown spectrum is symmetrized.
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Figure D.3 Top: combined C,H-HSQC (red) and C,H-HMBC (blue) spectrum of syn-50
at 700.3MHz/176.1MHz in D2O. Significant signals of both isomers syn-50-A
and syn-50-B are labeled. Dashed arrows refer to key couplings indicating the
C -1–O-5 ring closure. Bottom: H,H-NOESY spectrum of syn-50 at 700.3MHz
in D2O. Dashed arrows refer to correlations indicating spatial proximity in a
syn-relationship in the respective isomer. The shown spectrum is symmetrized.
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Figure D.4 Section of the H,H-NOESY spectrum of α,β-51 (α/β≈ 1.4:1) at 600.1MHz in
acetone-D6. Significant signals are labeled, and dashed arrows refer to NOE
contacts between the side chain H -9(β) and H -8(β), and between H -9(α) and
OH -8(α). The shown spectrum is symmetrized.
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Figure D.5 Top: combined C,H-HSQC (red) and C,H-HMBC (blue) spectrum of syn-
52 at 700.3MHz/176.1MHz in D2O. Significant signals of isomer syn-52-A
are labeled. Dashed arrows refer to key couplings indicating the C -1–O-5
ring closure. Bottom: H,H-NOESY spectrum of syn-52 at 700.3MHz in
D2O. Dashed arrows refer to correlations indicating spatial proximity in a
syn-relationship in the respective isomer. The shown spectrum is symmetrized.
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Figure D.6 Section of the H,H-NOESY spectrum of α,β-68 (α/β≈ 1:1) at 600.1MHz in
acetone-D6. Significant signals are labeled, and dashed arrows refer to NOE
contacts between the side chain H -7 and the carbohydrate H -1. The shown
spectrum is symmetrized.
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Figure D.7 Top: combined C,H-HSQC (red) and C,H-HMBC (blue) spectrum of anti-70
at 700.3MHz/176.1MHz in D2O. Significant signals of isomers anti-70-A
and anti-70-B are labeled. Dashed arrows refer to key couplings indicating
the C -1–O-4 and C -9–O-7 ring closures. Bottom: H,H-NOESY spectrum of
anti-70 at 700.3MHz in D2O. Dashed arrows refer to correlations indicating
spatial proximity in a syn-relationship in the respective isomer. The shown
spectrum is symmetrized.
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Figure D.8 Section of the H,H-NOESY spectrum of (±)-75 at 600.1MHz in acetone-
D6. Significant signals are labeled, and dashed arrows refer to NOE contacts
between the H -5 and the C -4-OH. The shown spectrum is unprocessed.
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Figure D.9 Section of the H,H-NOESY spectrum of (±)-76 at 600.1MHz in acetone-
D6. Significant signals are labeled, and dashed arrows refer to NOE contacts
between the C -4-OH and the CH3, and between the H -5 and the PhCH2OCH 2,
respectively. The shown spectrum is unprocessed.
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
0.860.991.012.011.011.002.032.032.021.011.011.001.012.0213.93
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0.760.981.011.022.022.760.850.991.031.001.960.991.011.9714.38
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
1.003.970.981.0211.141.040.970.980.9530.29
3.53
3.57
3.66
3.69
3.76
4.34
4.444.48
4.55
4.74
4.82
5.66
5.69
5.72
5.77
6.18
6.20
7.16
7.24
7.36
7
89
23
(DMSO-D6)
OBnO
BnO
OBn
OBn
OH
BnO
BnO
7
89
23
(DMSO-D6)
OBnO
BnO
OBn
OBn
OH
BnO
BnO
180 160 140 120 100 80 60 40 20 0
66.3
67.5
69.1
70.2
72.374.1
74.5
74.9
75.6
78.7
84.3
97.5
100.7
127.2
127.4
127.7
128.1
128.2
129.8
133.2
137.7
138.4
138.4
138.5
Appendix E. NMR Spectra 333
7
8
9
24
(CDCl3)
OBnO
BnO
OBn
OBn
OAc
BnO
OBn
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
2.991.004.002.071.104.334.111.020.990.982.0829.96
2.18
3.47
3.52
3.68
3.78
4.46
4.50
4.55
4.58
4.63
4.66
4.74
4.774.85
4.95
4.98
5.29
5.31
5.53
7.12
7.14
7.22
7.42
180 160 140 120 100 80 60 40 20 0
22.267.6
67.6
69.2
71.2
73.6
74.775.2
75.4
75.7
84.4
86.1
91.0
100.6
127.7
128.7
136.7
137.6
137.6
138.0
138.2
138.3
168.3
7
8
9
24
(CDCl3)
OBnO
BnO
OBn
OBn
OAc
BnO
OBn
82.2
334 Appendix E. NMR Spectra
25
(CDCl3)
7
89
OBnO
BnO
OBn
OBn
OAc
BnO
BnO
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
2.951.094.075.083.043.180.990.971.001.000.9932.05
1.83
3.75
3.79
3.82
3.85
3.86
3.89
3.94
4.38
4.404.42
4.46
4.50
4.56
4.64
4.88
5.275.68
5.74
5.79
6.19
6.22
7.19
7.33
25
(CDCl3)
7
89
OBnO
BnO
OBn
OBn
OAc
BnO
BnO
180 160 140 120 100 80 60 40 20 0
22.2
65.2
66.8
70.6
71.1
72.3
73.3
74.8
74.9
75.1
79.7
80.2
95.8
99.8127.1
127.5
127.9
128.2
128.5
133.1
137.8
138.1
138.2
138.4
138.5
169.4
Appendix E. NMR Spectra 335
7
8
9
26
(CDCl3)
OBnO
BnO
OBn
OBn
OH
MeO
OMe
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
0.686.001.044.054.212.051.021.021.031.002.0218.39
3.03
3.36
3.46
3.50
3.68
3.75
3.85
4.52
4.54
4.61
4.65
4.69
4.754.83
4.92
5.02
5.09
5.18
7.16
7.19
7.30
7.39
7.45
7
8
9
26
(CDCl3)
OBnO
BnO
OBn
OBn
OH
MeO
OMe
180 160 140 120 100 80 60 40 20 0
52.6
52.8
69.1
70.9
71.7
73.6
75.0
75.2
75.4
76.1
84.9
85.4
93.1
99.9127.7
128.4
136.8
137.9
138.1
138.3
80.5
336 Appendix E. NMR Spectra
7
89
27
(DMSO-D6)
OBnO
BnO
OBn
OBn
OH
MeO
MeO
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
6.070.970.991.304.961.029.861.450.160.161.031.020.992.5922.81
3.14
3.26
3.35
3.51
3.56
3.62
3.75
4.26
4.49
4.59
4.67
4.72
4.83
5.25
5.515.58
5.63
5.697.17
7.19
7.297.37
7
89
27
(DMSO-D6)
OBnO
BnO
OBn
OBn
OH
MeO
MeO
200 180 160 140 120 100 80 60 40 20 0
51.652.0
52.1
52.8
69.0
70.0
70.8
72.3
74.1
74.5
74.875.6
78.4
84.1
92.5
99.0
100.7
127.4
128.2
129.8
133.2
137.6
137.7
138.3
138.4
138.5
Appendix E. NMR Spectra 337
7
8
9
28
(CDCl3)
OBnO
BnO
OBn
OBn
OH
O
O
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
2.280.961.016.192.024.112.061.021.011.000.992.1314.144.06
1.74
3.07
3.46
3.50
3.70
3.85
4.15
4.53
4.564.584.68
4.77
4.84
4.92
5.03
5.12
5.46
7.17
7.20
7.31
7.40
7.43
7.47
4.21
180 160 140 120 100 80 60 40 20 0
25.764.6
69.1
70.9
71.7
73.6
75.0
75.2
75.4
76.1
85.185.4
90.299.9
127.7
128.4
128.5
136.9
137.9
138.1
138.3
80.6
7
8
9
28
(CDCl3)
OBnO
BnO
OBn
OBn
OH
O
O
338 Appendix E. NMR Spectra
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